{"BGC0000186.1|Thailandamide_1 # 1 # 3513 # -1 # ID=1_1;partial=00;start_type=ATG;rbs_motif=GGAG;rbs_spacer=6bp;gc_cont=0.735": {"gnl|BL_ORD_ID|1130|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 1, "orf_end": 3513, "orf_from": "BGC0000186.1|Thailandamide_1 ", "model_name": "mel", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "800", "model_id": "1231", "ARO_accession": "3000616", "ARO_name": "mel", "ARO_category": {"41695": {"category_aro_accession": "3004471", "category_aro_cvterm_id": "41695", "category_aro_name": "msr-type ABC-F protein", "category_aro_description": "msr-type ABC-F subfamily ribosomal protection proteins expression in Staphylococci species and confer resistance to erythromycin and streptogramin B antibiotics through antibiotic target protection mechanisms.", "category_aro_class_name": "AMR Gene Family"}, "35925": {"category_aro_accession": "0000006", "category_aro_cvterm_id": "35925", "category_aro_name": "erythromycin", "category_aro_description": "Erythromycin is a macrolide antibiotic with a 14-carbon ring that has an antimicrobial spectrum similar to or slightly wider than that of penicillin, and is often used for people that have an allergy to penicillins. Erythromycin may possess bacteriocidal activity, particularly at higher concentrations by binding to the 50S subunit of the bacterial 70S rRNA complex, inhibiting peptidyl-tRNA translocation. Thus, protein synthesis and subsequently structure/function processes critical for life or replication are inhibited.", "category_aro_class_name": "Antibiotic"}, "35974": {"category_aro_accession": "0000057", "category_aro_cvterm_id": "35974", "category_aro_name": "telithromycin", "category_aro_description": "Telithromycin is a semi-synthetic derivative of erythromycin. It is a 14-membered macrolide and is the first ketolide antibiotic to be used in clinics. Telithromycin binds the 50S subunit of the bacterial ribosome to inhibit protein synthesis.", "category_aro_class_name": "Antibiotic"}, "35919": {"category_aro_accession": "0000000", "category_aro_cvterm_id": "35919", "category_aro_name": "macrolide antibiotic", "category_aro_description": "Macrolides are a group of drugs (typically antibiotics) that have a large macrocyclic lactone ring of 12-16 carbons to which one or more deoxy sugars, usually cladinose and desosamine, may be attached. Macrolides bind to the 50S-subunit of bacterial ribosomes, inhibiting the synthesis of vital proteins.", "category_aro_class_name": "Drug Class"}, "35945": {"category_aro_accession": "0000026", "category_aro_cvterm_id": "35945", "category_aro_name": "streptogramin antibiotic", "category_aro_description": "Streptogramin antibiotics are natural products produced by various members of the Streptomyces genus. These antibiotics bind to the P site of the 50S subunit of bacterial ribosomes to inhibit protein synthesis. The family consists of two subgroups, type A and type B, which are simultaneously produced by the same bacterial species in a ratio of roughly 70:30.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 8.92107, "max_identities": 32, "bit_score": 27.335, "cvterm_id": "36764", "query": "RADAMIAADLVVASAGEALEMI-----RPGHTRIVANLHEAQTGAMLRDP--DASVDVDAIDALLRACAGASRVASVDAHARVQAIGGALYGNMFLLGYAWQLGLVPVSLGALERAIDMLGADAPS", "match": "R   MI ADL++A+AG  L ++      P    ++  L     G     P  +A   +   +  L  CAG S+     ++    A+   LY         W+L  +         AID+LGA   S", "sequence_from_db": "RKKIMIGADLIIAAAGSVLTIVAFYMELPVWMVMIV-LFIRSIGTAFHTPALNAVTPLLVPEEQLTKCAGYSQSLQSISYIVSPAVAALLYS-------VWELNAI--------IAIDVLGAVIAS", "sequence_from_broadstreet": "MEKYNNWKLKFYTIWAGQAVSLITSAILQMAIIFYLTEKTGSAMVLSMASLLGFLPYAVFGPAIGVLVDRHDRKKIMIGADLIIAAAGSVLTIVAFYMELPVWMVMIVLFIRSIGTAFHTPALNAVTPLLVPEEQLTKCAGYSQSLQSISYIVSPAVAALLYSVWELNAIIAIDVLGAVIASITVAIVRIPKLGDRVQSLDPNFIREMQEGMAVLRQNKGLFALLLVGTLYMFVYMPINALFPLISMDYFNGTPVHISITEISFASGMLIGGLLLGLFGNYQKRILLITASIFMMGISLTISGLLPQSGFFIFVVCCAIMGLSVPFYSGVQTALFQEKIKPEYLGRVFSLTGSIMSLAMPIGLILSALFADRIGVNHWFLLSGTLIICIAIVCPMINEIRKLDLK", "dna_sequence_from_broadstreet": "ATGGAAAAATACAACAATTGGAAACTTAAGTTTTATACAATATGGGCAGGGCAAGCAGTATCATTAATCACTAGTGCCATCTTGCAAATGGCGATTATTTTTTACCTTACAGAAAAAACTGGATCCGCGATGGTCTTGTCTATGGCTTCACTATTAGGTTTTTTACCCTATGCGGTCTTTGGACCTGCAATTGGTGTGCTAGTGGATCGTCATGATAGGAAGAAGATAATGATTGGTGCTGATTTAATTATCGCAGCAGCTGGTTCGGTGCTTACTATTGTTGCATTCTATATGGAGCTACCTGTCTGGATGGTTATGATAGTATTGTTTATCCGTAGCATTGGAACAGCTTTTCACACCCCGGCTCTCAATGCGGTTACGCCACTTTTAGTACCAGAAGAACAGCTTACGAAATGTGCAGGCTATAGTCAGTCTTTGCAGTCTATAAGCTATATTGTTAGTCCGGCGGTTGCAGCACTCTTATACTCCGTTTGGGAACTAAATGCTATTATTGCCATCGATGTATTGGGTGCTGTGATTGCATCTATTACGGTAGCAATTGTACGTATTCCTAAGCTGGGTGATCGCGTGCAAAGTTTGGACCCAAATTTCATAAGAGAAATGCAAGAAGGAATGGCTGTACTACGGCAAAATAAAGGATTATTTGCTTTATTACTCGTTGGAACATTATATATGTTTGTTTATATGCCAATTAATGCACTATTCCCTTTAATTAGCATGGATTACTTTAATGGAACACCTGTGCATATTTCTATTACGGAAATTTCCTTTGCATCTGGAATGTTGATAGGGGGTCTATTATTAGGGTTATTTGGGAATTACCAAAAGCGAATCTTATTAATAACGGCATCCATTTTTATGATGGGGATAAGCTTAACCATTTCAGGATTACTTCCCCAAAGTGGATTTTTCATTTTTGTAGTCTGCTGTGCAATAATGGGGCTTTCTGTTCCGTTTTACAGCGGTGTGCAAACAGCTCTTTTTCAGGAGAAAATTAAGCCTGAATATTTAGGACGTGTATTTTCTTTAACTGGAAGTATCATGTCTCTTGCTATGCCAATTGGATTAATTCTTTCTGCACTCTTTGCTGATAGAATCGGTGTAAATCATTGGTTTTTACTATCAGGTACTTTAATTATTTGCATTGCAATAGTTTGCCCAATGATAAATGAGATTAGAAAATTAGATTTAAAATAA", "partial": "0", "query_start": 2362, "query_end": 2718, "hit_start": 216, "hit_end": 546, "orf_dna_sequence": "ATGATCGATCGCGACTATGCGCAGTTCTCGCGCTACACGCGCGGCATCAGTGAGCCGCGTGGGCCGATCCTGCTGTCCGGCACGCAGGCGCTCGTGCGGATGCTGCTCGCGCAGGCGCAGGCCGACCGCCGCGCGGGGCGCGACACCGCGGGCTTCGTGAGCGGCTACCGAGGCTCGCCGCTCGGCTCGGTCGACCTCGAGATGTGGCGCGCCGCGAAGCTGCTCGATGCGGCGAACGTGCGCTTTCATCCGGCCGTCAACGAGGAGCTCGCCGCGACCGCGGTGCTCGGCTCGCAGAAGGTCGAGACCGATCCGACGCGCGCGCGCGACGGCGTGTTCGCGATGTGGTACGGCAAGGGGCCGGGCGTCGACCGCTCGGGTGACGCGCTGCGGCACGGCAATGCGTACGGCGCGTCGCCGACGGGCGGGGTGCTCGTCGTTGCGGGCGACGATCACGGCTGCGCGTCGTCGTCGATGTCGCATCAGTCGGATCTCGCGCTGATCGCGTGGGGCCTGCCCGTCGTGCATCCGGCAAGCATCGCCGACTACGTCGAGTTCGGGCTCTGGGGTTGGGCGCTGTCGCGCTTCTGCGGCCTTTGGGTCGGCTTCAAGGCGGTGACCGAAACGGTCGAGACGGTGCGCACGCTCGACGACGACGCCGGCCGCGCATGGAGCGACGCGCTCGTGCTGCCGCCCGTCGACGCGGGCCCGGACGGCCTGCACTGGCGCTGGCCCGACCTGCCCGGGCCGCAGATCGAGCGGCGGCTCGAATACAAGGCGCGCGCGGCCGCCGCGTTCGCCGCCGCGAATCCGCTCGAGCGCCTCGCCGCGCCGTGCGCTTCGCCGAAGTGCCTGATCGCGGCGGTCGGCAAGGCCTACCTCGACGTGCTCGAGGCGCTGCGCATCGGCGGGCTCACGCCCGACGCGCTCGCGCGCGCGGGCGTCGCGCTGATGAAGGTCGGGCTCGTGTCGCCGCTGTCGCCCGCGCTCGCGGCCCTCGCCGCGCGCGTCGACGAGGTGTTCGTCGTCGAGGAAAAGGCGGCGGTGGTCGAGCCGCTGCTCAAGGCGCATCTGTACGGCGCCGCGCACGCGCGCCCGCGAATCGTGGGCAAGCACGACGAGGCGGGGCGGCCGCTGTTGCCGAGCGCGACCGAGCTGCGGCCGTCCCGGCTCGCCGCCGCGCTCGCGTCGCGGCTCGGGCGGTACGGGCTCGCACTGCGCGAGCCCGATCACGCGCGCTCGCCTTCGGTGCCGCCGCTCGCGTTGCCCAAGCGCAAGCCGTTCTTCTGCGCGGGCTGCCCGCACAATGCGTCGACGCGCGTGCCCGACGGCAGCCGCGCGCAGCTCGGCATCGGCTGCCACGCGCTCGCCGCGCAGATGCCGGAGCGCAACACGAGCGGCAGCGTGCAGATGGGCGGCGAGGGCGTCGACTGGATCGGCCAGTCGCCGTTCGTGCGCGAGCCGCACATCTTCCAGAATCTCGGCGACGGCACGCTGTTCCATTCCGGGCATCTCGCGGTGCGGCAGGCCGTGGCGGCGGGCGTCAACGTCACGTACAAGATCCTCTACAACGACGCCGTCGCGATGACGGGCGGGCAGCCGATCGACGGCCGCCTCACCGTCGCGCAGATCACGCGGCTGATGCAGGCGGAGGGCGTGCGGCGCATCGTCGTCGTGACGCCGGAGCCGGCCGCCTATCGAACCGACGGTTTCGCCGACGGCGTCGGCGTCGAGCCGCGCGAGCGCCTCGACGCGGTGCAGCGCGAGCTGCGCGACGCGCGCGGCGTGTCGGTGCTGATCTACGACCAGGTCTGCGCGACCGAGGAGCGCCGCCGCAGGAAGAAGGCGGGCGCGGCGGCGGCCGCGCGCGCGCGGCCGAAGGTCTTCATCAACGAAAGCGTCTGCGAGGGGTGCGGCGACTGCCAGCGGCAGTCGAACTGCCTCGCGGTCGTGCCTGTCGACACCGAGTTCGGCCGCAAGCGCCAGATCGACCAGCAGGCGTGCAACAGCGATCTGTCGTGCCTGGCGGGCTTCTGCCCGAGCTTCGTGACGATCGACGGCGCAAGCGGCGCGCCGTCGCGGGATCGCGCCCGCGCCGACGCGGCGCTCGCGCGCGTCGCGCAACTGCCGCTGCCCGAGACCGCGCTCGGCGACGCGCCGTACGAGCTCGCGATCTGCGGCATCGGCGGGACGGGCGTCGTGACGGTCGCGGGCGTCGTCGCGCTCGCCGCGCACCTCGAAGGCAACGTGGCGAGCACGCTGAACTTCTCCGGCTTCGCGCAGAAGGGCGGCGCGGTGCTGAGCCATTTGCGCATCGCGAGGCCTTCGGCGGCGCTGCACCAGGCGCGCATCGACACGGGCCGCGCCGATGCGATGATCGCCGCGGATCTCGTCGTCGCGAGCGCGGGCGAGGCGCTGGAGATGATCCGCCCGGGGCATACGCGGATCGTCGCCAACCTGCACGAGGCGCAGACGGGCGCGATGCTGCGGGACCCGGATGCGAGCGTCGACGTCGATGCGATCGACGCGCTGCTGCGCGCGTGCGCCGGCGCGTCGCGCGTCGCGTCCGTCGATGCGCACGCGCGCGTGCAGGCGATCGGCGGCGCGCTCTACGGCAACATGTTCCTGCTCGGTTACGCGTGGCAACTCGGACTCGTTCCGGTGTCGCTCGGCGCGCTCGAGCGGGCGATCGACATGCTGGGAGCCGATGCACCGTCGAACCGCCGGGCGTTCTCGTACGGCCGGCTCGAGGCCGCCGGCGGCGCGCACGGCGCCGAAGGCGACGGCGGAGAGGACGGCGCGCGCGGGCGGCAGGCGTCGCCGAGCGTCGACGATCGCGTCGAATCGCGCGCCGCGTACCTGGCCGCGTACCAGGACGCGCGCTATGCGAGCCGATACCGGGCGCGCGTGGACGCGGCGCGCGCGGCGGGCGAGCGGATCGGCGACGCGCGGCTCGCGGACGCGGTGGCCGTCAACCTGTTCCGGCTGATGGCCTGCAAGGACGAGTACGAAGTCGCGCGGCTGCACACGGAGCCCGCGTTCCTTGACCGGATCGCGGCCGAGTTCGGGCCCGGCGCGCGCGTGAGCTTTCACTTGCGTGCGCCGCTCGCCGGCTGGCTGTCGCGCGAGCGCGGCGCGCAGCGTGCGATCCGCGTGGGCGCGGGGATGCTGCCGGCGCTGCGGATGCTCGCTTGGCTGCGGCGTCTGCGCGGCACGCCTTTCGACGTGTTCGGCTATCTGCCGCATCGCCGGGCCGAGCGCCGGCTGATCGCCGAATACGACGCGCTGCTCGACGAAGTGCTGCCGAGCGTGACGGCGGCGACGGCCGACATTGCGCTCATGCTGCTCGACTTGCCGCAGACGATTCGCGGGTACGGCGAGATCAAGCGGCGTTCGATTGCCGAGGCCGCGCTGAAGCGGCGGGAATGGCTCGCGCGGTACAGAGGCGCGCGCACCGGGCGGGCGAAGTTCGTGCCGATCGTGTTCGAGCGCGGGCAGCGGGAATCGGCGTGA", "orf_prot_sequence": "MIDRDYAQFSRYTRGISEPRGPILLSGTQALVRMLLAQAQADRRAGRDTAGFVSGYRGSPLGSVDLEMWRAAKLLDAANVRFHPAVNEELAATAVLGSQKVETDPTRARDGVFAMWYGKGPGVDRSGDALRHGNAYGASPTGGVLVVAGDDHGCASSSMSHQSDLALIAWGLPVVHPASIADYVEFGLWGWALSRFCGLWVGFKAVTETVETVRTLDDDAGRAWSDALVLPPVDAGPDGLHWRWPDLPGPQIERRLEYKARAAAAFAAANPLERLAAPCASPKCLIAAVGKAYLDVLEALRIGGLTPDALARAGVALMKVGLVSPLSPALAALAARVDEVFVVEEKAAVVEPLLKAHLYGAAHARPRIVGKHDEAGRPLLPSATELRPSRLAAALASRLGRYGLALREPDHARSPSVPPLALPKRKPFFCAGCPHNASTRVPDGSRAQLGIGCHALAAQMPERNTSGSVQMGGEGVDWIGQSPFVREPHIFQNLGDGTLFHSGHLAVRQAVAAGVNVTYKILYNDAVAMTGGQPIDGRLTVAQITRLMQAEGVRRIVVVTPEPAAYRTDGFADGVGVEPRERLDAVQRELRDARGVSVLIYDQVCATEERRRRKKAGAAAAARARPKVFINESVCEGCGDCQRQSNCLAVVPVDTEFGRKRQIDQQACNSDLSCLAGFCPSFVTIDGASGAPSRDRARADAALARVAQLPLPETALGDAPYELAICGIGGTGVVTVAGVVALAAHLEGNVASTLNFSGFAQKGGAVLSHLRIARPSAALHQARIDTGRADAMIAADLVVASAGEALEMIRPGHTRIVANLHEAQTGAMLRDPDASVDVDAIDALLRACAGASRVASVDAHARVQAIGGALYGNMFLLGYAWQLGLVPVSLGALERAIDMLGADAPSNRRAFSYGRLEAAGGAHGAEGDGGEDGARGRQASPSVDDRVESRAAYLAAYQDARYASRYRARVDAARAAGERIGDARLADAVAVNLFRLMACKDEYEVARLHTEPAFLDRIAAEFGPGARVSFHLRAPLAGWLSRERGAQRAIRVGAGMLPALRMLAWLRRLRGTPFDVFGYLPHRRAERRLIAEYDALLDEVLPSVTAATADIALMLLDLPQTIRGYGEIKRRSIAEAALKRREWLARYRGARTGRAKFVPIVFERGQRESA", "perc_identity": 25.4}}, "BGC0000186.1|Thailandamide_2 # 3510 # 9662 # -1 # ID=1_2;partial=00;start_type=ATG;rbs_motif=GGA;rbs_spacer=6bp;gc_cont=0.731": {"gnl|BL_ORD_ID|4956|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 3510, "orf_end": 9662, "orf_from": "BGC0000186.1|Thailandamide_2 ", "model_name": "EstT", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "600", "model_id": "5948", "ARO_accession": "3007459", "ARO_name": "EstT", "ARO_category": {"36459": {"category_aro_accession": "3000320", "category_aro_cvterm_id": "36459", "category_aro_name": "macrolide esterase", "category_aro_description": "Hydrolytic enzymes that cleave the macrocycle lactone ring of macrolide antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35949": {"category_aro_accession": "0000030", "category_aro_cvterm_id": "35949", "category_aro_name": "tigecycline", "category_aro_description": "Tigecycline is an glycylcycline antibiotic. It works by inhibiting action of the prokaryotic 30S ribosome.", "category_aro_class_name": "Antibiotic"}, "35919": {"category_aro_accession": "0000000", "category_aro_cvterm_id": "35919", "category_aro_name": "macrolide antibiotic", "category_aro_description": "Macrolides are a group of drugs (typically antibiotics) that have a large macrocyclic lactone ring of 12-16 carbons to which one or more deoxy sugars, usually cladinose and desosamine, may be attached. Macrolides bind to the 50S-subunit of bacterial ribosomes, inhibiting the synthesis of vital proteins.", "category_aro_class_name": "Drug Class"}, "35960": {"category_aro_accession": "0000042", "category_aro_cvterm_id": "35960", "category_aro_name": "glycylcycline", "category_aro_description": "Glycylcyclines are a new class of antibiotics derived from tetracycline. These tetracycline analogues are specifically designed to overcome two common mechanisms of tetracycline resistance. Presently, there is only one glycylcycline antibiotic for clinical use: tigecycline. It works by inhibiting action of the prokaryotic 30S ribosome, preventing the binding of aminoacyl-tRNA.", "category_aro_class_name": "Drug Class"}, "36189": {"category_aro_accession": "3000050", "category_aro_cvterm_id": "36189", "category_aro_name": "tetracycline antibiotic", "category_aro_description": "These antibiotics are derived from tetracycline, a polyketide antibiotic that inhibits the 30S subunit of bacterial ribosomes.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 7.13648, "max_identities": 14, "bit_score": 28.1054, "cvterm_id": "46223", "query": "QLPSLRMPTLVVAGTADHFGDPAHAEQLVSLIPNARLARIAGAGH", "match": "+L  ++ PTL++ GT D      +A  L+  I  + L  + G GH", "sequence_from_db": "RLNEIKQPTLIIHGTDDKIWHYKNAGFLLEKIKGSNLITLEGTGH", "sequence_from_broadstreet": "MKKKLLWILILGLIIISCKQRKTEMKEKIIKTNGIELCTESFGNKKNPAILLVAGATVSMLYWDTEFCQQLSEKGFFVIRYDNRDVGKSTNYEPGSTPYDIVDLTNDAISILDGYKIDKAHFVGISLGGLISQIASIKFADRVNSLTLMSSGPWGDSDPTIPEMDTSILDFHSKAGTVNWTNEDSVVNYLIQGAELMSGKKQFDKQRSEKLIRAEFNRANNYISMFNHAASQGGGGEEYWNRLNEIKQPTLIIHGTDDKIWHYKNAGFLLEKIKGSNLITLEGTGHELHVDDWKSIIDGIEKHIND", "dna_sequence_from_broadstreet": "ATGAAAAAAAAACTACTTTGGATATTAATTTTAGGACTGATAATAATCAGTTGCAAACAAAGGAAAACAGAAATGAAAGAGAAAATAATTAAAACAAACGGCATTGAACTCTGTACGGAAAGTTTTGGAAATAAGAAAAATCCAGCAATCCTTTTGGTAGCAGGTGCAACCGTATCAATGCTGTATTGGGACACTGAATTTTGCCAACAATTATCTGAAAAAGGATTTTTTGTTATTCGTTACGACAACAGAGATGTAGGAAAATCCACTAATTATGAACCAGGTTCTACTCCATACGATATTGTTGACTTAACTAATGACGCTATTTCAATATTGGATGGCTACAAGATTGACAAAGCACATTTTGTGGGGATTTCTTTGGGCGGACTAATTTCTCAAATAGCATCAATAAAGTTTGCCGACAGAGTTAACTCCTTAACTCTTATGTCATCAGGCCCTTGGGGAGACTCAGACCCAACTATACCTGAAATGGACACGAGTATTTTAGATTTCCATAGTAAAGCAGGTACAGTCAATTGGACAAATGAAGACAGTGTGGTAAACTATTTAATTCAGGGTGCAGAATTAATGAGTGGCAAGAAACAATTTGACAAACAAAGAAGTGAAAAACTGATAAGAGCTGAGTTCAATAGAGCCAACAATTATATAAGTATGTTCAATCACGCTGCATCGCAAGGTGGTGGTGGTGAAGAATATTGGAACAGATTAAACGAAATCAAACAACCCACCTTAATTATCCACGGAACAGACGACAAAATTTGGCATTATAAGAATGCAGGTTTTTTACTAGAAAAAATAAAAGGTTCAAATCTAATCACCCTTGAAGGTACAGGACACGAATTACACGTTGATGATTGGAAATCAATAATTGATGGAATAGAAAAACACATAAATGACTGA", "partial": "0", "query_start": 9327, "query_end": 9461, "hit_start": 723, "hit_end": 858, "orf_dna_sequence": "ATGAACGTGCAAGAAAGCATTTTCCCGATCACGCCGAACGGCTTCGCCGGGCACTCGATGGACGATCTGATGCAGCGCTGGCTGCTCGCGCAGTTGCAGGCGACGGGCATCCTCGCCGACGGCCGCGCGCACGCATTCGACGCGCTCGCCGGCCGGGTGCAGCCGCTCTACCGCCGCTGGCTCGAGGAGAGCCTGCGCCTGCTGCGCGACGCGGGCCTCGTGCGCGACGACGCGCAAGGCTGGCGCGCGGCCGAGCGCGCGCCGATCGACGCGCGCGACGCGCAGCGCCACTGGGACGCGTCGCGCGACGCGTGGCTCGCCGACCGCGAACGCGCGGTCTACGTCGTGCTGATCGAAGCGGTGCTCGCGCAACTGCCGGCGATCCTCACGGGCCGCCGGCGCGCGACCGACGTGCTGTTTCCGAACGGCTCGATGGCGCGCGTGCAGGGCGTCTACACGGGCAACCACGTGTCCGACCACTTCAACCGCGTGCTTGTCGATCACGCGGTGCGCTACGTCGCCGGCTGCGCCGCGCGGCGTGCCGACGCGAAGCTGCGCTTCATCGAGGTGGGCGCGGGCACGGGCGGCACCACCGAGGGCCTGCTGGCGGCGCTCGCGCCGCACGCGCGGCACGTCGGCGAGTACTGCTTCACCGATATCTCGAAGGCGTTCCTGAATCACGCGCAACGCCGCTTCGGCGAAGGCGCGCCGTTCTTCGGCGCGCGCGTGCTCGACATCGAGCAGCCGATCGACGCGCAGGGCTTCGAGCCGGGCGCGTACGACGCGCTCGTCGCGACGAACGTGCTGCACGCGACGCGCGACATCCGCACGACGCTGCGCCACTGCAAGGCGCTCCTCAAGCACAACGGACTGCTCTTCATCAACGAGATGACGGGCAGCGTGCCGTACCTGCATCTGACGTTCGGCATGCTCGAAGGCTGGTGGCGCTTCACGGACGACGCGCTGCGCGTCGCGGGATGCCCGGCCGTCGCGCCGCAGACGTGGGACCGGGTGCTGCGCGAGGAGGGCTTCTCGTCCGTGATTTTTCCCGCGCGCGATGCGCACGGGCAGGGGCAGCAGATCGTCATCGCGCAGAACGACGCGCGGCGGGCGGGGAGCGCGCGCCGCGACGCGCGCGCGTCGAACGGCGACGCGCAACACGGCGCGCGCCATGAGGCGGCGCACGACGCGCAGCAAGACGCGAGCGGCGACACGCAAGCAGACGCGCACGACAGCGCGCACGACAGCGCACACGACAGCGCTCACGACAGCGCTCACGACAGCGCTCACGACAGCGCTCACGCCGCCGCCGCGCTGCGCCGCGAAGGCCGCGCGTATCTGCGCGCGCGCGCCGCGGAACTGCTCGGCATGCCGGCGGGCGCGATCGATCCGGACGAAGGGCTGCATGCATACGGGCTCGATTCGATTCTTGCGTCCCAGTTCGCCGCGCAGCTCGCCGAGGCGTTCGACGGATTCGACGGCGCGCTGCTGTTCGAGCACAAGACGATCAACGCGTTGCTCGACCATCTGCTCGCCGCGCATGCCGACGCGCTCGCGAGGCTCTTGCCGCCCGCGGGCGGCGCGCCCGCCCGCGGCGTCGGCGCGCGCGCGCAGGCAGCGCAAGCGTCAGGCGAGGGGCGCGCCGCGCCGCCGGCCGCGCCGCACGCCGACGCGCGGTCCGACACGCCGTCGAGCGCGCCGTCGAGCGCGCCGGCGCGGCCGGATCAGCCCGCACCGAGCGGGCCGCCCGCGCAACCCGCCCAACCCGCGCCGCGCGCCGACACGCCGCCGCCCGCCGCGAGCGCCGGGCATCGCGGCGAAGCGCGCGCGAGCGATACGCGATATGCGCCGCGCGCGCCGCATCCGGACGCCGCCGCGGAGCCGGTCGCGATCATCGGCATCAGCGGCCGCTATCCCGGCGCGTACGACGTGCCGGCGTTCTGGCGCAACCTCCTCGCGGGTGCGTGCGCGATCACGGAGGTGCCCGCCGAGCGCTGGGACTGGCGGGCGCATTACCGGGCCGATGCCGCCGAGGCGGCGCGCGAGGGCAAGAGCTACAGCAAGTGGGGCGGATTCGTCGACGACGTCGGCCGCTTCGATCCGGCGTTCTTCGGCATGACGCCGCAGGACGCGCAGCACACCGATCCGCAGGAGCTCCTGTTCCTCGAGATGTGCTGGCACGCGCTGCAGGACGCGGGGCAGACGCCCGCGCTGTTGCCGGGCGACGTGCGCCGCCGCGCGGGCGTGTTCGCCGCGATCACGAAGCACTACGCGTTTCCGCCGACGTCGTTCGCGTCGCTCGCGAATCGCGTGTCGCATGCGCTCGACTTCGGGGGCAAGAGCCTCGCGATCGATACGATGTGCTCGTCGTCGCTCGTCGCCGTGAACGAGGCATGGGAATACCTGCAGCGCGACGGGCGGCTCGCGGTCGTCGGCGGCGTCAATCTCTATCTCGATCCGCAGCAGTACGCACATCTGTCGCGCTTTCGCTTCGCGTCGAGCGGCCCGGTGTGCAAGGCGTTCGGCGAAGGCGGCGACGGGTTCGTGCCGGGCGAGGGCGCGGGCGCGATCGTGCTCAAGCGCCTGTCCGACGCCGAGCGCGACGGCGATCCGATCCACGCGGTGATCCGCGGCTGCGCGGTCAATCACAACGGCCGCTCGACGAGCTTCACCGCATCCGATCCCGCGCGCCAGGCCGACGTCGTGCGGGACGCGCTCACGCGCGCGGGCGTCGATCCGCGCACGATCGGCTATGTCGAGGCGGCGGCCAACGGCCACGCGATGGGCGATGCGATCGAGATGACGGGGCTCGGCAAGGTGTTCGCCGCGTGCGACGGCGTATCGGGTACGCGCGCGATCGGCTCCGTGAAGGCGAACATCGGGCACTGCGAGGCTGCATCGGGCATGTCGCAGTTGACGAAGGTCGTGATGGCGATGCGCGACGGCGTGCTCGCGCCGACGCTGCGCGACGGCACGCGCAACCCGAACATCGCGTTCGAGCGGCTGCCGTTCGAGGTTCAGGAGCAGGCCGCGCCGTGGCGGCGGCTGATCGTCGACGGCAGCGAGGTGCCGCGGCGCGCGGGCGTCACGAGCATCGGCGGCGGCGGCGTCAACGCGCACGTCGTGCTCGAGGAGTACGTGGCGCCGCCGCGCGCCGCGCGCCCTGGCGCGGGCACGGACGACGAAGTCCTGTTCGTGCTGTCCGCGCGCACGCGCGAGCAACTGGGCGCGTACGCCGAACGCTGGGCCGGCTACCTCGAGGCGCATCCCGACTGCGATGTCGACGCGATCGCGCATACCGTGCGCACGGCGCGCGAGCCGATGGCGCACCGGCTCGCCGTGCTCGCGCACGGACGCGGCGAGCTCGCGGCGCTGCTGCGGGGCTGGGCGGCGGGCGGCGCGGCGAGTGGCGCGGCAAGTGGCGCGGCGAGCGATCAGGTGTTCTACGGCGACGTGAAGCAGCATCGCGTGGTGCTCTCGGACGCGCTCGTGCAAGCGGCGCGGCGCGAGGGCGCGGCGAGCCTCGCGAAGCTCTGGGTGCTCGGCAACGCGCTTGGCGCGGCGCACGGCGCGGACGAACCCGCGCCGCGCCGAGTGGGCCTGCTGCCGCCGTACCCGTTCGAGCGGCGGCTCGTCTGGACGTCCGCGCACGCGCCCGGCACGCGGCATGCGAGCGCCGGGGAAGCCACGGAAGCGGCAGAAGCCGCGGAAGCCGCGGAAGCCGGCGCGGCAGCCGTGGCCGAAAGCGCCGAAGCCGGCGCGCCCGCCGCCGCCGGCGACGCCCGCCTGCAGCCGGCGCCCGCGAGCAACGCGGAGGCGTTCTACTCGCTCAGCACGCTGAACGCGTCGAAGGATTTTCAGGAGCAGTACCTGACGCTGTGCCCGTTCCCCGAGCGCATTCCGGGCTTCTCGATGACGCGCATGTTCATCGAGCCGCAGAAGTACCCGAACGAATTCGCGCTGATGCAGGCGCGCCAGATCGAAATGCGCCAGGTGCTGTTCGGTCGCGAGCATTTCGAGCGGATCTCACGCGTGCTCGACATCGGCTGCGGGATGGGCACCGATGTGATCCAGCTCGCGAAACGCTTCGCGCATCTGCGCACGACGGGCTACACGATCACGCGCGCGCAGGCCGAGCTGGGCGCCGGGCGCATCGCGCGCGAGGGCCTGCAAGGCCGCGCGGAGATCCGCCACGGCGACAGCGCGAAAGACCCGTTCCCGGGCAAATACGATCTCGTGATCGGCATCGAGGTGATCTGCCACATCCAGGACAAGCACGGCGTGTTCGGCAACATCGCGCGCTCGCTCGACGACGACGGGCACGTGCTGCTGATGGATTTCGTCGCGAACGGCCGCGGGCGCATCAGCTCGCCGGAGATCGATATCGACATCGGCACGCGGCAGGACTGGATCGACGTCGCGGCGGCGCACGGCCTCGTGGTCGACGAGGTGATCGACGTGTCGCCGCAGATCGCGAACTTCCTGCACGACCCCGAGCACGAGCGGAACATCGCCGCGCTGCCTGGCGTCGCGCAGGCGTCGTTCCGCAACTTCGCGAACACGTGCGTGTCGCTCGAGAAGGGCTGGGTCAGCTATTGCCTGCTGCGCCTGAGCAAGGCGAGCCGCTTGAGCGAGGCCGAGCGCCGGCGCCTGAACGCCGAGCGGTTCGGCGCGAGCGTCGCGTATCCGGACGCGCTGAAGGCGATGCACGCGCGCGGCCCCGCGCCGTATCCGCGCAGCCCGGACGCGCAACCGCCGGCCGCGCGCGCGCAGGCGGGCGTGGACGGGGGCGTCGAGGCGAGCGCGCCGGCTGGCGTGAAAGCGGACTCGAAAGCAGGCCCGAAATCGGAAGTGAAATCGGATGCGGCCGCTCGCGCGTCGCGCGCCGACATCGCCGCCAGCGTTGCCGCCAGCGTTGCCGCCAGCGTCGAGGATGCGTTCGAGGCGTCGCTCGGCCTGCGGCGCGCGGATCTCGAGCGCGCCGACGATCTGCGCGCGCTCGGCATCGGCTCGATCCAGGCGGTGATGCTCGCCGAGGCGATCAACGAGCGTCTCGACCTCGCGCTGCCGAGCCGCTTCGTGCTCGAGCACGCGACGTTCGGCGCGCTCGTGCGCGCGGTGGCTGAAGCCGTCGCGGGCGGGCGCGGCAGCTCGCGCGACGCGCCGGCGCGCGAGCTCGCCTATCTGTCGCTGCTCGAGCCGGGCGGCGCGATGACGGCCGAGCTGCTCGAGCTGCCGGGCGGCGCGCGCGCCGAGATCCTGCGCGGCGGACGCGGGCCGCGCGTCGTGCTGATTCCCGGGCTCGGGATGGCGGGCACTGTGTTTCGCGATCTGTGCCGCGCGTTGACGCGGCGCCACGAGGTGATCGTCTACCACTATCCGGGGCTCGGCCGCAGCGATCCCGTCGCGCCGATCGACGTCGACGCCGCCGCCGCTCATCTGTACCGCACGCTCGACGCATGCGGCGGCGACGGCGCGGCCGCGCTCCTCGGCTGGTCGTTCGGCGGCGTGATCGCGCAGCGCGCGGCGCTGATGCGGCCGCGCGCGTGGCGCGCGCTCGTCCTCGTCAACACGCTCGGCGCATACCGGCCGCTCGCGCCGCAATTCCTGACGCCGGGCGCGTCGCGTGACGGCGAACCGCGCGGCCTCGGCGGCCTCTACCAGACCGATCTCGATTTCGTGTTCGCCGGCGACGCGCCGCCGGCCGCGCTCGCGCGCAAGGACGCGTGCGCGGCGCTGATGCGCGACAGCCTCGCGCTCGACGCCGCGCAGGCGATCGATTATCTCGATGCGCTCGTGCGCTTCGACGCGACCGCGCAACTGCCGTCGCTGCGGATGCCGACGCTCGTCGTCGCCGGCACGGCCGATCACTTCGGCGATCCGGCGCACGCGGAGCAGCTCGTGTCGCTGATTCCGAACGCGCGGCTCGCGCGGATCGCGGGCGCGGGGCACGCGGTGTTCCTCACGCACGGCGAAGCGTTCGAGCCGGCGGTGCTCGCGTTTCTCGACGAGACGCTGCGCGCGGCCGAAGCGGGCGGCGCGGCGGAATCGGTTGAATCGGTTGAGGCGACCGAGGCGGCCGAGGCGGCCCGCTCGCCCGCCGTCGCGCGCCGGCGGGCGACCGACGACGCGCCGGTCGGGAGCGACGCATGA", "orf_prot_sequence": "MNVQESIFPITPNGFAGHSMDDLMQRWLLAQLQATGILADGRAHAFDALAGRVQPLYRRWLEESLRLLRDAGLVRDDAQGWRAAERAPIDARDAQRHWDASRDAWLADRERAVYVVLIEAVLAQLPAILTGRRRATDVLFPNGSMARVQGVYTGNHVSDHFNRVLVDHAVRYVAGCAARRADAKLRFIEVGAGTGGTTEGLLAALAPHARHVGEYCFTDISKAFLNHAQRRFGEGAPFFGARVLDIEQPIDAQGFEPGAYDALVATNVLHATRDIRTTLRHCKALLKHNGLLFINEMTGSVPYLHLTFGMLEGWWRFTDDALRVAGCPAVAPQTWDRVLREEGFSSVIFPARDAHGQGQQIVIAQNDARRAGSARRDARASNGDAQHGARHEAAHDAQQDASGDTQADAHDSAHDSAHDSAHDSAHDSAHDSAHAAAALRREGRAYLRARAAELLGMPAGAIDPDEGLHAYGLDSILASQFAAQLAEAFDGFDGALLFEHKTINALLDHLLAAHADALARLLPPAGGAPARGVGARAQAAQASGEGRAAPPAAPHADARSDTPSSAPSSAPARPDQPAPSGPPAQPAQPAPRADTPPPAASAGHRGEARASDTRYAPRAPHPDAAAEPVAIIGISGRYPGAYDVPAFWRNLLAGACAITEVPAERWDWRAHYRADAAEAAREGKSYSKWGGFVDDVGRFDPAFFGMTPQDAQHTDPQELLFLEMCWHALQDAGQTPALLPGDVRRRAGVFAAITKHYAFPPTSFASLANRVSHALDFGGKSLAIDTMCSSSLVAVNEAWEYLQRDGRLAVVGGVNLYLDPQQYAHLSRFRFASSGPVCKAFGEGGDGFVPGEGAGAIVLKRLSDAERDGDPIHAVIRGCAVNHNGRSTSFTASDPARQADVVRDALTRAGVDPRTIGYVEAAANGHAMGDAIEMTGLGKVFAACDGVSGTRAIGSVKANIGHCEAASGMSQLTKVVMAMRDGVLAPTLRDGTRNPNIAFERLPFEVQEQAAPWRRLIVDGSEVPRRAGVTSIGGGGVNAHVVLEEYVAPPRAARPGAGTDDEVLFVLSARTREQLGAYAERWAGYLEAHPDCDVDAIAHTVRTAREPMAHRLAVLAHGRGELAALLRGWAAGGAASGAASGAASDQVFYGDVKQHRVVLSDALVQAARREGAASLAKLWVLGNALGAAHGADEPAPRRVGLLPPYPFERRLVWTSAHAPGTRHASAGEATEAAEAAEAAEAGAAAVAESAEAGAPAAAGDARLQPAPASNAEAFYSLSTLNASKDFQEQYLTLCPFPERIPGFSMTRMFIEPQKYPNEFALMQARQIEMRQVLFGREHFERISRVLDIGCGMGTDVIQLAKRFAHLRTTGYTITRAQAELGAGRIAREGLQGRAEIRHGDSAKDPFPGKYDLVIGIEVICHIQDKHGVFGNIARSLDDDGHVLLMDFVANGRGRISSPEIDIDIGTRQDWIDVAAAHGLVVDEVIDVSPQIANFLHDPEHERNIAALPGVAQASFRNFANTCVSLEKGWVSYCLLRLSKASRLSEAERRRLNAERFGASVAYPDALKAMHARGPAPYPRSPDAQPPAARAQAGVDGGVEASAPAGVKADSKAGPKSEVKSDAAARASRADIAASVAASVAASVEDAFEASLGLRRADLERADDLRALGIGSIQAVMLAEAINERLDLALPSRFVLEHATFGALVRAVAEAVAGGRGSSRDAPARELAYLSLLEPGGAMTAELLELPGGARAEILRGGRGPRVVLIPGLGMAGTVFRDLCRALTRRHEVIVYHYPGLGRSDPVAPIDVDAAAAHLYRTLDACGGDGAAALLGWSFGGVIAQRAALMRPRAWRALVLVNTLGAYRPLAPQFLTPGASRDGEPRGLGGLYQTDLDFVFAGDAPPAALARKDACAALMRDSLALDAAQAIDYLDALVRFDATAQLPSLRMPTLVVAGTADHFGDPAHAEQLVSLIPNARLARIAGAGHAVFLTHGEAFEPAVLAFLDETLRAAEAGGAAESVESVEATEAAEAARSPAVARRRATDDAPVGSDA", "perc_identity": 31.11}, "gnl|BL_ORD_ID|1287|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 3510, "orf_end": 9662, "orf_from": "BGC0000186.1|Thailandamide_2 ", "model_name": "armA", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "450", "model_id": "1405", "ARO_accession": "3000858", "ARO_name": "armA", "ARO_category": {"41435": {"category_aro_accession": "3004271", "category_aro_cvterm_id": "41435", "category_aro_name": "16S rRNA methyltransferase (G1405)", "category_aro_description": "Methyltransferases that methylate the G1405 position of 16S rRNA, which is part of an aminoglycoside binding site.", "category_aro_class_name": "AMR Gene Family"}, "35926": {"category_aro_accession": "0000007", "category_aro_cvterm_id": "35926", "category_aro_name": "dibekacin", "category_aro_description": "Dibekacin is an aminoglycoside antibiotic used to treat different types of bacterial infections. Dibekacin works by binding to the bacterial 30S ribosomal subunit, causing misreading of mRNA and leaving the bacterium unable to synthesize proteins vital to its growth.", "category_aro_class_name": "Antibiotic"}, "35932": {"category_aro_accession": "0000013", "category_aro_cvterm_id": "35932", "category_aro_name": "amikacin", "category_aro_description": "Amikacin is an aminoglycoside antibiotic that works by binding to the bacterial 30S ribosomal subunit, causing misreading of mRNA and leaving the bacterium unable to synthesize proteins vital to its growth.", "category_aro_class_name": "Antibiotic"}, "35933": {"category_aro_accession": "0000014", "category_aro_cvterm_id": "35933", "category_aro_name": "gentamicin C", "category_aro_description": "Gentamicin C is a mixture of gentamicin C1, gentamicin C1a, and gentamicin C2 (these differ in substituents at position C6'). Gentamicin works by binding to the bacterial 30S ribosomal subunit, causing misreading of mRNA and leaving the bacterium unable to synthesize proteins vital to its growth.", "category_aro_class_name": "Antibiotic"}, "35953": {"category_aro_accession": "0000035", "category_aro_cvterm_id": "35953", "category_aro_name": "sisomicin", "category_aro_description": "Sisomicin is an aminoglycoside antibiotic used to treat different types of bacterial infections. Sisomicin works by binding to the bacterial 30S ribosomal subunit, causing misreading of mRNA and leaving the bacterium unable to synthesize proteins vital to its growth.", "category_aro_class_name": "Antibiotic"}, "35956": {"category_aro_accession": "0000038", "category_aro_cvterm_id": "35956", "category_aro_name": "netilmicin", "category_aro_description": "Netilmicin is a member of the aminoglycoside family of antibiotics. These antibiotics have the ability to kill a wide variety of bacteria by binding to the bacterial 30S ribosomal subunit, causing misreading of mRNA and leaving the bacterium unable to synthesize proteins vital to its growth. Netilmicin is not absorbed from the gut and is therefore only given by injection or infusion. It is only used in the treatment of serious infections particularly those resistant to gentamicin.", "category_aro_class_name": "Antibiotic"}, "35966": {"category_aro_accession": "0000049", "category_aro_cvterm_id": "35966", "category_aro_name": "kanamycin A", "category_aro_description": "Kanamycin is an aminoglycoside antibiotic used to treat different types of bacterial infections. Kanamycin works by binding to the bacterial 30S ribosomal subunit, causing misreading of mRNA and leaving the bacterium unable to synthesize proteins vital to its growth.", "category_aro_class_name": "Antibiotic"}, "35969": {"category_aro_accession": "0000052", "category_aro_cvterm_id": "35969", "category_aro_name": "tobramycin", "category_aro_description": "Tobramycin is an aminoglycoside antibiotic used to treat different types of bacterial infections. Tobramycin works by binding to the bacterial 30S ribosomal subunit, causing misreading of mRNA and leaving the bacterium unable to synthesize proteins vital to its growth.", "category_aro_class_name": "Antibiotic"}, "36996": {"category_aro_accession": "3000652", "category_aro_cvterm_id": "36996", "category_aro_name": "isepamicin", "category_aro_description": "A semi-synthetic derivative of gentamicin B (hydroxyamino propionyl genamicin B). It is modified to combat microbial inactivation and has a slightly larger spectrum of activity compared to other aminoglycosides, including Ser marcescens, Enterobacteria, and K pneumoniae.", "category_aro_class_name": "Antibiotic"}, "36997": {"category_aro_accession": "3000653", "category_aro_cvterm_id": "36997", "category_aro_name": "G418", "category_aro_description": "A gentamicin class aminoglycoside antibiotic often used in mammalian cell culture work as a selectable marker for the neo cassette (APH3').", "category_aro_class_name": "Antibiotic"}, "36998": {"category_aro_accession": "3000654", "category_aro_cvterm_id": "36998", "category_aro_name": "arbekacin", "category_aro_description": "A synthetic derivative (1-N-(4-amino-2-hydroxybutyryl) of dibekacin used in Japan. It is active against methicillin-resistant Staph. aureus and shows synergy with ampicillin when treating gentamicin and vancomycin resistant enterocci.", "category_aro_class_name": "Antibiotic"}, "36999": {"category_aro_accession": "3000655", "category_aro_cvterm_id": "36999", "category_aro_name": "gentamicin B", "category_aro_description": "Gentamicin B is a semisynthetic aminoglycoside antibacterial.", "category_aro_class_name": "Antibiotic"}, "46133": {"category_aro_accession": "3007382", "category_aro_cvterm_id": "46133", "category_aro_name": "gentamicin", "category_aro_description": "Gentamicin is a commonly used aminoglycoside antibiotic derived from members of the Micromonospora genus of bacteria. It acts by binding the 30S ribosomal subunit, thus inhibiting protein synthesis. Gentamicin is typically used to treat Gram-negative infections of the repiratory and urinary tract, as well as infections of the bone and soft tissue. It also exhibits considerable nephrotoxicity and ototoxicity. Gentamicin is administered as a mixture of gentamicin type C (which makes about around 80% of the complex) and types A, B, and X (distributed in the remaining 20% of the complex).", "category_aro_class_name": "Antibiotic"}, "35935": {"category_aro_accession": "0000016", "category_aro_cvterm_id": "35935", "category_aro_name": "aminoglycoside antibiotic", "category_aro_description": "Aminoglycosides are a group of antibiotics that are mostly effective against Gram-negative bacteria. These molecules consist of aminated sugars attached to a dibasic cyclitol. Aminoglycosides work by binding to the bacterial 30S ribosomal subunit (some work by binding to the 50S subunit), inhibiting the translocation of the peptidyl-tRNA from the A-site to the P-site and also causing misreading of mRNA, leaving the bacterium unable to synthesize proteins vital to its growth.", "category_aro_class_name": "Drug Class"}, "35997": {"category_aro_accession": "0001001", "category_aro_cvterm_id": "35997", "category_aro_name": "antibiotic target alteration", "category_aro_description": "Mutational alteration or enzymatic modification of antibiotic target which results in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 9.48691, "max_identities": 20, "bit_score": 27.7202, "cvterm_id": "36752", "query": "LFGREHFERISRVLDIGCGMGTDVIQLAKRFAHLRTTGYTITRAQAELGAGRIAREGLQGRAEIRHGDSAKDPFPGKYDLVIGIEVI", "match": "+FG  + + +S +LD GCG     +        +    Y I RA+    +  I +  L+   + R  +   D + G YD+V  ++++", "sequence_from_db": "VFG--NIKHVSSILDFGCGFNPLALYQWNENEKIIYHAYDIDRAEIAFLSSIIGK--LKTTIKYRFLNKESDVYKGTYDVVFLLKML", "sequence_from_broadstreet": "MDKNDVVKKILESKKYENLDSDIVEKVVSISEKKYKLKEVENYSKKKLHQIWGSYYSAYPNWDKLLKKYNQGQLSIEDLLKIHSSTNERVATLNDFYTYVFGNIKHVSSILDFGCGFNPLALYQWNENEKIIYHAYDIDRAEIAFLSSIIGKLKTTIKYRFLNKESDVYKGTYDVVFLLKMLPVLKQQDVNILDFLQLFHTQNFVISFPIKSLSGKEKGMEENYQLWFESFTKGWIKILDSKVIGNELVYITSGFQK", "dna_sequence_from_broadstreet": "ATGGATAAGAATGATGTTGTTAAGAAGATACTTGAATCAAAAAAGTACGAAAACCTTGATTCAGATATTGTTGAAAAGGTTGTTTCCATTTCTGAGAAGAAATATAAATTAAAGGAAGTTGAGAATTATTCTAAAAAGAAATTGCATCAAATATGGGGGTCTTACTATTCTGCCTATCCTAATTGGGATAAATTATTAAAAAAGTACAATCAGGGGCAGTTATCAATAGAAGATTTACTAAAGATTCATTCTTCGACGAATGAAAGAGTCGCAACATTAAATGACTTTTACACTTATGTATTTGGAAATATCAAACATGTCTCATCTATTTTAGATTTTGGTTGTGGCTTCAATCCATTAGCTTTATACCAATGGAATGAAAATGAAAAAATAATATATCATGCATACGATATTGATAGAGCTGAGATAGCTTTTTTGAGTAGCATTATTGGGAAGTTAAAGACGACGATAAAGTATAGGTTTTTGAATAAAGAGAGTGATGTCTACAAAGGTACTTATGATGTAGTATTCCTTTTAAAGATGCTTCCTGTGCTAAAACAGCAAGATGTAAATATCTTGGATTTCCTACAGCTTTTTCATACTCAAAACTTTGTAATATCTTTTCCAATAAAGTCTTTATCTGGAAAGGAGAAGGGAATGGAAGAGAATTACCAGCTATGGTTTGAATCTTTTACAAAAGGTTGGATAAAAATCCTTGATTCGAAGGTTATAGGGAATGAGTTAGTATATATTACTAGTGGATTTCAGAAATAA", "partial": "0", "query_start": 7506, "query_end": 7766, "hit_start": 297, "hit_end": 546, "orf_dna_sequence": "ATGAACGTGCAAGAAAGCATTTTCCCGATCACGCCGAACGGCTTCGCCGGGCACTCGATGGACGATCTGATGCAGCGCTGGCTGCTCGCGCAGTTGCAGGCGACGGGCATCCTCGCCGACGGCCGCGCGCACGCATTCGACGCGCTCGCCGGCCGGGTGCAGCCGCTCTACCGCCGCTGGCTCGAGGAGAGCCTGCGCCTGCTGCGCGACGCGGGCCTCGTGCGCGACGACGCGCAAGGCTGGCGCGCGGCCGAGCGCGCGCCGATCGACGCGCGCGACGCGCAGCGCCACTGGGACGCGTCGCGCGACGCGTGGCTCGCCGACCGCGAACGCGCGGTCTACGTCGTGCTGATCGAAGCGGTGCTCGCGCAACTGCCGGCGATCCTCACGGGCCGCCGGCGCGCGACCGACGTGCTGTTTCCGAACGGCTCGATGGCGCGCGTGCAGGGCGTCTACACGGGCAACCACGTGTCCGACCACTTCAACCGCGTGCTTGTCGATCACGCGGTGCGCTACGTCGCCGGCTGCGCCGCGCGGCGTGCCGACGCGAAGCTGCGCTTCATCGAGGTGGGCGCGGGCACGGGCGGCACCACCGAGGGCCTGCTGGCGGCGCTCGCGCCGCACGCGCGGCACGTCGGCGAGTACTGCTTCACCGATATCTCGAAGGCGTTCCTGAATCACGCGCAACGCCGCTTCGGCGAAGGCGCGCCGTTCTTCGGCGCGCGCGTGCTCGACATCGAGCAGCCGATCGACGCGCAGGGCTTCGAGCCGGGCGCGTACGACGCGCTCGTCGCGACGAACGTGCTGCACGCGACGCGCGACATCCGCACGACGCTGCGCCACTGCAAGGCGCTCCTCAAGCACAACGGACTGCTCTTCATCAACGAGATGACGGGCAGCGTGCCGTACCTGCATCTGACGTTCGGCATGCTCGAAGGCTGGTGGCGCTTCACGGACGACGCGCTGCGCGTCGCGGGATGCCCGGCCGTCGCGCCGCAGACGTGGGACCGGGTGCTGCGCGAGGAGGGCTTCTCGTCCGTGATTTTTCCCGCGCGCGATGCGCACGGGCAGGGGCAGCAGATCGTCATCGCGCAGAACGACGCGCGGCGGGCGGGGAGCGCGCGCCGCGACGCGCGCGCGTCGAACGGCGACGCGCAACACGGCGCGCGCCATGAGGCGGCGCACGACGCGCAGCAAGACGCGAGCGGCGACACGCAAGCAGACGCGCACGACAGCGCGCACGACAGCGCACACGACAGCGCTCACGACAGCGCTCACGACAGCGCTCACGACAGCGCTCACGCCGCCGCCGCGCTGCGCCGCGAAGGCCGCGCGTATCTGCGCGCGCGCGCCGCGGAACTGCTCGGCATGCCGGCGGGCGCGATCGATCCGGACGAAGGGCTGCATGCATACGGGCTCGATTCGATTCTTGCGTCCCAGTTCGCCGCGCAGCTCGCCGAGGCGTTCGACGGATTCGACGGCGCGCTGCTGTTCGAGCACAAGACGATCAACGCGTTGCTCGACCATCTGCTCGCCGCGCATGCCGACGCGCTCGCGAGGCTCTTGCCGCCCGCGGGCGGCGCGCCCGCCCGCGGCGTCGGCGCGCGCGCGCAGGCAGCGCAAGCGTCAGGCGAGGGGCGCGCCGCGCCGCCGGCCGCGCCGCACGCCGACGCGCGGTCCGACACGCCGTCGAGCGCGCCGTCGAGCGCGCCGGCGCGGCCGGATCAGCCCGCACCGAGCGGGCCGCCCGCGCAACCCGCCCAACCCGCGCCGCGCGCCGACACGCCGCCGCCCGCCGCGAGCGCCGGGCATCGCGGCGAAGCGCGCGCGAGCGATACGCGATATGCGCCGCGCGCGCCGCATCCGGACGCCGCCGCGGAGCCGGTCGCGATCATCGGCATCAGCGGCCGCTATCCCGGCGCGTACGACGTGCCGGCGTTCTGGCGCAACCTCCTCGCGGGTGCGTGCGCGATCACGGAGGTGCCCGCCGAGCGCTGGGACTGGCGGGCGCATTACCGGGCCGATGCCGCCGAGGCGGCGCGCGAGGGCAAGAGCTACAGCAAGTGGGGCGGATTCGTCGACGACGTCGGCCGCTTCGATCCGGCGTTCTTCGGCATGACGCCGCAGGACGCGCAGCACACCGATCCGCAGGAGCTCCTGTTCCTCGAGATGTGCTGGCACGCGCTGCAGGACGCGGGGCAGACGCCCGCGCTGTTGCCGGGCGACGTGCGCCGCCGCGCGGGCGTGTTCGCCGCGATCACGAAGCACTACGCGTTTCCGCCGACGTCGTTCGCGTCGCTCGCGAATCGCGTGTCGCATGCGCTCGACTTCGGGGGCAAGAGCCTCGCGATCGATACGATGTGCTCGTCGTCGCTCGTCGCCGTGAACGAGGCATGGGAATACCTGCAGCGCGACGGGCGGCTCGCGGTCGTCGGCGGCGTCAATCTCTATCTCGATCCGCAGCAGTACGCACATCTGTCGCGCTTTCGCTTCGCGTCGAGCGGCCCGGTGTGCAAGGCGTTCGGCGAAGGCGGCGACGGGTTCGTGCCGGGCGAGGGCGCGGGCGCGATCGTGCTCAAGCGCCTGTCCGACGCCGAGCGCGACGGCGATCCGATCCACGCGGTGATCCGCGGCTGCGCGGTCAATCACAACGGCCGCTCGACGAGCTTCACCGCATCCGATCCCGCGCGCCAGGCCGACGTCGTGCGGGACGCGCTCACGCGCGCGGGCGTCGATCCGCGCACGATCGGCTATGTCGAGGCGGCGGCCAACGGCCACGCGATGGGCGATGCGATCGAGATGACGGGGCTCGGCAAGGTGTTCGCCGCGTGCGACGGCGTATCGGGTACGCGCGCGATCGGCTCCGTGAAGGCGAACATCGGGCACTGCGAGGCTGCATCGGGCATGTCGCAGTTGACGAAGGTCGTGATGGCGATGCGCGACGGCGTGCTCGCGCCGACGCTGCGCGACGGCACGCGCAACCCGAACATCGCGTTCGAGCGGCTGCCGTTCGAGGTTCAGGAGCAGGCCGCGCCGTGGCGGCGGCTGATCGTCGACGGCAGCGAGGTGCCGCGGCGCGCGGGCGTCACGAGCATCGGCGGCGGCGGCGTCAACGCGCACGTCGTGCTCGAGGAGTACGTGGCGCCGCCGCGCGCCGCGCGCCCTGGCGCGGGCACGGACGACGAAGTCCTGTTCGTGCTGTCCGCGCGCACGCGCGAGCAACTGGGCGCGTACGCCGAACGCTGGGCCGGCTACCTCGAGGCGCATCCCGACTGCGATGTCGACGCGATCGCGCATACCGTGCGCACGGCGCGCGAGCCGATGGCGCACCGGCTCGCCGTGCTCGCGCACGGACGCGGCGAGCTCGCGGCGCTGCTGCGGGGCTGGGCGGCGGGCGGCGCGGCGAGTGGCGCGGCAAGTGGCGCGGCGAGCGATCAGGTGTTCTACGGCGACGTGAAGCAGCATCGCGTGGTGCTCTCGGACGCGCTCGTGCAAGCGGCGCGGCGCGAGGGCGCGGCGAGCCTCGCGAAGCTCTGGGTGCTCGGCAACGCGCTTGGCGCGGCGCACGGCGCGGACGAACCCGCGCCGCGCCGAGTGGGCCTGCTGCCGCCGTACCCGTTCGAGCGGCGGCTCGTCTGGACGTCCGCGCACGCGCCCGGCACGCGGCATGCGAGCGCCGGGGAAGCCACGGAAGCGGCAGAAGCCGCGGAAGCCGCGGAAGCCGGCGCGGCAGCCGTGGCCGAAAGCGCCGAAGCCGGCGCGCCCGCCGCCGCCGGCGACGCCCGCCTGCAGCCGGCGCCCGCGAGCAACGCGGAGGCGTTCTACTCGCTCAGCACGCTGAACGCGTCGAAGGATTTTCAGGAGCAGTACCTGACGCTGTGCCCGTTCCCCGAGCGCATTCCGGGCTTCTCGATGACGCGCATGTTCATCGAGCCGCAGAAGTACCCGAACGAATTCGCGCTGATGCAGGCGCGCCAGATCGAAATGCGCCAGGTGCTGTTCGGTCGCGAGCATTTCGAGCGGATCTCACGCGTGCTCGACATCGGCTGCGGGATGGGCACCGATGTGATCCAGCTCGCGAAACGCTTCGCGCATCTGCGCACGACGGGCTACACGATCACGCGCGCGCAGGCCGAGCTGGGCGCCGGGCGCATCGCGCGCGAGGGCCTGCAAGGCCGCGCGGAGATCCGCCACGGCGACAGCGCGAAAGACCCGTTCCCGGGCAAATACGATCTCGTGATCGGCATCGAGGTGATCTGCCACATCCAGGACAAGCACGGCGTGTTCGGCAACATCGCGCGCTCGCTCGACGACGACGGGCACGTGCTGCTGATGGATTTCGTCGCGAACGGCCGCGGGCGCATCAGCTCGCCGGAGATCGATATCGACATCGGCACGCGGCAGGACTGGATCGACGTCGCGGCGGCGCACGGCCTCGTGGTCGACGAGGTGATCGACGTGTCGCCGCAGATCGCGAACTTCCTGCACGACCCCGAGCACGAGCGGAACATCGCCGCGCTGCCTGGCGTCGCGCAGGCGTCGTTCCGCAACTTCGCGAACACGTGCGTGTCGCTCGAGAAGGGCTGGGTCAGCTATTGCCTGCTGCGCCTGAGCAAGGCGAGCCGCTTGAGCGAGGCCGAGCGCCGGCGCCTGAACGCCGAGCGGTTCGGCGCGAGCGTCGCGTATCCGGACGCGCTGAAGGCGATGCACGCGCGCGGCCCCGCGCCGTATCCGCGCAGCCCGGACGCGCAACCGCCGGCCGCGCGCGCGCAGGCGGGCGTGGACGGGGGCGTCGAGGCGAGCGCGCCGGCTGGCGTGAAAGCGGACTCGAAAGCAGGCCCGAAATCGGAAGTGAAATCGGATGCGGCCGCTCGCGCGTCGCGCGCCGACATCGCCGCCAGCGTTGCCGCCAGCGTTGCCGCCAGCGTCGAGGATGCGTTCGAGGCGTCGCTCGGCCTGCGGCGCGCGGATCTCGAGCGCGCCGACGATCTGCGCGCGCTCGGCATCGGCTCGATCCAGGCGGTGATGCTCGCCGAGGCGATCAACGAGCGTCTCGACCTCGCGCTGCCGAGCCGCTTCGTGCTCGAGCACGCGACGTTCGGCGCGCTCGTGCGCGCGGTGGCTGAAGCCGTCGCGGGCGGGCGCGGCAGCTCGCGCGACGCGCCGGCGCGCGAGCTCGCCTATCTGTCGCTGCTCGAGCCGGGCGGCGCGATGACGGCCGAGCTGCTCGAGCTGCCGGGCGGCGCGCGCGCCGAGATCCTGCGCGGCGGACGCGGGCCGCGCGTCGTGCTGATTCCCGGGCTCGGGATGGCGGGCACTGTGTTTCGCGATCTGTGCCGCGCGTTGACGCGGCGCCACGAGGTGATCGTCTACCACTATCCGGGGCTCGGCCGCAGCGATCCCGTCGCGCCGATCGACGTCGACGCCGCCGCCGCTCATCTGTACCGCACGCTCGACGCATGCGGCGGCGACGGCGCGGCCGCGCTCCTCGGCTGGTCGTTCGGCGGCGTGATCGCGCAGCGCGCGGCGCTGATGCGGCCGCGCGCGTGGCGCGCGCTCGTCCTCGTCAACACGCTCGGCGCATACCGGCCGCTCGCGCCGCAATTCCTGACGCCGGGCGCGTCGCGTGACGGCGAACCGCGCGGCCTCGGCGGCCTCTACCAGACCGATCTCGATTTCGTGTTCGCCGGCGACGCGCCGCCGGCCGCGCTCGCGCGCAAGGACGCGTGCGCGGCGCTGATGCGCGACAGCCTCGCGCTCGACGCCGCGCAGGCGATCGATTATCTCGATGCGCTCGTGCGCTTCGACGCGACCGCGCAACTGCCGTCGCTGCGGATGCCGACGCTCGTCGTCGCCGGCACGGCCGATCACTTCGGCGATCCGGCGCACGCGGAGCAGCTCGTGTCGCTGATTCCGAACGCGCGGCTCGCGCGGATCGCGGGCGCGGGGCACGCGGTGTTCCTCACGCACGGCGAAGCGTTCGAGCCGGCGGTGCTCGCGTTTCTCGACGAGACGCTGCGCGCGGCCGAAGCGGGCGGCGCGGCGGAATCGGTTGAATCGGTTGAGGCGACCGAGGCGGCCGAGGCGGCCCGCTCGCCCGCCGTCGCGCGCCGGCGGGCGACCGACGACGCGCCGGTCGGGAGCGACGCATGA", "orf_prot_sequence": "MNVQESIFPITPNGFAGHSMDDLMQRWLLAQLQATGILADGRAHAFDALAGRVQPLYRRWLEESLRLLRDAGLVRDDAQGWRAAERAPIDARDAQRHWDASRDAWLADRERAVYVVLIEAVLAQLPAILTGRRRATDVLFPNGSMARVQGVYTGNHVSDHFNRVLVDHAVRYVAGCAARRADAKLRFIEVGAGTGGTTEGLLAALAPHARHVGEYCFTDISKAFLNHAQRRFGEGAPFFGARVLDIEQPIDAQGFEPGAYDALVATNVLHATRDIRTTLRHCKALLKHNGLLFINEMTGSVPYLHLTFGMLEGWWRFTDDALRVAGCPAVAPQTWDRVLREEGFSSVIFPARDAHGQGQQIVIAQNDARRAGSARRDARASNGDAQHGARHEAAHDAQQDASGDTQADAHDSAHDSAHDSAHDSAHDSAHDSAHAAAALRREGRAYLRARAAELLGMPAGAIDPDEGLHAYGLDSILASQFAAQLAEAFDGFDGALLFEHKTINALLDHLLAAHADALARLLPPAGGAPARGVGARAQAAQASGEGRAAPPAAPHADARSDTPSSAPSSAPARPDQPAPSGPPAQPAQPAPRADTPPPAASAGHRGEARASDTRYAPRAPHPDAAAEPVAIIGISGRYPGAYDVPAFWRNLLAGACAITEVPAERWDWRAHYRADAAEAAREGKSYSKWGGFVDDVGRFDPAFFGMTPQDAQHTDPQELLFLEMCWHALQDAGQTPALLPGDVRRRAGVFAAITKHYAFPPTSFASLANRVSHALDFGGKSLAIDTMCSSSLVAVNEAWEYLQRDGRLAVVGGVNLYLDPQQYAHLSRFRFASSGPVCKAFGEGGDGFVPGEGAGAIVLKRLSDAERDGDPIHAVIRGCAVNHNGRSTSFTASDPARQADVVRDALTRAGVDPRTIGYVEAAANGHAMGDAIEMTGLGKVFAACDGVSGTRAIGSVKANIGHCEAASGMSQLTKVVMAMRDGVLAPTLRDGTRNPNIAFERLPFEVQEQAAPWRRLIVDGSEVPRRAGVTSIGGGGVNAHVVLEEYVAPPRAARPGAGTDDEVLFVLSARTREQLGAYAERWAGYLEAHPDCDVDAIAHTVRTAREPMAHRLAVLAHGRGELAALLRGWAAGGAASGAASGAASDQVFYGDVKQHRVVLSDALVQAARREGAASLAKLWVLGNALGAAHGADEPAPRRVGLLPPYPFERRLVWTSAHAPGTRHASAGEATEAAEAAEAAEAGAAAVAESAEAGAPAAAGDARLQPAPASNAEAFYSLSTLNASKDFQEQYLTLCPFPERIPGFSMTRMFIEPQKYPNEFALMQARQIEMRQVLFGREHFERISRVLDIGCGMGTDVIQLAKRFAHLRTTGYTITRAQAELGAGRIAREGLQGRAEIRHGDSAKDPFPGKYDLVIGIEVICHIQDKHGVFGNIARSLDDDGHVLLMDFVANGRGRISSPEIDIDIGTRQDWIDVAAAHGLVVDEVIDVSPQIANFLHDPEHERNIAALPGVAQASFRNFANTCVSLEKGWVSYCLLRLSKASRLSEAERRRLNAERFGASVAYPDALKAMHARGPAPYPRSPDAQPPAARAQAGVDGGVEASAPAGVKADSKAGPKSEVKSDAAARASRADIAASVAASVAASVEDAFEASLGLRRADLERADDLRALGIGSIQAVMLAEAINERLDLALPSRFVLEHATFGALVRAVAEAVAGGRGSSRDAPARELAYLSLLEPGGAMTAELLELPGGARAEILRGGRGPRVVLIPGLGMAGTVFRDLCRALTRRHEVIVYHYPGLGRSDPVAPIDVDAAAAHLYRTLDACGGDGAAALLGWSFGGVIAQRAALMRPRAWRALVLVNTLGAYRPLAPQFLTPGASRDGEPRGLGGLYQTDLDFVFAGDAPPAALARKDACAALMRDSLALDAAQAIDYLDALVRFDATAQLPSLRMPTLVVAGTADHFGDPAHAEQLVSLIPNARLARIAGAGHAVFLTHGEAFEPAVLAFLDETLRAAEAGGAAESVESVEATEAAEAARSPAVARRRATDDAPVGSDA", "perc_identity": 22.99}}, "BGC0000186.1|Thailandamide_3 # 9683 # 22696 # -1 # ID=1_3;partial=00;start_type=ATG;rbs_motif=GGA;rbs_spacer=10bp;gc_cont=0.746": {"gnl|BL_ORD_ID|2230|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 9683, "orf_end": 22696, "orf_from": "BGC0000186.1|Thailandamide_3 ", "model_name": "TaeA", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "1200", "model_id": "2522", "ARO_accession": "3003986", "ARO_name": "TaeA", "ARO_category": {"36002": {"category_aro_accession": "0010001", "category_aro_cvterm_id": "36002", "category_aro_name": "ATP-binding cassette (ABC) antibiotic efflux pump", "category_aro_description": "Directed pumping of antibiotic out of a cell to confer resistance. ATP-binding cassette (ABC) transporters are present in all cells of all organisms and use the energy of ATP binding/hydrolysis to transport substrates across cell membranes.", "category_aro_class_name": "AMR Gene Family"}, "37716": {"category_aro_accession": "3001317", "category_aro_cvterm_id": "37716", "category_aro_name": "pleuromutilin", "category_aro_description": "Pleuromutilin is a natural product antibiotic produced by Clitopilus passeckerianus. Related antibiotics of clinical significance, such as tiamulin and retapamulin, are semi-synthetic derivatives of this compound.", "category_aro_class_name": "Antibiotic"}, "37014": {"category_aro_accession": "3000670", "category_aro_cvterm_id": "37014", "category_aro_name": "pleuromutilin antibiotic", "category_aro_description": "Pleuromutilins are natural fungal products that target bacterial protein translation by binding the the 23S rRNA, blocking the ribosome P site at the 50S subunit. They are mostly used for agriculture and veterinary purposes.", "category_aro_class_name": "Drug Class"}, "36298": {"category_aro_accession": "3000159", "category_aro_cvterm_id": "36298", "category_aro_name": "efflux pump complex or subunit conferring antibiotic resistance", "category_aro_description": "Efflux proteins that pump antibiotic out of a cell to confer resistance.", "category_aro_class_name": "Efflux Component"}, "36001": {"category_aro_accession": "0010000", "category_aro_cvterm_id": "36001", "category_aro_name": "antibiotic efflux", "category_aro_description": "Antibiotic resistance via the transport of antibiotics out of the cell.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 5.28032, "max_identities": 21, "bit_score": 30.0314, "cvterm_id": "40862", "query": "FADYGIDSIVVLRMTRQLEKHFGPLSKTLLFEQRRLDDLADYFVRAYEAACAAWIGARADAARAGGARADHANGANGSADADAAAHAP", "match": "F D  +D I+      Q+  H G  S+   + QR                     G  A  ++A  + A  A+G++   D+D+A  AP", "sequence_from_db": "FLDRTVDKIMAFEGDGQIRVHVGSYSEYAEWMQRH--------------------GGEASGSKAEASIAKSASGSSDGTDSDSAKEAP", "sequence_from_broadstreet": "MNILTVEQVTKSYGDKILFQDASFGMEDQDKIGIIGVNGTGKSTFLRVIAGLEPPDSGKISMGNRIRVRYLAQNPEFDPDKTVLQQVFEGDLPEMKAVREYTETMELLELHPSHEELQQKLLKLNQTLETLQAWQLESDAKTILSKLGIRNYEAKMGTLSGGQRKRVALAAALIQPSDLLILDEPTNHIDNESVAWLEQYLQKRRGALLMITHDRYFLDRVANVMLELDHGRLFRYEANYSRFLELKAEREEREAASEQKRQNLLRSELAWIRRGAKARTTKQKARIERFEKLKDQEMVHSSGELDVSVASTRLGRKILEIEGLRMKIDDKTLIQDLSYIAVPEDRIGIVGPNGSGKSTLLNLIAGRIQPGGGEVVLGPTVKLGYFTQEHQEMDGSQRVIEYIKDEAEVVRTADGSAITAAQMLERFLFPPALQWTPIAKLSGGEKRRLYLLRVLMSAPNVLLLDEPTNDLDIQTLSVLEQYLDEFPGVCIVVSHDRFFLDRTVDKIMAFEGDGQIRVHVGSYSEYAEWMQRHGGEASGSKAEASIAKSASGSSDGTDSDSAKEAPRERLKFSYKEQREFDQIDGLIEDTESKLASIQSEMETAGSDAARLQELMKAQEETERELEHLMERWTYLNELAEKIEQSKKS", "dna_sequence_from_broadstreet": "ATGAATATTTTGACCGTCGAACAGGTAACAAAAAGCTATGGAGACAAAATTCTGTTTCAAGATGCATCCTTCGGAATGGAGGATCAGGATAAAATCGGCATTATCGGCGTGAATGGCACGGGGAAATCCACATTTCTGCGGGTCATCGCGGGGCTCGAGCCGCCCGACTCCGGTAAAATATCGATGGGCAATCGCATCCGGGTTCGTTACCTCGCGCAAAATCCGGAGTTTGATCCGGACAAAACCGTCCTGCAGCAGGTGTTTGAGGGCGATCTTCCGGAGATGAAGGCCGTGCGGGAATACACCGAAACGATGGAACTGCTGGAGCTGCATCCAAGTCATGAGGAGCTCCAGCAGAAACTGCTGAAGCTCAATCAGACGCTGGAAACGCTGCAGGCATGGCAGCTTGAAAGCGATGCGAAAACCATCCTGTCCAAGCTGGGGATTCGGAATTATGAAGCGAAGATGGGAACGCTGTCGGGCGGCCAGCGTAAGCGGGTGGCATTAGCCGCCGCCTTGATTCAGCCTTCCGACTTGCTTATTTTGGACGAGCCGACCAACCACATTGACAATGAATCCGTTGCCTGGCTGGAGCAGTATTTGCAGAAGCGCCGCGGCGCGCTGCTCATGATTACGCATGACCGGTATTTTCTGGACCGGGTAGCCAATGTTATGCTGGAGCTGGATCACGGACGGCTGTTTCGATATGAGGCGAACTACAGCCGTTTTCTGGAGCTGAAGGCAGAACGCGAGGAGCGTGAAGCCGCTTCCGAGCAAAAGCGCCAAAATTTGCTGCGGAGCGAGCTTGCCTGGATCCGCAGAGGGGCCAAGGCCCGCACGACCAAGCAGAAGGCGAGGATTGAACGCTTCGAGAAACTCAAGGATCAGGAGATGGTGCACAGCTCCGGTGAACTGGACGTTTCGGTCGCTTCCACCCGCTTGGGACGCAAAATTCTGGAGATTGAAGGTCTCCGGATGAAGATCGACGACAAAACGTTAATTCAGGACCTTTCCTATATCGCCGTTCCCGAGGATCGGATAGGTATCGTAGGCCCGAACGGCAGCGGCAAATCCACGCTGCTCAATCTGATTGCCGGGCGGATTCAGCCGGGTGGCGGGGAAGTCGTGCTCGGACCGACGGTCAAGCTCGGTTATTTCACGCAGGAGCATCAGGAGATGGACGGCAGTCAGCGCGTGATTGAGTATATCAAGGATGAGGCCGAGGTTGTCCGCACGGCGGACGGTTCGGCGATTACCGCAGCCCAGATGCTGGAACGCTTTCTGTTCCCGCCCGCGCTGCAGTGGACGCCGATTGCGAAGCTGTCCGGAGGCGAGAAGCGCCGCTTGTATCTGCTGCGGGTGCTGATGAGCGCACCGAATGTGCTGCTGCTTGATGAACCGACCAATGATTTGGATATCCAGACATTGTCCGTCCTGGAGCAGTATTTGGATGAGTTCCCGGGCGTCTGTATCGTGGTATCCCATGATCGCTTTTTCCTGGATCGAACCGTGGACAAGATTATGGCTTTTGAGGGCGACGGTCAGATTCGTGTCCATGTCGGCTCTTACAGCGAATATGCGGAATGGATGCAGCGTCACGGCGGTGAAGCTTCCGGGAGCAAGGCGGAGGCATCCATAGCCAAATCTGCTTCGGGGAGCAGCGATGGCACGGACAGTGATTCAGCTAAAGAAGCGCCGCGTGAGCGCTTGAAATTCAGTTACAAAGAACAACGGGAGTTTGATCAGATTGACGGGCTCATCGAGGATACCGAGAGCAAGCTCGCTTCGATTCAATCCGAGATGGAGACCGCCGGCAGCGACGCAGCCAGGCTTCAGGAGCTGATGAAGGCTCAGGAGGAAACGGAACGTGAGCTGGAGCATCTGATGGAACGCTGGACCTATCTGAACGAGCTCGCGGAGAAGATTGAACAGAGCAAGAAATCGTAA", "partial": "0", "query_start": 13886, "query_end": 14149, "hit_start": 1494, "hit_end": 1698, "orf_dna_sequence": "ATGGAACGCCAGAATCTGCGGAATGTGCTGGAACGACTGAAAGCGGCGGCGATCGGCCCGGACGAGGCGAAGCGGATGCTGTCCGCCGCGCGCGCGGGCGACGCCGCGGACAAGCCGCAACCCGGGCCGGCCGCCGCCGCGCCGCGCGACGCCGAGCCGATCGCCGTCGTCGGCATGTCGGGCCGCTATCCGGGCAGCCCCGATCTCGACGCGTACTGGTCGCTGCTCGCGCGCGGCGAGGATGCGGTGAAGGAGATCCCGCCCGCGCGCTGGAACGTGGGCGAGTACTTCGACGCCGAGCCCGGCAAGCCTGGCGCGATGTACTGCAAGTGGCTCGGCGCGCTCGACGACGTCGATTCGTTCGATTCGCTGTTCTTCCGGATTCCGCCGTCCGAGGCCGAGTTCATCGATCCGCAGCACCGGCTCTTCCTCGAAGAGGCGTACCGCGCGTTCGAGGATGCGGGCATCGCGCCGGGGCGGCTCGGCGGGCGCGCATGCGGCGTCTATCTCGGCATCATGAGCAACGAATACAACCTGCTGCTCGCGCGCAACGCGCCCGACAGCGGCCACGCGGTCGCCAATCATTTCTCGATCGGCGCCGCGCGCATCGCGTACCACCTCGACCTGAAAGGGCCGGCGATTCCGGTCGACACGGCCTGCTCGTCGTCGCTCGTGGCCGCGCACCTTGCGTGCCAGGCGCTGCGCGCGGGCGAGATCGACGTCGCGCTGGTCGGCGGCGTCACGCTCTATCTGAGCCCCGACGCGTACATCGGCATGTGCGCGGCGGGCATGCTGTCGCCCGACGGCCGGTGCAAGACGTTCGACCAGCGCGCGAACGGCTTCGTCCCGGGCGAGGGCGTCGGCGCGCTCGTGCTCAAGCGCCTCGCCGACGCGCGCGCGCACGGCGATCCGATCCACGGCGTGATCGTCGGCTCGGGCGTCAACCAGGACGGGCGCAGCAACGGCATGACGGCGCCCAACGGCGCGAGCCAGACCGCGCTCGAGCGCGCGGTCTACGAGCGCTACGGCGTGGACCCGGACAGCTTCCAGTACGCGGAGCTGCACGGCACGGGCACGAAGCTCGGCGATCCGATCGAGCTCGCCGCGCTCGCCGACGCGTTCCGCGCGTATACCGGGCGGCGCGGCTTCTGCGCGATCGGCTCCGTCAAGACGAACGTCGGCCATACGTCGGCGGCGGCGGGCGTCGCGAGCGTGCAGAAGGTGCTGCTGTCGATGCGGCACGGCCAGATCGCGCCGTCGCTGCATTTTCGCGAGCCGAACGAGCATTTCGATTTCGCGGCGTCGCCGTTTTACGTGAGCACCGCGCTCGCGCCGTGGCCGACGCCCGAGCACGGGCCGAGGCGCGCGTGCGTGAGCGCGTTCGGCTTCAGCGGCACCAACGCGCACATGGTGTTGCAGGCGGACGAGCCGCCGAGCGCGGGCGCCGCGGCGCCGGGCGCGCCAGCCGGCGGCGCGCCGCACCTGTTCGTGTTTTCCGCGCGCACCGAGCCGCAGCTCGACGCGCTGCTCGATACGTACGTCGCGTTCCTGCGGCGCACGCGCGTCGCGCCGGAGTCGGTCGCCTACACGCTGCAAACGGGGCGCGACGCGATGGCGTGCCGCTTGGCCGTGCGCGCGTCGTCGCTCGCGGCGCTCGCCGACGTGCTCGAGCAGGTGCGCGCGCTCGCGTGCCCGGACGGCGTGTGGCGCGGGCGCGGCGCGCATCGCGAACCGGCCGAGAAGATCGACGCCGCGCTGCGCGCGCGCGATCTCGATACGCTCGGCGAATGCTGGGCGAACGGCCAGACCGTCGACTGGGCCGCGCTCTACCCGCACGCGCGCCCGACGCGCGCGCATTTGCCGACTTACCGCTTCGCGCCGGCGCGCCACTGGTTCCAGGCAGCGCCCGCCACGCCGCCGGACGCCGCGGCCGTCACCGCCGTCACCGCCGCCGTTGTCGCGGCCGCGGACGATGCCGCCGCCGCCACGCCGTTCGAGCAGCGCGCAAGCATTCCGGCGGACGCACCGTGCTTCGTCGATCACGTGATCGACGGCGAGCGCGTGCTGCCCGGCTCGGCCTATCTCGAACTGGTTCGCGCCGCGCTCGCCGACGCGCGGCGCGAGCCGGCGAGCGGGTGTCTCGTGTTGTCCGACGTGCGCTGGCGGCGCACGCTGCAGGCCGGCGGCGGCGTGCGGCTGCGCGTCGTGCTGTCCGCGCGCGGCGCGCCGGCCGCATGGAAGGTCGTGTCCGCCGATGACGGCGCGATCGTCTATTGCAGCGGCTCCGCGCAATGGGAAGCGCTCGCCGGCGCGCGCGTCGACATCGATGCGTTGCGCGCGCGCGTCGCGTCGGCCACGGCCGTCGACGCGAACGCGTGCTATCGCCGCTTCGCGTCGCTCGGCATCGAATACGGCGCGTCGCATCGGCTGATCGAGACGCTGAGCGGCGACGCGCAGCGCGCGCTCGCGCGGCTGCGCGCGCACGGCGATGACGCGTGCGCGGGCGAGGCCGCCGACGCGCTGCCGATCGGCCGGCTCGACGCCGCGCTGCAAAGCGTGCTGGGGCTCGCGCTCGGCGACGGCGGCGAAGGCCCGTCCGACGCCGCGCTGCCGCTCGGCATCGGGCGGCTCGAGCTTTACGGCCCGTGCGCCGACGTCGTGTGGGTGAGCGTCGAGCGCGCGCGGGCGGACGGCGACGTGACGCTCACGCTCGCGAACGCCGACGGCCTCGTGCGGGCGGCGATGCGCGACATCACGTTCGCGCCGAAGCCGCCGCAACACCGCGCGGTGCCGCTCGTCGGCGCGTGGCGCCGCGCGCGGCCGGCCGCGCCGCGCGCGAGCGACGCGGCGCCGCGCTGGATCTGTCTGGCGGGGCCGCTCGCCGCGCACGCGGCGCGCGTCGAACAGGCGCTGTCGCCCGCGCGCGTCGCCGCGCTGCCGGGCGACGCCGACGAGGCGGGCGAGCACTATGCGTCGTGCGTGCTCACGCTCGTCGAGACACTGCAGGCGATCGCGCGCGACCATGCGGCGGGCGCGCGCGTCGACGTCGTGATCCCGGGCGACGCGGCGTTTCACGGCCACCGCGGGCTCGCGAGCCTTCTCAGGACGGCGCGGCAGGAGATGCCGCGGCTGCGCGTCGCGCTCGTCGAATGCGCGGCGGGTGCGCACGCGGTCGTCGATGCGCTGCGCGCCGTGCAGGAGCATGCCGAAGGCGAATGGCAGTGGCGCGAGGACGGCGCGTGGCGCCGTACGTGGACGCCCGCCGAGCTGCGCGGCGGCGGCGCGCCGTGGCGCGACGGCAAGCTTTACTGGATCACGGGCGGCGCGGGCGCGCTCGGCATGCTGCTCGCGGCGCAGATCGTCGAGCACGCGCCCGCCGCGCGCATCGTGCTGAGCGGGCGCTCGCCGCTGGCCGGCGAGGCCGCCGAAACGTTGCGCGCGTGGCGCGAGCGCGGCGTGGCGATCGATTATCGCGAGCTCGACGTCGCCGACCGCGACGCCGTCGTCCGGACGGTGCGCGAGATCACCGCGCGCCACGGTCCACTCGCGGGCGTCGTGCACGCGGCGGGCGTCCGGCGCGACGGGCTGCTGATCGCCAAGACCCGCGAGGACGTCGAAGCGGTGCTCGCGCCGAAGGTGCGCGGGGTGCTCAACATCGACGCGGCCACGCGCGGGCAGCCGCTCGAGTTCTTCGTGCTGTTCTCGTCGATCGCGGGCGCGCTCGGCAACGTCGGCCAGGCCGACTATGCGGCCGCGAACGGCTTTCTCGACGGCTTCGCGCAGTATCGCAACGCGCGCGCGGCGCGCGGCGAGCGGCGCGGCGTCACGCGCGCGATCGGATGGCCGCTGTGGGACGCGGCCGGCATGACGCCCGACGCCGACACGCTCGCCGAGATCGCGCGCGCGGGGCTCGCGCCGATGCCGCCGTCGCACGGATGGCGCATGCTGCATGCGGCGCTCGACGCGCCGCACGACGCGCTCGCCGTGCTGTACGGCGACGCGCGGACGATCGCGGCGCGGCTTGCCGCGGCCGAAATGGCCGATGCGCCGGACGAAGCCGGGGCGGCGGGCGACGCGCCGGCGGGCGGACGCGGCGCGGGCGGCGGCGATGCCGGCCTGCGCGCGCCGGTGCTCGCGCGGTTGAAGGCGATGTTCGCCGACGCGTTCAAGATGTCGCCGGACGACGTGCTCGAGACGGCGGAGTTCGCGGATTACGGGATCGATTCGATCGTCGTGCTGCGGATGACGCGGCAACTCGAAAAGCACTTCGGCCCGCTGTCGAAGACGCTGCTGTTCGAGCAGCGCCGGCTCGACGATCTGGCCGACTACTTCGTGCGCGCGTACGAGGCGGCGTGCGCGGCGTGGATCGGAGCGCGCGCCGATGCCGCTCGGGCGGGCGGCGCGCGGGCGGATCACGCGAACGGCGCGAACGGCAGCGCAGATGCAGATGCCGCCGCGCACGCGCCCGGTGCCGTCGCGGCCGGATCGGATGCCGGCGCGTTCGACTTGCGAGGCCGGGCGGCGGCGGACGGGAGCGCCGCCGACGGCGGCGATCGCATGAGCGGCGCGATCCGCGCGAGCCGCGAGTGTCATGAGAGCGACGAGGCGTGCGCGCGCCGCGCCGCCGCTTCGCCGGATGCGTCGCCGCCGCGCGCGCGGCCGCCGCACGCGGCGACGGGCGCGCGCATGAACATCGCCGTCGTCGGGCTCGCGGGCCGCTATCCGAAGGCGCGCGATCTCGACGCGTTCTGGGCGAATCTCGCGGGCGGCGTCGACTGCATCGAGGAGATTCCCGCCGAGCGCTGGGATCACGCGCGCTACTACGACAGCGATCGCGACGCCACCGGCAAGACTTATGCGAAGTGGGGCGGCTTTGTCGACGGCGTCGACGAGTTCGATCCGCTCTTCTTCAACATCTCGCCGAAGGAGGCGAGCGTGATGGACCCGCAGGAGCGGCTGTTCGTCCAGTGCGCGTACGAGGCGCTCGAGGACGCGGGCTACGGGCGCGTCGCGCTCGGCGGCGAGCGGCCGCACGGCGCCGAGCGCAACATCGGCGTCTACGTCGGCGTGATGTACGAGGAGTATCCGTACTTCGGCGTCGAGCACACGCTGAACGGGCGGCCGATGGCGCTGTCGGGCAATCCGTCGTCGATCGCCAACCGCGTGTCCTATCTGCTCGACCTGCACGGGCCGAGCATGGCCGTCGACACGATGTGCTCGTCGTCGTTCACGGCGCTCCATCTCGCGTGCGAAAGCCTGCTGTCCGGCCAGTGCCGGATGGCGATTGCGGGCGGCGTGAATCTGTCGCTGCACCCGAACAAGTTCATCGCGCTCGCGCAGGGCGGATTCGCCGCGAGCGACGGGCGCTGCCGCAGCTTCGGCGAGGGCGGCGACGGTTATGTGCCGTCGGAGGGCGTCGGCGCGGTGGTGCTCAAGCCGCTCGCGCACGCGCTCGCGGACGGCGATCACGTGTACGGGCTCATCCAGGGCATCGCGATCAACCACGGCGGCAAGTCGAACGCGTACACGGTGCCGAATCCCGATGCGCAGGCGGGCGTGATCGAGGCGGCGTACCGGCGCGCCGGCATCTCGCCGCGCGACGTGTCGTATCTCGAGGCGCACGGCACGGGCACGGCGCTCGGCGATCCGATCGAGATCGCGGGCCTCGTCAGCGCGTTTCGCGCGTTCACCGACGCGCGGCAGTTCTGCGCGATCGGCTCGGTGAAGTCGACGATCGGACACTGCGAGAGCGCGGCCGGCATCAGCGCGCTCACGAAGGTGCTGCTGCAGATGAAGCACGGCCGCCTCGCGCCGTCGCTGCATGCGCGCACGCCCAATCCGCACATCGATTTCGACGCGAGCCCGTTCGTGCTCCAGCGCACGCTCGCGCCGTGGCCCGCGCCGGACGGCGGCACGCGCATCGCGGGCATTTCGTCGTTCGGCGCGGGCGGCACCAACGCGCACGTCGTCGTGGAGGAGTACCGGGCCGCCGCCGCGCACGCGCACGACGGCGCGCAGGCGGCCGCGTCGCCCGCCGCCGTCGTGCTGTCCGCGCGCGACGACGCGCGCCTGCGCGCGCTCGCGCAGCGGTTGCGCGACGCGGTGGCGGCGGGGCGCTTCGCGCCGCACGCGCTGCACGATCTCGCGTTCACGCTGCAAAGCGGGCGCGACCACTGGGAGCGGCGCATCGCGATGCGCGTCGAGTCGTTCGACGAACTGCACGCGGCGCTCGACGATTTCGTCGCCGGGCGGCCGGTGGGCGCGCGCCACTGGCTCGGCGCGTGCCGCGTCGGCGGCGCGAGCCGGCGCGCGCCCGAGCCGTGCGCGTCGCTCGACGACGCGGCCGCCGTGTGGGCGTCGGGGCGCGAGGTCGACTGGTCGCCGTGGCGCGGTGCGCGCGCATGCCGCCGCGTGAGCGCGCCCACCTATCCGTTCGCGCGCGTGCGCTGCCGGATTCCGGACGCGCCCGCGTCGCCCGCCGCGCCGCGCGACGGCGCGCCGTCGCATCCGCTGCTGCATCGCAACCGATCGACGTTCGGCGCGTACCGGTTCGAATCGCACTGGCGCGACAGCGATCCGCTCGTGCGGGACCACCGCGTGCAGGGCCGCGCGGTCGTGCCGGGCGTCGCGCAGCTCGAGCTCGCGTGCGCGGCGTTCGCGCGGCTGCAGCCCGAGGGCGCGGACGCGCCGCGCGGCGTCGTGCGGCTTGCCGATGTCGCGTGGGTGCGCCCGCTCGTCGTCGCGCCGCACGCGCACGTGCGCGTGGACGTCGCCCCGCCCGGCGAGACGGCGCACGGCGGAGCCGCGAGCTGGCGGGTCCATGCGTCGGCGCACGGCGGCGACTGGCAGCTTTGCAGCCAGGGCGACATTCGCCGCGTCGACGCGGCCGCGCCGGCCGAGCGCGCGGACCTCGCGGCGCTGCGCGCTCGATGCGCGGGGCGCGCGATCGATGCCGACACGCTGTACCGCGCGTTCGCGTCGCTCGGCATCGAATACGGGCCGGCGTATCGCGCGCTCGTCGACGTGCAGGTGGGCGAGGGCGGCGCGTTCGCGCGGCTTGCGCTGCCCGAGGCCGCCGCTTCGTCGCTCGACACGTGCGCGATGCCGCCGTCGCTGCTCGACGCCGCGTTTCAGGCCGCGGCGGCGTTCGCGATCGCGCGCGCGGCGAACGGCGACGCGGGCGAAGACGGTCCCGCGCCGCTGCCGTTTTGCGCGGACGCGGTCGAGCTGCATGCTCGGTGCGCCGCGCGGATGTGGGCGCACGTGCGGATGCGCGACGGCAAGCGCGACGCCGTCGACATCGATCTTTACGCGGACTCGGGCGAGCGCTGCGTCGCCGTGCGCAATCTGGTGAGCCGCCGCGCGACGCACGTCGCGGCCGCGAACATGGCTGCGGGCATCGCCGCGCAGCCGGCCGGCGCGAACGCCGAGGTCGCCTTCGAAGGCAACGTCGAAGCCGACGCGAACGCCGAGGTCGACATCGAAGCCAACATCGAAGCCAACGCCGAAGCATGGCGCGCGCCGGACGCGACAGGCGACATCGTGCTCGCGCCCGTCTGGGAGATCGTCGACGCGGCGGCCGGCACGCCGTTCTCGCCCGGCATCGTCGTCGCCGACGATGCGGCCGAGCGCGCGCGCTGGGCCGAGCGCTGTCCGCACGCGCGCATCGTCGGCGCGGATGCGTTCGCCGCGCGCGAGGTCGCGGCGGCGCTCGGCGCCGTCGACGCGTTCGTCTGGATCGCGCCGCGCGCCGCGCGCGGCGGCGCGCTCGCCGATTCGCCCGCGCTCGACTGCGCGGCGAACTGCTTCGAATGGATCGCGGCGCTGCTCGCCGCGGGCGCGGCGAACCGCGCGATCGACGCGCTGTTCGTCACGAGCGGCTGCCGCGCGATCGCCGCCGACGATCCGGGCGACCCCGCGCACGCGGCCATCGCCGGGCTCGTCGGCGCGCTCGCGAAAGAGCACCCGCGCTGGCGGGTGCGGATCGCGGATCACGCGTCGGCCGAGCCGGCGCCCGTCGACGCGCTGCTGCGGCTGTCGCCCGACCCGCAGGGCGACGCGCTCGCGTACCGCGACGGGCAGTGGCTGCGCAGGCGGCTGTTGCCCGTCGCGCGGGAGACGATGGGCGAGCCGGCCGCGCACCGCGCGGGCGGCGTCTATCTGCTGATCGGCGGCGCGGGCGGGCTCGGCGTCGTCTACAGCGAGTACCTGATCCGGCGCTACGGCGCGCAGGTGATCTGGGTCGGCCGGCGCGAGCGGGACGCCGACATCGACGCCGCCGTCGCCCGGCTCGCGGCGCTTGGCCCCGCGCCCGTCTACCGGCGTGCCGACGCGGCCGATCCCGCCGCGCTGCGCGCGGTGTGCGACGACGCGCGCGCGCGGTTCGGCGCGCTTCACGGCGTCGTGCATGCGGCGATGGTGCTCGCGGACCGCAGCCTCGCGCGGATGACGCAACAGACGCTGCGCGCGGCGCTCGTGCCGAAGATCGACGTCGCGCGCAGCATGGCGGCCGTGCTGCTGCCCGCCGCCGATCTCGATTTCATGCTGTTCTTCTCGTCGATGAACGCGTTCACGACGCAGCCGGGGCAGGGCAACTACGCGGCCGGCTGCACGTTCGTCGACGCATTCGCGCACGCGTTGCGCGCGCAGGCCGCGTGCGCGGTGAAGGTCGTCGACTGGGGGTTCTGGGGCAGCGCCGGCGCGGTGGCCACGCCGTATTTCCGCGCGCGCATGGCCGAGGCGGGGATCGGCTCGATCGAGGCGCCGCAGGCGATGCGCGTGCTCGAGCGTCTGCTCGCCGGGCCGCACGGCCAGCTTGCGATGATTCACGCGATCCGGCCGACGATGCAGGACGGCGCTCGGCGCTGGCTCGCCGCCGCGCCGGAACAGGCGGCCGCGTGGCGCGCGTGCGCGCCGGCGTGGCCGCCCGCGCCCGCGTTCGACGCGAGCGCGGCCGCGGCGCTCGACGCCGCGCTCGCCGGGACGCTCGCCGCGCGCCTCGCCGCGCTCGGCTGGCCCGAGCAAGGCTTGCCGCGCGCGTCGTGCGCGGCGCGGCTCGGCGTCGCTCCCGCGCATGCCGCATGGCTCGACGCGAGCATCGACATCCTGAAGCGCGCGGGTCTCGCGAGCGAGGCGGCCGACGGCACGGTGACGCTCGCCGCCGCCGCCGCGCGACCTGAAACGAATGCGGACGCGGCGTCCGGCGCGCCGACGAGCGCGCCGGGCACGGACGGCGCGCACGGGCAATCGGCGCAGCTCGCGCTGCTGCGCACGATGACCGACGCGCTGCCCGACATCCTGCGCGGCGCGAAGCGCGCGACCGACGTGATGTTCGCGAGCGGCTCGATCAATCAGGTCGAATCGGTTTATCGCGGCAACGCGGTGTCCGACTACTTCAACGACGTGCTGGCGGCCGCGCTCGACGCCTATCTGTCGCACCGCGCGCGCACCGCGCCGGGCGAGCCGCTGCGCATCCTCGAAATCGGCGCGGGCTCGGGCGGCACGTCGGCGCGGGCGCTCGAATGCGCAGACCGGTTCGCGCCGCAACTCGTCGAATACCGCTACACGGACGTGTCGGCCGGCTTTCTTGCGCATGGCCGCGCGACGTTCGCCGAAGGCCGGCCGTACCTCGCGTTCGCGAAGTTCGACGTCGAGCGCGACGCGCGCGCGCAAGGGCTCGAATACGGCCGCTACGACGTCGTCATCGCGGCGAACGTCCTGCACGCGACGCGCGACATGCAGCGCACCGTCGCGTCGGTGAAGTCGCTGCTCAAGCGCGACGGGCTGCTGCTCGTCAACGAGCTGAGCGCGAACACGCTGTTCACGCACCTGACGTTCGGCCTGCTCGACGGATGGTGGCGCTTCGACGACGGATTCCTGCGCCTGCCGGGCGGGCCGGCGCTCGCCGGCGCGCAATGGCGGGCGCTGCTCGCGTCGGCCGGATTCCATTCGATCGCATTCCCGGCCGCCGATGCGGCCGGACACGGGCAGACGATCGTCTGCGCGTCGAGCGACGGTGTCGTGCGGCTCGATGCGGCGGATGCGACGGGTGCGGATGATGCGGATGCACGCGGCGATGCTAGCGGCGCGCACGAGCTCGCCGCCGCACCGCTTGCCGCGCATCGGGACGGCGGGCGGGGCTCGGTTGCCGCAGTCGCCGACGCCGAGCCTGACGCCGACACCGACGCCGACGCCGACGCGCGGCTGCGCGACGCGGCGTCGGCATGGCTGCGCGCGCGGATCGGCGCGGCGCTCGACATTCGCGCGGACGACATCGATTCGCGCGAAACGCTCGAACGGTACGGGATCGATTCGATCACCGTGCTGCAACTGACCAAGCGCTTGCGCGATGCGTTCGACGACGTGCCGAATACGTTGCTGTTCGAATACAACACCGTCGATGCGCTCGTCGACCACTGGCTCGCGACGCAGCCCGACGCGCTGCGCGCCGCGCTCGCGAAGGACGCAGGCGAGGCGGTTGCCGGCGCGGCGCGCGACGGCCGCGAAAGCGGCCGCGCGGCGAGCGATGCGGCGTCGGCGCACGCGGTCAGTGGGGCCGCGTGCGCGAGTGTCGACGGTGCATACGCGAGCGGCGCGCGCTGCGGCGACGACATTCGCATCGCGACCGACGCCGGGCGCGCGACCGCCCCCGCAACCGTCACCACGGCCGCACCTATCGCCGACTCCAAGGCCGACTCCAAGACCGACTCGACGCCCCCCTATCCGCCGCACGCGCGCGAGGCCGAGCCGGTCGCCGTGATCGGCATCGCGGGCCGCTATCCGAAGGCCGCGTCGCTCGACGCGTTCTGGCGCAACCTGCGCGACGGCCGCGACTGCATCGGCCCGCTGCCGGCGCCGCGCGGCGACTGGCGAAGCAGCGGCGGCGCGCAAGGCGCGCCGATCGGCGGCTTCATCGACGACATCGACCGCTTCGATCCGCTGTTCTTCCAGATCTCGATGCGCGAGGCGCAGAGCATGGACCCGCAGGAGCGCCTGTTCATCGAGCAGGCGTACGCATGCGTCGAGGACGCCGGCTACACGCCCGCCACGCTGAGCGCGACGAAGCGCGTCGGCGTCTACGTCGGCGTGATGAACGGCAACTATGCGGGCGGCACGCGCTACTGGTCGATCGCCAACCGCGTGTCGTATCTGTTCGACCTGCACGGCCCGAGCGTGGCGGTGGACAGCGCGTGCTCGTCGTCGCTCACGGCCGTGCATTTCGCGCTCGACGCGCTGCGCGGCGGCTCGATCGATTGCGCGCTCGTCGGCGGCGTGAACCTCATCGTCGCGCCCGAGCATCTGGCGCGCCTGTCGGCGATGAACATGCTGTCGACGCGCGGCAAGGTGAGCGCGTTCGGCGCCGACGCGGACGGCTTCGTCGACGGCGAGGGCGTGGGCGCGCTGCTGCTCAAGCCGCTCGCGCGGGCGCAGGCGGACGGCGACGCGATCTACGGCGTGCTGCTCGGCAGCGCGATCAACGCGGGCGGGCGCACGCACGGCTACACGGTGCCGAGCCCGCACGCGCAAGCCGACGCGGTGGCGGGCGCGTATCGCGCCGCGGGCGTCGAGCCGCACATGCTCGGCTACGTGGAAGCGCACGGCACCGGCACGGCGCTCGGCGACCCGATCGAGATTCGCGGCCTCGCGCGCGCGTTCGAGCGGGACGCGGCCATGCGCGGCGGCTGCGCGATCGGCTCGGTGAAGACCAACATCGGCCACGCCGAGAGCGCGGCCGGCATCGCCGGGTTGACGAAGGTGCTGCTGCAGATGCGGCATCGCCGGCTCGTGCCTTCGCTGAACGCGGACACGCCGAATCCCGACATCGACTTCTCGCGCACGCCGTTCCGGTTGCAGCGGCGCGACGAGCCTTGGGCGCTGCCCGCGCACGCCGCGTGGCCGCGCATCGCGAGCGTGTCGTCGTTCGGCGCGGGCGGCGCGAATGCCGTCGTCGTCGCGCGCGAGCACGTGAGCGACGCGCGCGTGCCGCGCGCAGGCGCGGCGTCGGCGCAGGCGATCGTCGTGCTGTCGGCGCGCGACGACGACCGGCTCGCCGCGCGCGCGCGCCAGTTGCTCGCGTTCCTGCGCGACGCGCCCGACGACGGCGACACGCTCGCGCGGATCGCGTTCACGCTGCAGGTGGGGCGCGTGCCGATGGCCGCGCGCGTCGCGATCGTCGCGGGCTCGCTGTCCGAGCTCGCCGACAGGCTCGATGCGTTCGTCGCGGGCGACGAACGCGCGGCGGGCGTGCATCGCGGGCGGCCGGTGCCGCCGGGCGCGTCGGTCGTGCACGTCGCGGCCGCGCACGCAACCGACGCGGCCGCGCGCGCCGTGCTCGCGCGCGGCGTGCCGGACGACATCGCGCGGTACTGGGCGGACGGCGGCAACCCGGACTGGACGGCGCTCCACGCGGCGCACACGCCCGGGCGCATCAACCTGCCCGCGTATCCGTTCGCCGGCGAGCGTTTCTGGCTGAGCCCGGCGGCCTCGGGCGATGCGCCGGCGCGCCTCGCGGCGGCGGGCGCGGGCGCGAACGCGGCGGCCGCCGCGGCTGGAACCGGCGAGGCCTTTGCAACCGCCGAAGCCGCCGCCGACACCGACCTCGCCGACATCGACACCGACATCGACACGGCAATTGAAATCGCCGCGGCCGACGTCTTCGCCGAATTGGCCGCATTCGCCGAAACCGGCGCGACCCGCGACGACGACCTGCCGTCGCTTGCCGAGCTTTTCGGCGAGCCGGACGCCAACGCGGACGACGCGGACGACGACGTCGACGTCGCGCATCTGCGCGACGTGGCCGCGCAAACGCTCGGCGTCGTGCCGGAGCTGATCGAGCCCGACGCGCCGCTGCGCGATTACGGCTTCGACGCGGTGTCCCTCGCGCTTTTCGCGCAGACGCTGAATGCGACGTTGCGCCCGCGCGCCGGCCGGCGCCGCGTGTGCGCCGCGCAATGCGCGACGGCGGGAAGCCTGACCGAATTGGCGCGGCAGCTCCGCTTCGCCGCGCTCCATTGA", "orf_prot_sequence": "MERQNLRNVLERLKAAAIGPDEAKRMLSAARAGDAADKPQPGPAAAAPRDAEPIAVVGMSGRYPGSPDLDAYWSLLARGEDAVKEIPPARWNVGEYFDAEPGKPGAMYCKWLGALDDVDSFDSLFFRIPPSEAEFIDPQHRLFLEEAYRAFEDAGIAPGRLGGRACGVYLGIMSNEYNLLLARNAPDSGHAVANHFSIGAARIAYHLDLKGPAIPVDTACSSSLVAAHLACQALRAGEIDVALVGGVTLYLSPDAYIGMCAAGMLSPDGRCKTFDQRANGFVPGEGVGALVLKRLADARAHGDPIHGVIVGSGVNQDGRSNGMTAPNGASQTALERAVYERYGVDPDSFQYAELHGTGTKLGDPIELAALADAFRAYTGRRGFCAIGSVKTNVGHTSAAAGVASVQKVLLSMRHGQIAPSLHFREPNEHFDFAASPFYVSTALAPWPTPEHGPRRACVSAFGFSGTNAHMVLQADEPPSAGAAAPGAPAGGAPHLFVFSARTEPQLDALLDTYVAFLRRTRVAPESVAYTLQTGRDAMACRLAVRASSLAALADVLEQVRALACPDGVWRGRGAHREPAEKIDAALRARDLDTLGECWANGQTVDWAALYPHARPTRAHLPTYRFAPARHWFQAAPATPPDAAAVTAVTAAVVAAADDAAAATPFEQRASIPADAPCFVDHVIDGERVLPGSAYLELVRAALADARREPASGCLVLSDVRWRRTLQAGGGVRLRVVLSARGAPAAWKVVSADDGAIVYCSGSAQWEALAGARVDIDALRARVASATAVDANACYRRFASLGIEYGASHRLIETLSGDAQRALARLRAHGDDACAGEAADALPIGRLDAALQSVLGLALGDGGEGPSDAALPLGIGRLELYGPCADVVWVSVERARADGDVTLTLANADGLVRAAMRDITFAPKPPQHRAVPLVGAWRRARPAAPRASDAAPRWICLAGPLAAHAARVEQALSPARVAALPGDADEAGEHYASCVLTLVETLQAIARDHAAGARVDVVIPGDAAFHGHRGLASLLRTARQEMPRLRVALVECAAGAHAVVDALRAVQEHAEGEWQWREDGAWRRTWTPAELRGGGAPWRDGKLYWITGGAGALGMLLAAQIVEHAPAARIVLSGRSPLAGEAAETLRAWRERGVAIDYRELDVADRDAVVRTVREITARHGPLAGVVHAAGVRRDGLLIAKTREDVEAVLAPKVRGVLNIDAATRGQPLEFFVLFSSIAGALGNVGQADYAAANGFLDGFAQYRNARAARGERRGVTRAIGWPLWDAAGMTPDADTLAEIARAGLAPMPPSHGWRMLHAALDAPHDALAVLYGDARTIAARLAAAEMADAPDEAGAAGDAPAGGRGAGGGDAGLRAPVLARLKAMFADAFKMSPDDVLETAEFADYGIDSIVVLRMTRQLEKHFGPLSKTLLFEQRRLDDLADYFVRAYEAACAAWIGARADAARAGGARADHANGANGSADADAAAHAPGAVAAGSDAGAFDLRGRAAADGSAADGGDRMSGAIRASRECHESDEACARRAAASPDASPPRARPPHAATGARMNIAVVGLAGRYPKARDLDAFWANLAGGVDCIEEIPAERWDHARYYDSDRDATGKTYAKWGGFVDGVDEFDPLFFNISPKEASVMDPQERLFVQCAYEALEDAGYGRVALGGERPHGAERNIGVYVGVMYEEYPYFGVEHTLNGRPMALSGNPSSIANRVSYLLDLHGPSMAVDTMCSSSFTALHLACESLLSGQCRMAIAGGVNLSLHPNKFIALAQGGFAASDGRCRSFGEGGDGYVPSEGVGAVVLKPLAHALADGDHVYGLIQGIAINHGGKSNAYTVPNPDAQAGVIEAAYRRAGISPRDVSYLEAHGTGTALGDPIEIAGLVSAFRAFTDARQFCAIGSVKSTIGHCESAAGISALTKVLLQMKHGRLAPSLHARTPNPHIDFDASPFVLQRTLAPWPAPDGGTRIAGISSFGAGGTNAHVVVEEYRAAAAHAHDGAQAAASPAAVVLSARDDARLRALAQRLRDAVAAGRFAPHALHDLAFTLQSGRDHWERRIAMRVESFDELHAALDDFVAGRPVGARHWLGACRVGGASRRAPEPCASLDDAAAVWASGREVDWSPWRGARACRRVSAPTYPFARVRCRIPDAPASPAAPRDGAPSHPLLHRNRSTFGAYRFESHWRDSDPLVRDHRVQGRAVVPGVAQLELACAAFARLQPEGADAPRGVVRLADVAWVRPLVVAPHAHVRVDVAPPGETAHGGAASWRVHASAHGGDWQLCSQGDIRRVDAAAPAERADLAALRARCAGRAIDADTLYRAFASLGIEYGPAYRALVDVQVGEGGAFARLALPEAAASSLDTCAMPPSLLDAAFQAAAAFAIARAANGDAGEDGPAPLPFCADAVELHARCAARMWAHVRMRDGKRDAVDIDLYADSGERCVAVRNLVSRRATHVAAANMAAGIAAQPAGANAEVAFEGNVEADANAEVDIEANIEANAEAWRAPDATGDIVLAPVWEIVDAAAGTPFSPGIVVADDAAERARWAERCPHARIVGADAFAAREVAAALGAVDAFVWIAPRAARGGALADSPALDCAANCFEWIAALLAAGAANRAIDALFVTSGCRAIAADDPGDPAHAAIAGLVGALAKEHPRWRVRIADHASAEPAPVDALLRLSPDPQGDALAYRDGQWLRRRLLPVARETMGEPAAHRAGGVYLLIGGAGGLGVVYSEYLIRRYGAQVIWVGRRERDADIDAAVARLAALGPAPVYRRADAADPAALRAVCDDARARFGALHGVVHAAMVLADRSLARMTQQTLRAALVPKIDVARSMAAVLLPAADLDFMLFFSSMNAFTTQPGQGNYAAGCTFVDAFAHALRAQAACAVKVVDWGFWGSAGAVATPYFRARMAEAGIGSIEAPQAMRVLERLLAGPHGQLAMIHAIRPTMQDGARRWLAAAPEQAAAWRACAPAWPPAPAFDASAAAALDAALAGTLAARLAALGWPEQGLPRASCAARLGVAPAHAAWLDASIDILKRAGLASEAADGTVTLAAAAARPETNADAASGAPTSAPGTDGAHGQSAQLALLRTMTDALPDILRGAKRATDVMFASGSINQVESVYRGNAVSDYFNDVLAAALDAYLSHRARTAPGEPLRILEIGAGSGGTSARALECADRFAPQLVEYRYTDVSAGFLAHGRATFAEGRPYLAFAKFDVERDARAQGLEYGRYDVVIAANVLHATRDMQRTVASVKSLLKRDGLLLVNELSANTLFTHLTFGLLDGWWRFDDGFLRLPGGPALAGAQWRALLASAGFHSIAFPAADAAGHGQTIVCASSDGVVRLDAADATGADDADARGDASGAHELAAAPLAAHRDGGRGSVAAVADAEPDADTDADADARLRDAASAWLRARIGAALDIRADDIDSRETLERYGIDSITVLQLTKRLRDAFDDVPNTLLFEYNTVDALVDHWLATQPDALRAALAKDAGEAVAGAARDGRESGRAASDAASAHAVSGAACASVDGAYASGARCGDDIRIATDAGRATAPATVTTAAPIADSKADSKTDSTPPYPPHAREAEPVAVIGIAGRYPKAASLDAFWRNLRDGRDCIGPLPAPRGDWRSSGGAQGAPIGGFIDDIDRFDPLFFQISMREAQSMDPQERLFIEQAYACVEDAGYTPATLSATKRVGVYVGVMNGNYAGGTRYWSIANRVSYLFDLHGPSVAVDSACSSSLTAVHFALDALRGGSIDCALVGGVNLIVAPEHLARLSAMNMLSTRGKVSAFGADADGFVDGEGVGALLLKPLARAQADGDAIYGVLLGSAINAGGRTHGYTVPSPHAQADAVAGAYRAAGVEPHMLGYVEAHGTGTALGDPIEIRGLARAFERDAAMRGGCAIGSVKTNIGHAESAAGIAGLTKVLLQMRHRRLVPSLNADTPNPDIDFSRTPFRLQRRDEPWALPAHAAWPRIASVSSFGAGGANAVVVAREHVSDARVPRAGAASAQAIVVLSARDDDRLAARARQLLAFLRDAPDDGDTLARIAFTLQVGRVPMAARVAIVAGSLSELADRLDAFVAGDERAAGVHRGRPVPPGASVVHVAAAHATDAAARAVLARGVPDDIARYWADGGNPDWTALHAAHTPGRINLPAYPFAGERFWLSPAASGDAPARLAAAGAGANAAAAAAGTGEAFATAEAAADTDLADIDTDIDTAIEIAAADVFAELAAFAETGATRDDDLPSLAELFGEPDANADDADDDVDVAHLRDVAAQTLGVVPELIEPDAPLRDYGFDAVSLALFAQTLNATLRPRAGRRRVCAAQCATAGSLTELARQLRFAALH", "perc_identity": 23.86}}, "BGC0000186.1|Thailandamide_4 # 22774 # 39474 # -1 # ID=1_4;partial=00;start_type=ATG;rbs_motif=GGAG;rbs_spacer=5bp;gc_cont=0.747": {"gnl|BL_ORD_ID|1498|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 22774, "orf_end": 39474, "orf_from": "BGC0000186.1|Thailandamide_4 ", "model_name": "EXO-1", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "600", "model_id": "1480", "ARO_accession": "3003564", "ARO_name": "EXO-1", "ARO_category": {"41398": {"category_aro_accession": "3004234", "category_aro_cvterm_id": "41398", "category_aro_name": "EXO beta-lactamase", "category_aro_description": "Beta-lactamases part of this family discovered in Streptomyces albus G.", "category_aro_class_name": "AMR Gene Family"}, "36017": {"category_aro_accession": "3000008", "category_aro_cvterm_id": "36017", "category_aro_name": "penam", "category_aro_description": "Penams are a group of antibiotics derived from Penicillium fungi that share a skeleton beta-lactam moiety fused with a thiazolidine ring. This is the most defining feature of penicillins. Penicillin antibiotics are historically significant because they are the first drugs that were effective against many previously serious diseases such as syphilis and Staphylococcus infections. Penicillins are still widely used today, though many types of bacteria are now resistant. All penicillins are beta-lactam antibiotics in the penam sub-group, and are used in the treatment of bacterial infections caused by susceptible, usually Gram-positive, organisms.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 8.63022, "max_identities": 45, "bit_score": 29.261, "cvterm_id": "40173", "query": "NAHVIVDAYADARVATHDDAGPSVVVLSAMSEPALRQYARALRDAMRAAPAAEPLVARIAELLAEQLGVTADMIDPDADWREFG---VDAAQRRRLARALEAWLDIDDA--------LPERAALDSVAGLARQLRREHA-------RA--VDAALAGATDLGAARNDGAAALSLRAIAHTL", "match": "NA + V+   +  +   D+   ++++       A+ ++ R+L D +      EP      EL + + G   D   P A  R +G   +  A   R  R L +WL  +          LP+   L    G  R      A       RA  V   L   T+  AAR+DG  A + R +A TL", "sequence_from_db": "NAQLTVEELCEVSITASDNCAANLMLRELGGPAAVTRFVRSLGDRVTRLDRWEP------ELNSAEPGRVTDTTSPRAITRTYGRLVLGDALNPRDRRLLTSWLLANTTSGDRFRAGLPDDWTLGDKTGAGRYGTNNDAGVTWPPGRAPIVLTVLTAKTEQDAARDDGLVADAARVLAETL", "sequence_from_broadstreet": "MHPSTSRPSRRTLLTATAGAALAAATLVPGTAHASSGGRGHGSGSVSDAERRLAGLERASGARLGVYAYDTGSGRTVAYRADELFPMCSVFKTLSSAAVLRDLDRNGEFLSRRILYTQDDVEQADGAGPETGKPQNLANAQLTVEELCEVSITASDNCAANLMLRELGGPAAVTRFVRSLGDRVTRLDRWEPELNSAEPGRVTDTTSPRAITRTYGRLVLGDALNPRDRRLLTSWLLANTTSGDRFRAGLPDDWTLGDKTGAGRYGTNNDAGVTWPPGRAPIVLTVLTAKTEQDAARDDGLVADAARVLAETLG", "dna_sequence_from_broadstreet": "GTGCACCCCAGCACTTCCCGTCCCTCCCGCCGCACCCTGTTGACCGCCACGGCGGGCGCAGCCCTGGCCGCCGCCACACTCGTACCCGGTACCGCGCACGCCTCCTCCGGCGGGCGGGGCCACGGTTCCGGTTCCGTCTCCGACGCCGAACGGCGGCTCGCGGGGCTGGAGCGGGCCAGTGGGGCGCGGCTCGGGGTGTACGCGTACGACACGGGGAGCGGGCGGACGGTCGCGTACCGGGCCGACGAGCTGTTCCCGATGTGTTCGGTGTTCAAGACGCTGTCGTCGGCGGCCGTTCTGCGGGACCTCGACCGGAACGGGGAGTTCCTGTCCCGCCGGATCTTGTACACGCAGGACGACGTGGAGCAGGCCGACGGCGCCGGCCCCGAGACAGGCAAGCCGCAGAACCTGGCCAACGCGCAATTGACCGTCGAGGAGTTGTGCGAGGTCTCCATCACCGCCTCCGACAACTGCGCCGCCAACCTCATGCTGCGCGAGCTGGGCGGGCCCGCCGCCGTCACCCGGTTCGTCCGCTCGCTCGGTGACCGGGTCACCCGGCTCGACCGCTGGGAGCCGGAGCTGAACTCCGCCGAGCCCGGCCGCGTCACCGACACCACCTCGCCGCGCGCCATCACCCGCACCTACGGCCGCCTCGTCCTCGGCGACGCCCTGAACCCGCGCGACCGCCGCCTGCTCACCAGCTGGCTCCTGGCCAACACCACGAGCGGCGACCGGTTCCGCGCGGGGCTCCCGGACGACTGGACCCTCGGCGACAAGACCGGCGCCGGCCGCTACGGCACCAACAACGACGCGGGCGTCACCTGGCCCCCCGGCCGCGCGCCGATCGTCCTGACCGTCCTCACGGCCAAGACCGAGCAGGACGCCGCCCGCGACGACGGGCTCGTCGCGGACGCGGCCCGGGTACTGGCGGAGACGCTGGGCTGA", "partial": "0", "query_start": 25591, "query_end": 26073, "hit_start": 414, "hit_end": 939, "orf_dna_sequence": "ATGGAAGACCAAGTCGTACTGACTTCGCAACATCCGCTGCTCGACGCCCACCGGATCGACGGCGAACCCTGGCTGCCGGGGCTCGCCTATCTCGACCTCGTCTATCAGCTCGGCGAGGCGCGCGGCATCGCGTTCGAGCGTCACGCGCTGCACGACCTCACGCTGCATGCGCCGCTTGCCGTCGCCGATGGCGAGGCGGTCGTGCTGACGCTGCGGTGGCGCGACGAACGCGCCGACGGCTGGCATCTGACGATCGAAGGCGCGCCGCTCGACGGCGGCGAGGGCGCGGCGCCGCGCCGGCTCGTCACCGTCCGGCTGCGCGAGGCCGCGCCGGCCGCCTTCGGCGCGATGCGTGACGGCGACATGGACGCGCCGGCCGTACTCGGCGCGACGCATGACGGCAACGTCGGCACAGCCGGCGACATCGTTCACGGCAACGGCGAAGCGACCGTCGTCGATCTCGCGTCGCTGTACGCACGCTGCCGCTCGCTCGGGCTCGTGCACGGCGCGGCGATGCAGGCGCGGGGCACCGCGCGGCTGACGGCCGAGCAGGTGCTCGTCGACGTGCGGCCGGCGACGGCCTCGCGACAGGCGGAAGGCGATACGGAGCGCAATACGGACGGCAATGCGGACGGCGACGCCGGTCCGTATCTGTTCGATCCCGCGTTGATCGACGGCAGCGGCATCGGCTCGGCTGCGTTCTTCGCGCATCTGTTCGACGACGCCGATGCGCCGCGCCTCTACCTGCCGCTGCATATCGGCGCATTCCGGGCGACGCGGCCGATTCGCGCGCACGTGCTCGCGCGCGTGCGCCGGGCGTCGGTGCGCCGGCGCCGCGAGCTCGTTACGGTGACGTTCGAATTCTTCGATCCCGCGACCGGCGAGCAGATCGCCGAGCTGACCGACGTGACCTGCAAGGCGGTGCGCGACGCGCGCGACGGCGCGCCGGCGCGGGCGCGCACGGATGCGGCGTCCGGCAGCGCGTGTTCCGGCGCGTGTTCCTGTGCGGCGCCCGCCGCGGCGCGAACCGTTGACGGACGAACCGACGGCGCGCGAACGGAACGCGCGCTGCCGGACGACGCATCACCGCCGCCCGGCGCGCGGGCCGAGCGATTCGTGCGCGACGCGATCGCCGCGCGGCTCGGCGTCGCGCCGGCCGCGATCGATGCGGACGCGGGCTTTTACGATCTGGGCCTCGACTCGGGCATGCTGCTCGAACTGGCGGAGACGATCGGCGCGGCGATCGGCGCGTCGTTGGCGCCGACGCTGCTGTTCGAGCACGCGAACGCGCGCGAGCTCGGCGCATGGCTCGACGCCGAGCACGGCGCCGCGTTCGCGGCGCGCGCGACGCCGCCGCATCGCGAGACCGAAGACGCGGCCCGGCATGCAGCGCCGCGAGCCGGCGCGGGCGATGCGAACGGTGCGCGCGACGGTGCGCGCGCGGGGACCGACGCGAACGACGCCGGCAACGCGAACAGCTCGAACGGCTCGAATCCCGTCGCCCGCCCGCCTGCGTCCGTGCGCTGCGGCTCGCTCGACATCGCCGTCGTCGGCATGGCCGGGCGCTACCCCGGCGCGCGCGATCTGGACGAATTGTGGGCGAACCTGCGCGACGGGCGCGACTGCGTGACCGAGGTGCCCGCCGAGCGCTGGCGCGCCGACGACGTCGCGCACGTGCGTTCGCCGTCGGGCAAGCCCGTGTCGCGATGGGGCGGCTTCATCGACGCGCCCGATTGCTTTGACGCGCGCTTTTTCCGGATCACGCCGCGCGAGGCGGAAGTGATGGACCCGCAGGAACGCGTGTTCCTGGAAACGGCGTGGGCGGCGATCGAGGACGCGGGCCACACGCCCGACACGCTCGCGCGCCGCGCGCCGGGCGGCGGCGACGCGGGCGCGCCCGTCGGCGTGTTCGTCGGCGTGATGCAGAGCGAATACGCGCTGATCCAGCGCGACGCGCTCGCGGGCGCGCCGACGCCGCTCGCCGTCAACCGCGCGCCCGTCGCGAACCGCGTGTCGTACGTCTGCGATTTCCACGGGCCGAGCGTCGCGATCGACACCGCGTGCTCGTCGTCGCTCGTCGCCGTGCACCTCGCGGCGCAGAGCCTCGCGGCCGGTGAATGCGCGGTTGCGATCGCGGGCGGCGTGAACCTGTCGCTGCATCCGGCGAAGTATGTGTCGTGCGCGCTGATGGACATGCACGCGTCGGACGGCCGCTGCCGCAGTTTCGGCGCGGGCGGCGACGGCTACGTGTCGGCCGAGGGCTGCGGCGCGCTCGTGCTCAAGCCGCTTTCGGCCGCGCTCGCGGACGGCGACGCGATCCACGGCGTGATTCGCGCGAGCGCGACGAACCACGTCGGCGCGGTCGCCGGCATCATGGCGCCGAGCCCCGCCGCGCAGGCCGCGCTGATCGGCGAGTGCCTGCGTCGCGCGAACGTCGACGCGCGCACGATCGGCTATGTCGAGGCGCACGGCACGGGCACCGCGCTCGGCGATCCGATCGAGATCGACGGGTTGACGCGCGCGTATCGCGCGCACACGCGCGACACGCAGTATTGCGCGCTCGGCTCGATCAAATCGGCGGTGGGGCACGCGGAGGCGGCGGCGGGCGTCGCCGGACTCACGAAGGTGCTGCTGCAGATGCGCCATCGGACGATCGCGCCCTCGCTGCACGCGCAGCCGCCCAATCCCCACATCGATCTCGCGGCGTCGCCGTTCTTCGTGCCGGCGCGGGCGATGCGGTGGGAGCCGCGCGCGCTTGCCGGCGGCGGCCGCGCGCCGCTGCGCGCGGCGGTGAGCTCGTTCGGCGCGTCGGGCACGAACGCGCACGTGATCGTCGACGCGTACGCGGACGCGCGCGTCGCGACGCACGACGACGCGGGGCCGTCCGTCGTCGTGCTCTCCGCGATGAGCGAGCCGGCGCTGCGGCAGTATGCGCGCGCGCTGCGCGACGCGATGCGCGCGGCGCCGGCGGCCGAGCCGCTCGTCGCGCGCATCGCCGAGCTGCTCGCCGAGCAGCTCGGCGTCACAGCCGACATGATCGATCCCGACGCGGACTGGCGCGAGTTCGGCGTCGACGCCGCGCAGCGGCGGCGCCTCGCGCGCGCGCTCGAGGCATGGCTCGACATCGACGACGCGCTGCCCGAGCGCGCGGCGCTCGATTCGGTCGCCGGGCTCGCGCGGCAGTTGCGGCGTGAGCACGCGCGCGCCGTCGATGCGGCGCTCGCCGGCGCGACGGACCTGGGCGCGGCGCGCAACGACGGCGCGGCCGCGCTGTCGCTGCGCGCGATCGCGCATACGCTGCAAGTGGGCCGCAAGGCGCTGCCCGAGCGCGCCGCGTTCGTCGCGCGCGACGTCGCGCATCTGGCGCGGCTGCTCGACACGTTCGCCGCGACGGGCGACGCGCCGCGACCGGACGGCCATCGCGGGCGAGCCCGCGCCGACGAACAGCCGGCCGAGCCGCTTTCGCCGCAACACGCGGACCCGCACCGGCTCGCCGCCGCGTGGGTCGAGGGCCGGGCGATCGACTGGGCGGCGGCGTATTCGAGCGGCGCGCCGCGCCGCGTGAGCCTGCCGACCTATCCGTTCGAGCGGCGGCGCTATTGGGTTCGCGCAGCGGATGCCCAGTCCGCCGTGCGCGCGACGGCCGACGGCGCGACTGCGCCGGACGCCGACGCGAAAGCCGATGTAAAAGCCGATGCAAGGGCTAATGCAAGGGCCGATGCGCAAGCCGGCGCGCACGTCGACGCCGGTGCGGCGGCCGCAGCCGCAGCCGCGGTCGCGGACATCCTGCAATCGGTCACCGGGCTGGGGCCGGACGAATGGCGCGACGATACGACGTTCGATGCGCTCGGTCTCGATTCGCTGATGATCGGCGAGTTCACGCGCCGCATCGAGGCGATGACGGGCGAGCGCGACACGACGCTGCTGTTCCGGTTCCGCGACTTGACCGCGCTCGCCGCGCATCTCGCGCATCGTCATCCGGCTGCGTGGCGGGCGGATGGGGCGCAGCGCGCGTCGTCCGCCGCATCGACGCCCGCGCCCGCGCCGGCGCAAGCCGGATCGCCGCCCGCGGCCCTCGCATCGCGCGCCGCGCGGCCGGCGCCGCGCGAGACGGCCGCCGCCGCGCCGCTCGACATCGCGATCATCGGCCTCGCGGGCCGCTATCCGCATGCGCCGACGCTTGACGCGTTCTGGCGCAACCTCGTCGCGGGCCGCGACTGCGTCGACGAGATCCCGCCGCAGCGCTGGCCGCTCGACGGCTTCTACGAGGCCGACCCCGCGCGCGCGGCGGCCGAGGGCAAGAGCGCGAGCAAGTGGGGCGCGTTCCTGTCCGATGTCGACCAGTTCGACCCGCTTTTCTTCGGCATCACGCCGAACGAAGCGCGGCTCACCGATCCGCACGAGCGGCTCTTTCTCGAAACCGCGTGGGCGTGCGTCGAGGACGCCGGCTACACGCGCGCGTCGCTCGCCGCGCTGCGCGACGGCCCGGGCGTCGGCGTGTTCGTCGGCGCGAGCTTCAACCAGTATCAGCTCATCGTGAGCGACGCGGCGCAGCGGCGCGGCGCGCGGCAGTTCGCGGCGCCGAGCCAGATCTTCTCGATCTCGAACCGCGTGTCGTACGTGATGAACTTCACGGGGCCGAGCCTGACCGTCGACACCGCGTGCTCGTCGTCGCTCTATGCGATCCATCTCGCATGCGAAAGCCTGCGGCGCGGCGAATCGAGCGTCGCGCTCGCGGGCGGCGTCAATCTTTCGCTGCACCCGAGCAAGTACGTGTCGCTGTCGCTCGGGCGCTTTCTCGCCGCCGACGGCCGGTGCCGCGCCTTCGACGAAGGCGGCACGGGCTACGTGCCGGGCGAGGCGGTGGGCGCGGTGCTGCTCAAGCCGCTCGCCGACGCCGAGCGCGACGGCGATGCGATCCACGGCGTGATCCGCGGCAGCGGCGTGAGCCACGGCGGCCGGACCAACGGCTTCGCGGTGCCGAGCCCCGACGCGCAGGCGCTCGCGATCCGGCGGGCGGTCGCGCAGGCGGGCGTCGCGCCGCGCAGCGTCGGCTACGTCGAGGCGCACGGCACGGGCACCGCGCTTGGCGATCCCGTCGAGATCGCGGGGCTGGAGGACGTGTTCCGCGCGGGCACCGACGACGTCGGGTTCTGCGCGATCGCGTCGGTGAAGACGATGATCGGCCACAGCGAGGCGGCGGCCGGCATCGCGCAGTTGACGAAGGTGCTGCTGCAGATGAAGCACGCGACGCTCGTGCGCAACCTGTCGCACGGCGGCGCGCCGAACCCGAACCTCGCGCTCGAACGCTCGCCGTTTCGCGTCGTGCGCGACAACGAGCCGTGGGCGGCCGGCGACGGCGGCGTGCGCCGCGCGGGCGTGAGCAGCTTCGGCGCGGGCGGCGCGAACGCGCACCTGATCGTCGACGCGTACCGCAACGCGCCCGAGCCGCGCGCGGGCGCGGACAGCGGCACGGACGACGCGCCCGCGCTGTGCGTGCTGTCGGCGAAGGACGACGCGCGCCTGCGCGAGATGGCGGCCCGGCTCGCCGCGCATCTGAGCGACGCGCGTCTCGGCGACGCGGACCTCGCCGACGTCGCGTTCACGCTTCAAGTCGGGCGCGAGCCGATGAACCGGCGCGCGGCGTTCGTCGTCAGCCGCGTGCGCGACGCGATCGATCTGCTGCACGCGATCGCGCGCGGAGACGAAGCGTCCGGCGCGCAGGCGTCCGGCGTGCTGCGCGGCGACGTGCGCGCGGCGGACGCGCAGCACGCGCCCGCCGTCGACGAGGCGACGCTCGCGCGCTGGCCGGCGGCCGACGCGGCGCGCGCGATCGCCTCCGCGTGGGTGCGGGGCGCGGCGATCGACTGGATGCGGCTGCGCCGCGCGCCGTCGGTGCGACGCATGTCGCTGCCGACCTATCCGTTCGCGCGCGAATCGTACTGGGTGCCCGGCGTCGCGCCGCAGTCGGCGCTTGCGCCGGCCGCCGGCCGCGCGAGCCGGGCCGTTGACGCGCACGGCGAGCACGGCGCGCCGCGCGCCGACGCGCCGGTTTGTCCGCCGGCCGGCCGCGCGCAGGAAACGCCGGGCACGGGCGTGCTCGTGCTCGCGCCGCAATGGCGGCCGGCCGAATGCTCGCCGAGCGCGAGCGCCGCGCCCGCGTTCGATGCGCGCGTGCTCGTGCTCTGCGAGACGCCGGCTTCGTTCGGCGCGGCGCTGGCGCCCGCGCTCGCGGACGGCGCGCGGATCGTCGCGCTGCGCTCGGACGAGCGCGATCCCGCCGCCCGCTTCGCGTCGCATGCGGCGCGCCTCTTCGCGCTCGTCAAGGACGAACTGCAGGCGCTCGCGAAGCGTCCGCTCGCGCGCGCGCTGCTGCAGGTCGTCGCGCCCGCGAGCGACGATGCGTGGGACTGCGCGGCGCTCGCCGCGCTGCTGAAGACGGCGGCGCAAGAGAATCCGCGTCTCGTCGCGCAGTGGATCGCGTTCGACGCGTGGCCCGATGCCGGCGGCGCCGCCGCGCGGCTGCGCGAGAACGCATCGGCGGCGGGCGACGTCGACATCCGCTATCTCGACGGCCGCCGCCACACGCTGCGCTGGGCGCAGACGCGGGCGGCCGACCGCGCGTTCGGCTGGCGCGCGAACGGCGTGTTCCTGATCACGGGCGGCGCGGGCGGGCTCGGCGCGCACGTGGCCGCGACGATCGCGCGCGGCGCGGTGCGCCCGACGATCGTGATCGCGGGCCGCTCGGCCGAAGGCGCGGCGCAGACCGCGCTGCTCGACGCGCTGCGCTCGGCGGGCGCGCGTGCGCAGTACCGGCAGGCCGACGTCGCGTCGCATGCCGATTGCGACGCGCTGATCGCCGGCTGCGTCGCCGAGTACGGCGCGCTGCACGGCGTCGTTCACTGCGCGGGCGTGATCCGCGACGGCTTCATCGTGCGCAAGCGCGCCGAAGACCTCGCGGCGGTATGCGCGCCGAAGGTGGCGGGCGTCGTCCATCTGGACGCGGCGACGCGGCGGCTGCCGCTCGATTTCCTGCTGTGCTTCTCGTCGGCGGCCGGCGCGCTCGGCAACGTCGGCCAAAGTGACTATGCGATGGCGAACGCGTTCATGGACGCGTTCGCCGCTCACCGCAACACGCTCGTCGCGCGCGGACAGCGGCGCGGGCGCACGTGCTCGATCGGCTGGCCGATCTGGCGCGACGGCGGCATGCGCGTCGATGACGCGACGCTCGCGGCGCTCGAAGCGCGCGCGGGGATGCTGCCGCTCGCGATCGACGAAGGAATGCGAACCATGCAAGACTGCCTTGCGCTCGATGCGCCGCACGTGATCGTCGCGGCTGGACACTTGACGACGTTGCGCCGGCTGCTGCGCGTCGATGCCGGCGCGGCCGGCGGGCATGCTGCGGATTCGGCCGATGCGGAAGCGGCCGATGCGGACGCGCGCGCGGCGAGCCCGGCCGGCGCGAATGCGGCCGTTGCCGATGCGGCAGGCGGCGATCGGGCCGGCATGAACACGGTCGGGCCGGACGCGCCCGGCGCGACGGCGCTCGCCGAAGGTCAGGCGGGCGCACGGGCGGCCGGCGAATCCGCGCCGGGCGACGACGTTGCCGGGACGCACGCCGCTTCGGGTGACGCGTCGCTTGCGGCGGCCGTCGCCGAGCGGCTCAAGCACGTGCTGAGCGAGGCGACCGGGATCGCCGTGTCGCGCCTTGACGCCGACGAGCCGTTCGACGCGTACGGCGTCGATTCGGTCGTCGTGATGACCGTCAACCGCGCGCTCGACGACGTGTTCGACGCGCTGTCGCAGACGCTGCTCTACGAATACGGCACGCTCGGCGCGCTCGCGGGCCACCTCGCGCACGCGCACGAAGCGGCGTGCCGCGACTGGTGCGGCGTCGCCGCGGCCGCGCGGCCGGGCGCGCGCGCCGCCGACGTGCGCGTGCGCGATACGCTCGCCGTCGACATGTCTCGCCCGGACGTGCGGACCCCGGACCTCCGGGTATCCGACGCGCGGGGCTTCGACGAGCGGGTATCCGACATGCGGGACTCCGACGCACAGGCCTCCAGCGCGCAGGCCTCCGACATGCTGGCCCGCGACACGCGCGACATCGACGCGCAGCGCATCGCCGACGCCGAACGGCAGCCCGCCGAGGACGGCGACGCGACGGCCGTCGGCCGCGCGGGAGCGCGCGCGCCCGGTGCGTCGTCCGATGCATTCGTCGGGGCGGCCGGCGCGGCCGCGGCCCCGGCCGGCCGCGACGAGCCGATCGCGATCATCGGCATCGCGGGCCGCTACCCGCAGGCGAGCGATCTCGACCAGTTCTGGCGCAACCTCGCGGGCGGCGTCGACAGCGTGACGACGATCCCGCCGGGCCGCTGGCCGCTCGAAGGCTTCTTCGAGCCGGACCGGGCGCGCGCGCTCGAAGCGGGCAAGAGCTACGGCAAGTGGGGCGCGTTCCTCGACGATCACGAGCGCTTCGATGCGCCGTTCTTTCAGATGTCGCCGCTCGAGGCGATCAACCTTGATCCGCAGATCCGGCTGTTCATCGAGACCTGCTGGGCGGCGCTCGAGGACGCGGGCTACACGCGCCGCCTGCTCGCGGAGCGCCACGGCAAGCGCGTCGGCGTGTTCGCGGGCATCACGAAGACGGGCTACGCGCTGCACGGCCCGCGCGTGTGGCCGCTCAGGCAGAGCTACAACCCGCAGACGTCGTTCAGCGCGCTCGTGAACCGCGTGTCGTACGTGCTCGACCTGCACGGCCCGAGCGTGCCGATCGACACGATGTGCTCGTCGTCGCTCACCGCCGTGCACGAGGCGTGCGAGCACATCCGCTCGGGCGCGTGCGCGCTCGCGCTCGCGGGCGGCGTCAACCTGTACCTGCATCCGTCGAATTTTCTCGAGCTGGCGGGCGTGCAGATGCTGTCGGCCGACGGGCGCTGCAAGAGCTTCGGGCAGGGCGCGGACGGCTTCGTGCCGGGCGAGGGCGTGGGCGCGGTGCTGCTCAAGCCGCTGTCGCGCGCGCTTGCCGACGGCGATCACGTGCACGCCGTCATTCGCGCGACGGGCATCAACCACGGCGGCAAGGTGAACGGCTTCACGGTGCCGAACCCGAACGCGCAGCGCGAGCTGATCCGCGCGACGCTCGAACGCGCGGGCGTGCGCGCGCGCCGCGTGAGCTACGTCGAGGCGCACGGCACCGGCACCGATCTCGGCGATCCGATCGAAGTCGCCGCGCTCGCGCAGGCGTTCGCCGCGAGCGGCGGCGATCGCGACACGGGCTACTGCGCGCTCGGCTCGGTGAAGTCGAACATCGGCCACCTGGAGGCCGCGGCCGGCATCGCCGGATTGACGAAGGTCGTCCTGCAGATGACGCACGGCATGCGCGCGCCGACGCTGCACGCGCGGATTCCGAACGAGAAGATTCCGTTCGCGCGCACGCCGTTCGTGCTGCAGCGCGAGCGCGACGACTGGCCGCACGCGCACGGCGACGCCGCGCAGTCGCGGATCGCGACGGTATCGTCGTTCGGCGCGGGCGGCGCGAACGCGTTCGCGGTCGTCGAGGAAGCGCCGCGCCGCGAGCGCGACGCGCGGCCCGACCGCCCCGAGGTGATCGTGCTGTCGGCGCGCGACGCCGACCGGCTCGCCGCACGCATCGCGCAGTTGCGCGGCCGTCTGCGCGAGGGCGTGCCGTACTCGCTCGCCGAGATCGCCTACACGCTGCAAGCCGGCCGTGAGGCGATGGCCGAGCGGATCGCGTTCGTCGCGGACTCGCTCGACGCGCTCGTCGACACGCTCGACACGCTCGACACGCTCGACACGGCGGGCGGCGCGCCGAATCCGGCGGCCGGCGCGGCGGCGGCGCGCGTGCATCGCGGCAGCGGCGTGACGCGCAAGACGCCGCTGTCGTTCCTGGCCGACGACGATCTCGCGGACACCGTGCGCGCGTGGCTCGCGAAGGGCAAGCTCGATCTCGTCGCGCAGGCGTGGGCGAGCGGCGTCGACATCGACTGGACGTTGCTGCACGGCGATCGCACGCCGCGCCGCGCGAGCCTGCCGGCCTATCCGTTCGCGGGCGAGCGGCACGCGTTGCCCGATGCGGCGCAGCCCGTCGCGGCGCACGCGCTGCATCCGCTGCTGCAGCGGAACACGTCGACGCTCGAGCGGGTGAGCTTCGCGTCGGTGTTCGGCGGCGACGAAGCGTTCCTGCGCGATCATCGCGTGTCGGGCCGGCCCGTGCTGCCCGCCGTCGCCTACATCGAAATCGCGTATCGCGCGCTGCGCGAGGCGGGCGTGCCGGGCGACGCGGTGCGCTTGACCGATCTCGTGTGGATGCGGCCCGCAATCGTCGAAGGCGAGCCGCTCCACGTGCGCGTCGAGCTCGCTTCCGAAGCTTCCGAAGCTTCCGAAGCTTCCGATACGTCCGATACGTCCGATACGTCCGATGCGGCGGGCGACACGCTCGCGCTGACGATCGGCGCGGCCGCGCCGTCCGGGCGCGGGCAACCGGGCTTCGCGACGGTGTTCGCGCGCGCTCGCGCGCGTCGCGTGCGCGTCGCCGCGCCGGCCGCGCTGCCGCTCGCGCGCTGGCGCGCGCAGTGCGGCGCCGCAATGACGGCGGATGACTGCTATCGCGTGTTCGAACGCGTCGGCCTGGCGTACGGCCCGGCGTTCCGCACGCTCGACACCCTCTGGCGCGGCGACGGCGTCGCCGTCGCGAAGCTGCGCGCCGCGTCGCCGCCGGCCGCGCCGCACGCGGCGGCCGACGTCGTCGATTCGCTCGACTGCGGCCTGCTCGACGGCGCGCTGCAGGCGGTGCTGGGCCTCGCGCCCGCATCGGACGCCGAGCGGCCGCTGCTGCCGTTCGCGCTCGACGCGTGCGAGCTTTACGGCGAGCGGCCCGACGAGCCGTGGTGCGTCGTGCGGCGCACCGAAGACGCGCGCGTCGACGTCACGCTGTGCGGCCCGCAGGGCGAGCCGTGGATCGCGCTGCGCGGCCTCGTGCTGCGCCGCTACGAAAGCGCGCCCGCCGCCGAGCGCGGGCTCGTCGCGCTCGCGCCGCAATGGCGGCGGGCGGACGCGACGCCCGTCGCGGCCGCCGCCGCGCCCGCATTCGCCGACACGCTCGTCGTGCTCTGCGGCGCGCAGCGTCTAGACGCCGGCGGCAGCGCGGATCGCATCCGCGTCGTGACTGTCGCGAACGATGCGACGCCGATCGGCGAGCGCTTCGCACAGACGCTGCAGGCGCTGATCGCCGAGACGCAGGCGCTGCTGCGCGACCGGCCGGACGCGCCCGCGCTGTTGCAGGTGGTCGTGCCGGATACGCCGGCGTTCGCGCCGATGATCGGGCTGGCGGGCTTTCTGCGCACGCTGTCGCACGAGGCGCCGCACATGTGCGGCCAATTGCTGCTGGTTCCGGCGCACGACACGGGCGCCGCGCTGCGCGCGAGGCTGGCCGAATGCGCGGCGCGCGCGCACGAAACGGTGGTGCGCTACGGGCAGGGGCCGGCGCGCGACGTGCTGCAGTGGCGCGAGTGGGCGGACGCGATGCCGCCGGCCGATGCCGGCCAGACGGCCGACGCGCATGCGGCGCCCGTCTGGCGCGACGACGGCGTGTATCTGGTGACGGGCGGCGCGGGCGGGCTCGCGTGGCTGCTCGCGCAGGACATGGCCCGGCGCGCCCCGGGCGCGCGCATGGTGCTTGTCGGGCGGCGGCCGCTCGACGCGCGCGCCGCATCGTCGCTCGATGCGCTGCGCGCGCGCATCGAATACGTCGAGGCCGATTGCGCCGACGCCGACGCGATCGCCGCGGCGGTCGCGTCCGTGCTCGAGCGCCACGGCCGGCTCGACGGCGTGGTGCACGCGGCGGGCGTGCTGCGCGACGAATTCATCCGGCGCAAGACGGCGGACGGCGTCGCGGCGGTGCTGCGCCCGAAGGTCGACGGCACGCTCGCGCTCGACCGCGCGACGCGCGACGTTCGCCTCGCGTTCTTCGTGCTGTTCTCGTCGGCCGCCGCGCAGGCCGGCAATCCGGGGCAGGCCGACTATGCGGCCGCGAACGGTTTCATGGACGGCTTCGCGCAGTATCGCCGCGCGCTCGTCGCGCTCGGCGAGCGGCACGGCGCGACGACGAGCATCGACTGGCCGCTGTGGCGCGACGGCGGGATGCGCATCGGCGCCGACGCGCAGCGCCTGCTCGAAACGCAGACGGGGATGTCGGCGATGCCGGGCGACGCGGGGCTCGCGTTCTTCCATCGCGCGGTGCGCGCGGGCGTGGCGCAGGTGATGCCGCTGTACGGGAATCCGGCGCGTCTGCGTGACGCGCTTGCGCCCGCCGCGCGCGACGACGCGGGTTCGGCCGCCGATGCGGCCGGCGCGAGCGACGCGGGCAGCGCGTACGCGGATGCCGGCGACGCGCGCGGGATGGCCGGCGCCGTGCTGATCGCGCGTCTTCGCGATGCGCTTGCCGCGGCGCTCGGCGTCGCGCGCGACGCGCTCGACGCGCACGTGCCCGTCGGCGAATTCGGCGTCGACCGGCAGGTGCTCGACGCGCTTGTCGAGCAGGTCGAGCCCGGCGGCGCGGTGCGTCGGGCGGAACTGCTCGATACGCGGCTCACGCTCGACGAGATCGCGTCGCGTCTTGCCGCCGCGACGCGCGGCGACGCGCACGCGGCGCACGCCGCTTCGCCGCGCGGCGAAGCGGGCGAGGCGCAGGAAGCGCCGCAAGCATACGAAGCGCACGGCGCGCATGAAGTGCCGCCGTTGGCCGAGCCGCGCGCGTCCGAGCTCGTCGACGCATCGCTCGCGCTGCTGACCGAGCGGCTTGCCGACGTGATCAAGCTGCCCGCGCCGCGCATCGATCCCGATGCCGAGCTCACGACGTACGGCATCGATTCGGTCGTCGTGATGCAGGTGACGACGCAACTCGAAAAGCAGCTCGGGCCATTGTCGAAGACGCTGTTCTTCGAATACGGCACGCTGCGCGCGATCGCGGCGCGCGTCGCGCACACGCATCGCGAGCGGGTCCGCGCGCTCGTCGAGCGGCGCGCCGCAGGCACGCAGGCGGCATCGGCGGCATCCGTCGCATCGCACCCGGCTGCGCCGCACGGCGCGAGGCCCGCGCACGAGCGGCGCGCCGACGCCGACGCGGCGAGCGTTCGCGGGGCACCGCGCGCCGTTGCCGCGAGGTCGTCGGCGGAGGTCTCGCGGGCAAGCGCGACCGCGAACACGAACACGACCACGACCACGACCACGACCGCGACCGCGACCGCGACCGCGACCGCGACCGCGACCGCGACCACCAACACGACTGAGAACGCCGCGCCGCACGCGTCGCGCGGCGATCGCGACGCGCGGCCGCCTGCGCAGCAGCCGCCCGGCGCGGCCGCGTTCGCGGCGGGCGACATCGCGATCGTCGGCATCGCGGGCCGCTATCCGCAGGCGGACGATCTCGCGCAGTTCTGGCGGAACCTCGCGCGCGGCGTCGACAGCGTGACGGAGATTCCCGCCGACCGCTGGGATTACCGGCGCTTCTACGATCCGCAGAAGGGCCGGCTCGGCAAGAGCTACAGCAAGTGGGGCGGCTTCCTGTCCGATGTCGCGCGCTTCGACGCGGCGTTCTTCAACATCTCCGCGCGCGAGGCGCAGATCATGGACCCGCAGGAGCGGCTGTTCCTCGAATGCGTGTATCACACGCTCGAGGATGCGGGCTACACGCGCCGCAACGTGAGCCGCAGCCGCCGGGTCGGCGTGTTCGTCGGCGTGATGTACGAGGAGTATCAGCTGTACGGCGTCGAGCGCATGCTGGAAGGCACGCCCGTCGCGCTCGCGGGCAATCCCGCCGCGATCGCGAACCGCGTGTCGTACTTCTGCGATTTCCACGGCCCGAGCATGGCGATCGACACGATGTGCTCGTCGTCGCTGAGCGCGATCCATCTCGCGTGCCAGAGCCTCATGCTCGGCGAATGCGAGGTCGCGGTGGCGGGCGGCGTCAACGTGTCGATTCATCCGAACAAGTATCAGATGCTGTCGCAGGGCCGCTTCGCGTCGAGCAACGGCCGCTGCGAGAGCTTCGGCGCGGGCGGCGACGGCTACGTGCCGAGCGAGGGCGTGGGCGCGGTGCTGCTCAAGCCGCTCGCGCGCGCGATCGCGGACGGCGACCGGATTCACGCGGTCATCAAGGCGACCGCGCTCAACCACGGCGGCAAGACGAACGGCTACACGGTGCCGAACCCGAACGCGCAGGCCGACGTGATCGGCGACGCGCTCGCGCGCGCGGGCATCGACGCGCGCAGCATCGGCTATGTCGAGGCGCACGGCACCGGCACGTCGCTCGGCGATCCGATCGAGATCGCGGGGCTCGCGCAGGCGTTCGGCCGCCACACGCCGGACAAGGGCTTCTGCGCGATCGGCTCGGTGAAGTCGAACATCGGCCACGGCGAGAGCGCGGCCGGCATGGCGGGCCTCACGAAGATCGTGCTGCAGATGCGGCACCGTCGGCTCGTGCCGTCGCTGCATGCCGACACGCCGAATCCGAACATCGATTTCGCCGATACGCCGTTCGTCGTGCAGACGACGTTGGCGCCGTGGCGCGGCGCGATCCTGCCCGACGAGGCGGGCCGGCCGGCCGAGCTGCCGCTGCGCGCCGGCCTGTCGTCGTTCGGCGCGGGCGGCGCGAACGCGCACGTCGTCGTCGAGGCGTACGACGTCGCGGGCGCGGAGCGGGGCGCGCACGAAGACGGTCCGGCCGTCGTCGTGCTGTCGGCTCGCACCGACGAGCGGCTCGCCGCGCAGGCGCGCAACCTGCTCGCGCATCTGTCGCGCGAGCCGCATCGCGACGGCGAGCTCGACCGCGACGGCGGTGCGACGCTCGCGTCGATCGCGTACACGCTGCAGGTCGGCCGCGAGGCGATGCCGGCGCGACTCGCGGTGATCGCGGCGTCGCTCGACGATCTGCGCGAGAAGCTCGCGGCGCTCGTCGACGGCGGTGAAGGGCTCGACGGCGTGTCGCGCGGCCGCGTCGATCCGCTCGGCGAGCCGCTCGCGCCCGGCGAGCTCGCGCAATGGCGCGCCGGCGCGCGGCTCGCCGAGCTCGCCGCCGCCTGGGTCGCGGGCCGCTTCGACGACTGGACGCCGTGTTACGGCGACGTTCGGCCGGCGCGCGTGTCGCTGCCGGGCTACGCGTTCGCGCCGACGCGCTACTGGGTGCCCGACGCGGAGCAACTGGCGAAGGCGGCCGGTGTGCACGCGGACGCAACGCAAGCGAAGGGGATCGCGGGCGTGGCGCAGGGTTCGGTGGCGTCGGGAAGTTCGGGCGCTTCGGCTGAGGCGGCCGGGCCGGCCGAGTCGAACGGGGCGGCTGGGTCGAACGGGTCGGCCGGGTCGGCCGGGTCGAACGACGCGGGACCGGGCGATGCGCGCAAGCGCGTGGCGGGGCCTTCGATCGACGCGGCGGCCCCGGCGAACACGGCTCAACCGGCCGAACCGGCCGAACCGGCCGCGCGCCGTCGCGGCGGCGTGACGTTGTCGCCGCCCGCCGAGGCGGCCGCATTCGATCTGTCGGCGCGCGCACCGGCCGCGAAGCCGACGGTGACGTTCGCGCAGCCCGCCGGCCGCGCGCACGAAGCCCTGCCGCCGGCATCTCGTCCGGAGGAATCCGCACCGCGCGTCGTCGCGACGCAGGCGCGCCGCGCGGATGCGGTTAGCGCCGCGCCCGCCGTCTCGCCGGAGGCGGTCGTGCCGGCGCTGCGCGCGCTGCTCGCCGATGCGCTGTACGTCGATGCGCAGACGATCGACGCCAACGCCGAATTCGTGTCGCTCGGCGTGGATTCGATCATCGGCGTCGAGTGGATCGACGCGGTGAACCGGCGGTTCGGCGTCGCGCTGTCGGCGACGACGATCTACGACCATCCGACGCTGTCGAGCTTCGCCCGGCATCTGGCGTCGGCGGCGGCATCGGCGCAGGCGTCGATGGCCGCGGCGGCGTCGCCGTCCGCGCCTGCGTCCGGCGCGCGGGCGGACACGGCCGCGCCCGAGGCTGCGGCGGAGGCGTCCGCGCCGTTCGAGCGCGAGCAGGCGGCGCGCGCGCGCGCCGCCGCGCACGGGGCGGACGACGCGGGCGATCCGGCGCCCGCCGCGCTCGAAGCGGCGCTGCGCGAGACGCTCGCCGACGCGCTGTTCGCCGACGCGCACGACATCGAGCCCGACGCGACGTTCCAGGACCTCGGCGTGGATTCGATCATCGGCGTCGAATGGGTGCAGGCGATCAACCGCCGCTACGGCACGTCGATCCCGGCGCCGCAGATCTATCAGTATCCGACGCTGCGTGCGTTTGGCGGCCTCGTCGCGTCCGAGCTGGCGCTCGCTCGCCGTCGCGCGGGCGGCGCGCCGCTGCCCGACGCCGAGGCGGCATCAGCGACGACGGCGACGACGGCAAGCGCGTCGGGCACCGCGCACGCGCCGAACGCAGCAGGCGACGCGCATGCGCCGAACGCAGCCGGGGCGCGCGCGGCGACTCCCGCGCCCGCGGAAAACGCGGCGGGCGCGGTACATGCCGCGCGGGCCGCAAACCCCGCAAACCCCGCCACTCTCGCAAACCCCGCGCCGGGCGGCGGCGTCCCGCTCGACGACGTGCTCGCGCGCGTGCATCGCGGCGAGCTGAGCGTCGAGGCGGCCGAGGCGCTGCTGGCGGGCGCGCTCGGTTGA", "orf_prot_sequence": "MEDQVVLTSQHPLLDAHRIDGEPWLPGLAYLDLVYQLGEARGIAFERHALHDLTLHAPLAVADGEAVVLTLRWRDERADGWHLTIEGAPLDGGEGAAPRRLVTVRLREAAPAAFGAMRDGDMDAPAVLGATHDGNVGTAGDIVHGNGEATVVDLASLYARCRSLGLVHGAAMQARGTARLTAEQVLVDVRPATASRQAEGDTERNTDGNADGDAGPYLFDPALIDGSGIGSAAFFAHLFDDADAPRLYLPLHIGAFRATRPIRAHVLARVRRASVRRRRELVTVTFEFFDPATGEQIAELTDVTCKAVRDARDGAPARARTDAASGSACSGACSCAAPAAARTVDGRTDGARTERALPDDASPPPGARAERFVRDAIAARLGVAPAAIDADAGFYDLGLDSGMLLELAETIGAAIGASLAPTLLFEHANARELGAWLDAEHGAAFAARATPPHRETEDAARHAAPRAGAGDANGARDGARAGTDANDAGNANSSNGSNPVARPPASVRCGSLDIAVVGMAGRYPGARDLDELWANLRDGRDCVTEVPAERWRADDVAHVRSPSGKPVSRWGGFIDAPDCFDARFFRITPREAEVMDPQERVFLETAWAAIEDAGHTPDTLARRAPGGGDAGAPVGVFVGVMQSEYALIQRDALAGAPTPLAVNRAPVANRVSYVCDFHGPSVAIDTACSSSLVAVHLAAQSLAAGECAVAIAGGVNLSLHPAKYVSCALMDMHASDGRCRSFGAGGDGYVSAEGCGALVLKPLSAALADGDAIHGVIRASATNHVGAVAGIMAPSPAAQAALIGECLRRANVDARTIGYVEAHGTGTALGDPIEIDGLTRAYRAHTRDTQYCALGSIKSAVGHAEAAAGVAGLTKVLLQMRHRTIAPSLHAQPPNPHIDLAASPFFVPARAMRWEPRALAGGGRAPLRAAVSSFGASGTNAHVIVDAYADARVATHDDAGPSVVVLSAMSEPALRQYARALRDAMRAAPAAEPLVARIAELLAEQLGVTADMIDPDADWREFGVDAAQRRRLARALEAWLDIDDALPERAALDSVAGLARQLRREHARAVDAALAGATDLGAARNDGAAALSLRAIAHTLQVGRKALPERAAFVARDVAHLARLLDTFAATGDAPRPDGHRGRARADEQPAEPLSPQHADPHRLAAAWVEGRAIDWAAAYSSGAPRRVSLPTYPFERRRYWVRAADAQSAVRATADGATAPDADAKADVKADARANARADAQAGAHVDAGAAAAAAAAVADILQSVTGLGPDEWRDDTTFDALGLDSLMIGEFTRRIEAMTGERDTTLLFRFRDLTALAAHLAHRHPAAWRADGAQRASSAASTPAPAPAQAGSPPAALASRAARPAPRETAAAAPLDIAIIGLAGRYPHAPTLDAFWRNLVAGRDCVDEIPPQRWPLDGFYEADPARAAAEGKSASKWGAFLSDVDQFDPLFFGITPNEARLTDPHERLFLETAWACVEDAGYTRASLAALRDGPGVGVFVGASFNQYQLIVSDAAQRRGARQFAAPSQIFSISNRVSYVMNFTGPSLTVDTACSSSLYAIHLACESLRRGESSVALAGGVNLSLHPSKYVSLSLGRFLAADGRCRAFDEGGTGYVPGEAVGAVLLKPLADAERDGDAIHGVIRGSGVSHGGRTNGFAVPSPDAQALAIRRAVAQAGVAPRSVGYVEAHGTGTALGDPVEIAGLEDVFRAGTDDVGFCAIASVKTMIGHSEAAAGIAQLTKVLLQMKHATLVRNLSHGGAPNPNLALERSPFRVVRDNEPWAAGDGGVRRAGVSSFGAGGANAHLIVDAYRNAPEPRAGADSGTDDAPALCVLSAKDDARLREMAARLAAHLSDARLGDADLADVAFTLQVGREPMNRRAAFVVSRVRDAIDLLHAIARGDEASGAQASGVLRGDVRAADAQHAPAVDEATLARWPAADAARAIASAWVRGAAIDWMRLRRAPSVRRMSLPTYPFARESYWVPGVAPQSALAPAAGRASRAVDAHGEHGAPRADAPVCPPAGRAQETPGTGVLVLAPQWRPAECSPSASAAPAFDARVLVLCETPASFGAALAPALADGARIVALRSDERDPAARFASHAARLFALVKDELQALAKRPLARALLQVVAPASDDAWDCAALAALLKTAAQENPRLVAQWIAFDAWPDAGGAAARLRENASAAGDVDIRYLDGRRHTLRWAQTRAADRAFGWRANGVFLITGGAGGLGAHVAATIARGAVRPTIVIAGRSAEGAAQTALLDALRSAGARAQYRQADVASHADCDALIAGCVAEYGALHGVVHCAGVIRDGFIVRKRAEDLAAVCAPKVAGVVHLDAATRRLPLDFLLCFSSAAGALGNVGQSDYAMANAFMDAFAAHRNTLVARGQRRGRTCSIGWPIWRDGGMRVDDATLAALEARAGMLPLAIDEGMRTMQDCLALDAPHVIVAAGHLTTLRRLLRVDAGAAGGHAADSADAEAADADARAASPAGANAAVADAAGGDRAGMNTVGPDAPGATALAEGQAGARAAGESAPGDDVAGTHAASGDASLAAAVAERLKHVLSEATGIAVSRLDADEPFDAYGVDSVVVMTVNRALDDVFDALSQTLLYEYGTLGALAGHLAHAHEAACRDWCGVAAAARPGARAADVRVRDTLAVDMSRPDVRTPDLRVSDARGFDERVSDMRDSDAQASSAQASDMLARDTRDIDAQRIADAERQPAEDGDATAVGRAGARAPGASSDAFVGAAGAAAAPAGRDEPIAIIGIAGRYPQASDLDQFWRNLAGGVDSVTTIPPGRWPLEGFFEPDRARALEAGKSYGKWGAFLDDHERFDAPFFQMSPLEAINLDPQIRLFIETCWAALEDAGYTRRLLAERHGKRVGVFAGITKTGYALHGPRVWPLRQSYNPQTSFSALVNRVSYVLDLHGPSVPIDTMCSSSLTAVHEACEHIRSGACALALAGGVNLYLHPSNFLELAGVQMLSADGRCKSFGQGADGFVPGEGVGAVLLKPLSRALADGDHVHAVIRATGINHGGKVNGFTVPNPNAQRELIRATLERAGVRARRVSYVEAHGTGTDLGDPIEVAALAQAFAASGGDRDTGYCALGSVKSNIGHLEAAAGIAGLTKVVLQMTHGMRAPTLHARIPNEKIPFARTPFVLQRERDDWPHAHGDAAQSRIATVSSFGAGGANAFAVVEEAPRRERDARPDRPEVIVLSARDADRLAARIAQLRGRLREGVPYSLAEIAYTLQAGREAMAERIAFVADSLDALVDTLDTLDTLDTAGGAPNPAAGAAAARVHRGSGVTRKTPLSFLADDDLADTVRAWLAKGKLDLVAQAWASGVDIDWTLLHGDRTPRRASLPAYPFAGERHALPDAAQPVAAHALHPLLQRNTSTLERVSFASVFGGDEAFLRDHRVSGRPVLPAVAYIEIAYRALREAGVPGDAVRLTDLVWMRPAIVEGEPLHVRVELASEASEASEASDTSDTSDTSDAAGDTLALTIGAAAPSGRGQPGFATVFARARARRVRVAAPAALPLARWRAQCGAAMTADDCYRVFERVGLAYGPAFRTLDTLWRGDGVAVAKLRAASPPAAPHAAADVVDSLDCGLLDGALQAVLGLAPASDAERPLLPFALDACELYGERPDEPWCVVRRTEDARVDVTLCGPQGEPWIALRGLVLRRYESAPAAERGLVALAPQWRRADATPVAAAAAPAFADTLVVLCGAQRLDAGGSADRIRVVTVANDATPIGERFAQTLQALIAETQALLRDRPDAPALLQVVVPDTPAFAPMIGLAGFLRTLSHEAPHMCGQLLLVPAHDTGAALRARLAECAARAHETVVRYGQGPARDVLQWREWADAMPPADAGQTADAHAAPVWRDDGVYLVTGGAGGLAWLLAQDMARRAPGARMVLVGRRPLDARAASSLDALRARIEYVEADCADADAIAAAVASVLERHGRLDGVVHAAGVLRDEFIRRKTADGVAAVLRPKVDGTLALDRATRDVRLAFFVLFSSAAAQAGNPGQADYAAANGFMDGFAQYRRALVALGERHGATTSIDWPLWRDGGMRIGADAQRLLETQTGMSAMPGDAGLAFFHRAVRAGVAQVMPLYGNPARLRDALAPAARDDAGSAADAAGASDAGSAYADAGDARGMAGAVLIARLRDALAAALGVARDALDAHVPVGEFGVDRQVLDALVEQVEPGGAVRRAELLDTRLTLDEIASRLAAATRGDAHAAHAASPRGEAGEAQEAPQAYEAHGAHEVPPLAEPRASELVDASLALLTERLADVIKLPAPRIDPDAELTTYGIDSVVVMQVTTQLEKQLGPLSKTLFFEYGTLRAIAARVAHTHRERVRALVERRAAGTQAASAASVASHPAAPHGARPAHERRADADAASVRGAPRAVAARSSAEVSRASATANTNTTTTTTTTATATATATATATATTNTTENAAPHASRGDRDARPPAQQPPGAAAFAAGDIAIVGIAGRYPQADDLAQFWRNLARGVDSVTEIPADRWDYRRFYDPQKGRLGKSYSKWGGFLSDVARFDAAFFNISAREAQIMDPQERLFLECVYHTLEDAGYTRRNVSRSRRVGVFVGVMYEEYQLYGVERMLEGTPVALAGNPAAIANRVSYFCDFHGPSMAIDTMCSSSLSAIHLACQSLMLGECEVAVAGGVNVSIHPNKYQMLSQGRFASSNGRCESFGAGGDGYVPSEGVGAVLLKPLARAIADGDRIHAVIKATALNHGGKTNGYTVPNPNAQADVIGDALARAGIDARSIGYVEAHGTGTSLGDPIEIAGLAQAFGRHTPDKGFCAIGSVKSNIGHGESAAGMAGLTKIVLQMRHRRLVPSLHADTPNPNIDFADTPFVVQTTLAPWRGAILPDEAGRPAELPLRAGLSSFGAGGANAHVVVEAYDVAGAERGAHEDGPAVVVLSARTDERLAAQARNLLAHLSREPHRDGELDRDGGATLASIAYTLQVGREAMPARLAVIAASLDDLREKLAALVDGGEGLDGVSRGRVDPLGEPLAPGELAQWRAGARLAELAAAWVAGRFDDWTPCYGDVRPARVSLPGYAFAPTRYWVPDAEQLAKAAGVHADATQAKGIAGVAQGSVASGSSGASAEAAGPAESNGAAGSNGSAGSAGSNDAGPGDARKRVAGPSIDAAAPANTAQPAEPAEPAARRRGGVTLSPPAEAAAFDLSARAPAAKPTVTFAQPAGRAHEALPPASRPEESAPRVVATQARRADAVSAAPAVSPEAVVPALRALLADALYVDAQTIDANAEFVSLGVDSIIGVEWIDAVNRRFGVALSATTIYDHPTLSSFARHLASAAASAQASMAAAASPSAPASGARADTAAPEAAAEASAPFEREQAARARAAAHGADDAGDPAPAALEAALRETLADALFADAHDIEPDATFQDLGVDSIIGVEWVQAINRRYGTSIPAPQIYQYPTLRAFGGLVASELALARRRAGGAPLPDAEAASATTATTASASGTAHAPNAAGDAHAPNAAGARAATPAPAENAAGAVHAARAANPANPATLANPAPGGGVPLDDVLARVHRGELSVEAAEALLAGALG", "perc_identity": 24.86}, "gnl|BL_ORD_ID|1964|hsp_num:0": {"type_match": "Loose", "snp": {"original": "S", "change": "A", "position": 94}, "query_snp": {"original": "S", "change": "A", "position": 57}, "orf_strand": "-", "orf_start": 22774, "orf_end": 39474, "orf_from": "BGC0000186.1|Thailandamide_4 ", "model_name": "Mycobacterium tuberculosis inhA mutations conferring resistance to isoniazid", "model_type": "protein variant model", "model_type_id": 40293, "pass_evalue": "n/a", "pass_bitscore": 500, "model_id": "1574", "ARO_accession": "3003393", "ARO_name": "Mycobacterium tuberculosis inhA mutations conferring resistance to isoniazid", "ARO_category": {"43060": {"category_aro_accession": "3004874", "category_aro_cvterm_id": "43060", "category_aro_name": "isoniazid resistant inhA", "category_aro_description": "Genes with mutations in inhA which confer resistance to isoniazid class antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "36659": {"category_aro_accession": "3000520", "category_aro_cvterm_id": "36659", "category_aro_name": "isoniazid", "category_aro_description": "Isoniazid is an organic compound that is the first-line anti tuberculosis medication in prevention and treatment. As a prodrug, it is activated by mycobacterial catalase-peroxidases such as M. tuberculosis KatG. Isoniazid inhibits mycolic acid synthesis, which prevents cell wall synthesis in mycobacteria.", "category_aro_class_name": "Antibiotic"}, "45734": {"category_aro_accession": "3007152", "category_aro_cvterm_id": "45734", "category_aro_name": "isoniazid-like antibiotic", "category_aro_description": "A group of antibiotics containing isoniazid and its derivatives.", "category_aro_class_name": "Drug Class"}, "35997": {"category_aro_accession": "0001001", "category_aro_cvterm_id": "35997", "category_aro_name": "antibiotic target alteration", "category_aro_description": "Mutational alteration or enzymatic modification of antibiotic target which results in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 8.87908, "bit_score": 29.261, "max_identities": 24, "cvterm_id": "39507", "query": "GARMVLVG--RRPLDARAASSLDALRARIEYVEADCADADAIAAAVASVLERHG---RLDGVVHAAGVL", "match": "GA++VL G  R  L  R     D L A+   +E D  + + +A+    V E  G   +LDGVVH+ G +", "sequence_from_db": "GAQLVLTGFDRLRLIQRIT---DRLPAKAPLLELDVQNEEHLASLAGRVTEAIGAGNKLDGVVHSIGFM", "sequence_from_broadstreet": "MTGLLDGKRILVSGIITDSSIAFHIARVAQEQGAQLVLTGFDRLRLIQRITDRLPAKAPLLELDVQNEEHLASLAGRVTEAIGAGNKLDGVVHSIGFMPQTGMGINPFFDAPYADVSKGIHISAYSYASMAKALLPIMNPGGSIVGMDFDPSRAMPAYNWMTVAKSALESVNRFVAREAGKYGVRSNLVAAGPIRTLAMSAIVGGALGEEAGAQIQLLEEGWDQRAPIGWNMKDATPVAKTVCALLSDWLPATTGDIIYADGGAHTQLL", "dna_sequence_from_broadstreet": "ATGACAGGACTGCTGGACGGCAAACGGATTCTGGTTAGCGGAATCATCACCGACTCGTCGATCGCGTTTCACATCGCACGGGTAGCCCAGGAGCAGGGCGCCCAGCTGGTGCTCACCGGGTTCGACCGGCTGCGGCTGATTCAGCGCATCACCGACCGGCTGCCGGCAAAGGCCCCGCTGCTCGAACTCGACGTGCAAAACGAGGAGCACCTGGCCAGCTTGGCCGGCCGGGTGACCGAGGCGATCGGGGCGGGCAACAAGCTCGACGGGGTGGTGCATTCGATTGGGTTCATGCCGCAGACCGGGATGGGCATCAACCCGTTCTTCGACGCGCCCTACGCGGATGTGTCCAAGGGCATCCACATCTCGGCGTATTCGTATGCTTCGATGGCCAAGGCGCTGCTGCCGATCATGAACCCCGGAGGTTCCATCGTCGGCATGGACTTCGACCCGAGCCGGGCGATGCCGGCCTACAACTGGATGACGGTCGCCAAGAGCGCGTTGGAGTCGGTCAACAGGTTCGTGGCGCGCGAGGCCGGCAAGTACGGTGTGCGTTCGAATCTCGTTGCCGCAGGCCCTATCCGGACGCTGGCGATGAGTGCGATCGTCGGCGGTGCGCTCGGCGAGGAGGCCGGCGCCCAGATCCAGCTGCTCGAGGAGGGCTGGGATCAGCGCGCTCCGATCGGCTGGAACATGAAGGATGCGACGCCGGTCGCCAAGACGGTGTGCGCGCTGCTGTCTGACTGGCTGCCGGCGACCACGGGTGACATCATCTACGCCGACGGCGGCGCGCACACCCAATTGCTCTAG", "partial": "0", "query_start": 34456, "query_end": 34647, "hit_start": 96, "hit_end": 294, "orf_dna_sequence": "ATGGAAGACCAAGTCGTACTGACTTCGCAACATCCGCTGCTCGACGCCCACCGGATCGACGGCGAACCCTGGCTGCCGGGGCTCGCCTATCTCGACCTCGTCTATCAGCTCGGCGAGGCGCGCGGCATCGCGTTCGAGCGTCACGCGCTGCACGACCTCACGCTGCATGCGCCGCTTGCCGTCGCCGATGGCGAGGCGGTCGTGCTGACGCTGCGGTGGCGCGACGAACGCGCCGACGGCTGGCATCTGACGATCGAAGGCGCGCCGCTCGACGGCGGCGAGGGCGCGGCGCCGCGCCGGCTCGTCACCGTCCGGCTGCGCGAGGCCGCGCCGGCCGCCTTCGGCGCGATGCGTGACGGCGACATGGACGCGCCGGCCGTACTCGGCGCGACGCATGACGGCAACGTCGGCACAGCCGGCGACATCGTTCACGGCAACGGCGAAGCGACCGTCGTCGATCTCGCGTCGCTGTACGCACGCTGCCGCTCGCTCGGGCTCGTGCACGGCGCGGCGATGCAGGCGCGGGGCACCGCGCGGCTGACGGCCGAGCAGGTGCTCGTCGACGTGCGGCCGGCGACGGCCTCGCGACAGGCGGAAGGCGATACGGAGCGCAATACGGACGGCAATGCGGACGGCGACGCCGGTCCGTATCTGTTCGATCCCGCGTTGATCGACGGCAGCGGCATCGGCTCGGCTGCGTTCTTCGCGCATCTGTTCGACGACGCCGATGCGCCGCGCCTCTACCTGCCGCTGCATATCGGCGCATTCCGGGCGACGCGGCCGATTCGCGCGCACGTGCTCGCGCGCGTGCGCCGGGCGTCGGTGCGCCGGCGCCGCGAGCTCGTTACGGTGACGTTCGAATTCTTCGATCCCGCGACCGGCGAGCAGATCGCCGAGCTGACCGACGTGACCTGCAAGGCGGTGCGCGACGCGCGCGACGGCGCGCCGGCGCGGGCGCGCACGGATGCGGCGTCCGGCAGCGCGTGTTCCGGCGCGTGTTCCTGTGCGGCGCCCGCCGCGGCGCGAACCGTTGACGGACGAACCGACGGCGCGCGAACGGAACGCGCGCTGCCGGACGACGCATCACCGCCGCCCGGCGCGCGGGCCGAGCGATTCGTGCGCGACGCGATCGCCGCGCGGCTCGGCGTCGCGCCGGCCGCGATCGATGCGGACGCGGGCTTTTACGATCTGGGCCTCGACTCGGGCATGCTGCTCGAACTGGCGGAGACGATCGGCGCGGCGATCGGCGCGTCGTTGGCGCCGACGCTGCTGTTCGAGCACGCGAACGCGCGCGAGCTCGGCGCATGGCTCGACGCCGAGCACGGCGCCGCGTTCGCGGCGCGCGCGACGCCGCCGCATCGCGAGACCGAAGACGCGGCCCGGCATGCAGCGCCGCGAGCCGGCGCGGGCGATGCGAACGGTGCGCGCGACGGTGCGCGCGCGGGGACCGACGCGAACGACGCCGGCAACGCGAACAGCTCGAACGGCTCGAATCCCGTCGCCCGCCCGCCTGCGTCCGTGCGCTGCGGCTCGCTCGACATCGCCGTCGTCGGCATGGCCGGGCGCTACCCCGGCGCGCGCGATCTGGACGAATTGTGGGCGAACCTGCGCGACGGGCGCGACTGCGTGACCGAGGTGCCCGCCGAGCGCTGGCGCGCCGACGACGTCGCGCACGTGCGTTCGCCGTCGGGCAAGCCCGTGTCGCGATGGGGCGGCTTCATCGACGCGCCCGATTGCTTTGACGCGCGCTTTTTCCGGATCACGCCGCGCGAGGCGGAAGTGATGGACCCGCAGGAACGCGTGTTCCTGGAAACGGCGTGGGCGGCGATCGAGGACGCGGGCCACACGCCCGACACGCTCGCGCGCCGCGCGCCGGGCGGCGGCGACGCGGGCGCGCCCGTCGGCGTGTTCGTCGGCGTGATGCAGAGCGAATACGCGCTGATCCAGCGCGACGCGCTCGCGGGCGCGCCGACGCCGCTCGCCGTCAACCGCGCGCCCGTCGCGAACCGCGTGTCGTACGTCTGCGATTTCCACGGGCCGAGCGTCGCGATCGACACCGCGTGCTCGTCGTCGCTCGTCGCCGTGCACCTCGCGGCGCAGAGCCTCGCGGCCGGTGAATGCGCGGTTGCGATCGCGGGCGGCGTGAACCTGTCGCTGCATCCGGCGAAGTATGTGTCGTGCGCGCTGATGGACATGCACGCGTCGGACGGCCGCTGCCGCAGTTTCGGCGCGGGCGGCGACGGCTACGTGTCGGCCGAGGGCTGCGGCGCGCTCGTGCTCAAGCCGCTTTCGGCCGCGCTCGCGGACGGCGACGCGATCCACGGCGTGATTCGCGCGAGCGCGACGAACCACGTCGGCGCGGTCGCCGGCATCATGGCGCCGAGCCCCGCCGCGCAGGCCGCGCTGATCGGCGAGTGCCTGCGTCGCGCGAACGTCGACGCGCGCACGATCGGCTATGTCGAGGCGCACGGCACGGGCACCGCGCTCGGCGATCCGATCGAGATCGACGGGTTGACGCGCGCGTATCGCGCGCACACGCGCGACACGCAGTATTGCGCGCTCGGCTCGATCAAATCGGCGGTGGGGCACGCGGAGGCGGCGGCGGGCGTCGCCGGACTCACGAAGGTGCTGCTGCAGATGCGCCATCGGACGATCGCGCCCTCGCTGCACGCGCAGCCGCCCAATCCCCACATCGATCTCGCGGCGTCGCCGTTCTTCGTGCCGGCGCGGGCGATGCGGTGGGAGCCGCGCGCGCTTGCCGGCGGCGGCCGCGCGCCGCTGCGCGCGGCGGTGAGCTCGTTCGGCGCGTCGGGCACGAACGCGCACGTGATCGTCGACGCGTACGCGGACGCGCGCGTCGCGACGCACGACGACGCGGGGCCGTCCGTCGTCGTGCTCTCCGCGATGAGCGAGCCGGCGCTGCGGCAGTATGCGCGCGCGCTGCGCGACGCGATGCGCGCGGCGCCGGCGGCCGAGCCGCTCGTCGCGCGCATCGCCGAGCTGCTCGCCGAGCAGCTCGGCGTCACAGCCGACATGATCGATCCCGACGCGGACTGGCGCGAGTTCGGCGTCGACGCCGCGCAGCGGCGGCGCCTCGCGCGCGCGCTCGAGGCATGGCTCGACATCGACGACGCGCTGCCCGAGCGCGCGGCGCTCGATTCGGTCGCCGGGCTCGCGCGGCAGTTGCGGCGTGAGCACGCGCGCGCCGTCGATGCGGCGCTCGCCGGCGCGACGGACCTGGGCGCGGCGCGCAACGACGGCGCGGCCGCGCTGTCGCTGCGCGCGATCGCGCATACGCTGCAAGTGGGCCGCAAGGCGCTGCCCGAGCGCGCCGCGTTCGTCGCGCGCGACGTCGCGCATCTGGCGCGGCTGCTCGACACGTTCGCCGCGACGGGCGACGCGCCGCGACCGGACGGCCATCGCGGGCGAGCCCGCGCCGACGAACAGCCGGCCGAGCCGCTTTCGCCGCAACACGCGGACCCGCACCGGCTCGCCGCCGCGTGGGTCGAGGGCCGGGCGATCGACTGGGCGGCGGCGTATTCGAGCGGCGCGCCGCGCCGCGTGAGCCTGCCGACCTATCCGTTCGAGCGGCGGCGCTATTGGGTTCGCGCAGCGGATGCCCAGTCCGCCGTGCGCGCGACGGCCGACGGCGCGACTGCGCCGGACGCCGACGCGAAAGCCGATGTAAAAGCCGATGCAAGGGCTAATGCAAGGGCCGATGCGCAAGCCGGCGCGCACGTCGACGCCGGTGCGGCGGCCGCAGCCGCAGCCGCGGTCGCGGACATCCTGCAATCGGTCACCGGGCTGGGGCCGGACGAATGGCGCGACGATACGACGTTCGATGCGCTCGGTCTCGATTCGCTGATGATCGGCGAGTTCACGCGCCGCATCGAGGCGATGACGGGCGAGCGCGACACGACGCTGCTGTTCCGGTTCCGCGACTTGACCGCGCTCGCCGCGCATCTCGCGCATCGTCATCCGGCTGCGTGGCGGGCGGATGGGGCGCAGCGCGCGTCGTCCGCCGCATCGACGCCCGCGCCCGCGCCGGCGCAAGCCGGATCGCCGCCCGCGGCCCTCGCATCGCGCGCCGCGCGGCCGGCGCCGCGCGAGACGGCCGCCGCCGCGCCGCTCGACATCGCGATCATCGGCCTCGCGGGCCGCTATCCGCATGCGCCGACGCTTGACGCGTTCTGGCGCAACCTCGTCGCGGGCCGCGACTGCGTCGACGAGATCCCGCCGCAGCGCTGGCCGCTCGACGGCTTCTACGAGGCCGACCCCGCGCGCGCGGCGGCCGAGGGCAAGAGCGCGAGCAAGTGGGGCGCGTTCCTGTCCGATGTCGACCAGTTCGACCCGCTTTTCTTCGGCATCACGCCGAACGAAGCGCGGCTCACCGATCCGCACGAGCGGCTCTTTCTCGAAACCGCGTGGGCGTGCGTCGAGGACGCCGGCTACACGCGCGCGTCGCTCGCCGCGCTGCGCGACGGCCCGGGCGTCGGCGTGTTCGTCGGCGCGAGCTTCAACCAGTATCAGCTCATCGTGAGCGACGCGGCGCAGCGGCGCGGCGCGCGGCAGTTCGCGGCGCCGAGCCAGATCTTCTCGATCTCGAACCGCGTGTCGTACGTGATGAACTTCACGGGGCCGAGCCTGACCGTCGACACCGCGTGCTCGTCGTCGCTCTATGCGATCCATCTCGCATGCGAAAGCCTGCGGCGCGGCGAATCGAGCGTCGCGCTCGCGGGCGGCGTCAATCTTTCGCTGCACCCGAGCAAGTACGTGTCGCTGTCGCTCGGGCGCTTTCTCGCCGCCGACGGCCGGTGCCGCGCCTTCGACGAAGGCGGCACGGGCTACGTGCCGGGCGAGGCGGTGGGCGCGGTGCTGCTCAAGCCGCTCGCCGACGCCGAGCGCGACGGCGATGCGATCCACGGCGTGATCCGCGGCAGCGGCGTGAGCCACGGCGGCCGGACCAACGGCTTCGCGGTGCCGAGCCCCGACGCGCAGGCGCTCGCGATCCGGCGGGCGGTCGCGCAGGCGGGCGTCGCGCCGCGCAGCGTCGGCTACGTCGAGGCGCACGGCACGGGCACCGCGCTTGGCGATCCCGTCGAGATCGCGGGGCTGGAGGACGTGTTCCGCGCGGGCACCGACGACGTCGGGTTCTGCGCGATCGCGTCGGTGAAGACGATGATCGGCCACAGCGAGGCGGCGGCCGGCATCGCGCAGTTGACGAAGGTGCTGCTGCAGATGAAGCACGCGACGCTCGTGCGCAACCTGTCGCACGGCGGCGCGCCGAACCCGAACCTCGCGCTCGAACGCTCGCCGTTTCGCGTCGTGCGCGACAACGAGCCGTGGGCGGCCGGCGACGGCGGCGTGCGCCGCGCGGGCGTGAGCAGCTTCGGCGCGGGCGGCGCGAACGCGCACCTGATCGTCGACGCGTACCGCAACGCGCCCGAGCCGCGCGCGGGCGCGGACAGCGGCACGGACGACGCGCCCGCGCTGTGCGTGCTGTCGGCGAAGGACGACGCGCGCCTGCGCGAGATGGCGGCCCGGCTCGCCGCGCATCTGAGCGACGCGCGTCTCGGCGACGCGGACCTCGCCGACGTCGCGTTCACGCTTCAAGTCGGGCGCGAGCCGATGAACCGGCGCGCGGCGTTCGTCGTCAGCCGCGTGCGCGACGCGATCGATCTGCTGCACGCGATCGCGCGCGGAGACGAAGCGTCCGGCGCGCAGGCGTCCGGCGTGCTGCGCGGCGACGTGCGCGCGGCGGACGCGCAGCACGCGCCCGCCGTCGACGAGGCGACGCTCGCGCGCTGGCCGGCGGCCGACGCGGCGCGCGCGATCGCCTCCGCGTGGGTGCGGGGCGCGGCGATCGACTGGATGCGGCTGCGCCGCGCGCCGTCGGTGCGACGCATGTCGCTGCCGACCTATCCGTTCGCGCGCGAATCGTACTGGGTGCCCGGCGTCGCGCCGCAGTCGGCGCTTGCGCCGGCCGCCGGCCGCGCGAGCCGGGCCGTTGACGCGCACGGCGAGCACGGCGCGCCGCGCGCCGACGCGCCGGTTTGTCCGCCGGCCGGCCGCGCGCAGGAAACGCCGGGCACGGGCGTGCTCGTGCTCGCGCCGCAATGGCGGCCGGCCGAATGCTCGCCGAGCGCGAGCGCCGCGCCCGCGTTCGATGCGCGCGTGCTCGTGCTCTGCGAGACGCCGGCTTCGTTCGGCGCGGCGCTGGCGCCCGCGCTCGCGGACGGCGCGCGGATCGTCGCGCTGCGCTCGGACGAGCGCGATCCCGCCGCCCGCTTCGCGTCGCATGCGGCGCGCCTCTTCGCGCTCGTCAAGGACGAACTGCAGGCGCTCGCGAAGCGTCCGCTCGCGCGCGCGCTGCTGCAGGTCGTCGCGCCCGCGAGCGACGATGCGTGGGACTGCGCGGCGCTCGCCGCGCTGCTGAAGACGGCGGCGCAAGAGAATCCGCGTCTCGTCGCGCAGTGGATCGCGTTCGACGCGTGGCCCGATGCCGGCGGCGCCGCCGCGCGGCTGCGCGAGAACGCATCGGCGGCGGGCGACGTCGACATCCGCTATCTCGACGGCCGCCGCCACACGCTGCGCTGGGCGCAGACGCGGGCGGCCGACCGCGCGTTCGGCTGGCGCGCGAACGGCGTGTTCCTGATCACGGGCGGCGCGGGCGGGCTCGGCGCGCACGTGGCCGCGACGATCGCGCGCGGCGCGGTGCGCCCGACGATCGTGATCGCGGGCCGCTCGGCCGAAGGCGCGGCGCAGACCGCGCTGCTCGACGCGCTGCGCTCGGCGGGCGCGCGTGCGCAGTACCGGCAGGCCGACGTCGCGTCGCATGCCGATTGCGACGCGCTGATCGCCGGCTGCGTCGCCGAGTACGGCGCGCTGCACGGCGTCGTTCACTGCGCGGGCGTGATCCGCGACGGCTTCATCGTGCGCAAGCGCGCCGAAGACCTCGCGGCGGTATGCGCGCCGAAGGTGGCGGGCGTCGTCCATCTGGACGCGGCGACGCGGCGGCTGCCGCTCGATTTCCTGCTGTGCTTCTCGTCGGCGGCCGGCGCGCTCGGCAACGTCGGCCAAAGTGACTATGCGATGGCGAACGCGTTCATGGACGCGTTCGCCGCTCACCGCAACACGCTCGTCGCGCGCGGACAGCGGCGCGGGCGCACGTGCTCGATCGGCTGGCCGATCTGGCGCGACGGCGGCATGCGCGTCGATGACGCGACGCTCGCGGCGCTCGAAGCGCGCGCGGGGATGCTGCCGCTCGCGATCGACGAAGGAATGCGAACCATGCAAGACTGCCTTGCGCTCGATGCGCCGCACGTGATCGTCGCGGCTGGACACTTGACGACGTTGCGCCGGCTGCTGCGCGTCGATGCCGGCGCGGCCGGCGGGCATGCTGCGGATTCGGCCGATGCGGAAGCGGCCGATGCGGACGCGCGCGCGGCGAGCCCGGCCGGCGCGAATGCGGCCGTTGCCGATGCGGCAGGCGGCGATCGGGCCGGCATGAACACGGTCGGGCCGGACGCGCCCGGCGCGACGGCGCTCGCCGAAGGTCAGGCGGGCGCACGGGCGGCCGGCGAATCCGCGCCGGGCGACGACGTTGCCGGGACGCACGCCGCTTCGGGTGACGCGTCGCTTGCGGCGGCCGTCGCCGAGCGGCTCAAGCACGTGCTGAGCGAGGCGACCGGGATCGCCGTGTCGCGCCTTGACGCCGACGAGCCGTTCGACGCGTACGGCGTCGATTCGGTCGTCGTGATGACCGTCAACCGCGCGCTCGACGACGTGTTCGACGCGCTGTCGCAGACGCTGCTCTACGAATACGGCACGCTCGGCGCGCTCGCGGGCCACCTCGCGCACGCGCACGAAGCGGCGTGCCGCGACTGGTGCGGCGTCGCCGCGGCCGCGCGGCCGGGCGCGCGCGCCGCCGACGTGCGCGTGCGCGATACGCTCGCCGTCGACATGTCTCGCCCGGACGTGCGGACCCCGGACCTCCGGGTATCCGACGCGCGGGGCTTCGACGAGCGGGTATCCGACATGCGGGACTCCGACGCACAGGCCTCCAGCGCGCAGGCCTCCGACATGCTGGCCCGCGACACGCGCGACATCGACGCGCAGCGCATCGCCGACGCCGAACGGCAGCCCGCCGAGGACGGCGACGCGACGGCCGTCGGCCGCGCGGGAGCGCGCGCGCCCGGTGCGTCGTCCGATGCATTCGTCGGGGCGGCCGGCGCGGCCGCGGCCCCGGCCGGCCGCGACGAGCCGATCGCGATCATCGGCATCGCGGGCCGCTACCCGCAGGCGAGCGATCTCGACCAGTTCTGGCGCAACCTCGCGGGCGGCGTCGACAGCGTGACGACGATCCCGCCGGGCCGCTGGCCGCTCGAAGGCTTCTTCGAGCCGGACCGGGCGCGCGCGCTCGAAGCGGGCAAGAGCTACGGCAAGTGGGGCGCGTTCCTCGACGATCACGAGCGCTTCGATGCGCCGTTCTTTCAGATGTCGCCGCTCGAGGCGATCAACCTTGATCCGCAGATCCGGCTGTTCATCGAGACCTGCTGGGCGGCGCTCGAGGACGCGGGCTACACGCGCCGCCTGCTCGCGGAGCGCCACGGCAAGCGCGTCGGCGTGTTCGCGGGCATCACGAAGACGGGCTACGCGCTGCACGGCCCGCGCGTGTGGCCGCTCAGGCAGAGCTACAACCCGCAGACGTCGTTCAGCGCGCTCGTGAACCGCGTGTCGTACGTGCTCGACCTGCACGGCCCGAGCGTGCCGATCGACACGATGTGCTCGTCGTCGCTCACCGCCGTGCACGAGGCGTGCGAGCACATCCGCTCGGGCGCGTGCGCGCTCGCGCTCGCGGGCGGCGTCAACCTGTACCTGCATCCGTCGAATTTTCTCGAGCTGGCGGGCGTGCAGATGCTGTCGGCCGACGGGCGCTGCAAGAGCTTCGGGCAGGGCGCGGACGGCTTCGTGCCGGGCGAGGGCGTGGGCGCGGTGCTGCTCAAGCCGCTGTCGCGCGCGCTTGCCGACGGCGATCACGTGCACGCCGTCATTCGCGCGACGGGCATCAACCACGGCGGCAAGGTGAACGGCTTCACGGTGCCGAACCCGAACGCGCAGCGCGAGCTGATCCGCGCGACGCTCGAACGCGCGGGCGTGCGCGCGCGCCGCGTGAGCTACGTCGAGGCGCACGGCACCGGCACCGATCTCGGCGATCCGATCGAAGTCGCCGCGCTCGCGCAGGCGTTCGCCGCGAGCGGCGGCGATCGCGACACGGGCTACTGCGCGCTCGGCTCGGTGAAGTCGAACATCGGCCACCTGGAGGCCGCGGCCGGCATCGCCGGATTGACGAAGGTCGTCCTGCAGATGACGCACGGCATGCGCGCGCCGACGCTGCACGCGCGGATTCCGAACGAGAAGATTCCGTTCGCGCGCACGCCGTTCGTGCTGCAGCGCGAGCGCGACGACTGGCCGCACGCGCACGGCGACGCCGCGCAGTCGCGGATCGCGACGGTATCGTCGTTCGGCGCGGGCGGCGCGAACGCGTTCGCGGTCGTCGAGGAAGCGCCGCGCCGCGAGCGCGACGCGCGGCCCGACCGCCCCGAGGTGATCGTGCTGTCGGCGCGCGACGCCGACCGGCTCGCCGCACGCATCGCGCAGTTGCGCGGCCGTCTGCGCGAGGGCGTGCCGTACTCGCTCGCCGAGATCGCCTACACGCTGCAAGCCGGCCGTGAGGCGATGGCCGAGCGGATCGCGTTCGTCGCGGACTCGCTCGACGCGCTCGTCGACACGCTCGACACGCTCGACACGCTCGACACGGCGGGCGGCGCGCCGAATCCGGCGGCCGGCGCGGCGGCGGCGCGCGTGCATCGCGGCAGCGGCGTGACGCGCAAGACGCCGCTGTCGTTCCTGGCCGACGACGATCTCGCGGACACCGTGCGCGCGTGGCTCGCGAAGGGCAAGCTCGATCTCGTCGCGCAGGCGTGGGCGAGCGGCGTCGACATCGACTGGACGTTGCTGCACGGCGATCGCACGCCGCGCCGCGCGAGCCTGCCGGCCTATCCGTTCGCGGGCGAGCGGCACGCGTTGCCCGATGCGGCGCAGCCCGTCGCGGCGCACGCGCTGCATCCGCTGCTGCAGCGGAACACGTCGACGCTCGAGCGGGTGAGCTTCGCGTCGGTGTTCGGCGGCGACGAAGCGTTCCTGCGCGATCATCGCGTGTCGGGCCGGCCCGTGCTGCCCGCCGTCGCCTACATCGAAATCGCGTATCGCGCGCTGCGCGAGGCGGGCGTGCCGGGCGACGCGGTGCGCTTGACCGATCTCGTGTGGATGCGGCCCGCAATCGTCGAAGGCGAGCCGCTCCACGTGCGCGTCGAGCTCGCTTCCGAAGCTTCCGAAGCTTCCGAAGCTTCCGATACGTCCGATACGTCCGATACGTCCGATGCGGCGGGCGACACGCTCGCGCTGACGATCGGCGCGGCCGCGCCGTCCGGGCGCGGGCAACCGGGCTTCGCGACGGTGTTCGCGCGCGCTCGCGCGCGTCGCGTGCGCGTCGCCGCGCCGGCCGCGCTGCCGCTCGCGCGCTGGCGCGCGCAGTGCGGCGCCGCAATGACGGCGGATGACTGCTATCGCGTGTTCGAACGCGTCGGCCTGGCGTACGGCCCGGCGTTCCGCACGCTCGACACCCTCTGGCGCGGCGACGGCGTCGCCGTCGCGAAGCTGCGCGCCGCGTCGCCGCCGGCCGCGCCGCACGCGGCGGCCGACGTCGTCGATTCGCTCGACTGCGGCCTGCTCGACGGCGCGCTGCAGGCGGTGCTGGGCCTCGCGCCCGCATCGGACGCCGAGCGGCCGCTGCTGCCGTTCGCGCTCGACGCGTGCGAGCTTTACGGCGAGCGGCCCGACGAGCCGTGGTGCGTCGTGCGGCGCACCGAAGACGCGCGCGTCGACGTCACGCTGTGCGGCCCGCAGGGCGAGCCGTGGATCGCGCTGCGCGGCCTCGTGCTGCGCCGCTACGAAAGCGCGCCCGCCGCCGAGCGCGGGCTCGTCGCGCTCGCGCCGCAATGGCGGCGGGCGGACGCGACGCCCGTCGCGGCCGCCGCCGCGCCCGCATTCGCCGACACGCTCGTCGTGCTCTGCGGCGCGCAGCGTCTAGACGCCGGCGGCAGCGCGGATCGCATCCGCGTCGTGACTGTCGCGAACGATGCGACGCCGATCGGCGAGCGCTTCGCACAGACGCTGCAGGCGCTGATCGCCGAGACGCAGGCGCTGCTGCGCGACCGGCCGGACGCGCCCGCGCTGTTGCAGGTGGTCGTGCCGGATACGCCGGCGTTCGCGCCGATGATCGGGCTGGCGGGCTTTCTGCGCACGCTGTCGCACGAGGCGCCGCACATGTGCGGCCAATTGCTGCTGGTTCCGGCGCACGACACGGGCGCCGCGCTGCGCGCGAGGCTGGCCGAATGCGCGGCGCGCGCGCACGAAACGGTGGTGCGCTACGGGCAGGGGCCGGCGCGCGACGTGCTGCAGTGGCGCGAGTGGGCGGACGCGATGCCGCCGGCCGATGCCGGCCAGACGGCCGACGCGCATGCGGCGCCCGTCTGGCGCGACGACGGCGTGTATCTGGTGACGGGCGGCGCGGGCGGGCTCGCGTGGCTGCTCGCGCAGGACATGGCCCGGCGCGCCCCGGGCGCGCGCATGGTGCTTGTCGGGCGGCGGCCGCTCGACGCGCGCGCCGCATCGTCGCTCGATGCGCTGCGCGCGCGCATCGAATACGTCGAGGCCGATTGCGCCGACGCCGACGCGATCGCCGCGGCGGTCGCGTCCGTGCTCGAGCGCCACGGCCGGCTCGACGGCGTGGTGCACGCGGCGGGCGTGCTGCGCGACGAATTCATCCGGCGCAAGACGGCGGACGGCGTCGCGGCGGTGCTGCGCCCGAAGGTCGACGGCACGCTCGCGCTCGACCGCGCGACGCGCGACGTTCGCCTCGCGTTCTTCGTGCTGTTCTCGTCGGCCGCCGCGCAGGCCGGCAATCCGGGGCAGGCCGACTATGCGGCCGCGAACGGTTTCATGGACGGCTTCGCGCAGTATCGCCGCGCGCTCGTCGCGCTCGGCGAGCGGCACGGCGCGACGACGAGCATCGACTGGCCGCTGTGGCGCGACGGCGGGATGCGCATCGGCGCCGACGCGCAGCGCCTGCTCGAAACGCAGACGGGGATGTCGGCGATGCCGGGCGACGCGGGGCTCGCGTTCTTCCATCGCGCGGTGCGCGCGGGCGTGGCGCAGGTGATGCCGCTGTACGGGAATCCGGCGCGTCTGCGTGACGCGCTTGCGCCCGCCGCGCGCGACGACGCGGGTTCGGCCGCCGATGCGGCCGGCGCGAGCGACGCGGGCAGCGCGTACGCGGATGCCGGCGACGCGCGCGGGATGGCCGGCGCCGTGCTGATCGCGCGTCTTCGCGATGCGCTTGCCGCGGCGCTCGGCGTCGCGCGCGACGCGCTCGACGCGCACGTGCCCGTCGGCGAATTCGGCGTCGACCGGCAGGTGCTCGACGCGCTTGTCGAGCAGGTCGAGCCCGGCGGCGCGGTGCGTCGGGCGGAACTGCTCGATACGCGGCTCACGCTCGACGAGATCGCGTCGCGTCTTGCCGCCGCGACGCGCGGCGACGCGCACGCGGCGCACGCCGCTTCGCCGCGCGGCGAAGCGGGCGAGGCGCAGGAAGCGCCGCAAGCATACGAAGCGCACGGCGCGCATGAAGTGCCGCCGTTGGCCGAGCCGCGCGCGTCCGAGCTCGTCGACGCATCGCTCGCGCTGCTGACCGAGCGGCTTGCCGACGTGATCAAGCTGCCCGCGCCGCGCATCGATCCCGATGCCGAGCTCACGACGTACGGCATCGATTCGGTCGTCGTGATGCAGGTGACGACGCAACTCGAAAAGCAGCTCGGGCCATTGTCGAAGACGCTGTTCTTCGAATACGGCACGCTGCGCGCGATCGCGGCGCGCGTCGCGCACACGCATCGCGAGCGGGTCCGCGCGCTCGTCGAGCGGCGCGCCGCAGGCACGCAGGCGGCATCGGCGGCATCCGTCGCATCGCACCCGGCTGCGCCGCACGGCGCGAGGCCCGCGCACGAGCGGCGCGCCGACGCCGACGCGGCGAGCGTTCGCGGGGCACCGCGCGCCGTTGCCGCGAGGTCGTCGGCGGAGGTCTCGCGGGCAAGCGCGACCGCGAACACGAACACGACCACGACCACGACCACGACCGCGACCGCGACCGCGACCGCGACCGCGACCGCGACCGCGACCACCAACACGACTGAGAACGCCGCGCCGCACGCGTCGCGCGGCGATCGCGACGCGCGGCCGCCTGCGCAGCAGCCGCCCGGCGCGGCCGCGTTCGCGGCGGGCGACATCGCGATCGTCGGCATCGCGGGCCGCTATCCGCAGGCGGACGATCTCGCGCAGTTCTGGCGGAACCTCGCGCGCGGCGTCGACAGCGTGACGGAGATTCCCGCCGACCGCTGGGATTACCGGCGCTTCTACGATCCGCAGAAGGGCCGGCTCGGCAAGAGCTACAGCAAGTGGGGCGGCTTCCTGTCCGATGTCGCGCGCTTCGACGCGGCGTTCTTCAACATCTCCGCGCGCGAGGCGCAGATCATGGACCCGCAGGAGCGGCTGTTCCTCGAATGCGTGTATCACACGCTCGAGGATGCGGGCTACACGCGCCGCAACGTGAGCCGCAGCCGCCGGGTCGGCGTGTTCGTCGGCGTGATGTACGAGGAGTATCAGCTGTACGGCGTCGAGCGCATGCTGGAAGGCACGCCCGTCGCGCTCGCGGGCAATCCCGCCGCGATCGCGAACCGCGTGTCGTACTTCTGCGATTTCCACGGCCCGAGCATGGCGATCGACACGATGTGCTCGTCGTCGCTGAGCGCGATCCATCTCGCGTGCCAGAGCCTCATGCTCGGCGAATGCGAGGTCGCGGTGGCGGGCGGCGTCAACGTGTCGATTCATCCGAACAAGTATCAGATGCTGTCGCAGGGCCGCTTCGCGTCGAGCAACGGCCGCTGCGAGAGCTTCGGCGCGGGCGGCGACGGCTACGTGCCGAGCGAGGGCGTGGGCGCGGTGCTGCTCAAGCCGCTCGCGCGCGCGATCGCGGACGGCGACCGGATTCACGCGGTCATCAAGGCGACCGCGCTCAACCACGGCGGCAAGACGAACGGCTACACGGTGCCGAACCCGAACGCGCAGGCCGACGTGATCGGCGACGCGCTCGCGCGCGCGGGCATCGACGCGCGCAGCATCGGCTATGTCGAGGCGCACGGCACCGGCACGTCGCTCGGCGATCCGATCGAGATCGCGGGGCTCGCGCAGGCGTTCGGCCGCCACACGCCGGACAAGGGCTTCTGCGCGATCGGCTCGGTGAAGTCGAACATCGGCCACGGCGAGAGCGCGGCCGGCATGGCGGGCCTCACGAAGATCGTGCTGCAGATGCGGCACCGTCGGCTCGTGCCGTCGCTGCATGCCGACACGCCGAATCCGAACATCGATTTCGCCGATACGCCGTTCGTCGTGCAGACGACGTTGGCGCCGTGGCGCGGCGCGATCCTGCCCGACGAGGCGGGCCGGCCGGCCGAGCTGCCGCTGCGCGCCGGCCTGTCGTCGTTCGGCGCGGGCGGCGCGAACGCGCACGTCGTCGTCGAGGCGTACGACGTCGCGGGCGCGGAGCGGGGCGCGCACGAAGACGGTCCGGCCGTCGTCGTGCTGTCGGCTCGCACCGACGAGCGGCTCGCCGCGCAGGCGCGCAACCTGCTCGCGCATCTGTCGCGCGAGCCGCATCGCGACGGCGAGCTCGACCGCGACGGCGGTGCGACGCTCGCGTCGATCGCGTACACGCTGCAGGTCGGCCGCGAGGCGATGCCGGCGCGACTCGCGGTGATCGCGGCGTCGCTCGACGATCTGCGCGAGAAGCTCGCGGCGCTCGTCGACGGCGGTGAAGGGCTCGACGGCGTGTCGCGCGGCCGCGTCGATCCGCTCGGCGAGCCGCTCGCGCCCGGCGAGCTCGCGCAATGGCGCGCCGGCGCGCGGCTCGCCGAGCTCGCCGCCGCCTGGGTCGCGGGCCGCTTCGACGACTGGACGCCGTGTTACGGCGACGTTCGGCCGGCGCGCGTGTCGCTGCCGGGCTACGCGTTCGCGCCGACGCGCTACTGGGTGCCCGACGCGGAGCAACTGGCGAAGGCGGCCGGTGTGCACGCGGACGCAACGCAAGCGAAGGGGATCGCGGGCGTGGCGCAGGGTTCGGTGGCGTCGGGAAGTTCGGGCGCTTCGGCTGAGGCGGCCGGGCCGGCCGAGTCGAACGGGGCGGCTGGGTCGAACGGGTCGGCCGGGTCGGCCGGGTCGAACGACGCGGGACCGGGCGATGCGCGCAAGCGCGTGGCGGGGCCTTCGATCGACGCGGCGGCCCCGGCGAACACGGCTCAACCGGCCGAACCGGCCGAACCGGCCGCGCGCCGTCGCGGCGGCGTGACGTTGTCGCCGCCCGCCGAGGCGGCCGCATTCGATCTGTCGGCGCGCGCACCGGCCGCGAAGCCGACGGTGACGTTCGCGCAGCCCGCCGGCCGCGCGCACGAAGCCCTGCCGCCGGCATCTCGTCCGGAGGAATCCGCACCGCGCGTCGTCGCGACGCAGGCGCGCCGCGCGGATGCGGTTAGCGCCGCGCCCGCCGTCTCGCCGGAGGCGGTCGTGCCGGCGCTGCGCGCGCTGCTCGCCGATGCGCTGTACGTCGATGCGCAGACGATCGACGCCAACGCCGAATTCGTGTCGCTCGGCGTGGATTCGATCATCGGCGTCGAGTGGATCGACGCGGTGAACCGGCGGTTCGGCGTCGCGCTGTCGGCGACGACGATCTACGACCATCCGACGCTGTCGAGCTTCGCCCGGCATCTGGCGTCGGCGGCGGCATCGGCGCAGGCGTCGATGGCCGCGGCGGCGTCGCCGTCCGCGCCTGCGTCCGGCGCGCGGGCGGACACGGCCGCGCCCGAGGCTGCGGCGGAGGCGTCCGCGCCGTTCGAGCGCGAGCAGGCGGCGCGCGCGCGCGCCGCCGCGCACGGGGCGGACGACGCGGGCGATCCGGCGCCCGCCGCGCTCGAAGCGGCGCTGCGCGAGACGCTCGCCGACGCGCTGTTCGCCGACGCGCACGACATCGAGCCCGACGCGACGTTCCAGGACCTCGGCGTGGATTCGATCATCGGCGTCGAATGGGTGCAGGCGATCAACCGCCGCTACGGCACGTCGATCCCGGCGCCGCAGATCTATCAGTATCCGACGCTGCGTGCGTTTGGCGGCCTCGTCGCGTCCGAGCTGGCGCTCGCTCGCCGTCGCGCGGGCGGCGCGCCGCTGCCCGACGCCGAGGCGGCATCAGCGACGACGGCGACGACGGCAAGCGCGTCGGGCACCGCGCACGCGCCGAACGCAGCAGGCGACGCGCATGCGCCGAACGCAGCCGGGGCGCGCGCGGCGACTCCCGCGCCCGCGGAAAACGCGGCGGGCGCGGTACATGCCGCGCGGGCCGCAAACCCCGCAAACCCCGCCACTCTCGCAAACCCCGCGCCGGGCGGCGGCGTCCCGCTCGACGACGTGCTCGCGCGCGTGCATCGCGGCGAGCTGAGCGTCGAGGCGGCCGAGGCGCTGCTGGCGGGCGCGCTCGGTTGA", "orf_prot_sequence": "MEDQVVLTSQHPLLDAHRIDGEPWLPGLAYLDLVYQLGEARGIAFERHALHDLTLHAPLAVADGEAVVLTLRWRDERADGWHLTIEGAPLDGGEGAAPRRLVTVRLREAAPAAFGAMRDGDMDAPAVLGATHDGNVGTAGDIVHGNGEATVVDLASLYARCRSLGLVHGAAMQARGTARLTAEQVLVDVRPATASRQAEGDTERNTDGNADGDAGPYLFDPALIDGSGIGSAAFFAHLFDDADAPRLYLPLHIGAFRATRPIRAHVLARVRRASVRRRRELVTVTFEFFDPATGEQIAELTDVTCKAVRDARDGAPARARTDAASGSACSGACSCAAPAAARTVDGRTDGARTERALPDDASPPPGARAERFVRDAIAARLGVAPAAIDADAGFYDLGLDSGMLLELAETIGAAIGASLAPTLLFEHANARELGAWLDAEHGAAFAARATPPHRETEDAARHAAPRAGAGDANGARDGARAGTDANDAGNANSSNGSNPVARPPASVRCGSLDIAVVGMAGRYPGARDLDELWANLRDGRDCVTEVPAERWRADDVAHVRSPSGKPVSRWGGFIDAPDCFDARFFRITPREAEVMDPQERVFLETAWAAIEDAGHTPDTLARRAPGGGDAGAPVGVFVGVMQSEYALIQRDALAGAPTPLAVNRAPVANRVSYVCDFHGPSVAIDTACSSSLVAVHLAAQSLAAGECAVAIAGGVNLSLHPAKYVSCALMDMHASDGRCRSFGAGGDGYVSAEGCGALVLKPLSAALADGDAIHGVIRASATNHVGAVAGIMAPSPAAQAALIGECLRRANVDARTIGYVEAHGTGTALGDPIEIDGLTRAYRAHTRDTQYCALGSIKSAVGHAEAAAGVAGLTKVLLQMRHRTIAPSLHAQPPNPHIDLAASPFFVPARAMRWEPRALAGGGRAPLRAAVSSFGASGTNAHVIVDAYADARVATHDDAGPSVVVLSAMSEPALRQYARALRDAMRAAPAAEPLVARIAELLAEQLGVTADMIDPDADWREFGVDAAQRRRLARALEAWLDIDDALPERAALDSVAGLARQLRREHARAVDAALAGATDLGAARNDGAAALSLRAIAHTLQVGRKALPERAAFVARDVAHLARLLDTFAATGDAPRPDGHRGRARADEQPAEPLSPQHADPHRLAAAWVEGRAIDWAAAYSSGAPRRVSLPTYPFERRRYWVRAADAQSAVRATADGATAPDADAKADVKADARANARADAQAGAHVDAGAAAAAAAAVADILQSVTGLGPDEWRDDTTFDALGLDSLMIGEFTRRIEAMTGERDTTLLFRFRDLTALAAHLAHRHPAAWRADGAQRASSAASTPAPAPAQAGSPPAALASRAARPAPRETAAAAPLDIAIIGLAGRYPHAPTLDAFWRNLVAGRDCVDEIPPQRWPLDGFYEADPARAAAEGKSASKWGAFLSDVDQFDPLFFGITPNEARLTDPHERLFLETAWACVEDAGYTRASLAALRDGPGVGVFVGASFNQYQLIVSDAAQRRGARQFAAPSQIFSISNRVSYVMNFTGPSLTVDTACSSSLYAIHLACESLRRGESSVALAGGVNLSLHPSKYVSLSLGRFLAADGRCRAFDEGGTGYVPGEAVGAVLLKPLADAERDGDAIHGVIRGSGVSHGGRTNGFAVPSPDAQALAIRRAVAQAGVAPRSVGYVEAHGTGTALGDPVEIAGLEDVFRAGTDDVGFCAIASVKTMIGHSEAAAGIAQLTKVLLQMKHATLVRNLSHGGAPNPNLALERSPFRVVRDNEPWAAGDGGVRRAGVSSFGAGGANAHLIVDAYRNAPEPRAGADSGTDDAPALCVLSAKDDARLREMAARLAAHLSDARLGDADLADVAFTLQVGREPMNRRAAFVVSRVRDAIDLLHAIARGDEASGAQASGVLRGDVRAADAQHAPAVDEATLARWPAADAARAIASAWVRGAAIDWMRLRRAPSVRRMSLPTYPFARESYWVPGVAPQSALAPAAGRASRAVDAHGEHGAPRADAPVCPPAGRAQETPGTGVLVLAPQWRPAECSPSASAAPAFDARVLVLCETPASFGAALAPALADGARIVALRSDERDPAARFASHAARLFALVKDELQALAKRPLARALLQVVAPASDDAWDCAALAALLKTAAQENPRLVAQWIAFDAWPDAGGAAARLRENASAAGDVDIRYLDGRRHTLRWAQTRAADRAFGWRANGVFLITGGAGGLGAHVAATIARGAVRPTIVIAGRSAEGAAQTALLDALRSAGARAQYRQADVASHADCDALIAGCVAEYGALHGVVHCAGVIRDGFIVRKRAEDLAAVCAPKVAGVVHLDAATRRLPLDFLLCFSSAAGALGNVGQSDYAMANAFMDAFAAHRNTLVARGQRRGRTCSIGWPIWRDGGMRVDDATLAALEARAGMLPLAIDEGMRTMQDCLALDAPHVIVAAGHLTTLRRLLRVDAGAAGGHAADSADAEAADADARAASPAGANAAVADAAGGDRAGMNTVGPDAPGATALAEGQAGARAAGESAPGDDVAGTHAASGDASLAAAVAERLKHVLSEATGIAVSRLDADEPFDAYGVDSVVVMTVNRALDDVFDALSQTLLYEYGTLGALAGHLAHAHEAACRDWCGVAAAARPGARAADVRVRDTLAVDMSRPDVRTPDLRVSDARGFDERVSDMRDSDAQASSAQASDMLARDTRDIDAQRIADAERQPAEDGDATAVGRAGARAPGASSDAFVGAAGAAAAPAGRDEPIAIIGIAGRYPQASDLDQFWRNLAGGVDSVTTIPPGRWPLEGFFEPDRARALEAGKSYGKWGAFLDDHERFDAPFFQMSPLEAINLDPQIRLFIETCWAALEDAGYTRRLLAERHGKRVGVFAGITKTGYALHGPRVWPLRQSYNPQTSFSALVNRVSYVLDLHGPSVPIDTMCSSSLTAVHEACEHIRSGACALALAGGVNLYLHPSNFLELAGVQMLSADGRCKSFGQGADGFVPGEGVGAVLLKPLSRALADGDHVHAVIRATGINHGGKVNGFTVPNPNAQRELIRATLERAGVRARRVSYVEAHGTGTDLGDPIEVAALAQAFAASGGDRDTGYCALGSVKSNIGHLEAAAGIAGLTKVVLQMTHGMRAPTLHARIPNEKIPFARTPFVLQRERDDWPHAHGDAAQSRIATVSSFGAGGANAFAVVEEAPRRERDARPDRPEVIVLSARDADRLAARIAQLRGRLREGVPYSLAEIAYTLQAGREAMAERIAFVADSLDALVDTLDTLDTLDTAGGAPNPAAGAAAARVHRGSGVTRKTPLSFLADDDLADTVRAWLAKGKLDLVAQAWASGVDIDWTLLHGDRTPRRASLPAYPFAGERHALPDAAQPVAAHALHPLLQRNTSTLERVSFASVFGGDEAFLRDHRVSGRPVLPAVAYIEIAYRALREAGVPGDAVRLTDLVWMRPAIVEGEPLHVRVELASEASEASEASDTSDTSDTSDAAGDTLALTIGAAAPSGRGQPGFATVFARARARRVRVAAPAALPLARWRAQCGAAMTADDCYRVFERVGLAYGPAFRTLDTLWRGDGVAVAKLRAASPPAAPHAAADVVDSLDCGLLDGALQAVLGLAPASDAERPLLPFALDACELYGERPDEPWCVVRRTEDARVDVTLCGPQGEPWIALRGLVLRRYESAPAAERGLVALAPQWRRADATPVAAAAAPAFADTLVVLCGAQRLDAGGSADRIRVVTVANDATPIGERFAQTLQALIAETQALLRDRPDAPALLQVVVPDTPAFAPMIGLAGFLRTLSHEAPHMCGQLLLVPAHDTGAALRARLAECAARAHETVVRYGQGPARDVLQWREWADAMPPADAGQTADAHAAPVWRDDGVYLVTGGAGGLAWLLAQDMARRAPGARMVLVGRRPLDARAASSLDALRARIEYVEADCADADAIAAAVASVLERHGRLDGVVHAAGVLRDEFIRRKTADGVAAVLRPKVDGTLALDRATRDVRLAFFVLFSSAAAQAGNPGQADYAAANGFMDGFAQYRRALVALGERHGATTSIDWPLWRDGGMRIGADAQRLLETQTGMSAMPGDAGLAFFHRAVRAGVAQVMPLYGNPARLRDALAPAARDDAGSAADAAGASDAGSAYADAGDARGMAGAVLIARLRDALAAALGVARDALDAHVPVGEFGVDRQVLDALVEQVEPGGAVRRAELLDTRLTLDEIASRLAAATRGDAHAAHAASPRGEAGEAQEAPQAYEAHGAHEVPPLAEPRASELVDASLALLTERLADVIKLPAPRIDPDAELTTYGIDSVVVMQVTTQLEKQLGPLSKTLFFEYGTLRAIAARVAHTHRERVRALVERRAAGTQAASAASVASHPAAPHGARPAHERRADADAASVRGAPRAVAARSSAEVSRASATANTNTTTTTTTTATATATATATATATTNTTENAAPHASRGDRDARPPAQQPPGAAAFAAGDIAIVGIAGRYPQADDLAQFWRNLARGVDSVTEIPADRWDYRRFYDPQKGRLGKSYSKWGGFLSDVARFDAAFFNISAREAQIMDPQERLFLECVYHTLEDAGYTRRNVSRSRRVGVFVGVMYEEYQLYGVERMLEGTPVALAGNPAAIANRVSYFCDFHGPSMAIDTMCSSSLSAIHLACQSLMLGECEVAVAGGVNVSIHPNKYQMLSQGRFASSNGRCESFGAGGDGYVPSEGVGAVLLKPLARAIADGDRIHAVIKATALNHGGKTNGYTVPNPNAQADVIGDALARAGIDARSIGYVEAHGTGTSLGDPIEIAGLAQAFGRHTPDKGFCAIGSVKSNIGHGESAAGMAGLTKIVLQMRHRRLVPSLHADTPNPNIDFADTPFVVQTTLAPWRGAILPDEAGRPAELPLRAGLSSFGAGGANAHVVVEAYDVAGAERGAHEDGPAVVVLSARTDERLAAQARNLLAHLSREPHRDGELDRDGGATLASIAYTLQVGREAMPARLAVIAASLDDLREKLAALVDGGEGLDGVSRGRVDPLGEPLAPGELAQWRAGARLAELAAAWVAGRFDDWTPCYGDVRPARVSLPGYAFAPTRYWVPDAEQLAKAAGVHADATQAKGIAGVAQGSVASGSSGASAEAAGPAESNGAAGSNGSAGSAGSNDAGPGDARKRVAGPSIDAAAPANTAQPAEPAEPAARRRGGVTLSPPAEAAAFDLSARAPAAKPTVTFAQPAGRAHEALPPASRPEESAPRVVATQARRADAVSAAPAVSPEAVVPALRALLADALYVDAQTIDANAEFVSLGVDSIIGVEWIDAVNRRFGVALSATTIYDHPTLSSFARHLASAAASAQASMAAAASPSAPASGARADTAAPEAAAEASAPFEREQAARARAAAHGADDAGDPAPAALEAALRETLADALFADAHDIEPDATFQDLGVDSIIGVEWVQAINRRYGTSIPAPQIYQYPTLRAFGGLVASELALARRRAGGAPLPDAEAASATTATTASASGTAHAPNAAGDAHAPNAAGARAATPAPAENAAGAVHAARAANPANPATLANPAPGGGVPLDDVLARVHRGELSVEAAEALLAGALG", "perc_identity": 34.78}}, "BGC0000186.1|Thailandamide_5 # 39500 # 45205 # -1 # ID=1_5;partial=00;start_type=ATG;rbs_motif=GGAG;rbs_spacer=6bp;gc_cont=0.746": {"gnl|BL_ORD_ID|4667|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 39500, "orf_end": 45205, "orf_from": "BGC0000186.1|Thailandamide_5 ", "model_name": "vanY gene in vanA cluster", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "50", "model_id": "89", "ARO_accession": "3002955", "ARO_name": "vanY gene in vanA cluster", "ARO_category": {"36216": {"category_aro_accession": "3000077", "category_aro_cvterm_id": "36216", "category_aro_name": "vanY", "category_aro_description": "VanY is a D,D-carboxypeptidase that cleaves removes the terminal D-Ala from peptidoglycan for the addition of D-Lactate. The D-Ala-D-Lac peptidoglycan subunits have reduced binding affinity with vancomycin compared to D-Ala-D-Ala.", "category_aro_class_name": "AMR Gene Family"}, "36373": {"category_aro_accession": "3000234", "category_aro_cvterm_id": "36373", "category_aro_name": "glycopeptide resistance gene cluster", "category_aro_description": "Genes that when expressed confer resistance to vancomycin and teicoplanin type antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35947": {"category_aro_accession": "0000028", "category_aro_cvterm_id": "35947", "category_aro_name": "vancomycin", "category_aro_description": "Vancomycin is a glycopeptide antibiotic used in the prophylaxis and treatment of infections caused by Gram-positive bacteria. Vancomycin inhibits the synthesis of peptidoglycan, the major component of the cell wall of gram-positive bacteria. Its mechanism of action is unusual in that it acts by binding precursors of peptidoglycan, rather than by interacting with an enzyme.", "category_aro_class_name": "Antibiotic"}, "35948": {"category_aro_accession": "0000029", "category_aro_cvterm_id": "35948", "category_aro_name": "teicoplanin", "category_aro_description": "Teicoplanin is a glycopeptide antibiotic used in the prophylaxis and treatment of serious infections caused by Gram-positive bacteria. Teicoplanin has a unique acyl-aliphatic chain, and binds to cell wall precursors to inhibit transglycosylation  and transpeptidation.", "category_aro_class_name": "Antibiotic"}, "36220": {"category_aro_accession": "3000081", "category_aro_cvterm_id": "36220", "category_aro_name": "glycopeptide antibiotic", "category_aro_description": "Glycopeptide antibiotics are natural products produced non-ribosomally by Actinomycetales bacteria. With the exception of bleomycins, they act by binding the terminal D-Ala-D-Ala in peptidoglycan precursors of the growing bacterial cell wall and are generally active against Gram-positive bacteria.  This inhibits transglycosylation leading to cell death due to osmotic stress.", "category_aro_class_name": "Drug Class"}, "35997": {"category_aro_accession": "0001001", "category_aro_cvterm_id": "35997", "category_aro_name": "antibiotic target alteration", "category_aro_description": "Mutational alteration or enzymatic modification of antibiotic target which results in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.873523, "max_identities": 28, "bit_score": 31.187, "cvterm_id": "36779", "query": "LLAHAHHPIVAVGQNYLAANLSRHFDLNGACALVDTACSSALVAMHSAVLALAAGEIDAAVVGGVSLLSSDAGHRLFEQRGLLAPD-GAFHL----FDERANGTVLSEGAGLVMLK", "match": "LL ++ +P+          NLS+H +L     L+D+      + M   +    +  ++ AV GGVS    ++G+R F+++ +L  + GA +     + E  +G  L  G+ L  ++", "sequence_from_db": "LLINSKYPVRQESVKSDIVNLSKHDELINGYGLLDSN-----IYMSKEIAQKFSEMVNDAVKGGVSHFIINSGYRDFDEQSVLYQEMGAEYALPAGYSEHNSGLSLDVGSSLTKME", "sequence_from_broadstreet": "MKKLFFLLLLLFLIYLGYDYVNEALFSQEKVEFQNYDQNPKEHLENSGTSENTQEKTITEEQVYQGNLLLINSKYPVRQESVKSDIVNLSKHDELINGYGLLDSNIYMSKEIAQKFSEMVNDAVKGGVSHFIINSGYRDFDEQSVLYQEMGAEYALPAGYSEHNSGLSLDVGSSLTKMERAPEGKWIEENAWKYGFILRYPEDKTELTGIQYEPWHIRYVGLPHSAIMKEKNFVLEEYMDYLKEEKTISVSVNGEKYEIFYYPVTKNTTIHVPTNLRYEISGNNIDGVIVTVFPGSTHTNSRR", "dna_sequence_from_broadstreet": "ATGAAGAAGTTGTTTTTTTTATTGTTATTGTTATTCTTAATATACTTAGGTTATGACTACGTTAATGAAGCACTGTTTTCTCAGGAAAAAGTCGAATTTCAAAATTATGATCAAAATCCCAAAGAACATTTAGAAAATAGTGGGACTTCTGAAAATACCCAAGAGAAAACAATTACAGAAGAACAGGTTTATCAAGGAAATCTGCTATTAATCAATAGTAAATATCCTGTTCGCCAAGAAAGTGTGAAGTCAGATATCGTGAATTTATCTAAACATGACGAATTAATAAATGGATACGGGTTGCTTGATAGTAATATTTATATGTCAAAAGAAATAGCACAAAAATTTTCAGAGATGGTCAATGATGCTGTAAAGGGTGGCGTTAGTCATTTTATTATTAATAGTGGCTATCGAGACTTTGATGAGCAAAGTGTGCTTTACCAAGAAATGGGGGCTGAGTATGCCTTACCAGCAGGTTATAGTGAGCATAATTCAGGTTTATCACTAGATGTAGGATCAAGCTTGACGAAAATGGAACGAGCCCCTGAAGGAAAGTGGATAGAAGAAAATGCTTGGAAATACGGGTTCATTTTACGTTATCCAGAGGACAAAACAGAGTTAACAGGAATTCAATATGAACCATGGCATATTCGCTATGTTGGTTTACCACATAGTGCGATTATGAAAGAAAAGAATTTCGTTCTCGAGGAATATATGGATTACCTAAAAGAAGAAAAAACCATTTCTGTTAGTGTAAATGGGGAAAAATATGAGATCTTTTATTATCCTGTTACTAAAAATACCACCATTCATGTGCCGACTAATCTTCGTTATGAGATATCAGGAAACAATATAGACGGTGTAATTGTGACAGTGTTTCCCGGATCAACACATACTAATTCAAGGAGGTAA", "partial": "0", "query_start": 44207, "query_end": 44539, "hit_start": 204, "hit_end": 537, "orf_dna_sequence": "ATGCGATCCAGCAAGGAGATCTTCGAGGCGCTGCGCGACGGGCGGCTGTCGCGCGAAGAGGCGCATGCGGCGCTGCGCAGCGCGCGGGCGGCGGCGGATGCGGCGGGTGCGAACGGCGCGGCCGATGCGGCCGATGCGGGCGATGCGGCAAGCGGGGCGAGCGCGGCGAACGGCGAGCGTGCCGCGCATGCGGCGAAGACGGCCGAATCGGCGGCCGCGGCCGACGCCATGCCGATCGCGATCATCGGCCGCTCGGGGCGCTATCCGGACGCGCCGGATCTCGCCGCGTACTGGCGCAATCTGGCGGCGGGGCGCGACTCGGTGCGCCCGATCGCGCCGTCGCGCTGGGACACGGACGCATGGTTCGACGCGCGGCGCGGCGAGCCGGGCAGGATCTATTGCCGCGCGCTCGGCGCGCTGGACGACATCGATTGCTTCGATCCGCTGTTTTTCCACATCTCGCCCGCCGAGGCGCAGTACATCGATCCGCAGCACCGCATCGTGCTCGAGGAGGCGTACCGCGCGTTCGAGGATGCCGGCTACACGCCGCAGCGGCTCGGCGGCCGCGCGTGCGGCGTCTATCTCGGCATCATGAGCAACGAATACGCGATGATGCTCGCGCGCGAGCGCGCGCCGATCGTGAACGCGACCGGCAACGCGTTCTCGATCGCGGCCGCGCGCATCGCGTACTGGCTCGACCTCAAGGGGCCCGCGCTCGCGCTCGACACCGCGTGCTCGTCGTCGCTCGTCGCCGTCCATCTCGCGTGCCAGGCGCTGCGCGCGGGCGAGGTGGAGATGGCGCTCGCATGCGGCGTGTCGCTGTATCTGACGGCCGAGTCGTACGTCGCGATGTGCGGCGCGAACATGCTGTCGGCGCGCGGCGCGTGCCGCGCGTTCGACAACGACGCCGACGGCTTCGTGCCGGGCGAGGGCGCGGGCGCGGTGCTGCTCAAGCGGCTCGACGCGGCCGAGCGCGACGGCGACCGGATTCTCGCGACGATCGCGGCGAGCGGCATCAACCAGGACGGCAAGACGAACGGCATCACCGCGCCGAGCGCGGCGAGCCAGAGCGCGCTCGTGCGCGACGTGTACGCGCGTTTCGGGATCGACGCGACGAGCGTCGACTACTGCGAGATGCACGGCACGGGCACGAAGCTCGGCGATCCGATCGAGCTGCGCGCGCTCGCCGACGTCTATCGCGAAGCGGGCGCGGCCGCCGGCGCGTGCGCGATCGGCTCGGTGAAGACGAACATCGGTCACACGTCGGCGGCGGCGGGCGTCGCGAGCCTGCACAAGGTCATGCTCGCGCTCGAGCACGGCGCGCTCGCGCCGAGCCTGCATTTCGACGCGCCGAACGAGCATTTCGATTTCGCCGCCTCGCCGTTTCGCGTCGTCACGCACGCGCAGCCGTGGCCGCGGCGCGCGGATCGCCCGCGCCGCGCCGCGATCAGCTCGTTCGGGCTGAGCGGGACGAACGCGCACGTGATCGTCGACGAATATCGCGGCCGGGCGCGCGGCGCCGCCTCGCATGCGTCGGGCGCGGCGCACGCGTCGGGCGTACCGGATGCGTCAAACGTCTCCGGCGTGCGGGACGCGCTGCCGGCGTCGAACGCCGCGAACGCACCGCGCCGACCGGAAGTCCCGGAAGCCCCGGAAACCCCGAGCGCGCGGCACCCGGCGACGGACGCGCTCGTCGTCCTGTCCGCGCGCGACGCCGAGCGCCTGCGCGACTATGCGCGGCGTCTGCTGCGCCACGTGAGCGACACGTCGCCGGTATCGTTGCCGGACCTCGCGTACACGCTGCAGACGGGGCGCGCGGCGATGCCGCATCGGCTCGCGATCGCCGCGGATGCCGTCGATACGCTGCGCGACGCGTTGAGCGCGTTCGTCGACGGCCGGCCGCATCCGGCGCTCGTCGCAGGCGCGGCGCAGGGCGGCGCCGGTACGGGGGCGGCGCGCGAAGCGCTCACGCATGCGCACGCCTGGGACGCGCTCGCGCGCGCATGGGTGGCGGGCGCGGAGATCGACTGGCCCGCCGCGCATGGCGCGGCGCTCGCCGAGCGCGTGCGCGTGAACGCGCCGACGTATCCGTTCGCGCGCGAGCGCTATTGGCTGCCGCGGCCGCCCGCGGACGAGGCTGGCGCGCGCCGGCGCGTCGCGCTCGTGAGGGACTGGACGTCCGCGCCGCTCGGCGCGCCGGCCGTGTCCGGCGCGCGGCCTGTGGCGACGCGCATCCTGATGGTCGGCCGCTGCGCGGCGAACCGCGCGCTCGCCGACGCGCTCGCGCCGATGCTGCCGGATGCGGCGCTGATCGACGTGTGCGACGACGCCTCGTTCGACCGCCTGCCCGCGGCGGCGGGCGTCGTCGACCTGACAGGCTGCGCGCGCGAGCCGATCGACGAGATGCGGTGGCTCGCGCTCGTGCAGCGGGTGGTCGCGAGCCGGCCGCGCGCGCTGTACGCCGTCACGGCAGGGCTCGAGACGCCCGCGCGCGGCGCGGCCGGCCTCGCGGGCGCCTGGCAGGCGGGGCTGTATCTCGCGCTGGCCGCCGAATATCCGAGCGTCGCGTCGCGCGTCGTCGATTTGCCCGAAGGCGGCGAGCCGTCGGCGCTCGCGGCGCTCGTGGCGGCCGAATACGACGGCGCGTCGGCCGATGTGCATTGCCGCTATCGCGACGGCGTGCGCGAGCGCGCGATCGTGCGTCCGCTCGACATCGATGCCGACGTCGACGCGCCCGGGCGCGCGCCGCGCGCGAGCGTGCTCGGCCCCGACGATTGCGTATGGATCACGGGCGGCACGCGCGGACTCGGCCTGACGTGCGCGCGGCACCTCGTGTCGCGCCACGGGGTGCGCCGGCTGCTGCTGACGGGCAGGACCGCGCTGCCGCCGCGTTCGGAATGGGACGCGCTCGGCGCGCGCGACGCGGATTTCGCGCGGCGGGCGGCCGGGCTGCGCGCGCTCGAGGCGATGGGCGCGCGGATCGAATATTCGGCCGTCGCGCTCGATGACGCGCGCGCCGTCGCGGCCGAGCTCGCGCGCGTGCGTCCGACGCTCGGCGCGGTGACGGCGCTCGTTCATTGCGCGGGCGCGGTCGACTGGTCCGAGCCGGCGTTTTTCGCGAAGTCGCGCGAATCGATGCGCGCGGTGCTGCAGCCGAAAACGGCCGGGCTCGCGACCGTCGTCGACGCGCTCGCGGGCGCGCCCGTCAAGCGGATCGTGCTGTTTTCGTCGGTTGCGGCGGCGATCCCCGCGCTCGGCGCGGGCCAGGCCGACTACGCGACGGCGAACGCGTGGCTTGACTACTTCGCGCGCGCCTATGCGCGCGCGCTGCCCGTCGTCAGCGTGCAATGGCCGAACTGGCGGGGCGCGGGAATGGGCGAGGTGCGCAGCCGCGCGTATGCGCAAAGCGGGCTGTCGGCGCTCGACGACGCGCAAGGGCTTGCGCTGTTCGACTGGGCGCTCGAGCGGATGCCCGCGCCGGTGGTGTTGCCCGCCTTCGTGCGCGACGGCGAACGCCCGTGGCTGGACTGGCTGGGAGCGCGGACGGCGCACCGAGCGGCATTTGACGCCGAGTCCGACGCAGGCCCGGCCGCGGCGCGGGCCTCGGTGGTCGCGGCGGAGGGGGAAGCCGGCCGCGACCGCCTGTCCGGCGGCGCAAGCGGCATCGCGAGCGGGGCGGCGTCCGTCGACGGCGGTGGCGATGGCCACCGCATTGGCGAGGCCGCCCGCGACGGCGACGGCGAAGGCGAGGGCAATGGCGAGGGCAATGGCGAGGGCGAAGGCGAGGGCGCTTTCGTCGCCGCCGTGCGCGCATGGCTCGCGTCGACGTTCGCGCGGGAGCTGGCGCTGCCGAGCGGGACGCTCGATCCGGCGAAGCCGTTTCGCGAGTACGGCGTCGATTCGATCATGCTGACGCAACTGCTGCGTCCGCTGAACCGGCTAGCCGATGCGCCGCTCGATCCGTCGTTGCTGTTCGAGTACGGCGACGTCGCGCAACTGGCCGATTGGCTCGTCGCGCATCGCGCGGAGCTGATGCGGCAAGCGCTCGCGGCCGAAGGCGCGCGCGCGCCGGCCGACGCGCGGCCGGCTGGGATCGCCGCGCCGGACCCGCGGGCGCTTTCGCCGGCCGCCGCGACGCACGCCGACGCGGCGCGGGTGGAGACGACTTGCGCGATGCGCGGGACGGCCGCGACATCGGCGGCAATCGAGACGCCCGCGCCGCCTGCGAGTCCGGCAGCGCCGACAGTCCCGGCAACATCGGCAACAGCGGCAACATCGGCAACAGCGGCGACAGCGGCAACAGCGGCGACACCCGCCGCCCCGCCATCCCCGATGCGGGATTCGCAGGCGCGCCCGTGCGACATCGCGGTCGTCGGGCTGGCCTGCCGCTTTCCCGGCGCGCCGTCGGTCGACGCGTACTGGGCGCTGCTGCGCGACGGCGCGCGCGGCATCGGCCCCGCGCCGCGCGAGCGCTTCGCGCAAGCCGATCGCTTTTGCGGCGGCTTTCTCGACGCCGTCGGCCGGTTCGACCCCGACCATTTCGGCATCGCGCCCGGCGACGCGCGCGCGATGGACCCGCAGGCGCTCTTGCTGCTCGAGCTCGGCGTCGAGCTGTTTCATCACGCGGGCTACCGTCCGGAAGAGCTCAGGGGCGGGGCCGTCGGCGTGTTTCTCGGCGGCCGCAGCCAGCACGCGCCCGACGCCGCGCTGCTTGCGCACGCGCATCACCCGATCGTCGCGGTCGGACAAAACTATCTGGCCGCGAACCTGTCGCGGCACTTCGACCTGAACGGCGCGTGCGCGCTCGTCGACACCGCGTGCTCGTCGGCGCTCGTCGCGATGCACTCGGCCGTGCTCGCGCTCGCGGCGGGCGAGATCGACGCGGCCGTCGTGGGCGGCGTGAGCCTGCTGTCGTCGGACGCCGGCCATCGCCTTTTCGAGCAGCGCGGCCTGCTCGCGCCGGACGGCGCGTTCCATCTGTTCGACGAGCGCGCGAACGGCACGGTGCTGAGCGAGGGCGCGGGCCTCGTGATGCTCAAGCCGCTTGCCGCCGCGCGCGCGCACGGCGACACGATCTACGCGGTGCTCAAGGGGCTCGCGGTCAACAACGACGGCCGCACGGCCGGCCCGTCGAGCCCGAATTTCGCCGCCCAGCAGGCGGTGATGCGCCGCGCGCTCGCGCAAAGCGGGCTGCGCGCCGACGACGTGCGGCACGTCGAGGCGAACGGCTCGGGCTCGCGCGTGACCGATCTGCTCGAGCTCAAGAGCATCCGCGCCGTGTACGGCGGCCAGTCGCGGGACGCCGCCTGGTGCGCGCTCGGCTCCGTGAAGCCGAGCATCGGCCACACGCTGTGCGCGCAGGGCATCGCGGCGTTCATCAAGAGCGTGCTGATGCTGCATCACCGCAGCGTGCCGCCGTTCCTGTCGGGGCAGCAGCCGATGCAGCACAGCCCGATCGAGCGCTCGCGGCTGCGCTTCGTCAGGGAAACGATCCCGTTCGACGTCGCGGCCCCCGCGGTCGCACTCAATTGCTTCGCCGACGGCGGCACGAACGTGCACGCGGTGCTGCAGGCGTGGGAGGGCCCGACGCGGCCGTCGCGCACGCCGCTCGCCGCGCCCGTGTTCGCGCGCCGGAGGCTCGACGCCCGCACGTCACATGCGAGCGCGCGGACGGCGGCGGCATGGCCGCGTTACGTCGCGCGCTGA", "orf_prot_sequence": "MRSSKEIFEALRDGRLSREEAHAALRSARAAADAAGANGAADAADAGDAASGASAANGERAAHAAKTAESAAAADAMPIAIIGRSGRYPDAPDLAAYWRNLAAGRDSVRPIAPSRWDTDAWFDARRGEPGRIYCRALGALDDIDCFDPLFFHISPAEAQYIDPQHRIVLEEAYRAFEDAGYTPQRLGGRACGVYLGIMSNEYAMMLARERAPIVNATGNAFSIAAARIAYWLDLKGPALALDTACSSSLVAVHLACQALRAGEVEMALACGVSLYLTAESYVAMCGANMLSARGACRAFDNDADGFVPGEGAGAVLLKRLDAAERDGDRILATIAASGINQDGKTNGITAPSAASQSALVRDVYARFGIDATSVDYCEMHGTGTKLGDPIELRALADVYREAGAAAGACAIGSVKTNIGHTSAAAGVASLHKVMLALEHGALAPSLHFDAPNEHFDFAASPFRVVTHAQPWPRRADRPRRAAISSFGLSGTNAHVIVDEYRGRARGAASHASGAAHASGVPDASNVSGVRDALPASNAANAPRRPEVPEAPETPSARHPATDALVVLSARDAERLRDYARRLLRHVSDTSPVSLPDLAYTLQTGRAAMPHRLAIAADAVDTLRDALSAFVDGRPHPALVAGAAQGGAGTGAAREALTHAHAWDALARAWVAGAEIDWPAAHGAALAERVRVNAPTYPFARERYWLPRPPADEAGARRRVALVRDWTSAPLGAPAVSGARPVATRILMVGRCAANRALADALAPMLPDAALIDVCDDASFDRLPAAAGVVDLTGCAREPIDEMRWLALVQRVVASRPRALYAVTAGLETPARGAAGLAGAWQAGLYLALAAEYPSVASRVVDLPEGGEPSALAALVAAEYDGASADVHCRYRDGVRERAIVRPLDIDADVDAPGRAPRASVLGPDDCVWITGGTRGLGLTCARHLVSRHGVRRLLLTGRTALPPRSEWDALGARDADFARRAAGLRALEAMGARIEYSAVALDDARAVAAELARVRPTLGAVTALVHCAGAVDWSEPAFFAKSRESMRAVLQPKTAGLATVVDALAGAPVKRIVLFSSVAAAIPALGAGQADYATANAWLDYFARAYARALPVVSVQWPNWRGAGMGEVRSRAYAQSGLSALDDAQGLALFDWALERMPAPVVLPAFVRDGERPWLDWLGARTAHRAAFDAESDAGPAAARASVVAAEGEAGRDRLSGGASGIASGAASVDGGGDGHRIGEAARDGDGEGEGNGEGNGEGEGEGAFVAAVRAWLASTFARELALPSGTLDPAKPFREYGVDSIMLTQLLRPLNRLADAPLDPSLLFEYGDVAQLADWLVAHRAELMRQALAAEGARAPADARPAGIAAPDPRALSPAAATHADAARVETTCAMRGTAATSAAIETPAPPASPAAPTVPATSATAATSATAATAATAATPAAPPSPMRDSQARPCDIAVVGLACRFPGAPSVDAYWALLRDGARGIGPAPRERFAQADRFCGGFLDAVGRFDPDHFGIAPGDARAMDPQALLLLELGVELFHHAGYRPEELRGGAVGVFLGGRSQHAPDAALLAHAHHPIVAVGQNYLAANLSRHFDLNGACALVDTACSSALVAMHSAVLALAAGEIDAAVVGGVSLLSSDAGHRLFEQRGLLAPDGAFHLFDERANGTVLSEGAGLVMLKPLAAARAHGDTIYAVLKGLAVNNDGRTAGPSSPNFAAQQAVMRRALAQSGLRADDVRHVEANGSGSRVTDLLELKSIRAVYGGQSRDAAWCALGSVKPSIGHTLCAQGIAAFIKSVLMLHHRSVPPFLSGQQPMQHSPIERSRLRFVRETIPFDVAAPAVALNCFADGGTNVHAVLQAWEGPTRPSRTPLAAPVFARRRLDARTSHASARTAAAWPRYVAR", "perc_identity": 24.14}, "gnl|BL_ORD_ID|1214|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 39500, "orf_end": 45205, "orf_from": "BGC0000186.1|Thailandamide_5 ", "model_name": "evgS", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "2300", "model_id": "1318", "ARO_accession": "3000833", "ARO_name": "evgS", "ARO_category": {"36003": {"category_aro_accession": "0010002", "category_aro_cvterm_id": "36003", "category_aro_name": "major facilitator superfamily (MFS) antibiotic efflux pump", "category_aro_description": "Directed pumping of antibiotic out of a cell to confer resistance. Major facilitator superfamily (MFS) transporters and ABC transporters comprise the two largest and most functionally diverse of the transporter superfamilies. However, MFS transporters are distinct from ABC transporters in both their primary sequence and structure and in the mechanism of energy coupling. As secondary transporters they are, like RND and SMR transporters, energized by the electrochemical proton gradient.", "category_aro_class_name": "AMR Gene Family"}, "36005": {"category_aro_accession": "0010004", "category_aro_cvterm_id": "36005", "category_aro_name": "resistance-nodulation-cell division (RND) antibiotic efflux pump", "category_aro_description": "Directed pumping of antibiotic out of a cell to confer resistance. Resistance-nodulation-division (RND) proteins are found in both prokaryotic and eukaryotic cells and have diverse substrate specificities and physiological roles. However, there are relatively few RND transporters and they are secondary transporters, energized not by ATP binding/hydrolysis but by proton movement down the transmembrane electrochemical gradient.", "category_aro_class_name": "AMR Gene Family"}, "35925": {"category_aro_accession": "0000006", "category_aro_cvterm_id": "35925", "category_aro_name": "erythromycin", "category_aro_description": "Erythromycin is a macrolide antibiotic with a 14-carbon ring that has an antimicrobial spectrum similar to or slightly wider than that of penicillin, and is often used for people that have an allergy to penicillins. Erythromycin may possess bacteriocidal activity, particularly at higher concentrations by binding to the 50S subunit of the bacterial 70S rRNA complex, inhibiting peptidyl-tRNA translocation. Thus, protein synthesis and subsequently structure/function processes critical for life or replication are inhibited.", "category_aro_class_name": "Antibiotic"}, "35930": {"category_aro_accession": "0000011", "category_aro_cvterm_id": "35930", "category_aro_name": "cloxacillin", "category_aro_description": "Cloxacillin is a semisynthetic, isoxazolyl penicillin derivative in the beta-lactam class of antibiotics. It interferes with peptidogylcan synthesis and is commonly used for treating penicillin-resistant Staphylococcus aureus infections.", "category_aro_class_name": "Antibiotic"}, "35968": {"category_aro_accession": "0000051", "category_aro_cvterm_id": "35968", "category_aro_name": "tetracycline", "category_aro_description": "Tetracycline is a broad-spectrum polyketide antibiotic produced by many Streptomyces. It works by inhibiting action of the prokaryotic 30S ribosome.", "category_aro_class_name": "Antibiotic"}, "35973": {"category_aro_accession": "0000056", "category_aro_cvterm_id": "35973", "category_aro_name": "oxacillin", "category_aro_description": "Oxacillin is a penicillinase-resistant beta-lactam. It is similar to methicillin, and has replaced methicillin in clinical use. Oxacillin, especially in combination with other antibiotics, is effective against many penicillinase-producing strains of Staphylococcus aureus and Staphylococcus epidermidis.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "35919": {"category_aro_accession": "0000000", "category_aro_cvterm_id": "35919", "category_aro_name": "macrolide antibiotic", "category_aro_description": "Macrolides are a group of drugs (typically antibiotics) that have a large macrocyclic lactone ring of 12-16 carbons to which one or more deoxy sugars, usually cladinose and desosamine, may be attached. Macrolides bind to the 50S-subunit of bacterial ribosomes, inhibiting the synthesis of vital proteins.", "category_aro_class_name": "Drug Class"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "36017": {"category_aro_accession": "3000008", "category_aro_cvterm_id": "36017", "category_aro_name": "penam", "category_aro_description": "Penams are a group of antibiotics derived from Penicillium fungi that share a skeleton beta-lactam moiety fused with a thiazolidine ring. This is the most defining feature of penicillins. Penicillin antibiotics are historically significant because they are the first drugs that were effective against many previously serious diseases such as syphilis and Staphylococcus infections. Penicillins are still widely used today, though many types of bacteria are now resistant. All penicillins are beta-lactam antibiotics in the penam sub-group, and are used in the treatment of bacterial infections caused by susceptible, usually Gram-positive, organisms.", "category_aro_class_name": "Drug Class"}, "36189": {"category_aro_accession": "3000050", "category_aro_cvterm_id": "36189", "category_aro_name": "tetracycline antibiotic", "category_aro_description": "These antibiotics are derived from tetracycline, a polyketide antibiotic that inhibits the 30S subunit of bacterial ribosomes.", "category_aro_class_name": "Drug Class"}, "36298": {"category_aro_accession": "3000159", "category_aro_cvterm_id": "36298", "category_aro_name": "efflux pump complex or subunit conferring antibiotic resistance", "category_aro_description": "Efflux proteins that pump antibiotic out of a cell to confer resistance.", "category_aro_class_name": "Efflux Component"}, "36590": {"category_aro_accession": "3000451", "category_aro_cvterm_id": "36590", "category_aro_name": "protein(s) and two-component regulatory system modulating antibiotic efflux", "category_aro_description": "Protein(s) and two component regulatory systems that directly or indirectly change rates of antibiotic efflux.", "category_aro_class_name": "Efflux Regulator"}, "36001": {"category_aro_accession": "0010000", "category_aro_cvterm_id": "36001", "category_aro_name": "antibiotic efflux", "category_aro_description": "Antibiotic resistance via the transport of antibiotics out of the cell.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 2.31196, "max_identities": 21, "bit_score": 30.0314, "cvterm_id": "36849", "query": "PAFFAKSRESMRAVLQPKTAGLATVVD------ALAGAPVKRIVLFSSVAAAIPALGAGQADYATANAWL--DYFARAYARALPVV", "match": "PA      +SMR +  PK   +A V +           P   I+ F+++  A+ ++ AG  DY   +  +     +R +  +L VV", "sequence_from_db": "PALVTTLHDSMRPLTSPKPVNIARVANYPPDEVIHQSFPKATIISFTNLYQALASVSAGHNDYFIGSNIITSSMISRYFTHSLNVV", "sequence_from_broadstreet": "MKFLPYIFLLCCGLWSTISFADEDYIEYRGISSNNRVTLDPLRLSNKELRWLASKKNLVIAVHKSQTATLLHTDSQQRVRGINADYLNLLKRALNIKLTLREYADHQKAMDALAEGEVDIVLSHLVTSPPLNNDIAATKPLIITFPALVTTLHDSMRPLTSPKPVNIARVANYPPDEVIHQSFPKATIISFTNLYQALASVSAGHNDYFIGSNIITSSMISRYFTHSLNVVKYYNSPRQYNFFLTRKESVILNEVLNRFVDALTNEVRYEVSQNWLDTGNLAFLNKPLELTEHEKQWIKQHPNLKVLENPYSPPYSMTDENGSVRGVMGDILNIITLQTGLNFSPITVSHNIHAGTQLSPGGWDIIPGAIYSEDRENNVLFAEAFITTPYVFVMQKAPDSEQTLKKGMKVAIPYYYELHSQLKEMYPEVEWIQVDNASAAFHKVKEGELDALVATQLNSRYMIDHYYPNELYHFLIPGVPNASLSFAFPRGEPELKDIINKALNAIPPSEVLRLTEKWIKMPNVTIDTWDLYSEQFYIVTTLSVLLVGSSLLWGFYLLRSVRRRKVIQGDLENQISFRKALSDSLPNPTYVVNWQGNVISHNSAFEHYFTADYYKNAMLPLENSDSPFKDVFSNAHEVTAETKENRTIYTQVFEIDNGIEKRCINHWHTLCNLPASDNAVYICGWQDITETRDLINALEVEKNKAIKATVAKSQFLATMSHEIRTPISSIMGFLELLSGSGLSKEQRVEAISLAYATGQSLLGLIGEILDVDKIESGNYQLQPQWVDIPTLVQNTCHSFGAIAASKSIALSCSSTFPEHYLVKIDPQAFKQVLSNLLSNALKFTTEGAVKITTSLGHIDDNHAVIKMTIMDSGSGLSQEEQQQLFKRYSQTSAGRQQTGSGLGLMICKELIKNMQGDLSLESHPGIGTTFTITIPVEISQQVATVEAKAEQPITLPEKLSILIADDHPTNRLLLKRQLNLLGYDVDEATDGVQALHKVSMQHYDLLITDVNMPNMDGFELTRKLREQNSSLPIWGLTANAQANEREKGLSCGMNLCLFKPLTLDVLKTHLSQLHQVAHIAPQYRHLDIEALKNNTANDLQLMQEILMTFQHETHKDLPAAFQALEAGDNRTFHQCIHRIHGAANILNLQKLINISHQLEITPVSDDSKPEILQLLNSVKEHIAELDQEIAVFCQKND", "dna_sequence_from_broadstreet": "ATGAAGTTTTTACCCTATATTTTTCTTCTCTGTTGTGGTCTTTGGTCGACCATAAGTTTCGCAGACGAAGATTACATCGAATATCGTGGCATCAGTAGTAACAACCGTGTCACACTTGATCCACTACGTCTGAGCAACAAGGAATTACGTTGGTTAGCGAGCAAAAAAAATCTTGTGATTGCAGTACATAAGTCCCAAACGGCTACGTTGTTGCATACCGATTCGCAGCAACGGGTTCGTGGTATTAATGCTGATTATTTAAATCTTTTAAAAAGAGCGTTAAATATCAAATTAACACTCCGGGAATACGCAGATCATCAAAAAGCAATGGACGCGCTTGCAGAAGGTGAAGTCGATATAGTGTTATCACATTTAGTTACTTCGCCGCCTCTTAATAATGACATTGCTGCAACCAAACCATTGATAATTACCTTTCCGGCGCTGGTAACCACCCTTCACGACTCAATGCGACCGCTTACCTCACCAAAACCAGTAAATATTGCTCGGGTAGCAAATTACCCCCCAGACGAGGTAATTCATCAATCATTTCCAAAAGCAACAATTATCTCTTTTACAAATTTATATCAGGCATTAGCATCCGTCTCAGCTGGGCACAATGATTACTTTATTGGTAGTAACATCATTACCAGCAGTATGATTTCCCGCTATTTCACTCACTCCTTAAATGTAGTGAAATATTATAACTCGCCGCGTCAATATAATTTTTTCTTGACCAGAAAAGAATCTGTCATTCTTAATGAAGTACTCAATAGATTTGTTGATGCTTTAACAAATGAAGTTCGCTATGAAGTATCACAAAATTGGCTTGATACAGGAAACCTGGCCTTTCTGAACAAACCATTAGAACTCACTGAACATGAAAAACAGTGGATTAAGCAGCATCCCAATTTAAAGGTGCTGGAAAATCCTTACTCGCCCCCCTATTCTATGACGGATGAAAATGGCTCGGTTCGGGGCGTTATGGGGGACATTCTTAATATTATTACCTTGCAAACAGGTTTAAATTTTTCTCCGATCACCGTTTCACACAATATCCATGCTGGAACACAGCTTAGCCCCGGAGGATGGGATATAATACCTGGCGCTATTTATAGTGAAGATCGAGAAAATAATGTTTTATTTGCTGAAGCCTTCATAACAACGCCTTACGTTTTTGTCATGCAAAAAGCGCCTGACAGTGAACAAACATTAAAAAAAGGAATGAAAGTTGCCATTCCATATTATTATGAGCTGCATTCGCAATTAAAAGAGATGTATCCGGAGGTTGAATGGATACAGGTCGATAATGCCAGCGCTGCATTTCACAAGGTTAAGGAAGGTGAACTTGATGCTCTGGTCGCGACACAGCTAAATTCGCGTTACATGATCGATCATTACTATCCTAATGAACTTTATCATTTTCTTATTCCTGGCGTTCCGAATGCATCGCTTTCGTTCGCTTTTCCTCGCGGAGAACCGGAACTTAAGGATATTATTAATAAAGCACTGAATGCAATTCCCCCAAGCGAAGTTCTGCGCCTGACGGAAAAATGGATTAAAATGCCCAATGTGACCATTGACACATGGGACCTATATAGCGAGCAATTTTATATTGTTACGACATTATCCGTTTTATTAGTTGGCAGTAGCCTTTTATGGGGATTCTACCTGTTACGCTCAGTTCGTCGTCGTAAAGTCATTCAGGGTGATTTAGAAAACCAAATATCATTCCGAAAAGCACTCTCGGATTCCTTACCGAATCCAACTTATGTTGTAAACTGGCAAGGTAATGTCATTAGTCATAATAGTGCTTTTGAACATTATTTCACTGCGGATTACTACAAAAATGCAATGTTACCATTAGAAAACAGTGACTCACCCTTTAAAGATGTTTTTTCTAATGCGCATGAAGTCACAGCAGAAACGAAAGAAAATCGAACAATATACACACAGGTATTTGAAATTGATAATGGCATCGAGAAAAGATGCATTAATCACTGGCATACATTATGCAATCTTCCTGCAAGTGACAATGCAGTATATATTTGTGGTTGGCAAGATATTACTGAAACGCGTGATCTAATTAATGCACTCGAGGTAGAAAAAAATAAAGCGATAAAGGCTACCGTAGCAAAAAGTCAGTTTCTGGCAACGATGAGTCACGAAATAAGAACACCAATAAGCTCTATTATGGGCTTCCTGGAACTTCTGTCGGGTTCTGGTCTTAGCAAGGAGCAACGGGTGGAGGCGATTTCACTTGCCTACGCCACCGGACAATCACTCCTCGGCTTAATTGGTGAAATCCTTGATGTCGACAAAATTGAATCGGGTAACTATCAACTTCAACCACAATGGGTCGATATCCCTACTTTAGTCCAGAACACTTGTCACTCTTTCGGTGCGATTGCTGCAAGCAAATCGATCGCATTAAGTTGCAGCAGTACGTTTCCTGAACATTACCTGGTTAAGATCGACCCTCAGGCGTTTAAGCAGGTCTTATCAAATTTACTGAGTAATGCTCTCAAATTTACCACCGAGGGGGCAGTAAAAATTACGACCTCCCTGGGTCACATTGATGACAACCACGCTGTTATCAAAATGACGATTATGGATTCTGGAAGTGGATTATCGCAGGAAGAACAACAACAACTGTTTAAACGCTACAGCCAAACAAGTGCAGGTCGTCAGCAAACAGGTTCTGGTTTAGGCTTAATGATCTGCAAAGAATTAATTAAAAATATGCAGGGCGATTTGTCATTAGAAAGTCATCCAGGCATAGGAACAACATTTACGATCACAATCCCGGTAGAAATTAGCCAGCAAGTGGCGACTGTCGAGGCAAAAGCAGAACAACCCATCACACTACCTGAAAAGTTGAGCATATTAATCGCGGATGATCATCCGACCAACAGGCTATTACTCAAACGCCAGCTAAATCTATTAGGATATGATGTTGATGAAGCCACTGATGGTGTGCAAGCGCTACACAAAGTCAGTATGCAACATTATGATCTGCTTATTACTGACGTTAATATGCCGAATATGGATGGTTTTGAGTTGACTCGCAAACTCCGTGAGCAAAATTCTTCCTTACCCATCTGGGGGCTTACAGCCAACGCACAGGCTAACGAACGTGAAAAAGGGTTAAGTTGCGGCATGAACTTATGTTTGTTCAAACCGTTGACCCTGGATGTACTGAAAACACATTTAAGTCAGTTACACCAAGTTGCGCATATTGCACCTCAGTATCGCCACCTTGATATCGAAGCCCTGAAAAATAATACGGCGAACGATCTACAACTGATGCAGGAGATTCTCATGACTTTCCAGCATGAAACGCATAAAGATCTACCCGCTGCGTTTCAAGCACTAGAAGCTGGCGATAACAGAACTTTCCATCAGTGTATTCATCGCATCCACGGTGCGGCTAACATCCTGAATTTGCAAAAGTTGATTAATATTAGCCATCAGTTAGAAATAACACCTGTTTCAGATGACAGTAAGCCTGAAATTCTTCAGTTGCTGAACTCTGTAAAAGAACACATTGCAGAGCTGGACCAGGAGATTGCTGTTTTCTGTCAGAAAAATGACTAA", "partial": "0", "query_start": 42605, "query_end": 42838, "hit_start": 435, "hit_end": 693, "orf_dna_sequence": "ATGCGATCCAGCAAGGAGATCTTCGAGGCGCTGCGCGACGGGCGGCTGTCGCGCGAAGAGGCGCATGCGGCGCTGCGCAGCGCGCGGGCGGCGGCGGATGCGGCGGGTGCGAACGGCGCGGCCGATGCGGCCGATGCGGGCGATGCGGCAAGCGGGGCGAGCGCGGCGAACGGCGAGCGTGCCGCGCATGCGGCGAAGACGGCCGAATCGGCGGCCGCGGCCGACGCCATGCCGATCGCGATCATCGGCCGCTCGGGGCGCTATCCGGACGCGCCGGATCTCGCCGCGTACTGGCGCAATCTGGCGGCGGGGCGCGACTCGGTGCGCCCGATCGCGCCGTCGCGCTGGGACACGGACGCATGGTTCGACGCGCGGCGCGGCGAGCCGGGCAGGATCTATTGCCGCGCGCTCGGCGCGCTGGACGACATCGATTGCTTCGATCCGCTGTTTTTCCACATCTCGCCCGCCGAGGCGCAGTACATCGATCCGCAGCACCGCATCGTGCTCGAGGAGGCGTACCGCGCGTTCGAGGATGCCGGCTACACGCCGCAGCGGCTCGGCGGCCGCGCGTGCGGCGTCTATCTCGGCATCATGAGCAACGAATACGCGATGATGCTCGCGCGCGAGCGCGCGCCGATCGTGAACGCGACCGGCAACGCGTTCTCGATCGCGGCCGCGCGCATCGCGTACTGGCTCGACCTCAAGGGGCCCGCGCTCGCGCTCGACACCGCGTGCTCGTCGTCGCTCGTCGCCGTCCATCTCGCGTGCCAGGCGCTGCGCGCGGGCGAGGTGGAGATGGCGCTCGCATGCGGCGTGTCGCTGTATCTGACGGCCGAGTCGTACGTCGCGATGTGCGGCGCGAACATGCTGTCGGCGCGCGGCGCGTGCCGCGCGTTCGACAACGACGCCGACGGCTTCGTGCCGGGCGAGGGCGCGGGCGCGGTGCTGCTCAAGCGGCTCGACGCGGCCGAGCGCGACGGCGACCGGATTCTCGCGACGATCGCGGCGAGCGGCATCAACCAGGACGGCAAGACGAACGGCATCACCGCGCCGAGCGCGGCGAGCCAGAGCGCGCTCGTGCGCGACGTGTACGCGCGTTTCGGGATCGACGCGACGAGCGTCGACTACTGCGAGATGCACGGCACGGGCACGAAGCTCGGCGATCCGATCGAGCTGCGCGCGCTCGCCGACGTCTATCGCGAAGCGGGCGCGGCCGCCGGCGCGTGCGCGATCGGCTCGGTGAAGACGAACATCGGTCACACGTCGGCGGCGGCGGGCGTCGCGAGCCTGCACAAGGTCATGCTCGCGCTCGAGCACGGCGCGCTCGCGCCGAGCCTGCATTTCGACGCGCCGAACGAGCATTTCGATTTCGCCGCCTCGCCGTTTCGCGTCGTCACGCACGCGCAGCCGTGGCCGCGGCGCGCGGATCGCCCGCGCCGCGCCGCGATCAGCTCGTTCGGGCTGAGCGGGACGAACGCGCACGTGATCGTCGACGAATATCGCGGCCGGGCGCGCGGCGCCGCCTCGCATGCGTCGGGCGCGGCGCACGCGTCGGGCGTACCGGATGCGTCAAACGTCTCCGGCGTGCGGGACGCGCTGCCGGCGTCGAACGCCGCGAACGCACCGCGCCGACCGGAAGTCCCGGAAGCCCCGGAAACCCCGAGCGCGCGGCACCCGGCGACGGACGCGCTCGTCGTCCTGTCCGCGCGCGACGCCGAGCGCCTGCGCGACTATGCGCGGCGTCTGCTGCGCCACGTGAGCGACACGTCGCCGGTATCGTTGCCGGACCTCGCGTACACGCTGCAGACGGGGCGCGCGGCGATGCCGCATCGGCTCGCGATCGCCGCGGATGCCGTCGATACGCTGCGCGACGCGTTGAGCGCGTTCGTCGACGGCCGGCCGCATCCGGCGCTCGTCGCAGGCGCGGCGCAGGGCGGCGCCGGTACGGGGGCGGCGCGCGAAGCGCTCACGCATGCGCACGCCTGGGACGCGCTCGCGCGCGCATGGGTGGCGGGCGCGGAGATCGACTGGCCCGCCGCGCATGGCGCGGCGCTCGCCGAGCGCGTGCGCGTGAACGCGCCGACGTATCCGTTCGCGCGCGAGCGCTATTGGCTGCCGCGGCCGCCCGCGGACGAGGCTGGCGCGCGCCGGCGCGTCGCGCTCGTGAGGGACTGGACGTCCGCGCCGCTCGGCGCGCCGGCCGTGTCCGGCGCGCGGCCTGTGGCGACGCGCATCCTGATGGTCGGCCGCTGCGCGGCGAACCGCGCGCTCGCCGACGCGCTCGCGCCGATGCTGCCGGATGCGGCGCTGATCGACGTGTGCGACGACGCCTCGTTCGACCGCCTGCCCGCGGCGGCGGGCGTCGTCGACCTGACAGGCTGCGCGCGCGAGCCGATCGACGAGATGCGGTGGCTCGCGCTCGTGCAGCGGGTGGTCGCGAGCCGGCCGCGCGCGCTGTACGCCGTCACGGCAGGGCTCGAGACGCCCGCGCGCGGCGCGGCCGGCCTCGCGGGCGCCTGGCAGGCGGGGCTGTATCTCGCGCTGGCCGCCGAATATCCGAGCGTCGCGTCGCGCGTCGTCGATTTGCCCGAAGGCGGCGAGCCGTCGGCGCTCGCGGCGCTCGTGGCGGCCGAATACGACGGCGCGTCGGCCGATGTGCATTGCCGCTATCGCGACGGCGTGCGCGAGCGCGCGATCGTGCGTCCGCTCGACATCGATGCCGACGTCGACGCGCCCGGGCGCGCGCCGCGCGCGAGCGTGCTCGGCCCCGACGATTGCGTATGGATCACGGGCGGCACGCGCGGACTCGGCCTGACGTGCGCGCGGCACCTCGTGTCGCGCCACGGGGTGCGCCGGCTGCTGCTGACGGGCAGGACCGCGCTGCCGCCGCGTTCGGAATGGGACGCGCTCGGCGCGCGCGACGCGGATTTCGCGCGGCGGGCGGCCGGGCTGCGCGCGCTCGAGGCGATGGGCGCGCGGATCGAATATTCGGCCGTCGCGCTCGATGACGCGCGCGCCGTCGCGGCCGAGCTCGCGCGCGTGCGTCCGACGCTCGGCGCGGTGACGGCGCTCGTTCATTGCGCGGGCGCGGTCGACTGGTCCGAGCCGGCGTTTTTCGCGAAGTCGCGCGAATCGATGCGCGCGGTGCTGCAGCCGAAAACGGCCGGGCTCGCGACCGTCGTCGACGCGCTCGCGGGCGCGCCCGTCAAGCGGATCGTGCTGTTTTCGTCGGTTGCGGCGGCGATCCCCGCGCTCGGCGCGGGCCAGGCCGACTACGCGACGGCGAACGCGTGGCTTGACTACTTCGCGCGCGCCTATGCGCGCGCGCTGCCCGTCGTCAGCGTGCAATGGCCGAACTGGCGGGGCGCGGGAATGGGCGAGGTGCGCAGCCGCGCGTATGCGCAAAGCGGGCTGTCGGCGCTCGACGACGCGCAAGGGCTTGCGCTGTTCGACTGGGCGCTCGAGCGGATGCCCGCGCCGGTGGTGTTGCCCGCCTTCGTGCGCGACGGCGAACGCCCGTGGCTGGACTGGCTGGGAGCGCGGACGGCGCACCGAGCGGCATTTGACGCCGAGTCCGACGCAGGCCCGGCCGCGGCGCGGGCCTCGGTGGTCGCGGCGGAGGGGGAAGCCGGCCGCGACCGCCTGTCCGGCGGCGCAAGCGGCATCGCGAGCGGGGCGGCGTCCGTCGACGGCGGTGGCGATGGCCACCGCATTGGCGAGGCCGCCCGCGACGGCGACGGCGAAGGCGAGGGCAATGGCGAGGGCAATGGCGAGGGCGAAGGCGAGGGCGCTTTCGTCGCCGCCGTGCGCGCATGGCTCGCGTCGACGTTCGCGCGGGAGCTGGCGCTGCCGAGCGGGACGCTCGATCCGGCGAAGCCGTTTCGCGAGTACGGCGTCGATTCGATCATGCTGACGCAACTGCTGCGTCCGCTGAACCGGCTAGCCGATGCGCCGCTCGATCCGTCGTTGCTGTTCGAGTACGGCGACGTCGCGCAACTGGCCGATTGGCTCGTCGCGCATCGCGCGGAGCTGATGCGGCAAGCGCTCGCGGCCGAAGGCGCGCGCGCGCCGGCCGACGCGCGGCCGGCTGGGATCGCCGCGCCGGACCCGCGGGCGCTTTCGCCGGCCGCCGCGACGCACGCCGACGCGGCGCGGGTGGAGACGACTTGCGCGATGCGCGGGACGGCCGCGACATCGGCGGCAATCGAGACGCCCGCGCCGCCTGCGAGTCCGGCAGCGCCGACAGTCCCGGCAACATCGGCAACAGCGGCAACATCGGCAACAGCGGCGACAGCGGCAACAGCGGCGACACCCGCCGCCCCGCCATCCCCGATGCGGGATTCGCAGGCGCGCCCGTGCGACATCGCGGTCGTCGGGCTGGCCTGCCGCTTTCCCGGCGCGCCGTCGGTCGACGCGTACTGGGCGCTGCTGCGCGACGGCGCGCGCGGCATCGGCCCCGCGCCGCGCGAGCGCTTCGCGCAAGCCGATCGCTTTTGCGGCGGCTTTCTCGACGCCGTCGGCCGGTTCGACCCCGACCATTTCGGCATCGCGCCCGGCGACGCGCGCGCGATGGACCCGCAGGCGCTCTTGCTGCTCGAGCTCGGCGTCGAGCTGTTTCATCACGCGGGCTACCGTCCGGAAGAGCTCAGGGGCGGGGCCGTCGGCGTGTTTCTCGGCGGCCGCAGCCAGCACGCGCCCGACGCCGCGCTGCTTGCGCACGCGCATCACCCGATCGTCGCGGTCGGACAAAACTATCTGGCCGCGAACCTGTCGCGGCACTTCGACCTGAACGGCGCGTGCGCGCTCGTCGACACCGCGTGCTCGTCGGCGCTCGTCGCGATGCACTCGGCCGTGCTCGCGCTCGCGGCGGGCGAGATCGACGCGGCCGTCGTGGGCGGCGTGAGCCTGCTGTCGTCGGACGCCGGCCATCGCCTTTTCGAGCAGCGCGGCCTGCTCGCGCCGGACGGCGCGTTCCATCTGTTCGACGAGCGCGCGAACGGCACGGTGCTGAGCGAGGGCGCGGGCCTCGTGATGCTCAAGCCGCTTGCCGCCGCGCGCGCGCACGGCGACACGATCTACGCGGTGCTCAAGGGGCTCGCGGTCAACAACGACGGCCGCACGGCCGGCCCGTCGAGCCCGAATTTCGCCGCCCAGCAGGCGGTGATGCGCCGCGCGCTCGCGCAAAGCGGGCTGCGCGCCGACGACGTGCGGCACGTCGAGGCGAACGGCTCGGGCTCGCGCGTGACCGATCTGCTCGAGCTCAAGAGCATCCGCGCCGTGTACGGCGGCCAGTCGCGGGACGCCGCCTGGTGCGCGCTCGGCTCCGTGAAGCCGAGCATCGGCCACACGCTGTGCGCGCAGGGCATCGCGGCGTTCATCAAGAGCGTGCTGATGCTGCATCACCGCAGCGTGCCGCCGTTCCTGTCGGGGCAGCAGCCGATGCAGCACAGCCCGATCGAGCGCTCGCGGCTGCGCTTCGTCAGGGAAACGATCCCGTTCGACGTCGCGGCCCCCGCGGTCGCACTCAATTGCTTCGCCGACGGCGGCACGAACGTGCACGCGGTGCTGCAGGCGTGGGAGGGCCCGACGCGGCCGTCGCGCACGCCGCTCGCCGCGCCCGTGTTCGCGCGCCGGAGGCTCGACGCCCGCACGTCACATGCGAGCGCGCGGACGGCGGCGGCATGGCCGCGTTACGTCGCGCGCTGA", "orf_prot_sequence": "MRSSKEIFEALRDGRLSREEAHAALRSARAAADAAGANGAADAADAGDAASGASAANGERAAHAAKTAESAAAADAMPIAIIGRSGRYPDAPDLAAYWRNLAAGRDSVRPIAPSRWDTDAWFDARRGEPGRIYCRALGALDDIDCFDPLFFHISPAEAQYIDPQHRIVLEEAYRAFEDAGYTPQRLGGRACGVYLGIMSNEYAMMLARERAPIVNATGNAFSIAAARIAYWLDLKGPALALDTACSSSLVAVHLACQALRAGEVEMALACGVSLYLTAESYVAMCGANMLSARGACRAFDNDADGFVPGEGAGAVLLKRLDAAERDGDRILATIAASGINQDGKTNGITAPSAASQSALVRDVYARFGIDATSVDYCEMHGTGTKLGDPIELRALADVYREAGAAAGACAIGSVKTNIGHTSAAAGVASLHKVMLALEHGALAPSLHFDAPNEHFDFAASPFRVVTHAQPWPRRADRPRRAAISSFGLSGTNAHVIVDEYRGRARGAASHASGAAHASGVPDASNVSGVRDALPASNAANAPRRPEVPEAPETPSARHPATDALVVLSARDAERLRDYARRLLRHVSDTSPVSLPDLAYTLQTGRAAMPHRLAIAADAVDTLRDALSAFVDGRPHPALVAGAAQGGAGTGAAREALTHAHAWDALARAWVAGAEIDWPAAHGAALAERVRVNAPTYPFARERYWLPRPPADEAGARRRVALVRDWTSAPLGAPAVSGARPVATRILMVGRCAANRALADALAPMLPDAALIDVCDDASFDRLPAAAGVVDLTGCAREPIDEMRWLALVQRVVASRPRALYAVTAGLETPARGAAGLAGAWQAGLYLALAAEYPSVASRVVDLPEGGEPSALAALVAAEYDGASADVHCRYRDGVRERAIVRPLDIDADVDAPGRAPRASVLGPDDCVWITGGTRGLGLTCARHLVSRHGVRRLLLTGRTALPPRSEWDALGARDADFARRAAGLRALEAMGARIEYSAVALDDARAVAAELARVRPTLGAVTALVHCAGAVDWSEPAFFAKSRESMRAVLQPKTAGLATVVDALAGAPVKRIVLFSSVAAAIPALGAGQADYATANAWLDYFARAYARALPVVSVQWPNWRGAGMGEVRSRAYAQSGLSALDDAQGLALFDWALERMPAPVVLPAFVRDGERPWLDWLGARTAHRAAFDAESDAGPAAARASVVAAEGEAGRDRLSGGASGIASGAASVDGGGDGHRIGEAARDGDGEGEGNGEGNGEGEGEGAFVAAVRAWLASTFARELALPSGTLDPAKPFREYGVDSIMLTQLLRPLNRLADAPLDPSLLFEYGDVAQLADWLVAHRAELMRQALAAEGARAPADARPAGIAAPDPRALSPAAATHADAARVETTCAMRGTAATSAAIETPAPPASPAAPTVPATSATAATSATAATAATAATPAAPPSPMRDSQARPCDIAVVGLACRFPGAPSVDAYWALLRDGARGIGPAPRERFAQADRFCGGFLDAVGRFDPDHFGIAPGDARAMDPQALLLLELGVELFHHAGYRPEELRGGAVGVFLGGRSQHAPDAALLAHAHHPIVAVGQNYLAANLSRHFDLNGACALVDTACSSALVAMHSAVLALAAGEIDAAVVGGVSLLSSDAGHRLFEQRGLLAPDGAFHLFDERANGTVLSEGAGLVMLKPLAAARAHGDTIYAVLKGLAVNNDGRTAGPSSPNFAAQQAVMRRALAQSGLRADDVRHVEANGSGSRVTDLLELKSIRAVYGGQSRDAAWCALGSVKPSIGHTLCAQGIAAFIKSVLMLHHRSVPPFLSGQQPMQHSPIERSRLRFVRETIPFDVAAPAVALNCFADGGTNVHAVLQAWEGPTRPSRTPLAAPVFARRRLDARTSHASARTAAAWPRYVAR", "perc_identity": 24.42}}, "BGC0000186.1|Thailandamide_6 # 45217 # 45963 # -1 # ID=1_6;partial=00;start_type=ATG;rbs_motif=GGAG;rbs_spacer=7bp;gc_cont=0.681": {"gnl|BL_ORD_ID|4807|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 45217, "orf_end": 45963, "orf_from": "BGC0000186.1|Thailandamide_6 ", "model_name": "Streptomyces rimosus otr(A)", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "275", "model_id": "1273", "ARO_accession": "3002891", "ARO_name": "Streptomyces rimosus otr(A)", "ARO_category": {"35921": {"category_aro_accession": "0000002", "category_aro_cvterm_id": "35921", "category_aro_name": "tetracycline-resistant ribosomal protection protein", "category_aro_description": "A family of proteins known to bind to the 30S ribosomal subunit. This interaction prevents tetracycline and tetracycline derivatives from inhibiting ribosomal function. Thus, these proteins confer elevated resistance to tetracycline derivatives as a ribosomal protection protein.", "category_aro_class_name": "AMR Gene Family"}, "37012": {"category_aro_accession": "3000668", "category_aro_cvterm_id": "37012", "category_aro_name": "oxytetracycline", "category_aro_description": "Oxytetracycline is a derivative of tetracycline with a 5-hydroxyl group. Its activity is similar to other tetracyclines.", "category_aro_class_name": "Antibiotic"}, "36189": {"category_aro_accession": "3000050", "category_aro_cvterm_id": "36189", "category_aro_name": "tetracycline antibiotic", "category_aro_description": "These antibiotics are derived from tetracycline, a polyketide antibiotic that inhibits the 30S subunit of bacterial ribosomes.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 1.85811, "max_identities": 16, "bit_score": 26.9498, "cvterm_id": "36773", "query": "SHMVRGLREQLPSIVADEVAMHDATFHNDDVKARIES", "match": " H+V G+RE LPS+ A + A   AT    D  AR E+", "sequence_from_db": "DHLVHGIRELLPSVHASQDAPLRATVFKVDRGARGEA", "sequence_from_broadstreet": "MNKLNLGILAHVDAGKTSLTERLLHRTGVIDEVGSVDAGTTTTDSMELERQRGITIRSAVATFVLDDLKVNLIDTPGHSDFISEVERALGVLDGAVLVVSAVEGVQPQTRILMRTLRRLGIPTLVFVNKIDRGGARPDGVLREIRDRLTPAAVALSAVADAGTPRARAIALGPDTDPDFAVRVGELLADHDDAFLTAYLDEEHVLTEKEYAEELAAQTARGLVHPVYFGSALTGEGLDHLVHGIRELLPSVHASQDAPLRATVFKVDRGARGEAVAYLRLVSGTLGTRDSVTLHRVDHTGRVTEHAGRITALRVFEHGSATSETRATAGDIAQAWGLKDVRVGDRAGHLDGPPPRNFFAPPSLETVIRPERPEEAGRLHAALRMLDEQDPSIDLRQDEENAAGAVVRLYGEVQKEILGSTLAESFGVRVRFDPTRTVCIEKPVGTGEALIELDTRTHNYFWGAPWVCASDRPSPARAITFRLAVELGSLPLAFHKAIEETVHTTLRHGLYGWQVTDCAVTLTRTGVRSPVSAADDFRKANARLVLMDALGRAGTEVHEPVSSFELEVPAARLSPVLAKLAELGATPGVPTAEGDVFRLEGTMPTSLVHDFNQRVPGLTQGEGVFLAEHRGYRPAVGQPPVRPRPEGPNPLNRDEYILHVLKRV", "dna_sequence_from_broadstreet": "ATGAACAAGCTGAATCTGGGCATCCTGGCCCACGTTGACGCCGGCAAGACCAGCCTCACCGAGCGCCTGCTGCACCGCACCGGTGTGATCGACGAGGTCGGCAGCGTGGACGCCGGCACCACGACGACCGACTCGATGGAGCTGGAGCGGCAGCGCGGCATCACCATCCGGTCCGCCGTGGCCACGTTCGTCCTGGACGATCTCAAGGTCAACCTCATCGACACCCCGGGCCACTCCGACTTCATCTCCGAGGTCGAGCGGGCGCTCGGGGTGCTCGACGGCGCGGTCCTGGTGGTCTCGGCCGTCGAGGGCGTCCAGCCGCAGACCCGCATCCTGATGCGGACCCTGCGCAGGCTGGGCATTCCCACGCTGGTCTTCGTCAACAAGATCGACCGGGGCGGCGCGCGTCCCGACGGTGTGCTGCGGGAGATCCGCGACCGGCTCACCCCCGCCGCGGTGGCACTGTCCGCCGTGGCGGACGCCGGCACGCCGCGGGCCCGCGCGATCGCGCTCGGCCCGGACACCGACCCGGACTTCGCCGTCCGGGTCGGTGAGCTGCTGGCCGACCACGACGACGCGTTCCTCACCGCCTACCTGGACGAGGAACACGTACTGACCGAGAAGGAGTACGCGGAGGAACTGGCCGCGCAGACCGCGCGCGGTCTGGTGCACCCGGTGTACTTCGGGTCCGCGCTGACCGGCGAGGGCCTGGACCATCTGGTGCACGGCATCCGGGAGTTGCTGCCGTCCGTGCACGCGTCGCAGGACGCGCCGCTGCGGGCCACCGTGTTCAAGGTGGACCGTGGCGCGCGCGGCGAGGCCGTCGCGTACCTGCGGCTGGTCTCCGGCACGCTGGGCACCCGCGATTCGGTGACGCTGCACCGCGTCGACCACACCGGCCGGGTCACCGAGCACGCCGGACGCATCACCGCGCTGCGGGTCTTCGAGCACGGGTCGGCCACCAGCGAGACCCGGGCGACCGCCGGGGACATCGCGCAGGCGTGGGGCCTGAAGGACGTACGGGTCGGTGACCGGGCCGGGCACCTCGACGGTCCCCCGCCGCGCAACTTCTTCGCGCCGCCCAGCCTGGAGACCGTGATCAGGCCGGAGCGCCCGGAGGAAGCGGGACGGCTGCACGCCGCGCTGCGCATGCTGGACGAGCAGGACCCCTCGATCGACCTGCGGCAGGACGAGGAGAACGCGGCCGGCGCGGTGGTCCGCCTCTACGGGGAGGTGCAGAAGGAGATCCTCGGCAGCACGCTCGCGGAGTCCTTCGGCGTACGGGTGCGCTTCGACCCGACCCGTACGGTCTGCATCGAAAAGCCCGTGGGGACCGGCGAGGCGCTGATCGAGCTGGACACGCGGACGCACAACTACTTCTGGGGCGCACCGTGGGTCTGCGCGTCGGACCGGCCGAGCCCGGCGCGGGCGATCACGTTCCGTTTGGCGGTGGAACTGGGCTCGCTCCCCCTGGCCTTCCACAAGGCCATCGAGGAGACGGTGCACACCACCCTGCGGCACGGTCTGTACGGCTGGCAGGTCACCGACTGCGCCGTCACCCTGACCCGTACCGGCGTTCGCAGTCCGGTCAGCGCGGCCGACGACTTCCGCAAGGCCAACGCGCGCTTGGTCCTGATGGACGCGCTCGGCAGGGCCGGTACGGAGGTGCACGAGCCGGTCAGCTCCTTCGAACTGGAGGTGCCCGCCGCCCGGCTCAGCCCGGTACTTGCGAAACTCGCGGAACTGGGCGCGACGCCCGGTGTGCCCACGGCCGAGGGGGACGTCTTCCGCCTGGAGGGCACGATGCCGACCAGCCTCGTGCACGACTTCAACCAGCGGGTTCCCGGACTGACCCAGGGCGAGGGCGTGTTCCTGGCCGAGCACCGGGGCTACCGGCCCGCCGTCGGACAGCCGCCCGTGCGGCCGCGGCCCGAGGGGCCCAACCCGCTCAACCGCGACGAGTACATCCTGCACGTGCTCAAGCGCGTGTGA", "partial": "0", "query_start": 45838, "query_end": 45948, "hit_start": 711, "hit_end": 822, "orf_dna_sequence": "ATGAATCACGCAGTCACGGTCAGCGAGCCGCAGGACGGCACGCTGCTCTTCACGATGCACGACCGCGAATCGAAGAACACGTTTTCCGAGGCGCTCGTCGGCGGGCTCATCGATGCGTTCGCGCGCGCGGCCGCTTCGCCCGCGTGCCGGTGCGTCGTGATGACGGGCTACGACAGCTACTTCGCGTGCGGCGGCACGCAGCAAGGGCTGCTCGCGATCCAGCGCGGCGAGCTCGCGTTCACCGACGTCAACATGTACAGCCTCGCGCTCGACTGCCCGGTGCCCGTGATCGCGGCGATGCAGGGGCACGGCATCGGCGGCGGCTTCGTGATGGGCATGTATTGCGACTTCGTGATCCTGAGCCGCGAGAGCGTCTACACGACCAACTTCATGAAGTACGGCTTCACGCCGGGCATGGGCGCGACGGCCGTCGTGCCGCACAAGCTCGGCTTCGCGCTCGCGCACGAGATGCTGCTCGGCGCGCAGACCTATCGCGGCGCGGATCTCGAGCGGCGCGGCGTGCCGTTTGCCGTGCTGCCGCGGCACGAGGTGCTGCCGCACGCGCTGTCGCTTGCCGCGCAGGTCGCGCAGAAGCCGCGCGGCGCGCTCGTCACGCTCAAGTCGCACATGGTGCGCGGGCTGCGCGAGCAACTGCCGTCGATCGTCGCGGACGAAGTGGCGATGCACGACGCGACATTCCACAACGACGATGTGAAGGCCCGCATCGAATCGAGGTTCGGCCAGTGA", "orf_prot_sequence": "MNHAVTVSEPQDGTLLFTMHDRESKNTFSEALVGGLIDAFARAAASPACRCVVMTGYDSYFACGGTQQGLLAIQRGELAFTDVNMYSLALDCPVPVIAAMQGHGIGGGFVMGMYCDFVILSRESVYTTNFMKYGFTPGMGATAVVPHKLGFALAHEMLLGAQTYRGADLERRGVPFAVLPRHEVLPHALSLAAQVAQKPRGALVTLKSHMVRGLREQLPSIVADEVAMHDATFHNDDVKARIESRFGQ", "perc_identity": 43.24}, "gnl|BL_ORD_ID|307|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 45217, "orf_end": 45963, "orf_from": "BGC0000186.1|Thailandamide_6 ", "model_name": "adeC", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "850", "model_id": "337", "ARO_accession": "3003811", "ARO_name": "adeC", "ARO_category": {"36005": {"category_aro_accession": "0010004", "category_aro_cvterm_id": "36005", "category_aro_name": "resistance-nodulation-cell division (RND) antibiotic efflux pump", "category_aro_description": "Directed pumping of antibiotic out of a cell to confer resistance. Resistance-nodulation-division (RND) proteins are found in both prokaryotic and eukaryotic cells and have diverse substrate specificities and physiological roles. However, there are relatively few RND transporters and they are secondary transporters, energized not by ATP binding/hydrolysis but by proton movement down the transmembrane electrochemical gradient.", "category_aro_class_name": "AMR Gene Family"}, "35949": {"category_aro_accession": "0000030", "category_aro_cvterm_id": "35949", "category_aro_name": "tigecycline", "category_aro_description": "Tigecycline is an glycylcycline antibiotic. It works by inhibiting action of the prokaryotic 30S ribosome.", "category_aro_class_name": "Antibiotic"}, "35968": {"category_aro_accession": "0000051", "category_aro_cvterm_id": "35968", "category_aro_name": "tetracycline", "category_aro_description": "Tetracycline is a broad-spectrum polyketide antibiotic produced by many Streptomyces. It works by inhibiting action of the prokaryotic 30S ribosome.", "category_aro_class_name": "Antibiotic"}, "35960": {"category_aro_accession": "0000042", "category_aro_cvterm_id": "35960", "category_aro_name": "glycylcycline", "category_aro_description": "Glycylcyclines are a new class of antibiotics derived from tetracycline. These tetracycline analogues are specifically designed to overcome two common mechanisms of tetracycline resistance. Presently, there is only one glycylcycline antibiotic for clinical use: tigecycline. It works by inhibiting action of the prokaryotic 30S ribosome, preventing the binding of aminoacyl-tRNA.", "category_aro_class_name": "Drug Class"}, "36189": {"category_aro_accession": "3000050", "category_aro_cvterm_id": "36189", "category_aro_name": "tetracycline antibiotic", "category_aro_description": "These antibiotics are derived from tetracycline, a polyketide antibiotic that inhibits the 30S subunit of bacterial ribosomes.", "category_aro_class_name": "Drug Class"}, "36298": {"category_aro_accession": "3000159", "category_aro_cvterm_id": "36298", "category_aro_name": "efflux pump complex or subunit conferring antibiotic resistance", "category_aro_description": "Efflux proteins that pump antibiotic out of a cell to confer resistance.", "category_aro_class_name": "Efflux Component"}, "36001": {"category_aro_accession": "0010000", "category_aro_cvterm_id": "36001", "category_aro_name": "antibiotic efflux", "category_aro_description": "Antibiotic resistance via the transport of antibiotics out of the cell.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 7.40002, "max_identities": 19, "bit_score": 25.0238, "cvterm_id": "35507", "query": "SEALVGGLIDAFAR-AAASPACRCVVMTGY----DSYFACGGTQQGLLAIQRGELAFTDVNM", "match": "+ A +G  +DA  R  +A+ A   + M  Y    DSYF     Q+   A Q+G LA   + +", "sequence_from_db": "THAHIGERLDAQRRLVSATAATYKLSMARYKAGVDSYFTVLDAQRSAYAAQQGLLALEQIKL", "sequence_from_broadstreet": "MSKSTIVSRGLILSTLSIALVACVNMQAPQPAITSHIPQNFSQNHSGKMIAEKSYKEFISDPKLLQVIEISLNNNRDLRTATLNIERVQQEYQITKNSQLPTIGVTGNAVRQVSPSINPNNPVSTFQVGLGMTAYELDFWGRVQNLKDAALNNYLATQSAKEAVQIGLISNITQVWLNYAFAQANLNLAEQTLKAQVDAYNLNKKRFDVGIDSEVPLKQAQISVETARNDVATYKTQIQQAKNLLDLLAGHPVPQNLLPDHAIQNITFEKNFAAGLPSDLLNHRPDLKAAEYELRVAGANIGAAKARMFPTISLTGSTGYASSELKDLFKTGNFAWSIGPNIDLPIFDWGTRKTNIKIAETDQKIALAKYEKAIQSAFREVNDALATHAHIGERLDAQRRLVSATAATYKLSMARYKAGVDSYFTVLDAQRSAYAAQQGLLALEQIKLNNQIEIYKVLGGGISKV", "dna_sequence_from_broadstreet": "ATGTCTAAATCGACAATCGTATCTCGTGGACTCATTCTTTCTACACTCTCAATTGCACTCGTTGCATGTGTCAATATGCAAGCGCCACAGCCTGCAATTACATCTCATATTCCTCAAAATTTTAGTCAAAATCATTCTGGAAAAATGATTGCAGAAAAAAGTTATAAAGAATTTATTTCTGATCCGAAATTATTACAGGTCATTGAAATCAGTTTAAATAACAACCGTGATTTACGGACTGCTACGCTTAATATTGAACGTGTACAGCAAGAATACCAAATCACAAAAAATAGCCAGCTCCCAACCATTGGTGTAACGGGAAATGCAGTGCGGCAGGTTAGCCCATCGATTAACCCCAATAACCCAGTTTCTACATTTCAAGTTGGCTTGGGAATGACTGCCTATGAGCTAGATTTTTGGGGCCGTGTTCAAAATTTAAAAGATGCTGCATTAAATAACTATCTTGCAACTCAAAGTGCAAAAGAAGCTGTACAAATTGGTTTAATCAGTAATATTACACAGGTCTGGTTAAATTATGCTTTTGCACAAGCAAATTTAAACCTTGCCGAGCAAACCTTAAAAGCACAAGTCGATGCTTATAACCTTAACAAGAAGCGCTTTGATGTTGGTATTGATAGTGAAGTGCCATTAAAACAAGCACAAATTTCGGTAGAGACTGCTCGAAATGATGTTGCAACTTATAAAACTCAAATTCAACAGGCAAAAAATTTACTGGATTTGTTAGCAGGTCATCCTGTTCCGCAAAATTTACTTCCGGATCATGCTATTCAAAATATTACCTTTGAGAAAAACTTTGCAGCCGGTTTACCAAGTGATTTATTAAATCATCGTCCAGACCTTAAAGCTGCCGAATATGAGTTACGTGTTGCAGGAGCAAATATTGGTGCTGCTAAAGCACGGATGTTCCCAACCATAAGCTTGACAGGCTCGACGGGTTATGCATCATCTGAACTGAAAGATTTATTTAAAACAGGCAATTTTGCATGGTCGATTGGACCTAATATCGATCTACCAATTTTTGATTGGGGAACAAGAAAAACTAATATTAAAATTGCGGAAACTGACCAGAAAATTGCTTTAGCTAAATATGAAAAAGCCATTCAATCAGCTTTTCGTGAAGTTAATGATGCACTTGCTACACATGCACATATTGGTGAACGATTAGACGCTCAGCGTCGCTTAGTCTCTGCGACTGCTGCAACCTATAAACTCTCAATGGCACGTTACAAAGCTGGAGTGGATAGTTATTTTACGGTTTTAGATGCTCAGCGTTCTGCTTATGCTGCACAACAAGGCTTACTTGCACTTGAACAAATAAAATTAAATAACCAAATTGAAATTTATAAAGTTTTAGGAGGAGGAATATCAAAAGTCTAA", "partial": "0", "query_start": 45301, "query_end": 45471, "hit_start": 1158, "hit_end": 1344, "orf_dna_sequence": "ATGAATCACGCAGTCACGGTCAGCGAGCCGCAGGACGGCACGCTGCTCTTCACGATGCACGACCGCGAATCGAAGAACACGTTTTCCGAGGCGCTCGTCGGCGGGCTCATCGATGCGTTCGCGCGCGCGGCCGCTTCGCCCGCGTGCCGGTGCGTCGTGATGACGGGCTACGACAGCTACTTCGCGTGCGGCGGCACGCAGCAAGGGCTGCTCGCGATCCAGCGCGGCGAGCTCGCGTTCACCGACGTCAACATGTACAGCCTCGCGCTCGACTGCCCGGTGCCCGTGATCGCGGCGATGCAGGGGCACGGCATCGGCGGCGGCTTCGTGATGGGCATGTATTGCGACTTCGTGATCCTGAGCCGCGAGAGCGTCTACACGACCAACTTCATGAAGTACGGCTTCACGCCGGGCATGGGCGCGACGGCCGTCGTGCCGCACAAGCTCGGCTTCGCGCTCGCGCACGAGATGCTGCTCGGCGCGCAGACCTATCGCGGCGCGGATCTCGAGCGGCGCGGCGTGCCGTTTGCCGTGCTGCCGCGGCACGAGGTGCTGCCGCACGCGCTGTCGCTTGCCGCGCAGGTCGCGCAGAAGCCGCGCGGCGCGCTCGTCACGCTCAAGTCGCACATGGTGCGCGGGCTGCGCGAGCAACTGCCGTCGATCGTCGCGGACGAAGTGGCGATGCACGACGCGACATTCCACAACGACGATGTGAAGGCCCGCATCGAATCGAGGTTCGGCCAGTGA", "orf_prot_sequence": "MNHAVTVSEPQDGTLLFTMHDRESKNTFSEALVGGLIDAFARAAASPACRCVVMTGYDSYFACGGTQQGLLAIQRGELAFTDVNMYSLALDCPVPVIAAMQGHGIGGGFVMGMYCDFVILSRESVYTTNFMKYGFTPGMGATAVVPHKLGFALAHEMLLGAQTYRGADLERRGVPFAVLPRHEVLPHALSLAAQVAQKPRGALVTLKSHMVRGLREQLPSIVADEVAMHDATFHNDDVKARIESRFGQ", "perc_identity": 30.65}}, "BGC0000186.1|Thailandamide_7 # 45960 # 46760 # -1 # ID=1_7;partial=00;start_type=ATG;rbs_motif=GAG;rbs_spacer=11bp;gc_cont=0.738": {"gnl|BL_ORD_ID|2349|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 45960, "orf_end": 46760, "orf_from": "BGC0000186.1|Thailandamide_7 ", "model_name": "tet(L)", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "880", "model_id": "1897", "ARO_accession": "3000179", "ARO_name": "tet(L)", "ARO_category": {"36003": {"category_aro_accession": "0010002", "category_aro_cvterm_id": "36003", "category_aro_name": "major facilitator superfamily (MFS) antibiotic efflux pump", "category_aro_description": "Directed pumping of antibiotic out of a cell to confer resistance. Major facilitator superfamily (MFS) transporters and ABC transporters comprise the two largest and most functionally diverse of the transporter superfamilies. However, MFS transporters are distinct from ABC transporters in both their primary sequence and structure and in the mechanism of energy coupling. As secondary transporters they are, like RND and SMR transporters, energized by the electrochemical proton gradient.", "category_aro_class_name": "AMR Gene Family"}, "35968": {"category_aro_accession": "0000051", "category_aro_cvterm_id": "35968", "category_aro_name": "tetracycline", "category_aro_description": "Tetracycline is a broad-spectrum polyketide antibiotic produced by many Streptomyces. It works by inhibiting action of the prokaryotic 30S ribosome.", "category_aro_class_name": "Antibiotic"}, "36189": {"category_aro_accession": "3000050", "category_aro_cvterm_id": "36189", "category_aro_name": "tetracycline antibiotic", "category_aro_description": "These antibiotics are derived from tetracycline, a polyketide antibiotic that inhibits the 30S subunit of bacterial ribosomes.", "category_aro_class_name": "Drug Class"}, "36298": {"category_aro_accession": "3000159", "category_aro_cvterm_id": "36298", "category_aro_name": "efflux pump complex or subunit conferring antibiotic resistance", "category_aro_description": "Efflux proteins that pump antibiotic out of a cell to confer resistance.", "category_aro_class_name": "Efflux Component"}, "36001": {"category_aro_accession": "0010000", "category_aro_cvterm_id": "36001", "category_aro_name": "antibiotic efflux", "category_aro_description": "Antibiotic resistance via the transport of antibiotics out of the cell.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 5.8197, "max_identities": 24, "bit_score": 25.409, "cvterm_id": "36826", "query": "GADFGALAAAAADEPAAGPAEFDPAPLYALWTQLLRGPFVSIAYV-------------EGRANAGGLGFVSACDIALAGPRAQFGLSELLFGLLPACVLPFLIRKV", "match": "G  FG + +  A     GPA       Y  W+ LL  P ++I  V             +G  +  G+  +S   +        + +S L+  +L   +    IRKV", "sequence_from_db": "GKAFGLIGSIVAMGEGVGPAIGGMIAHYIHWSYLLLIPMITIITVPFLMKLLKKEVRIKGHFDIKGIILMSVGIVFFMLFTTSYSISFLIVSVLSFLIFVKHIRKV", "sequence_from_broadstreet": "MNTSYSQSNLRHNQILIWLCILSFFSVLNEMVLNVSLPDIANDFNKPPASTNWVNTAFMLTFSIGTAVYGKLSDQLGIKRLLLFGIIINCFGSVIGFVGHSFFSLLIMARFIQGAGAAAFPALVMVVVARYIPKENRGKAFGLIGSIVAMGEGVGPAIGGMIAHYIHWSYLLLIPMITIITVPFLMKLLKKEVRIKGHFDIKGIILMSVGIVFFMLFTTSYSISFLIVSVLSFLIFVKHIRKVTDPFVDPGLGKNIPFMIGVLCGGIIFGTVAGFVSMVPYMMKDVHQLSTAEIGSVIIFPGTMSVIIFGYIGGILVDRRGPLYVLNIGVTFLSVSFLTASFLLETTSWFMTIIIVFVLGGLLFTKTVISTIVSSSLKQQEAGAGMSLLNFTSFLSEGTGIAIVGGLLSIPLLDQRLLPMEVDQSTYLYSNLLLLFSGIIVISWLVTLNVYKHSQRDF", "dna_sequence_from_broadstreet": "GTGAATACATCCTATTCACAATCGAATTTACGACACAACCAAATTTTAATTTGGCTTTGCATTTTATCTTTTTTTAGCGTATTAAATGAAATGGTTTTGAACGTCTCATTACCTGATATTGCAAATGATTTTAATAAACCACCTGCGAGTACAAACTGGGTGAACACAGCCTTTATGTTAACCTTTTCCATTGGAACAGCTGTATATGGAAAGCTATCTGATCAATTAGGCATCAAAAGGTTACTCCTATTTGGAATTATAATAAATTGTTTCGGGTCGGTAATTGGGTTTGTTGGCCATTCTTTCTTTTCCTTACTTATTATGGCTCGTTTTATTCAAGGGGCTGGTGCAGCTGCATTTCCAGCACTCGTAATGGTTGTAGTTGCGCGCTATATTCCAAAGGAAAATAGGGGTAAAGCATTTGGTCTTATTGGATCGATAGTAGCCATGGGAGAAGGAGTCGGTCCAGCGATTGGTGGAATGATAGCCCATTATATTCATTGGTCCTATCTTCTACTCATTCCTATGATAACAATTATCACTGTTCCGTTTCTTATGAAATTATTAAAGAAAGAAGTAAGGATAAAAGGTCATTTTGATATCAAAGGAATTATACTAATGTCTGTAGGCATTGTATTTTTTATGTTGTTTACAACATCATATAGCATTTCTTTTCTTATCGTTAGCGTGCTGTCATTCCTGATATTTGTAAAACATATCAGGAAAGTAACAGATCCTTTTGTTGATCCCGGATTAGGGAAAAATATACCTTTTATGATTGGAGTTCTTTGTGGGGGAATTATATTTGGAACAGTAGCAGGGTTTGTCTCTATGGTTCCTTATATGATGAAAGATGTTCACCAGCTAAGTACTGCCGAAATCGGAAGTGTAATTATTTTCCCTGGAACAATGAGTGTCATTATTTTCGGCTACATTGGTGGGATACTTGTTGATAGAAGAGGTCCTTTATACGTGTTAAACATCGGAGTTACATTTCTTTCTGTTAGCTTTTTAACTGCTTCCTTTCTTTTAGAAACAACATCATGGTTCATGACAATTATAATCGTATTTGTTTTAGGTGGGCTTCTGTTCACCAAAACAGTTATATCAACAATTGTTTCAAGTAGCTTGAAACAGCAGGAAGCTGGTGCTGGAATGAGTTTGCTTAACTTTACCAGCTTTTTATCAGAGGGAACAGGTATTGCAATTGTAGGTGGTTTATTATCCATACCCTTACTTGATCAAAGGTTATTACCTATGGAAGTTGATCAGTCAACTTATCTGTATAGTAATTTGTTATTACTTTTTTCAGGAATCATTGTCATTAGTTGGCTGGTTACCTTGAATGTATATAAACATTCTCAAAGGGATTTCTAA", "partial": "0", "query_start": 46146, "query_end": 46424, "hit_start": 411, "hit_end": 729, "orf_dna_sequence": "ATGAGCGGCTATTCGACGATCGAAGTTGAGATCGACGCGAACGTCGGCTATCTGACGCTGCATCGGCCGGGCGCGGGCAACGCGATCGACGCGACGCTCGTCGCCGAATGCGCGCACGCGCTCGAGCGGCTCGCACGCGACGCGAGCGTCGTCGTGCTGCGCGGCGACGCCCAGACGTTCTGCAACGGCGCGGACTTCGGCGCGCTCGCCGCCGCCGCGGCCGACGAGCCCGCGGCGGGGCCCGCCGAATTCGATCCCGCGCCGCTCTACGCGCTGTGGACGCAACTGCTGCGCGGCCCGTTCGTGTCGATCGCGTACGTCGAGGGGCGCGCGAACGCGGGCGGGCTCGGGTTCGTGAGCGCGTGCGACATCGCGCTCGCGGGCCCGCGCGCGCAATTCGGGCTCTCCGAGCTGCTGTTCGGGCTGCTGCCCGCGTGCGTGCTGCCGTTCCTGATCCGCAAGGTGGGCTGGCAGCGGGCCCACTACATGACGCTGATGACGCGCCCGTTCGACGCGGCGCAGGCGTGCGAGTGGGGGCTCGTCGACGCGCGCGACGAGCATCCCGAGCGCCTGCTGCGCGCGCACCTCGCGCGGCTGCGCCGGCTGCCGCGCGCGGGCGTCGAGCGCTACAAGCGCTACGCGTCGCAGCTCGACGGCCTCGTCGAGCGCGCGCGCGACGCGGCGCTCGCGCTGAACCGCGAGGCGTTCGCCGACGCGCGCAATCTGGCCGCGATCCGCTCGTTCGTCGAGCACGGGCGCATGCCGTGGGAATCGACCCCGCCGCACGGAGGACACGCATGA", "orf_prot_sequence": "MSGYSTIEVEIDANVGYLTLHRPGAGNAIDATLVAECAHALERLARDASVVVLRGDAQTFCNGADFGALAAAAADEPAAGPAEFDPAPLYALWTQLLRGPFVSIAYVEGRANAGGLGFVSACDIALAGPRAQFGLSELLFGLLPACVLPFLIRKVGWQRAHYMTLMTRPFDAAQACEWGLVDARDEHPERLLRAHLARLRRLPRAGVERYKRYASQLDGLVERARDAALALNREAFADARNLAAIRSFVEHGRMPWESTPPHGGHA", "perc_identity": 22.64}, "gnl|BL_ORD_ID|1021|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 45960, "orf_end": 46760, "orf_from": "BGC0000186.1|Thailandamide_7 ", "model_name": "arr-2", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "250", "model_id": "1116", "ARO_accession": "3002847", "ARO_name": "arr-2", "ARO_category": {"36529": {"category_aro_accession": "3000390", "category_aro_cvterm_id": "36529", "category_aro_name": "rifampin ADP-ribosyltransferase (Arr)", "category_aro_description": "Enzyme responsible for the ADP-ribosylative inactivation of rifampin at the 23-OH position using NAD+.", "category_aro_class_name": "AMR Gene Family"}, "36308": {"category_aro_accession": "3000169", "category_aro_cvterm_id": "36308", "category_aro_name": "rifampin", "category_aro_description": "Rifampin is a semi-synthetic rifamycin, and inhibits RNA synthesis by binding to RNA polymerase. Rifampin is the mainstay agent for the treatment of tuberculosis, leprosy and complicated Gram-positive infections.", "category_aro_class_name": "Antibiotic"}, "36656": {"category_aro_accession": "3000517", "category_aro_cvterm_id": "36656", "category_aro_name": "rifaximin", "category_aro_description": "Rifaximin is a semi-synthetic rifamycin used to treat traveller's diarrhea. Rifaximin inhibits RNA synthesis by binding to the beta subunit of bacterial RNA polymerase.", "category_aro_class_name": "Antibiotic"}, "36669": {"category_aro_accession": "3000530", "category_aro_cvterm_id": "36669", "category_aro_name": "rifabutin", "category_aro_description": "Rifabutin is a semisynthetic rifamycin used in tuberculosis therapy. It inhibits DNA-dependent RNA synthesis.", "category_aro_class_name": "Antibiotic"}, "36673": {"category_aro_accession": "3000534", "category_aro_cvterm_id": "36673", "category_aro_name": "rifapentine", "category_aro_description": "Rifapentine is a semisynthetic rifamycin that inhibits DNA-dependent RNA synthesis. It is often used in the treatment of tuberculosis and leprosy.", "category_aro_class_name": "Antibiotic"}, "36296": {"category_aro_accession": "3000157", "category_aro_cvterm_id": "36296", "category_aro_name": "rifamycin antibiotic", "category_aro_description": "Rifamycin antibiotics are a group of broad-spectrum ansamycin antibiotics that inhibit bacterial RNA polymerase by binding to a highly conserved region, blocking the oligonucleotide exit tunnel, and preventing the extension of nascent mRNAs.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 9.36794, "max_identities": 14, "bit_score": 24.2534, "cvterm_id": "36752", "query": "RPFDAAQACE----WGLVDARDEHPERLLRAHLARLRRLPRAGV", "match": " P  + + CE     G+V+  + HP  L+R  L  L  L R G+", "sequence_from_db": "NPTQSYRTCEPLRIVGVVEDWEGHPVELIRGMLDSLEDLKRRGL", "sequence_from_broadstreet": "MVKDWIPISHDNYKQVQGPFYHGTKANLAIGDLLTTGFISHFEDGRILKHIYFSALMEPAVWGAELAMSLSGLEGRGYIYIVEPTGPFEDDPNLTNKKFPGNPTQSYRTCEPLRIVGVVEDWEGHPVELIRGMLDSLEDLKRRGLHVIED", "dna_sequence_from_broadstreet": "ATGGTAAAAGATTGGATTCCCATCTCTCATGATAATTACAAGCAGGTGCAAGGACCGTTCTATCATGGAACCAAAGCCAATTTGGCGATTGGTGACTTGCTAACCACAGGGTTCATCTCTCATTTCGAGGACGGTCGTATTCTTAAGCACATCTACTTTTCAGCCTTGATGGAGCCAGCAGTTTGGGGAGCTGAACTTGCTATGTCACTGTCTGGCCTCGAGGGTCGCGGCTACATATACATAGTTGAGCCAACAGGACCGTTCGAAGACGATCCGAATCTTACGAACAAAAAATTTCCCGGTAATCCAACACAGTCCTATAGAACCTGCGAACCCTTGAGAATTGTTGGCGTTGTTGAAGACTGGGAGGGGCATCCTGTTGAATTAATAAGGGGAATGTTGGATTCGTTAGAGGACTTAAAGCGCCGTGGTTTACACGTCATTGAAGACTAG", "partial": "0", "query_start": 46461, "query_end": 46580, "hit_start": 303, "hit_end": 435, "orf_dna_sequence": "ATGAGCGGCTATTCGACGATCGAAGTTGAGATCGACGCGAACGTCGGCTATCTGACGCTGCATCGGCCGGGCGCGGGCAACGCGATCGACGCGACGCTCGTCGCCGAATGCGCGCACGCGCTCGAGCGGCTCGCACGCGACGCGAGCGTCGTCGTGCTGCGCGGCGACGCCCAGACGTTCTGCAACGGCGCGGACTTCGGCGCGCTCGCCGCCGCCGCGGCCGACGAGCCCGCGGCGGGGCCCGCCGAATTCGATCCCGCGCCGCTCTACGCGCTGTGGACGCAACTGCTGCGCGGCCCGTTCGTGTCGATCGCGTACGTCGAGGGGCGCGCGAACGCGGGCGGGCTCGGGTTCGTGAGCGCGTGCGACATCGCGCTCGCGGGCCCGCGCGCGCAATTCGGGCTCTCCGAGCTGCTGTTCGGGCTGCTGCCCGCGTGCGTGCTGCCGTTCCTGATCCGCAAGGTGGGCTGGCAGCGGGCCCACTACATGACGCTGATGACGCGCCCGTTCGACGCGGCGCAGGCGTGCGAGTGGGGGCTCGTCGACGCGCGCGACGAGCATCCCGAGCGCCTGCTGCGCGCGCACCTCGCGCGGCTGCGCCGGCTGCCGCGCGCGGGCGTCGAGCGCTACAAGCGCTACGCGTCGCAGCTCGACGGCCTCGTCGAGCGCGCGCGCGACGCGGCGCTCGCGCTGAACCGCGAGGCGTTCGCCGACGCGCGCAATCTGGCCGCGATCCGCTCGTTCGTCGAGCACGGGCGCATGCCGTGGGAATCGACCCCGCCGCACGGAGGACACGCATGA", "orf_prot_sequence": "MSGYSTIEVEIDANVGYLTLHRPGAGNAIDATLVAECAHALERLARDASVVVLRGDAQTFCNGADFGALAAAAADEPAAGPAEFDPAPLYALWTQLLRGPFVSIAYVEGRANAGGLGFVSACDIALAGPRAQFGLSELLFGLLPACVLPFLIRKVGWQRAHYMTLMTRPFDAAQACEWGLVDARDEHPERLLRAHLARLRRLPRAGVERYKRYASQLDGLVERARDAALALNREAFADARNLAAIRSFVEHGRMPWESTPPHGGHA", "perc_identity": 31.82}}, "BGC0000186.1|Thailandamide_8 # 46757 # 48013 # -1 # ID=1_8;partial=00;start_type=ATG;rbs_motif=GGAG;rbs_spacer=7bp;gc_cont=0.683": {"gnl|BL_ORD_ID|2259|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 46757, "orf_end": 48013, "orf_from": "BGC0000186.1|Thailandamide_8 ", "model_name": "OXA-443", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "545", "model_id": "3513", "ARO_accession": "3003599", "ARO_name": "OXA-443", "ARO_category": {"36026": {"category_aro_accession": "3000017", "category_aro_cvterm_id": "36026", "category_aro_name": "OXA beta-lactamase", "category_aro_description": "OXA beta-lactamases were long recognized as a less common but also plasmid-mediated beta-lactamase variety that could hydrolyze oxacillin and related anti-staphylococcal penicillins. These beta-lactamases differ from the TEM and SHV enzymes in that they belong to molecular class D and functional group 2d. The OXA-type beta-lactamases confer resistance to ampicillin and cephalothin and are characterized by their high hydrolytic activity against oxacillin and cloxacillin and the fact that they are poorly inhibited by clavulanic acid. Amino acid substitutions in OXA enzymes can also give the ESBL phenotype. The OXA beta-lactamase family was originally created as a phenotypic rather than a genotypic group for a few beta-lactamases that had a specific hydrolysis profile. Therefore, there is as little as 20% sequence homology among some of the members of this family. However, recent additions to this family show some degree of homology to one or more of the existing members of the OXA beta-lactamase family. Some confer resistance predominantly to ceftazidime, but OXA-17 confers greater resistance to cefotaxime and cefepime than it does resistance to ceftazidime.", "category_aro_class_name": "AMR Gene Family"}, "35930": {"category_aro_accession": "0000011", "category_aro_cvterm_id": "35930", "category_aro_name": "cloxacillin", "category_aro_description": "Cloxacillin is a semisynthetic, isoxazolyl penicillin derivative in the beta-lactam class of antibiotics. It interferes with peptidogylcan synthesis and is commonly used for treating penicillin-resistant Staphylococcus aureus infections.", "category_aro_class_name": "Antibiotic"}, "35973": {"category_aro_accession": "0000056", "category_aro_cvterm_id": "35973", "category_aro_name": "oxacillin", "category_aro_description": "Oxacillin is a penicillinase-resistant beta-lactam. It is similar to methicillin, and has replaced methicillin in clinical use. Oxacillin, especially in combination with other antibiotics, is effective against many penicillinase-producing strains of Staphylococcus aureus and Staphylococcus epidermidis.", "category_aro_class_name": "Antibiotic"}, "37084": {"category_aro_accession": "3000704", "category_aro_cvterm_id": "37084", "category_aro_name": "cefalotin", "category_aro_description": "Cefalotin is a semisynthetic cephalosporin antibiotic activate against staphylococci. It is resistant to staphylococci beta-lactamases but hydrolyzed by enterobacterial beta-lactamases.", "category_aro_class_name": "Antibiotic"}, "35939": {"category_aro_accession": "0000020", "category_aro_cvterm_id": "35939", "category_aro_name": "carbapenem", "category_aro_description": "Carbapenems are a class of beta-lactam antibiotics with a broad spectrum of antibacterial activity, and have a structure which renders them highly resistant to beta-lactamases. Carbapenem antibiotics are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "35951": {"category_aro_accession": "0000032", "category_aro_cvterm_id": "35951", "category_aro_name": "cephalosporin", "category_aro_description": "Cephalosporins are a class of beta-lactam antibiotics, containing the beta-lactam ring fused with a dihydrothiazolidine ring. Together with cephamycins they belong to a sub-group called cephems. Cephalosporin are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "36017": {"category_aro_accession": "3000008", "category_aro_cvterm_id": "36017", "category_aro_name": "penam", "category_aro_description": "Penams are a group of antibiotics derived from Penicillium fungi that share a skeleton beta-lactam moiety fused with a thiazolidine ring. This is the most defining feature of penicillins. Penicillin antibiotics are historically significant because they are the first drugs that were effective against many previously serious diseases such as syphilis and Staphylococcus infections. Penicillins are still widely used today, though many types of bacteria are now resistant. All penicillins are beta-lactam antibiotics in the penam sub-group, and are used in the treatment of bacterial infections caused by susceptible, usually Gram-positive, organisms.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 1.48285, "max_identities": 10, "bit_score": 28.1054, "cvterm_id": "42837", "query": "YCQRVANVMGATVFLSLASTIDHGDF", "match": "Y QR+ + MGA +F S    +D+G+ ", "sequence_from_db": "YSQRITHAMGAQMFASYVRKLDYGNM", "sequence_from_broadstreet": "MTKLRHATTGAFLAALATFAHAEHPVCTLVADAATGKVVLQEGKCNERVTPASTFKLALAVMGYDAGFLKDPHTPVEHFRRGDPDWGGRPWRQPVDPTLWLKYSVVWYSQRITHAMGAQMFASYVRKLDYGNMDVSGDPGKNNGLDRSWITSSLKISPEEQVGFLRRLVNRQLPVSAQTYEMVDRTVQTWQVPGGWAVQGKTGTAGPAPGNTSADGTWDQAHAYGWFVGWAKKGGRTYVFANLIQDDKIEPTSGGIRSRDAMLARLPQVLAAAKP", "dna_sequence_from_broadstreet": "ATGACGAAACTCCGCCACGCCACCACCGGCGCCTTCCTTGCCGCCCTGGCCACCTTCGCCCATGCCGAACACCCTGTCTGCACGCTCGTTGCCGACGCCGCCACGGGCAAGGTCGTCCTGCAGGAGGGCAAGTGCAACGAGCGCGTGACGCCGGCGTCCACCTTCAAGCTGGCGCTGGCCGTCATGGGCTACGACGCCGGCTTCCTGAAAGACCCGCACACGCCGGTCGAACACTTCAGGCGCGGCGACCCCGACTGGGGCGGCCGGCCGTGGCGCCAGCCTGTCGACCCGACGCTGTGGCTCAAGTATTCGGTGGTCTGGTATTCCCAGCGCATCACCCACGCGATGGGCGCGCAGATGTTCGCCTCGTACGTGCGCAAGCTCGACTACGGCAACATGGATGTGAGCGGCGACCCGGGCAAGAACAACGGCCTGGATCGCTCGTGGATCACCTCGTCGCTGAAGATCTCGCCCGAGGAGCAGGTCGGCTTTCTGCGCCGGCTCGTCAACCGGCAGTTGCCCGTGTCGGCGCAGACGTACGAGATGGTCGACCGCACCGTGCAGACGTGGCAGGTGCCCGGCGGCTGGGCCGTGCAGGGCAAGACGGGCACGGCGGGCCCGGCGCCGGGCAATACCTCGGCCGACGGCACGTGGGATCAGGCCCACGCTTATGGCTGGTTTGTCGGCTGGGCGAAGAAAGGAGGCCGGACCTACGTGTTTGCGAACCTGATCCAGGACGACAAGATCGAGCCCACCTCGGGCGGCATCCGCTCGCGCGACGCGATGCTGGCGCGCCTGCCGCAGGTGCTGGCTGCCGCCAAGCCCTGA", "partial": "0", "query_start": 47621, "query_end": 47698, "hit_start": 321, "hit_end": 399, "orf_dna_sequence": "ATGCCGGTCGGTATTGAGGCCATGAACGTCTACGGCGGATCGGCCGCGCTCGACGTGAGCGAGCTCGCGCGCCACCGCAAGCTCGACATGTCGCGTTTCGCGAATCTGCTGATGCGCGAGAAGGCGGTGGCGCTGCCGTTCGAGGACCCGATCACGTTCGGCGTCAACGCGGCGAAGCCGATCGTCGACGCGCTGTCGGACGCCGAGCGCGAGCGCATCGAGATGCTGATCACGTGCACCGAATCGGGCATCGATTTCGGCAAGTCGATCAGCACCTACCTGCATCACCATCTCGGCCTGAACCGCAACTGCCGGCTGTTCGAGGTCAAGCAGGCGTGCTATTCGGGCACGGCCGGCTTCCAGACGGCCGTGAACTTCATCCTGTCGCAGACCTCGCCGGGCGCGAAGGCGCTCGTCGTCGCCACCGACATCTCGCGCTTCATGGTCGTCGAAGGCGGCGACGCGATCTCCGAGGACTGGTCGTTCGCCGAGCCGAGCGCGGGCGCGGGCGCCGTCGCGATGCTCGTGAGCGACGCGCCCGCCGTGTTCCAGCTCGACGTCGGCGCGCACGGCTATTACGGCTACGAGGTGATGGACACGTGCCGGCCGGTGCCGGACAGCGAGGCGGGCGATTCGGACCTGTCGCTGATGTCGTATCTCGAATGCTGCGAGCGCGCGTGGGGCGAGTATGCGAGCCGCGTCACGGGCGCCGACTATCGGAACACGTTCCAGTACCTCGCGTTCCATACGCCGTTCGGCGGAATGGTCAAGGGCGCGCATCGCAGCATGATGCGCAAGGTCGTGCGCGCGCGCGCCGACGAGGCCGAAGCCGATTTCGTCGCGCGCGTCGAGCCGGGGCTCGCGTATTGCCAGCGCGTCGCGAACGTGATGGGCGCGACCGTGTTTCTGTCGCTCGCGAGCACGATCGACCACGGCGATTTTTCGACGCCCAGGCGCATCGGGCTCTTCTCGTACGGCTCCGGCTGCTGCTCGGAGTTCTTCAGCGGCGTGGTCACGCAGGAAGGGCAGCGCCGGCTCGCCGCGATGCGCATCGGGCAGCAGCTCGACGCGCGCTACCGCCTCTCGCTCGCCGAGTACGACGCGCTGCTGCTCGGCAGCGGGGCGGTCCGGTTCGGCACGCGCAACGTCGAGCTCGGCGCGTCGCTGCTGCCCGGCCCGCGCGCGATGCTCGCCGGCAAGAACCGTCTCGTGCTCGCGCGCATCCGCGAATTCCACCGCGAGTACGTCTGGTCATGA", "orf_prot_sequence": "MPVGIEAMNVYGGSAALDVSELARHRKLDMSRFANLLMREKAVALPFEDPITFGVNAAKPIVDALSDAERERIEMLITCTESGIDFGKSISTYLHHHLGLNRNCRLFEVKQACYSGTAGFQTAVNFILSQTSPGAKALVVATDISRFMVVEGGDAISEDWSFAEPSAGAGAVAMLVSDAPAVFQLDVGAHGYYGYEVMDTCRPVPDSEAGDSDLSLMSYLECCERAWGEYASRVTGADYRNTFQYLAFHTPFGGMVKGAHRSMMRKVVRARADEAEADFVARVEPGLAYCQRVANVMGATVFLSLASTIDHGDFSTPRRIGLFSYGSGCCSEFFSGVVTQEGQRRLAAMRIGQQLDARYRLSLAEYDALLLGSGAVRFGTRNVELGASLLPGPRAMLAGKNRLVLARIREFHREYVWS", "perc_identity": 38.46}, "gnl|BL_ORD_ID|3829|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 46757, "orf_end": 48013, "orf_from": "BGC0000186.1|Thailandamide_8 ", "model_name": "OXA-572", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "500", "model_id": "4899", "ARO_accession": "3005794", "ARO_name": "OXA-572", "ARO_category": {"36026": {"category_aro_accession": "3000017", "category_aro_cvterm_id": "36026", "category_aro_name": "OXA beta-lactamase", "category_aro_description": "OXA beta-lactamases were long recognized as a less common but also plasmid-mediated beta-lactamase variety that could hydrolyze oxacillin and related anti-staphylococcal penicillins. These beta-lactamases differ from the TEM and SHV enzymes in that they belong to molecular class D and functional group 2d. The OXA-type beta-lactamases confer resistance to ampicillin and cephalothin and are characterized by their high hydrolytic activity against oxacillin and cloxacillin and the fact that they are poorly inhibited by clavulanic acid. Amino acid substitutions in OXA enzymes can also give the ESBL phenotype. The OXA beta-lactamase family was originally created as a phenotypic rather than a genotypic group for a few beta-lactamases that had a specific hydrolysis profile. Therefore, there is as little as 20% sequence homology among some of the members of this family. However, recent additions to this family show some degree of homology to one or more of the existing members of the OXA beta-lactamase family. Some confer resistance predominantly to ceftazidime, but OXA-17 confers greater resistance to cefotaxime and cefepime than it does resistance to ceftazidime.", "category_aro_class_name": "AMR Gene Family"}, "35930": {"category_aro_accession": "0000011", "category_aro_cvterm_id": "35930", "category_aro_name": "cloxacillin", "category_aro_description": "Cloxacillin is a semisynthetic, isoxazolyl penicillin derivative in the beta-lactam class of antibiotics. It interferes with peptidogylcan synthesis and is commonly used for treating penicillin-resistant Staphylococcus aureus infections.", "category_aro_class_name": "Antibiotic"}, "35973": {"category_aro_accession": "0000056", "category_aro_cvterm_id": "35973", "category_aro_name": "oxacillin", "category_aro_description": "Oxacillin is a penicillinase-resistant beta-lactam. It is similar to methicillin, and has replaced methicillin in clinical use. Oxacillin, especially in combination with other antibiotics, is effective against many penicillinase-producing strains of Staphylococcus aureus and Staphylococcus epidermidis.", "category_aro_class_name": "Antibiotic"}, "37084": {"category_aro_accession": "3000704", "category_aro_cvterm_id": "37084", "category_aro_name": "cefalotin", "category_aro_description": "Cefalotin is a semisynthetic cephalosporin antibiotic activate against staphylococci. It is resistant to staphylococci beta-lactamases but hydrolyzed by enterobacterial beta-lactamases.", "category_aro_class_name": "Antibiotic"}, "35939": {"category_aro_accession": "0000020", "category_aro_cvterm_id": "35939", "category_aro_name": "carbapenem", "category_aro_description": "Carbapenems are a class of beta-lactam antibiotics with a broad spectrum of antibacterial activity, and have a structure which renders them highly resistant to beta-lactamases. Carbapenem antibiotics are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "35951": {"category_aro_accession": "0000032", "category_aro_cvterm_id": "35951", "category_aro_name": "cephalosporin", "category_aro_description": "Cephalosporins are a class of beta-lactam antibiotics, containing the beta-lactam ring fused with a dihydrothiazolidine ring. Together with cephamycins they belong to a sub-group called cephems. Cephalosporin are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "36017": {"category_aro_accession": "3000008", "category_aro_cvterm_id": "36017", "category_aro_name": "penam", "category_aro_description": "Penams are a group of antibiotics derived from Penicillium fungi that share a skeleton beta-lactam moiety fused with a thiazolidine ring. This is the most defining feature of penicillins. Penicillin antibiotics are historically significant because they are the first drugs that were effective against many previously serious diseases such as syphilis and Staphylococcus infections. Penicillins are still widely used today, though many types of bacteria are now resistant. All penicillins are beta-lactam antibiotics in the penam sub-group, and are used in the treatment of bacterial infections caused by susceptible, usually Gram-positive, organisms.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 1.7223, "max_identities": 10, "bit_score": 27.7202, "cvterm_id": "42837", "query": "YCQRVANVMGATVFLSLASTIDHGDF", "match": "Y QR+ + MGA  F S    +D+G+ ", "sequence_from_db": "YSQRITHAMGAQTFASYVRKLDYGNM", "sequence_from_broadstreet": "MMKLRHAATGAFLAALATFAHAEHPICTLVADAATGKVVVQEGKCNERVTPASTFKLALAVMGYDAGFLKDPHTPVEHFRRGDPDWGGQPWRQPVDPTLWLKYSVVWYSQRITHAMGAQTFASYVRKLDYGNMDVSGDPGKNNGLDRSWITSSLKISPEEQVGFLRRLVNRQLPVSAQTYEMVDRIVQTWQVPGGWAVQGKTGTAGPAPGNTSADGTWDQAHAYGWFVGWAKKGGQTYVFANLIQDDKIEPTSGGIRSRDAMLARLAQVLAAAKP", "dna_sequence_from_broadstreet": "ATGATGAAACTCCGCCACGCCGCCACGGGCGCCTTCCTTGCCGCGCTGGCCACCTTCGCCCATGCCGAACACCCTATCTGCACGCTCGTTGCCGATGCAGCCACGGGCAAGGTCGTCGTGCAGGAGGGCAAGTGCAACGAGCGCGTGACGCCGGCGTCCACCTTCAAGCTGGCGCTGGCCGTCATGGGTTACGACGCCGGCTTCCTGAAAGATCCGCACACGCCGGTCGAACACTTCAGGCGCGGCGACCCCGACTGGGGCGGCCAGCCGTGGCGCCAGCCTGTCGACCCGACGCTGTGGCTCAAGTATTCGGTGGTCTGGTATTCCCAGCGCATCACCCACGCGATGGGCGCGCAGACGTTCGCCTCGTACGTGCGCAAGCTCGACTACGGCAACATGGATGTGAGCGGCGACCCGGGCAAGAACAACGGCCTGGACCGCTCGTGGATCACCTCGTCGCTGAAGATCTCGCCCGAGGAGCAGGTCGGCTTTCTGCGCCGGCTCGTCAACCGGCAGTTGCCGGTGTCGGCGCAGACGTACGAGATGGTCGACCGCATCGTGCAGACGTGGCAGGTGCCGGGCGGCTGGGCCGTGCAGGGCAAGACGGGCACGGCGGGCCCGGCACCGGGCAATACCTCGGCCGACGGCACGTGGGATCAGGCGCACGCTTACGGCTGGTTTGTCGGCTGGGCGAAGAAAGGAGGCCAGACCTACGTGTTTGCGAACCTGATCCAGGACGACAAGATCGAGCCCACCTCGGGCGGCATCCGCTCGCGCGATGCGATGCTGGCGCGCCTGGCGCAGGTGCTGGCTGCCGCCAAGCCCTGA", "partial": "0", "query_start": 47621, "query_end": 47698, "hit_start": 321, "hit_end": 399, "orf_dna_sequence": "ATGCCGGTCGGTATTGAGGCCATGAACGTCTACGGCGGATCGGCCGCGCTCGACGTGAGCGAGCTCGCGCGCCACCGCAAGCTCGACATGTCGCGTTTCGCGAATCTGCTGATGCGCGAGAAGGCGGTGGCGCTGCCGTTCGAGGACCCGATCACGTTCGGCGTCAACGCGGCGAAGCCGATCGTCGACGCGCTGTCGGACGCCGAGCGCGAGCGCATCGAGATGCTGATCACGTGCACCGAATCGGGCATCGATTTCGGCAAGTCGATCAGCACCTACCTGCATCACCATCTCGGCCTGAACCGCAACTGCCGGCTGTTCGAGGTCAAGCAGGCGTGCTATTCGGGCACGGCCGGCTTCCAGACGGCCGTGAACTTCATCCTGTCGCAGACCTCGCCGGGCGCGAAGGCGCTCGTCGTCGCCACCGACATCTCGCGCTTCATGGTCGTCGAAGGCGGCGACGCGATCTCCGAGGACTGGTCGTTCGCCGAGCCGAGCGCGGGCGCGGGCGCCGTCGCGATGCTCGTGAGCGACGCGCCCGCCGTGTTCCAGCTCGACGTCGGCGCGCACGGCTATTACGGCTACGAGGTGATGGACACGTGCCGGCCGGTGCCGGACAGCGAGGCGGGCGATTCGGACCTGTCGCTGATGTCGTATCTCGAATGCTGCGAGCGCGCGTGGGGCGAGTATGCGAGCCGCGTCACGGGCGCCGACTATCGGAACACGTTCCAGTACCTCGCGTTCCATACGCCGTTCGGCGGAATGGTCAAGGGCGCGCATCGCAGCATGATGCGCAAGGTCGTGCGCGCGCGCGCCGACGAGGCCGAAGCCGATTTCGTCGCGCGCGTCGAGCCGGGGCTCGCGTATTGCCAGCGCGTCGCGAACGTGATGGGCGCGACCGTGTTTCTGTCGCTCGCGAGCACGATCGACCACGGCGATTTTTCGACGCCCAGGCGCATCGGGCTCTTCTCGTACGGCTCCGGCTGCTGCTCGGAGTTCTTCAGCGGCGTGGTCACGCAGGAAGGGCAGCGCCGGCTCGCCGCGATGCGCATCGGGCAGCAGCTCGACGCGCGCTACCGCCTCTCGCTCGCCGAGTACGACGCGCTGCTGCTCGGCAGCGGGGCGGTCCGGTTCGGCACGCGCAACGTCGAGCTCGGCGCGTCGCTGCTGCCCGGCCCGCGCGCGATGCTCGCCGGCAAGAACCGTCTCGTGCTCGCGCGCATCCGCGAATTCCACCGCGAGTACGTCTGGTCATGA", "orf_prot_sequence": "MPVGIEAMNVYGGSAALDVSELARHRKLDMSRFANLLMREKAVALPFEDPITFGVNAAKPIVDALSDAERERIEMLITCTESGIDFGKSISTYLHHHLGLNRNCRLFEVKQACYSGTAGFQTAVNFILSQTSPGAKALVVATDISRFMVVEGGDAISEDWSFAEPSAGAGAVAMLVSDAPAVFQLDVGAHGYYGYEVMDTCRPVPDSEAGDSDLSLMSYLECCERAWGEYASRVTGADYRNTFQYLAFHTPFGGMVKGAHRSMMRKVVRARADEAEADFVARVEPGLAYCQRVANVMGATVFLSLASTIDHGDFSTPRRIGLFSYGSGCCSEFFSGVVTQEGQRRLAAMRIGQQLDARYRLSLAEYDALLLGSGAVRFGTRNVELGASLLPGPRAMLAGKNRLVLARIREFHREYVWS", "perc_identity": 38.46}}, "BGC0000186.1|Thailandamide_9 # 47997 # 49250 # -1 # ID=1_9;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.757": {"gnl|BL_ORD_ID|1736|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 47997, "orf_end": 49250, "orf_from": "BGC0000186.1|Thailandamide_9 ", "model_name": "AAC(3)-IIIa", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "450", "model_id": "1879", "ARO_accession": "3002536", "ARO_name": "AAC(3)-IIIa", "ARO_category": {"36461": {"category_aro_accession": "3000322", "category_aro_cvterm_id": "36461", "category_aro_name": "AAC(3)", "category_aro_description": "A category of aminoglycoside N-acetyltransferase enzymes with modification regiospecificity based at the 3-amino group of the respective antibiotic. These enzymes inactivate aminoglycoside antibiotics through acetylation of the 3-amino group of the compound.", "category_aro_class_name": "AMR Gene Family"}, "35924": {"category_aro_accession": "0000005", "category_aro_cvterm_id": "35924", "category_aro_name": "neomycin", "category_aro_description": "Neomycin is an aminoglycoside antibiotic used to treat different types of bacterial infections. Neomycin works by binding to the bacterial 30S ribosomal subunit, causing misreading of mRNA and leaving the bacterium unable to synthesize proteins vital to its growth.", "category_aro_class_name": "Antibiotic"}, "35926": {"category_aro_accession": "0000007", "category_aro_cvterm_id": "35926", "category_aro_name": "dibekacin", "category_aro_description": "Dibekacin is an aminoglycoside antibiotic used to treat different types of bacterial infections. Dibekacin works by binding to the bacterial 30S ribosomal subunit, causing misreading of mRNA and leaving the bacterium unable to synthesize proteins vital to its growth.", "category_aro_class_name": "Antibiotic"}, "35953": {"category_aro_accession": "0000035", "category_aro_cvterm_id": "35953", "category_aro_name": "sisomicin", "category_aro_description": "Sisomicin is an aminoglycoside antibiotic used to treat different types of bacterial infections. Sisomicin works by binding to the bacterial 30S ribosomal subunit, causing misreading of mRNA and leaving the bacterium unable to synthesize proteins vital to its growth.", "category_aro_class_name": "Antibiotic"}, "35966": {"category_aro_accession": "0000049", "category_aro_cvterm_id": "35966", "category_aro_name": "kanamycin A", "category_aro_description": "Kanamycin is an aminoglycoside antibiotic used to treat different types of bacterial infections. Kanamycin works by binding to the bacterial 30S ribosomal subunit, causing misreading of mRNA and leaving the bacterium unable to synthesize proteins vital to its growth.", "category_aro_class_name": "Antibiotic"}, "35969": {"category_aro_accession": "0000052", "category_aro_cvterm_id": "35969", "category_aro_name": "tobramycin", "category_aro_description": "Tobramycin is an aminoglycoside antibiotic used to treat different types of bacterial infections. Tobramycin works by binding to the bacterial 30S ribosomal subunit, causing misreading of mRNA and leaving the bacterium unable to synthesize proteins vital to its growth.", "category_aro_class_name": "Antibiotic"}, "37001": {"category_aro_accession": "3000657", "category_aro_cvterm_id": "37001", "category_aro_name": "paromomycin", "category_aro_description": "An aminoglycoside antibiotic used for the treatment of parasitic infections. It is similar to neomycin sharing a similar spectrum of activity, but its hydroxyl group at the 6'-position instead of an amino group makes it resistant to AAC(6') modifying enzymes.", "category_aro_class_name": "Antibiotic"}, "37002": {"category_aro_accession": "3000658", "category_aro_cvterm_id": "37002", "category_aro_name": "lividomycin", "category_aro_description": "Lividomycins are aminoglycosidic antibiotics produced by Streptomyces lividus. They contain 2-amino-2,3-dideoxy-D-glucose.", "category_aro_class_name": "Antibiotic"}, "46129": {"category_aro_accession": "3007379", "category_aro_cvterm_id": "46129", "category_aro_name": "5-episisomicin", "category_aro_description": "5-episosomicin is a semisynthetic aminoglycoside antibiotic similar to sisomicin.", "category_aro_class_name": "Antibiotic"}, "46133": {"category_aro_accession": "3007382", "category_aro_cvterm_id": "46133", "category_aro_name": "gentamicin", "category_aro_description": "Gentamicin is a commonly used aminoglycoside antibiotic derived from members of the Micromonospora genus of bacteria. It acts by binding the 30S ribosomal subunit, thus inhibiting protein synthesis. Gentamicin is typically used to treat Gram-negative infections of the repiratory and urinary tract, as well as infections of the bone and soft tissue. It also exhibits considerable nephrotoxicity and ototoxicity. Gentamicin is administered as a mixture of gentamicin type C (which makes about around 80% of the complex) and types A, B, and X (distributed in the remaining 20% of the complex).", "category_aro_class_name": "Antibiotic"}, "35935": {"category_aro_accession": "0000016", "category_aro_cvterm_id": "35935", "category_aro_name": "aminoglycoside antibiotic", "category_aro_description": "Aminoglycosides are a group of antibiotics that are mostly effective against Gram-negative bacteria. These molecules consist of aminated sugars attached to a dibasic cyclitol. Aminoglycosides work by binding to the bacterial 30S ribosomal subunit (some work by binding to the 50S subunit), inhibiting the translocation of the peptidyl-tRNA from the A-site to the P-site and also causing misreading of mRNA, leaving the bacterium unable to synthesize proteins vital to its growth.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 8.61867, "max_identities": 18, "bit_score": 25.409, "cvterm_id": "36752", "query": "ALVVESPESAGRRGARARAALAGWSVVSGANRGPNATLDAEADAI---GRALAHAGWR", "match": "A +V++ ++ G R  +A    A    V     GPN  L A  DA+   G  + +AGW+", "sequence_from_db": "AHLVDAFQALGIRAGQALMLHASVKAVGAVMGGPNVILQALMDALTPDGTLMMYAGWQ", "sequence_from_broadstreet": "MTDLNIPHTHAHLVDAFQALGIRAGQALMLHASVKAVGAVMGGPNVILQALMDALTPDGTLMMYAGWQDIPDFIDSLPDALKAVYLEQHPPFDPATARAVRENSVLAEFLRTWPCVHRSANPEASMVAVGRQAALLTANHALDYGYGVESPLAKLVAIEGYVLMLGAPLDTITLLHHAEYLAKMRHKNVVRYPCPILRDGRKVWVTVEDYDTGDPHDDYSFEQIARDYVAQGGGTRGKVGDADAYLFAAQDLTRFAVQWLESRFGDSASYG", "dna_sequence_from_broadstreet": "ATGACCGATTTGAATATCCCGCATACACACGCGCACCTTGTAGACGCATTTCAGGCGCTCGGCATCCGCGCGGGGCAGGCGCTCATGCTGCACGCATCCGTTAAAGCAGTGGGCGCGGTGATGGGCGGCCCCAATGTGATCTTGCAGGCGCTCATGGATGCGCTCACGCCCGACGGCACGCTGATGATGTATGCGGGATGGCAAGACATCCCCGACTTTATCGACTCGCTGCCGGACGCGCTCAAGGCCGTGTATCTTGAGCAGCACCCACCCTTTGACCCCGCCACCGCCCGCGCCGTGCGCGAAAACAGCGTGCTAGCGGAATTTTTGCGCACATGGCCGTGCGTGCATCGCAGCGCAAACCCCGAAGCCTCTATGGTGGCGGTAGGCAGGCAGGCCGCTTTGCTGACCGCTAATCACGCGCTGGATTATGGCTACGGAGTCGAGTCGCCGCTGGCTAAACTGGTGGCAATAGAAGGATACGTGCTGATGCTTGGCGCGCCGCTGGATACCATCACACTGCTGCACCACGCGGAATATCTGGCCAAGATGCGCCACAAGAACGTGGTCCGCTACCCGTGCCCGATTCTGCGGGACGGGCGCAAAGTGTGGGTGACCGTTGAGGACTATGACACCGGTGATCCGCACGACGATTATAGTTTTGAGCAAATCGCGCGCGATTATGTGGCGCAGGGCGGCGGCACACGCGGCAAAGTCGGTGATGCGGATGCTTACCTGTTCGCCGCGCAGGACCTCACACGGTTTGCGGTGCAGTGGCTTGAATCACGGTTCGGTGACTCAGCGTCATACGGATAG", "partial": "0", "query_start": 48699, "query_end": 48863, "hit_start": 30, "hit_end": 204, "orf_dna_sequence": "ATGGCTAGAGCGGTCGTCACGGGGCTCGGCGTCGTGAGCCCGATCGGCATCGGGGTGCCGGCGTTCGAGGCCGCGCTGTTCGCGGGCGGCGCGGCGTTCGGCGTGATGCGCCGCGAAGGCCGCCAGCACGCGGCGTCGGCATTCCTCGGCGCGGAGCTGCCGGCGTTCGAGCTGCCGGCCTCGGCGTTCGCGGGCGCGCAGCGGCTTTCGCTGCCCGCGCGGGCCGCGCTCGCCGCGCTCGGCGAGGCGTGGGCCGATGCGGCGCTTCGCGAGCTCGATCCCGCGCGCGTCGGTCTCGTCATCGGCGGCTCCAACCTGCAGCAGCGCGAGCTCGCGCGCGTGCACGAGGCGTTCCGCGAGCGGCCGCTCTACGTGCGGCCGAATCACGCGGTGTCGTACATGGACACCGACCTCGCGGGCGCGTGCGCGCAAGCGTTCGGCGTGCGCGGCGCGGCCTGCACGGTGGGCGGCGCGTCCGCGAGCGGGCTGCTCGCCGTCGTCGAGGCCGCGCGGCTCGTGCAGGCGGGCGAGCTCGACGCGTGCGTCGCCGTCGGCGGTCTCGCGGATCTGTCGCATCTCGAATGCCAGGCGTTTCGCTCGCTCGGCGCGATGGGCTCCGAGCGCTTCGCCGACGATCCCGGCGCGGCGTGCCGCCCGTTCGATCGCGCGCGCGACGGGTTCATCTACGGCGAAGCGTGCGCGGCGCTCGTCGTCGAGTCGCCCGAGTCGGCGGGCCGCCGCGGCGCGCGGGCGCGCGCGGCGCTCGCCGGCTGGAGCGTCGTGAGCGGCGCGAATCGCGGCCCGAACGCGACGCTCGACGCGGAAGCCGACGCGATCGGCCGCGCGCTCGCGCACGCGGGCTGGCGCGCGGCCGACGTCGACTACGTGAACCCGCACGGCAGCGGCTCCGTGAGCGGCGACGAAATCGAGCTCGCCGCGCTCGCGGCCGCCGGGCTCGGCCATGCGTGGCTGAACGCGACGAAGTCGCTGACGGGGCACGCGCTGAGCGCGGCGGGCGCGGTCGAGACGCTGGCGACGGTGCTGCAGATGCAGGCGTCGCGGCTGCACCCGACGCGCAATCTCGACGATCCGATCGCGCCCGCGCGATGGGTGCGCGGCGCGCCGCAGCCGGCGCGCGTCGGCCGCGCGCTGAAGCTTTCCTACGGCTTCGGCGGCATCAACGCCGCCTTGTGCCTCGAACACGTTTCCCAACGAATTCCACGCGAGGAGGTATCCCATGCCGGTCGGTATTGA", "orf_prot_sequence": "MARAVVTGLGVVSPIGIGVPAFEAALFAGGAAFGVMRREGRQHAASAFLGAELPAFELPASAFAGAQRLSLPARAALAALGEAWADAALRELDPARVGLVIGGSNLQQRELARVHEAFRERPLYVRPNHAVSYMDTDLAGACAQAFGVRGAACTVGGASASGLLAVVEAARLVQAGELDACVAVGGLADLSHLECQAFRSLGAMGSERFADDPGAACRPFDRARDGFIYGEACAALVVESPESAGRRGARARAALAGWSVVSGANRGPNATLDAEADAIGRALAHAGWRAADVDYVNPHGSGSVSGDEIELAALAAAGLGHAWLNATKSLTGHALSAAGAVETLATVLQMQASRLHPTRNLDDPIAPARWVRGAPQPARVGRALKLSYGFGGINAALCLEHVSQRIPREEVSHAGRY", "perc_identity": 31.03}, "gnl|BL_ORD_ID|1968|hsp_num:0": {"type_match": "Loose", "snp": {"original": "F", "change": "L", "position": 413}, "query_snp": {"original": "F", "change": "L", "position": 328}, "orf_strand": "-", "orf_start": 47997, "orf_end": 49250, "orf_from": "BGC0000186.1|Thailandamide_9 ", "model_name": "Mycobacterium tuberculosis kasA mutant conferring resistance to isoniazid", "model_type": "protein variant model", "model_type_id": 40293, "pass_evalue": "n/a", "pass_bitscore": 750, "model_id": "1943", "ARO_accession": "3003463", "ARO_name": "Mycobacterium tuberculosis kasA mutant conferring resistance to isoniazid", "ARO_category": {"40055": {"category_aro_accession": "3003462", "category_aro_cvterm_id": "40055", "category_aro_name": "antibiotic resistant kasA", "category_aro_description": "kasA is a  ketoacyl acyl carrier protein synthase that catalyzes the condensation reaction of fatty acid synthesis by the addition to an acyl acceptor of two carbons from malonyl-ACP. It is involved in elongation of fatty acids intermediate in the biosynthetic pathway of mycolic acids.", "category_aro_class_name": "AMR Gene Family"}, "36659": {"category_aro_accession": "3000520", "category_aro_cvterm_id": "36659", "category_aro_name": "isoniazid", "category_aro_description": "Isoniazid is an organic compound that is the first-line anti tuberculosis medication in prevention and treatment. As a prodrug, it is activated by mycobacterial catalase-peroxidases such as M. tuberculosis KatG. Isoniazid inhibits mycolic acid synthesis, which prevents cell wall synthesis in mycobacteria.", "category_aro_class_name": "Antibiotic"}, "45734": {"category_aro_accession": "3007152", "category_aro_cvterm_id": "45734", "category_aro_name": "isoniazid-like antibiotic", "category_aro_description": "A group of antibiotics containing isoniazid and its derivatives.", "category_aro_class_name": "Drug Class"}, "35997": {"category_aro_accession": "0001001", "category_aro_cvterm_id": "35997", "category_aro_name": "antibiotic target alteration", "category_aro_description": "Mutational alteration or enzymatic modification of antibiotic target which results in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 2.06848e-38, "bit_score": 140.969, "max_identities": 115, "cvterm_id": "39507", "query": "QRLSLPARAALAALGEAWADAALRELDPARVGLVIGGSNLQQRELARVHEAFRER----PLYVRPNHAVSYMDTDLAGACAQAFGVRGAACTVGGASASGLLAVVEAARLVQAGELDACVAVGGLADLSHLECQAFRSLGAMGSERFADDPGAACRPFDRARDGFIYGEACAALVVESPESAGRRGARARAALAGWSVVSGANR--GPNATLDAEADAIGRALAHAGWRAADVDYVNPHGSGSVSGDEIELAALAAAGLGHAWLNATKSLTGHALSAAGAVETLATVLQMQASRLHPTRNLD--DPIAPARWVRGAPQPARVGRALKLSYGFGGINAALCL", "match": "+R+S   R      G+ W  A   E+DP R  +V+G + L   E  R+ E++       P  V P      M    A       G R    T   A +SG  A+  A R +  G+ D  V  G    +  L   AF  + AM +    D+P  A RPFD+ RDGF++GEA A +++E+ E A  RGA+  A L G  + S A     P A       A+ R+L  AG   AD+D+VN HG+ +  GD  E  A+  AG   A + A KS  GH++ A GA+E++ TVL ++   + PT N +  DP      V G P+      A+  S+GFGG N AL  ", "sequence_from_db": "RRMSYVQRMGKLLGGQLWESAGSPEVDPDRFAVVVG-TGLGGAE--RIVESYDLMNAGGPRKVSPLAVQMIMPNGAAAVIGLQLGARAGVMTPVSACSSGSEAIAHAWRQIVMGDADVAVCGGVEGPIEALPIAAFSMMRAMSTRN--DEPERASRPFDKDRDGFVFGEAGALMLIETEEHAKARGAKPLARLLGAGITSDAFHMVAPAADGVRAGRAMTRSLELAGLSPADIDHVNAHGTATPIGDAAEANAIRVAGCDQAAVYAPKSALGHSIGAVGALESVLTVLTLRDGVIPPTLNYETPDPEIDLDVVAGEPRYGDYRYAVNNSFGFGGHNVALAF", "sequence_from_broadstreet": "MSQPSTANGGFPSVVVTAVTATTSISPDIESTWKGLLAGESGIHALEDEFVTKWDLAVKIGGHLKDPVDSHMGRLDMRRMSYVQRMGKLLGGQLWESAGSPEVDPDRFAVVVGTGLGGAERIVESYDLMNAGGPRKVSPLAVQMIMPNGAAAVIGLQLGARAGVMTPVSACSSGSEAIAHAWRQIVMGDADVAVCGGVEGPIEALPIAAFSMMRAMSTRNDEPERASRPFDKDRDGFVFGEAGALMLIETEEHAKARGAKPLARLLGAGITSDAFHMVAPAADGVRAGRAMTRSLELAGLSPADIDHVNAHGTATPIGDAAEANAIRVAGCDQAAVYAPKSALGHSIGAVGALESVLTVLTLRDGVIPPTLNYETPDPEIDLDVVAGEPRYGDYRYAVNNSFGFGGHNVALAFGRY", "dna_sequence_from_broadstreet": "GTGAGTCAGCCTTCCACCGCTAATGGCGGTTTCCCCAGCGTTGTGGTGACCGCCGTCACAGCGACGACGTCGATCTCGCCGGACATCGAGAGCACGTGGAAGGGTCTGTTGGCCGGCGAGAGCGGCATCCACGCACTCGAAGACGAGTTCGTCACCAAGTGGGATCTAGCGGTCAAGATCGGCGGTCACCTCAAGGATCCGGTCGACAGCCACATGGGCCGACTCGACATGCGACGCATGTCGTACGTCCAGCGGATGGGCAAGTTGCTGGGCGGACAGCTATGGGAGTCCGCCGGCAGCCCGGAGGTCGATCCAGACCGGTTCGCCGTTGTTGTCGGCACCGGTCTAGGTGGAGCCGAGAGGATTGTCGAGAGCTACGACCTGATGAATGCGGGCGGCCCCCGGAAGGTGTCCCCGCTGGCCGTTCAGATGATCATGCCCAACGGTGCCGCGGCGGTGATCGGTCTGCAGCTTGGGGCCCGCGCCGGGGTGATGACCCCGGTGTCGGCCTGTTCGTCGGGCTCGGAAGCGATCGCCCACGCGTGGCGTCAGATCGTGATGGGCGACGCCGACGTCGCCGTCTGCGGCGGTGTCGAAGGACCCATCGAGGCGCTGCCCATCGCGGCGTTCTCCATGATGCGGGCCATGTCGACCCGCAACGACGAGCCTGAGCGGGCCTCCCGGCCGTTCGACAAGGACCGCGACGGCTTTGTGTTCGGCGAGGCCGGTGCGCTGATGCTCATCGAGACGGAGGAGCACGCCAAAGCCCGTGGCGCCAAGCCGTTGGCCCGATTGCTGGGTGCCGGTATCACCTCGGACGCCTTTCATATGGTGGCGCCCGCGGCCGATGGTGTTCGTGCCGGTAGGGCGATGACTCGCTCGCTGGAGCTGGCCGGGTTGTCGCCGGCGGACATCGACCACGTCAACGCGCACGGCACGGCGACGCCTATCGGCGACGCCGCGGAGGCCAACGCCATCCGCGTCGCCGGTTGTGATCAGGCCGCGGTGTACGCGCCGAAGTCTGCGCTGGGCCACTCGATCGGCGCGGTCGGTGCGCTCGAGTCGGTGCTCACGGTGCTGACGCTGCGCGACGGCGTCATCCCGCCGACCCTGAACTACGAGACACCCGATCCCGAGATCGACCTTGACGTCGTCGCCGGCGAACCGCGCTATGGCGATTACCGCTACGCAGTCAACAACTCGTTCGGGTTCGGCGGCCACAATGTGGCGCTTGCCTTCGGGCGTTACTGA", "partial": "0", "query_start": 48195, "query_end": 49193, "hit_start": 231, "hit_end": 1239, "orf_dna_sequence": "ATGGCTAGAGCGGTCGTCACGGGGCTCGGCGTCGTGAGCCCGATCGGCATCGGGGTGCCGGCGTTCGAGGCCGCGCTGTTCGCGGGCGGCGCGGCGTTCGGCGTGATGCGCCGCGAAGGCCGCCAGCACGCGGCGTCGGCATTCCTCGGCGCGGAGCTGCCGGCGTTCGAGCTGCCGGCCTCGGCGTTCGCGGGCGCGCAGCGGCTTTCGCTGCCCGCGCGGGCCGCGCTCGCCGCGCTCGGCGAGGCGTGGGCCGATGCGGCGCTTCGCGAGCTCGATCCCGCGCGCGTCGGTCTCGTCATCGGCGGCTCCAACCTGCAGCAGCGCGAGCTCGCGCGCGTGCACGAGGCGTTCCGCGAGCGGCCGCTCTACGTGCGGCCGAATCACGCGGTGTCGTACATGGACACCGACCTCGCGGGCGCGTGCGCGCAAGCGTTCGGCGTGCGCGGCGCGGCCTGCACGGTGGGCGGCGCGTCCGCGAGCGGGCTGCTCGCCGTCGTCGAGGCCGCGCGGCTCGTGCAGGCGGGCGAGCTCGACGCGTGCGTCGCCGTCGGCGGTCTCGCGGATCTGTCGCATCTCGAATGCCAGGCGTTTCGCTCGCTCGGCGCGATGGGCTCCGAGCGCTTCGCCGACGATCCCGGCGCGGCGTGCCGCCCGTTCGATCGCGCGCGCGACGGGTTCATCTACGGCGAAGCGTGCGCGGCGCTCGTCGTCGAGTCGCCCGAGTCGGCGGGCCGCCGCGGCGCGCGGGCGCGCGCGGCGCTCGCCGGCTGGAGCGTCGTGAGCGGCGCGAATCGCGGCCCGAACGCGACGCTCGACGCGGAAGCCGACGCGATCGGCCGCGCGCTCGCGCACGCGGGCTGGCGCGCGGCCGACGTCGACTACGTGAACCCGCACGGCAGCGGCTCCGTGAGCGGCGACGAAATCGAGCTCGCCGCGCTCGCGGCCGCCGGGCTCGGCCATGCGTGGCTGAACGCGACGAAGTCGCTGACGGGGCACGCGCTGAGCGCGGCGGGCGCGGTCGAGACGCTGGCGACGGTGCTGCAGATGCAGGCGTCGCGGCTGCACCCGACGCGCAATCTCGACGATCCGATCGCGCCCGCGCGATGGGTGCGCGGCGCGCCGCAGCCGGCGCGCGTCGGCCGCGCGCTGAAGCTTTCCTACGGCTTCGGCGGCATCAACGCCGCCTTGTGCCTCGAACACGTTTCCCAACGAATTCCACGCGAGGAGGTATCCCATGCCGGTCGGTATTGA", "orf_prot_sequence": "MARAVVTGLGVVSPIGIGVPAFEAALFAGGAAFGVMRREGRQHAASAFLGAELPAFELPASAFAGAQRLSLPARAALAALGEAWADAALRELDPARVGLVIGGSNLQQRELARVHEAFRERPLYVRPNHAVSYMDTDLAGACAQAFGVRGAACTVGGASASGLLAVVEAARLVQAGELDACVAVGGLADLSHLECQAFRSLGAMGSERFADDPGAACRPFDRARDGFIYGEACAALVVESPESAGRRGARARAALAGWSVVSGANRGPNATLDAEADAIGRALAHAGWRAADVDYVNPHGSGSVSGDEIELAALAAAGLGHAWLNATKSLTGHALSAAGAVETLATVLQMQASRLHPTRNLDDPIAPARWVRGAPQPARVGRALKLSYGFGGINAALCLEHVSQRIPREEVSHAGRY", "perc_identity": 33.72}, "gnl|BL_ORD_ID|1968|hsp_num:1": {"type_match": "Loose", "snp": {"original": "G", "change": "S", "position": 269}, "query_snp": {"original": "G", "change": "S", "position": 188}, "orf_strand": "-", "orf_start": 47997, "orf_end": 49250, "orf_from": "BGC0000186.1|Thailandamide_9 ", "model_name": "Mycobacterium tuberculosis kasA mutant conferring resistance to isoniazid", "model_type": "protein variant model", "model_type_id": 40293, "pass_evalue": "n/a", "pass_bitscore": 750, "model_id": "1943", "ARO_accession": "3003463", "ARO_name": "Mycobacterium tuberculosis kasA mutant conferring resistance to isoniazid", "ARO_category": {"40055": {"category_aro_accession": "3003462", "category_aro_cvterm_id": "40055", "category_aro_name": "antibiotic resistant kasA", "category_aro_description": "kasA is a  ketoacyl acyl carrier protein synthase that catalyzes the condensation reaction of fatty acid synthesis by the addition to an acyl acceptor of two carbons from malonyl-ACP. It is involved in elongation of fatty acids intermediate in the biosynthetic pathway of mycolic acids.", "category_aro_class_name": "AMR Gene Family"}, "36659": {"category_aro_accession": "3000520", "category_aro_cvterm_id": "36659", "category_aro_name": "isoniazid", "category_aro_description": "Isoniazid is an organic compound that is the first-line anti tuberculosis medication in prevention and treatment. As a prodrug, it is activated by mycobacterial catalase-peroxidases such as M. tuberculosis KatG. Isoniazid inhibits mycolic acid synthesis, which prevents cell wall synthesis in mycobacteria.", "category_aro_class_name": "Antibiotic"}, "45734": {"category_aro_accession": "3007152", "category_aro_cvterm_id": "45734", "category_aro_name": "isoniazid-like antibiotic", "category_aro_description": "A group of antibiotics containing isoniazid and its derivatives.", "category_aro_class_name": "Drug Class"}, "35997": {"category_aro_accession": "0001001", "category_aro_cvterm_id": "35997", "category_aro_name": "antibiotic target alteration", "category_aro_description": "Mutational alteration or enzymatic modification of antibiotic target which results in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 2.06848e-38, "bit_score": 140.969, "max_identities": 115, "cvterm_id": "39507", "query": "QRLSLPARAALAALGEAWADAALRELDPARVGLVIGGSNLQQRELARVHEAFRER----PLYVRPNHAVSYMDTDLAGACAQAFGVRGAACTVGGASASGLLAVVEAARLVQAGELDACVAVGGLADLSHLECQAFRSLGAMGSERFADDPGAACRPFDRARDGFIYGEACAALVVESPESAGRRGARARAALAGWSVVSGANR--GPNATLDAEADAIGRALAHAGWRAADVDYVNPHGSGSVSGDEIELAALAAAGLGHAWLNATKSLTGHALSAAGAVETLATVLQMQASRLHPTRNLD--DPIAPARWVRGAPQPARVGRALKLSYGFGGINAALCL", "match": "+R+S   R      G+ W  A   E+DP R  +V+G + L   E  R+ E++       P  V P      M    A       G R    T   A +SG  A+  A R +  G+ D  V  G    +  L   AF  + AM +    D+P  A RPFD+ RDGF++GEA A +++E+ E A  RGA+  A L G  + S A     P A       A+ R+L  AG   AD+D+VN HG+ +  GD  E  A+  AG   A + A KS  GH++ A GA+E++ TVL ++   + PT N +  DP      V G P+      A+  S+GFGG N AL  ", "sequence_from_db": "RRMSYVQRMGKLLGGQLWESAGSPEVDPDRFAVVVG-TGLGGAE--RIVESYDLMNAGGPRKVSPLAVQMIMPNGAAAVIGLQLGARAGVMTPVSACSSGSEAIAHAWRQIVMGDADVAVCGGVEGPIEALPIAAFSMMRAMSTRN--DEPERASRPFDKDRDGFVFGEAGALMLIETEEHAKARGAKPLARLLGAGITSDAFHMVAPAADGVRAGRAMTRSLELAGLSPADIDHVNAHGTATPIGDAAEANAIRVAGCDQAAVYAPKSALGHSIGAVGALESVLTVLTLRDGVIPPTLNYETPDPEIDLDVVAGEPRYGDYRYAVNNSFGFGGHNVALAF", "sequence_from_broadstreet": "MSQPSTANGGFPSVVVTAVTATTSISPDIESTWKGLLAGESGIHALEDEFVTKWDLAVKIGGHLKDPVDSHMGRLDMRRMSYVQRMGKLLGGQLWESAGSPEVDPDRFAVVVGTGLGGAERIVESYDLMNAGGPRKVSPLAVQMIMPNGAAAVIGLQLGARAGVMTPVSACSSGSEAIAHAWRQIVMGDADVAVCGGVEGPIEALPIAAFSMMRAMSTRNDEPERASRPFDKDRDGFVFGEAGALMLIETEEHAKARGAKPLARLLGAGITSDAFHMVAPAADGVRAGRAMTRSLELAGLSPADIDHVNAHGTATPIGDAAEANAIRVAGCDQAAVYAPKSALGHSIGAVGALESVLTVLTLRDGVIPPTLNYETPDPEIDLDVVAGEPRYGDYRYAVNNSFGFGGHNVALAFGRY", "dna_sequence_from_broadstreet": "GTGAGTCAGCCTTCCACCGCTAATGGCGGTTTCCCCAGCGTTGTGGTGACCGCCGTCACAGCGACGACGTCGATCTCGCCGGACATCGAGAGCACGTGGAAGGGTCTGTTGGCCGGCGAGAGCGGCATCCACGCACTCGAAGACGAGTTCGTCACCAAGTGGGATCTAGCGGTCAAGATCGGCGGTCACCTCAAGGATCCGGTCGACAGCCACATGGGCCGACTCGACATGCGACGCATGTCGTACGTCCAGCGGATGGGCAAGTTGCTGGGCGGACAGCTATGGGAGTCCGCCGGCAGCCCGGAGGTCGATCCAGACCGGTTCGCCGTTGTTGTCGGCACCGGTCTAGGTGGAGCCGAGAGGATTGTCGAGAGCTACGACCTGATGAATGCGGGCGGCCCCCGGAAGGTGTCCCCGCTGGCCGTTCAGATGATCATGCCCAACGGTGCCGCGGCGGTGATCGGTCTGCAGCTTGGGGCCCGCGCCGGGGTGATGACCCCGGTGTCGGCCTGTTCGTCGGGCTCGGAAGCGATCGCCCACGCGTGGCGTCAGATCGTGATGGGCGACGCCGACGTCGCCGTCTGCGGCGGTGTCGAAGGACCCATCGAGGCGCTGCCCATCGCGGCGTTCTCCATGATGCGGGCCATGTCGACCCGCAACGACGAGCCTGAGCGGGCCTCCCGGCCGTTCGACAAGGACCGCGACGGCTTTGTGTTCGGCGAGGCCGGTGCGCTGATGCTCATCGAGACGGAGGAGCACGCCAAAGCCCGTGGCGCCAAGCCGTTGGCCCGATTGCTGGGTGCCGGTATCACCTCGGACGCCTTTCATATGGTGGCGCCCGCGGCCGATGGTGTTCGTGCCGGTAGGGCGATGACTCGCTCGCTGGAGCTGGCCGGGTTGTCGCCGGCGGACATCGACCACGTCAACGCGCACGGCACGGCGACGCCTATCGGCGACGCCGCGGAGGCCAACGCCATCCGCGTCGCCGGTTGTGATCAGGCCGCGGTGTACGCGCCGAAGTCTGCGCTGGGCCACTCGATCGGCGCGGTCGGTGCGCTCGAGTCGGTGCTCACGGTGCTGACGCTGCGCGACGGCGTCATCCCGCCGACCCTGAACTACGAGACACCCGATCCCGAGATCGACCTTGACGTCGTCGCCGGCGAACCGCGCTATGGCGATTACCGCTACGCAGTCAACAACTCGTTCGGGTTCGGCGGCCACAATGTGGCGCTTGCCTTCGGGCGTTACTGA", "partial": "0", "query_start": 48195, "query_end": 49193, "hit_start": 231, "hit_end": 1239, "orf_dna_sequence": "ATGGCTAGAGCGGTCGTCACGGGGCTCGGCGTCGTGAGCCCGATCGGCATCGGGGTGCCGGCGTTCGAGGCCGCGCTGTTCGCGGGCGGCGCGGCGTTCGGCGTGATGCGCCGCGAAGGCCGCCAGCACGCGGCGTCGGCATTCCTCGGCGCGGAGCTGCCGGCGTTCGAGCTGCCGGCCTCGGCGTTCGCGGGCGCGCAGCGGCTTTCGCTGCCCGCGCGGGCCGCGCTCGCCGCGCTCGGCGAGGCGTGGGCCGATGCGGCGCTTCGCGAGCTCGATCCCGCGCGCGTCGGTCTCGTCATCGGCGGCTCCAACCTGCAGCAGCGCGAGCTCGCGCGCGTGCACGAGGCGTTCCGCGAGCGGCCGCTCTACGTGCGGCCGAATCACGCGGTGTCGTACATGGACACCGACCTCGCGGGCGCGTGCGCGCAAGCGTTCGGCGTGCGCGGCGCGGCCTGCACGGTGGGCGGCGCGTCCGCGAGCGGGCTGCTCGCCGTCGTCGAGGCCGCGCGGCTCGTGCAGGCGGGCGAGCTCGACGCGTGCGTCGCCGTCGGCGGTCTCGCGGATCTGTCGCATCTCGAATGCCAGGCGTTTCGCTCGCTCGGCGCGATGGGCTCCGAGCGCTTCGCCGACGATCCCGGCGCGGCGTGCCGCCCGTTCGATCGCGCGCGCGACGGGTTCATCTACGGCGAAGCGTGCGCGGCGCTCGTCGTCGAGTCGCCCGAGTCGGCGGGCCGCCGCGGCGCGCGGGCGCGCGCGGCGCTCGCCGGCTGGAGCGTCGTGAGCGGCGCGAATCGCGGCCCGAACGCGACGCTCGACGCGGAAGCCGACGCGATCGGCCGCGCGCTCGCGCACGCGGGCTGGCGCGCGGCCGACGTCGACTACGTGAACCCGCACGGCAGCGGCTCCGTGAGCGGCGACGAAATCGAGCTCGCCGCGCTCGCGGCCGCCGGGCTCGGCCATGCGTGGCTGAACGCGACGAAGTCGCTGACGGGGCACGCGCTGAGCGCGGCGGGCGCGGTCGAGACGCTGGCGACGGTGCTGCAGATGCAGGCGTCGCGGCTGCACCCGACGCGCAATCTCGACGATCCGATCGCGCCCGCGCGATGGGTGCGCGGCGCGCCGCAGCCGGCGCGCGTCGGCCGCGCGCTGAAGCTTTCCTACGGCTTCGGCGGCATCAACGCCGCCTTGTGCCTCGAACACGTTTCCCAACGAATTCCACGCGAGGAGGTATCCCATGCCGGTCGGTATTGA", "orf_prot_sequence": "MARAVVTGLGVVSPIGIGVPAFEAALFAGGAAFGVMRREGRQHAASAFLGAELPAFELPASAFAGAQRLSLPARAALAALGEAWADAALRELDPARVGLVIGGSNLQQRELARVHEAFRERPLYVRPNHAVSYMDTDLAGACAQAFGVRGAACTVGGASASGLLAVVEAARLVQAGELDACVAVGGLADLSHLECQAFRSLGAMGSERFADDPGAACRPFDRARDGFIYGEACAALVVESPESAGRRGARARAALAGWSVVSGANRGPNATLDAEADAIGRALAHAGWRAADVDYVNPHGSGSVSGDEIELAALAAAGLGHAWLNATKSLTGHALSAAGAVETLATVLQMQASRLHPTRNLDDPIAPARWVRGAPQPARVGRALKLSYGFGGINAALCLEHVSQRIPREEVSHAGRY", "perc_identity": 33.72}}, "BGC0000186.1|Thailandamide_10 # 49243 # 49491 # -1 # ID=1_10;partial=00;start_type=ATG;rbs_motif=GGA;rbs_spacer=8bp;gc_cont=0.655": {"gnl|BL_ORD_ID|3889|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 49243, "orf_end": 49491, "orf_from": "BGC0000186.1|Thailandamide_10 ", "model_name": "OXA-633", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "500", "model_id": "4959", "ARO_accession": "3005854", "ARO_name": "OXA-633", "ARO_category": {"36026": {"category_aro_accession": "3000017", "category_aro_cvterm_id": "36026", "category_aro_name": "OXA beta-lactamase", "category_aro_description": "OXA beta-lactamases were long recognized as a less common but also plasmid-mediated beta-lactamase variety that could hydrolyze oxacillin and related anti-staphylococcal penicillins. These beta-lactamases differ from the TEM and SHV enzymes in that they belong to molecular class D and functional group 2d. The OXA-type beta-lactamases confer resistance to ampicillin and cephalothin and are characterized by their high hydrolytic activity against oxacillin and cloxacillin and the fact that they are poorly inhibited by clavulanic acid. Amino acid substitutions in OXA enzymes can also give the ESBL phenotype. The OXA beta-lactamase family was originally created as a phenotypic rather than a genotypic group for a few beta-lactamases that had a specific hydrolysis profile. Therefore, there is as little as 20% sequence homology among some of the members of this family. However, recent additions to this family show some degree of homology to one or more of the existing members of the OXA beta-lactamase family. Some confer resistance predominantly to ceftazidime, but OXA-17 confers greater resistance to cefotaxime and cefepime than it does resistance to ceftazidime.", "category_aro_class_name": "AMR Gene Family"}, "35930": {"category_aro_accession": "0000011", "category_aro_cvterm_id": "35930", "category_aro_name": "cloxacillin", "category_aro_description": "Cloxacillin is a semisynthetic, isoxazolyl penicillin derivative in the beta-lactam class of antibiotics. It interferes with peptidogylcan synthesis and is commonly used for treating penicillin-resistant Staphylococcus aureus infections.", "category_aro_class_name": "Antibiotic"}, "35973": {"category_aro_accession": "0000056", "category_aro_cvterm_id": "35973", "category_aro_name": "oxacillin", "category_aro_description": "Oxacillin is a penicillinase-resistant beta-lactam. It is similar to methicillin, and has replaced methicillin in clinical use. Oxacillin, especially in combination with other antibiotics, is effective against many penicillinase-producing strains of Staphylococcus aureus and Staphylococcus epidermidis.", "category_aro_class_name": "Antibiotic"}, "37084": {"category_aro_accession": "3000704", "category_aro_cvterm_id": "37084", "category_aro_name": "cefalotin", "category_aro_description": "Cefalotin is a semisynthetic cephalosporin antibiotic activate against staphylococci. It is resistant to staphylococci beta-lactamases but hydrolyzed by enterobacterial beta-lactamases.", "category_aro_class_name": "Antibiotic"}, "35939": {"category_aro_accession": "0000020", "category_aro_cvterm_id": "35939", "category_aro_name": "carbapenem", "category_aro_description": "Carbapenems are a class of beta-lactam antibiotics with a broad spectrum of antibacterial activity, and have a structure which renders them highly resistant to beta-lactamases. Carbapenem antibiotics are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "35951": {"category_aro_accession": "0000032", "category_aro_cvterm_id": "35951", "category_aro_name": "cephalosporin", "category_aro_description": "Cephalosporins are a class of beta-lactam antibiotics, containing the beta-lactam ring fused with a dihydrothiazolidine ring. Together with cephamycins they belong to a sub-group called cephems. Cephalosporin are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "36017": {"category_aro_accession": "3000008", "category_aro_cvterm_id": "36017", "category_aro_name": "penam", "category_aro_description": "Penams are a group of antibiotics derived from Penicillium fungi that share a skeleton beta-lactam moiety fused with a thiazolidine ring. This is the most defining feature of penicillins. Penicillin antibiotics are historically significant because they are the first drugs that were effective against many previously serious diseases such as syphilis and Staphylococcus infections. Penicillins are still widely used today, though many types of bacteria are now resistant. All penicillins are beta-lactam antibiotics in the penam sub-group, and are used in the treatment of bacterial infections caused by susceptible, usually Gram-positive, organisms.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 8.78132, "max_identities": 7, "bit_score": 21.9422, "cvterm_id": "36772", "query": "AQHPFQPSESFKTLGA", "match": "A+ PF P+ +FK   A", "sequence_from_db": "AKEPFSPASTFKIFNA", "sequence_from_broadstreet": "MKKILLLFSLFYSFALANDKLKDFFKDYNTSGVFITFDGKHYASNNFKRAKEPFSPASTFKIFNALIALDNGVVKDTKEIFYHYKGEKVFLPSWKQDASLRSAIKRSQVPAFKELARKIGLKTMQESLNKLSYGNTKISKIDTFWLDNSLQISAKNQADLLFKLSQNSLPFSKKSQEEVKKIILFKEDKIQKIYAKTGFNDNINLAWIVGFVKTKNKILSFALNVDIKNIKNLKIREELLEKYIYSLN", "dna_sequence_from_broadstreet": "TTGAAAAAAATACTTTTACTTTTTAGTCTTTTTTACTCTTTTGCTTTGGCAAATGATAAATTAAAAGATTTTTTTAAAGACTACAATACAAGCGGAGTTTTTATAACTTTTGATGGAAAACATTATGCAAGTAATAATTTTAAAAGAGCTAAAGAACCTTTTTCTCCTGCTTCGACTTTTAAAATTTTTAATGCTTTAATTGCGCTTGATAATGGTGTAGTTAAAGATACAAAGGAAATTTTTTATCATTATAAGGGTGAAAAAGTATTTTTGCCCTCTTGGAAACAAGATGCTAGTTTAAGATCAGCCATAAAACGCTCTCAAGTGCCTGCTTTTAAAGAATTGGCAAGAAAAATAGGACTTAAAACCATGCAAGAAAGCTTAAATAAACTTTCCTATGGAAATACAAAAATTTCAAAAATCGATACCTTTTGGTTGGATAATTCTTTACAAATTTCTGCAAAAAATCAAGCTGATTTGCTTTTTAAACTTTCACAAAATTCTTTACCTTTTTCCAAGAAAAGTCAAGAAGAAGTTAAAAAAATTATTCTTTTTAAAGAAGATAAAATCCAAAAAATTTATGCTAAAACAGGTTTTAATGATAATATAAATTTAGCTTGGATTGTTGGATTCGTAAAGACTAAAAACAAAATTTTATCTTTTGCCTTAAATGTTGATATAAAGAACATTAAAAATCTTAAAATAAGAGAAGAATTGCTAGAAAAATATATTTATTCTTTAAACTAA", "partial": "0", "query_start": 49306, "query_end": 49353, "hit_start": 147, "hit_end": 195, "orf_dna_sequence": "ATGAACCAAGAAGCCGTCTTTCAACTGCTCGTCTCCCACGCGCGCGAGGTCGTGCCGCATCTCGCGCAGCATCCGTTCCAGCCTTCCGAGAGCTTCAAGACGCTCGGCGCGAATTCGATGGACCGCGCGGACATCCTGATGATGACGATGGAGGCGCTGTCGATCCGCTGCTCGCTCACCGAGCTCGCCGGGCCGGCCAACATCGGCGAGCTCGCCGCGCTGCTCGCGCAAAAGGCGCGCCATGGCTAG", "orf_prot_sequence": "MNQEAVFQLLVSHAREVVPHLAQHPFQPSESFKTLGANSMDRADILMMTMEALSIRCSLTELAGPANIGELAALLAQKARHG", "perc_identity": 43.75}, "gnl|BL_ORD_ID|3882|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 49243, "orf_end": 49491, "orf_from": "BGC0000186.1|Thailandamide_10 ", "model_name": "OXA-626", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "500", "model_id": "4952", "ARO_accession": "3005847", "ARO_name": "OXA-626", "ARO_category": {"36026": {"category_aro_accession": "3000017", "category_aro_cvterm_id": "36026", "category_aro_name": "OXA beta-lactamase", "category_aro_description": "OXA beta-lactamases were long recognized as a less common but also plasmid-mediated beta-lactamase variety that could hydrolyze oxacillin and related anti-staphylococcal penicillins. These beta-lactamases differ from the TEM and SHV enzymes in that they belong to molecular class D and functional group 2d. The OXA-type beta-lactamases confer resistance to ampicillin and cephalothin and are characterized by their high hydrolytic activity against oxacillin and cloxacillin and the fact that they are poorly inhibited by clavulanic acid. Amino acid substitutions in OXA enzymes can also give the ESBL phenotype. The OXA beta-lactamase family was originally created as a phenotypic rather than a genotypic group for a few beta-lactamases that had a specific hydrolysis profile. Therefore, there is as little as 20% sequence homology among some of the members of this family. However, recent additions to this family show some degree of homology to one or more of the existing members of the OXA beta-lactamase family. Some confer resistance predominantly to ceftazidime, but OXA-17 confers greater resistance to cefotaxime and cefepime than it does resistance to ceftazidime.", "category_aro_class_name": "AMR Gene Family"}, "35930": {"category_aro_accession": "0000011", "category_aro_cvterm_id": "35930", "category_aro_name": "cloxacillin", "category_aro_description": "Cloxacillin is a semisynthetic, isoxazolyl penicillin derivative in the beta-lactam class of antibiotics. It interferes with peptidogylcan synthesis and is commonly used for treating penicillin-resistant Staphylococcus aureus infections.", "category_aro_class_name": "Antibiotic"}, "35973": {"category_aro_accession": "0000056", "category_aro_cvterm_id": "35973", "category_aro_name": "oxacillin", "category_aro_description": "Oxacillin is a penicillinase-resistant beta-lactam. It is similar to methicillin, and has replaced methicillin in clinical use. Oxacillin, especially in combination with other antibiotics, is effective against many penicillinase-producing strains of Staphylococcus aureus and Staphylococcus epidermidis.", "category_aro_class_name": "Antibiotic"}, "37084": {"category_aro_accession": "3000704", "category_aro_cvterm_id": "37084", "category_aro_name": "cefalotin", "category_aro_description": "Cefalotin is a semisynthetic cephalosporin antibiotic activate against staphylococci. It is resistant to staphylococci beta-lactamases but hydrolyzed by enterobacterial beta-lactamases.", "category_aro_class_name": "Antibiotic"}, "35939": {"category_aro_accession": "0000020", "category_aro_cvterm_id": "35939", "category_aro_name": "carbapenem", "category_aro_description": "Carbapenems are a class of beta-lactam antibiotics with a broad spectrum of antibacterial activity, and have a structure which renders them highly resistant to beta-lactamases. Carbapenem antibiotics are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "35951": {"category_aro_accession": "0000032", "category_aro_cvterm_id": "35951", "category_aro_name": "cephalosporin", "category_aro_description": "Cephalosporins are a class of beta-lactam antibiotics, containing the beta-lactam ring fused with a dihydrothiazolidine ring. Together with cephamycins they belong to a sub-group called cephems. Cephalosporin are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "36017": {"category_aro_accession": "3000008", "category_aro_cvterm_id": "36017", "category_aro_name": "penam", "category_aro_description": "Penams are a group of antibiotics derived from Penicillium fungi that share a skeleton beta-lactam moiety fused with a thiazolidine ring. This is the most defining feature of penicillins. Penicillin antibiotics are historically significant because they are the first drugs that were effective against many previously serious diseases such as syphilis and Staphylococcus infections. Penicillins are still widely used today, though many types of bacteria are now resistant. All penicillins are beta-lactam antibiotics in the penam sub-group, and are used in the treatment of bacterial infections caused by susceptible, usually Gram-positive, organisms.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 8.95496, "max_identities": 7, "bit_score": 21.9422, "cvterm_id": "36772", "query": "AQHPFQPSESFKTLGA", "match": "A+ PF P+ +FK   A", "sequence_from_db": "AKEPFSPASTFKIFNA", "sequence_from_broadstreet": "MKKILLLFSLFYSFALANDKLKDFFKDYNTSGVFITFDGKHYASNNFKRAKEPFSPASTFKIFNALIALDNGIVKDTKEIFYHYKGEKVFLPSWKQDASLSSAIKRSQVPAFKELARKIGLKTMQESLNKLSYGNAKISKIDTFWLDNSLQISAKNQADLLFKLSQNSLPFSKKSQEEVKKIILFKEDKIQKIYAKTGFNDGINLAWIVGFIESKNKILSFALNVDIKNIKNLKIREELLEKYIYSLN", "dna_sequence_from_broadstreet": "TTGAAAAAAATACTTTTACTTTTTAGTCTTTTTTACTCTTTTGCTTTGGCAAATGATAAATTAAAAGATTTTTTTAAAGACTACAATACAAGCGGAGTTTTTATAACTTTTGATGGAAAACATTATGCAAGTAATAATTTTAAAAGAGCTAAAGAACCTTTTTCTCCTGCTTCGACTTTTAAAATTTTTAATGCTTTAATTGCGCTTGATAATGGTATAGTTAAAGATACAAAGGAAATTTTTTATCATTATAAGGGTGAAAAAGTATTTTTGCCCTCTTGGAAACAAGATGCTAGTTTAAGCTCAGCCATAAAACGCTCTCAAGTGCCTGCTTTTAAAGAATTGGCAAGAAAAATAGGACTTAAAACCATGCAAGAAAGCTTAAATAAACTTTCCTATGGAAATGCAAAAATTTCAAAAATCGATACCTTTTGGTTGGATAATTCTTTACAAATTTCTGCAAAAAATCAAGCTGATTTGCTTTTTAAACTTTCACAAAATTCTTTACCTTTTTCCAAGAAAAGTCAAGAAGAAGTTAAAAAAATTATTCTTTTTAAAGAAGATAAAATCCAAAAAATTTATGCTAAAACAGGTTTTAATGATGGTATAAATTTGGCTTGGATTGTCGGATTTATAGAGAGTAAAAACAAAATTTTATCTTTTGCCTTAAATGTTGATATAAAGAATATTAAAAATCTTAAAATAAGAGAAGAATTGCTAGAAAAATATATTTATTCTTTAAACTAA", "partial": "0", "query_start": 49306, "query_end": 49353, "hit_start": 147, "hit_end": 195, "orf_dna_sequence": "ATGAACCAAGAAGCCGTCTTTCAACTGCTCGTCTCCCACGCGCGCGAGGTCGTGCCGCATCTCGCGCAGCATCCGTTCCAGCCTTCCGAGAGCTTCAAGACGCTCGGCGCGAATTCGATGGACCGCGCGGACATCCTGATGATGACGATGGAGGCGCTGTCGATCCGCTGCTCGCTCACCGAGCTCGCCGGGCCGGCCAACATCGGCGAGCTCGCCGCGCTGCTCGCGCAAAAGGCGCGCCATGGCTAG", "orf_prot_sequence": "MNQEAVFQLLVSHAREVVPHLAQHPFQPSESFKTLGANSMDRADILMMTMEALSIRCSLTELAGPANIGELAALLAQKARHG", "perc_identity": 43.75}, "gnl|BL_ORD_ID|1231|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 49243, "orf_end": 49491, "orf_from": "BGC0000186.1|Thailandamide_10 ", "model_name": "baeR", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "450", "model_id": "1337", "ARO_accession": "3000828", "ARO_name": "baeR", "ARO_category": {"36005": {"category_aro_accession": "0010004", "category_aro_cvterm_id": "36005", "category_aro_name": "resistance-nodulation-cell division (RND) antibiotic efflux pump", "category_aro_description": "Directed pumping of antibiotic out of a cell to confer resistance. Resistance-nodulation-division (RND) proteins are found in both prokaryotic and eukaryotic cells and have diverse substrate specificities and physiological roles. However, there are relatively few RND transporters and they are secondary transporters, energized not by ATP binding/hydrolysis but by proton movement down the transmembrane electrochemical gradient.", "category_aro_class_name": "AMR Gene Family"}, "36250": {"category_aro_accession": "3000111", "category_aro_cvterm_id": "36250", "category_aro_name": "novobiocin", "category_aro_description": "Novobiocin is an aminocoumarin antibiotic produced by Streptomyces spheroides and Streptomyces niveus, and binds DNA gyrase subunit B inhibiting ATP-dependent DNA supercoiling.", "category_aro_class_name": "Antibiotic"}, "35935": {"category_aro_accession": "0000016", "category_aro_cvterm_id": "35935", "category_aro_name": "aminoglycoside antibiotic", "category_aro_description": "Aminoglycosides are a group of antibiotics that are mostly effective against Gram-negative bacteria. These molecules consist of aminated sugars attached to a dibasic cyclitol. Aminoglycosides work by binding to the bacterial 30S ribosomal subunit (some work by binding to the 50S subunit), inhibiting the translocation of the peptidyl-tRNA from the A-site to the P-site and also causing misreading of mRNA, leaving the bacterium unable to synthesize proteins vital to its growth.", "category_aro_class_name": "Drug Class"}, "36242": {"category_aro_accession": "3000103", "category_aro_cvterm_id": "36242", "category_aro_name": "aminocoumarin antibiotic", "category_aro_description": "Aminocoumarin antibiotics bind DNA gyrase subunit B to inhibit ATP-dependent DNA supercoiling.", "category_aro_class_name": "Drug Class"}, "36298": {"category_aro_accession": "3000159", "category_aro_cvterm_id": "36298", "category_aro_name": "efflux pump complex or subunit conferring antibiotic resistance", "category_aro_description": "Efflux proteins that pump antibiotic out of a cell to confer resistance.", "category_aro_class_name": "Efflux Component"}, "36590": {"category_aro_accession": "3000451", "category_aro_cvterm_id": "36590", "category_aro_name": "protein(s) and two-component regulatory system modulating antibiotic efflux", "category_aro_description": "Protein(s) and two component regulatory systems that directly or indirectly change rates of antibiotic efflux.", "category_aro_class_name": "Efflux Regulator"}, "36001": {"category_aro_accession": "0010000", "category_aro_cvterm_id": "36001", "category_aro_name": "antibiotic efflux", "category_aro_description": "Antibiotic resistance via the transport of antibiotics out of the cell.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 9.00074, "max_identities": 7, "bit_score": 21.9422, "cvterm_id": "36839", "query": "LVSHAREVVPHLAQHP", "match": "L+SH  +V+P++ Q P", "sequence_from_db": "LISHGDQVLPYVRQTP", "sequence_from_broadstreet": "MTELPIDENTPRILIVEDEPKLGQLLIDYLRAASYAPTLISHGDQVLPYVRQTPPDLILLDLMLPGTDGLTLCREIRRFSDIPIVMVTAKIEEIDRLLGLEIGADDYICKPYSPREVVARVKTILRRCKPQRELQQQDAESPLIIDEGRFQASWRGKMLDLTPAEFRLLKTLSHEPGKVFSREQLLNHLYDDYRVVTDRTIDSHIKNLRRKLESLDAEQSFIRAVYGVGYRWEADACRIV", "dna_sequence_from_broadstreet": "ATGACCGAGTTACCAATCGACGAAAACACACCGCGTATTTTGATCGTGGAAGATGAACCGAAGCTGGGGCAGTTGCTCATTGATTATCTGCGTGCTGCGAGCTATGCGCCGACGCTTATCAGCCACGGCGATCAGGTACTGCCGTATGTGCGCCAGACACCACCGGATCTGATCCTGTTAGATCTGATGCTCCCTGGCACCGATGGCCTGACGCTGTGCCGGGAAATTCGTCGTTTTTCTGACATTCCGATCGTGATGGTGACGGCAAAAATCGAAGAGATCGATCGCCTGCTGGGGCTGGAGATTGGCGCAGATGATTATATCTGTAAGCCGTACAGCCCACGGGAAGTGGTAGCGCGCGTCAAAACCATTTTGCGCCGTTGCAAACCGCAGCGCGAGTTGCAGCAACAGGATGCTGAAAGCCCGTTGATTATCGACGAAGGTCGTTTTCAGGCTTCATGGCGCGGTAAAATGCTTGACCTGACGCCTGCGGAATTTCGTCTGCTGAAAACGCTCTCTCACGAACCAGGAAAAGTGTTCTCCCGCGAGCAATTGCTCAATCATCTTTATGACGACTACCGCGTAGTAACCGACCGCACCATCGACAGCCACATTAAAAACCTGCGCCGCAAGCTGGAATCTCTCGACGCCGAACAGTCATTTATCCGCGCCGTTTATGGCGTCGGTTACCGCTGGGAAGCCGACGCCTGCCGCATCGTTTAG", "partial": "0", "query_start": 49270, "query_end": 49317, "hit_start": 114, "hit_end": 162, "orf_dna_sequence": "ATGAACCAAGAAGCCGTCTTTCAACTGCTCGTCTCCCACGCGCGCGAGGTCGTGCCGCATCTCGCGCAGCATCCGTTCCAGCCTTCCGAGAGCTTCAAGACGCTCGGCGCGAATTCGATGGACCGCGCGGACATCCTGATGATGACGATGGAGGCGCTGTCGATCCGCTGCTCGCTCACCGAGCTCGCCGGGCCGGCCAACATCGGCGAGCTCGCCGCGCTGCTCGCGCAAAAGGCGCGCCATGGCTAG", "orf_prot_sequence": "MNQEAVFQLLVSHAREVVPHLAQHPFQPSESFKTLGANSMDRADILMMTMEALSIRCSLTELAGPANIGELAALLAQKARHG", "perc_identity": 43.75}, "gnl|BL_ORD_ID|3888|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 49243, "orf_end": 49491, "orf_from": "BGC0000186.1|Thailandamide_10 ", "model_name": "OXA-632", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "500", "model_id": "4958", "ARO_accession": "3005853", "ARO_name": "OXA-632", "ARO_category": {"36026": {"category_aro_accession": "3000017", "category_aro_cvterm_id": "36026", "category_aro_name": "OXA beta-lactamase", "category_aro_description": "OXA beta-lactamases were long recognized as a less common but also plasmid-mediated beta-lactamase variety that could hydrolyze oxacillin and related anti-staphylococcal penicillins. These beta-lactamases differ from the TEM and SHV enzymes in that they belong to molecular class D and functional group 2d. The OXA-type beta-lactamases confer resistance to ampicillin and cephalothin and are characterized by their high hydrolytic activity against oxacillin and cloxacillin and the fact that they are poorly inhibited by clavulanic acid. Amino acid substitutions in OXA enzymes can also give the ESBL phenotype. The OXA beta-lactamase family was originally created as a phenotypic rather than a genotypic group for a few beta-lactamases that had a specific hydrolysis profile. Therefore, there is as little as 20% sequence homology among some of the members of this family. However, recent additions to this family show some degree of homology to one or more of the existing members of the OXA beta-lactamase family. Some confer resistance predominantly to ceftazidime, but OXA-17 confers greater resistance to cefotaxime and cefepime than it does resistance to ceftazidime.", "category_aro_class_name": "AMR Gene Family"}, "35930": {"category_aro_accession": "0000011", "category_aro_cvterm_id": "35930", "category_aro_name": "cloxacillin", "category_aro_description": "Cloxacillin is a semisynthetic, isoxazolyl penicillin derivative in the beta-lactam class of antibiotics. It interferes with peptidogylcan synthesis and is commonly used for treating penicillin-resistant Staphylococcus aureus infections.", "category_aro_class_name": "Antibiotic"}, "35973": {"category_aro_accession": "0000056", "category_aro_cvterm_id": "35973", "category_aro_name": "oxacillin", "category_aro_description": "Oxacillin is a penicillinase-resistant beta-lactam. It is similar to methicillin, and has replaced methicillin in clinical use. Oxacillin, especially in combination with other antibiotics, is effective against many penicillinase-producing strains of Staphylococcus aureus and Staphylococcus epidermidis.", "category_aro_class_name": "Antibiotic"}, "37084": {"category_aro_accession": "3000704", "category_aro_cvterm_id": "37084", "category_aro_name": "cefalotin", "category_aro_description": "Cefalotin is a semisynthetic cephalosporin antibiotic activate against staphylococci. It is resistant to staphylococci beta-lactamases but hydrolyzed by enterobacterial beta-lactamases.", "category_aro_class_name": "Antibiotic"}, "35939": {"category_aro_accession": "0000020", "category_aro_cvterm_id": "35939", "category_aro_name": "carbapenem", "category_aro_description": "Carbapenems are a class of beta-lactam antibiotics with a broad spectrum of antibacterial activity, and have a structure which renders them highly resistant to beta-lactamases. Carbapenem antibiotics are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "35951": {"category_aro_accession": "0000032", "category_aro_cvterm_id": "35951", "category_aro_name": "cephalosporin", "category_aro_description": "Cephalosporins are a class of beta-lactam antibiotics, containing the beta-lactam ring fused with a dihydrothiazolidine ring. Together with cephamycins they belong to a sub-group called cephems. Cephalosporin are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "36017": {"category_aro_accession": "3000008", "category_aro_cvterm_id": "36017", "category_aro_name": "penam", "category_aro_description": "Penams are a group of antibiotics derived from Penicillium fungi that share a skeleton beta-lactam moiety fused with a thiazolidine ring. This is the most defining feature of penicillins. Penicillin antibiotics are historically significant because they are the first drugs that were effective against many previously serious diseases such as syphilis and Staphylococcus infections. Penicillins are still widely used today, though many types of bacteria are now resistant. All penicillins are beta-lactam antibiotics in the penam sub-group, and are used in the treatment of bacterial infections caused by susceptible, usually Gram-positive, organisms.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 9.04307, "max_identities": 7, "bit_score": 21.9422, "cvterm_id": "36772", "query": "AQHPFQPSESFKTLGA", "match": "A+ PF P+ +FK   A", "sequence_from_db": "AKEPFSPASTFKIFNA", "sequence_from_broadstreet": "MKKILLLFSLFYSFALANDKLKDFFKDYNTSGVFITFDGKHYASNNFKRAKEPFSPASTFKIFNALIALDNGIVKDTKEIFYHYKGEKVFLPSWKQDASLSSAIKRSQVPAFKELARKIGLKTMQESLNKLSYGNTKISKIDTFWLDNSLQISAKNQADLLFKLSQNSLPFSKKSQEEVKKIILFKEDKIQKIYAKTGFNDGINLAWIVGFIESKNKILSFALNVDIKDIKNIKIREELLEKYIYSLN", "dna_sequence_from_broadstreet": "TTGAAAAAAATACTTTTACTTTTTAGTCTTTTTTACTCTTTTGCTTTGGCAAATGATAAATTAAAAGATTTTTTTAAAGACTACAATACAAGCGGAGTTTTTATAACTTTTGATGGAAAACATTATGCAAGTAATAATTTTAAAAGAGCTAAAGAACCTTTTTCTCCTGCTTCGACTTTTAAAATTTTTAATGCTTTAATTGCGCTTGATAACGGTATAGTTAAAGATACAAAGGAAATTTTTTATCATTATAAGGGTGAAAAAGTATTTTTGCCTTCTTGGAAACAAGATGCTAGTTTAAGCTCAGCCATAAAACGCTCTCAAGTGCCTGCTTTTAAAGAATTGGCAAGAAAAATAGGACTTAAAACCATGCAAGAAAGCTTAAATAAACTTTCCTATGGAAATACAAAAATTTCAAAAATCGATACCTTTTGGTTGGATAATTCTTTACAAATTTCTGCAAAAAATCAAGCTGATTTGCTTTTTAAACTTTCACAAAATTCTTTACCTTTTTCCAAGAAAAGTCAAGAAGAAGTTAAAAAAATTATTCTTTTTAAAGAAGATAAAATCCAAAAAATTTATGCTAAAACAGGTTTTAATGATGGTATAAATTTGGCTTGGATTGTTGGATTTATAGAGAGTAAAAACAAAATTTTATCTTTTGCTTTAAATGTTGATATAAAGGACATTAAAAATATTAAAATAAGAGAAGAATTGCTAGAAAAATATATTTATTCTTTAAACTAA", "partial": "0", "query_start": 49306, "query_end": 49353, "hit_start": 147, "hit_end": 195, "orf_dna_sequence": "ATGAACCAAGAAGCCGTCTTTCAACTGCTCGTCTCCCACGCGCGCGAGGTCGTGCCGCATCTCGCGCAGCATCCGTTCCAGCCTTCCGAGAGCTTCAAGACGCTCGGCGCGAATTCGATGGACCGCGCGGACATCCTGATGATGACGATGGAGGCGCTGTCGATCCGCTGCTCGCTCACCGAGCTCGCCGGGCCGGCCAACATCGGCGAGCTCGCCGCGCTGCTCGCGCAAAAGGCGCGCCATGGCTAG", "orf_prot_sequence": "MNQEAVFQLLVSHAREVVPHLAQHPFQPSESFKTLGANSMDRADILMMTMEALSIRCSLTELAGPANIGELAALLAQKARHG", "perc_identity": 43.75}, "gnl|BL_ORD_ID|3887|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 49243, "orf_end": 49491, "orf_from": "BGC0000186.1|Thailandamide_10 ", "model_name": "OXA-631", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "500", "model_id": "4957", "ARO_accession": "3005852", "ARO_name": "OXA-631", "ARO_category": {"36026": {"category_aro_accession": "3000017", "category_aro_cvterm_id": "36026", "category_aro_name": "OXA beta-lactamase", "category_aro_description": "OXA beta-lactamases were long recognized as a less common but also plasmid-mediated beta-lactamase variety that could hydrolyze oxacillin and related anti-staphylococcal penicillins. These beta-lactamases differ from the TEM and SHV enzymes in that they belong to molecular class D and functional group 2d. The OXA-type beta-lactamases confer resistance to ampicillin and cephalothin and are characterized by their high hydrolytic activity against oxacillin and cloxacillin and the fact that they are poorly inhibited by clavulanic acid. Amino acid substitutions in OXA enzymes can also give the ESBL phenotype. The OXA beta-lactamase family was originally created as a phenotypic rather than a genotypic group for a few beta-lactamases that had a specific hydrolysis profile. Therefore, there is as little as 20% sequence homology among some of the members of this family. However, recent additions to this family show some degree of homology to one or more of the existing members of the OXA beta-lactamase family. Some confer resistance predominantly to ceftazidime, but OXA-17 confers greater resistance to cefotaxime and cefepime than it does resistance to ceftazidime.", "category_aro_class_name": "AMR Gene Family"}, "35930": {"category_aro_accession": "0000011", "category_aro_cvterm_id": "35930", "category_aro_name": "cloxacillin", "category_aro_description": "Cloxacillin is a semisynthetic, isoxazolyl penicillin derivative in the beta-lactam class of antibiotics. It interferes with peptidogylcan synthesis and is commonly used for treating penicillin-resistant Staphylococcus aureus infections.", "category_aro_class_name": "Antibiotic"}, "35973": {"category_aro_accession": "0000056", "category_aro_cvterm_id": "35973", "category_aro_name": "oxacillin", "category_aro_description": "Oxacillin is a penicillinase-resistant beta-lactam. It is similar to methicillin, and has replaced methicillin in clinical use. Oxacillin, especially in combination with other antibiotics, is effective against many penicillinase-producing strains of Staphylococcus aureus and Staphylococcus epidermidis.", "category_aro_class_name": "Antibiotic"}, "37084": {"category_aro_accession": "3000704", "category_aro_cvterm_id": "37084", "category_aro_name": "cefalotin", "category_aro_description": "Cefalotin is a semisynthetic cephalosporin antibiotic activate against staphylococci. It is resistant to staphylococci beta-lactamases but hydrolyzed by enterobacterial beta-lactamases.", "category_aro_class_name": "Antibiotic"}, "35939": {"category_aro_accession": "0000020", "category_aro_cvterm_id": "35939", "category_aro_name": "carbapenem", "category_aro_description": "Carbapenems are a class of beta-lactam antibiotics with a broad spectrum of antibacterial activity, and have a structure which renders them highly resistant to beta-lactamases. Carbapenem antibiotics are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "35951": {"category_aro_accession": "0000032", "category_aro_cvterm_id": "35951", "category_aro_name": "cephalosporin", "category_aro_description": "Cephalosporins are a class of beta-lactam antibiotics, containing the beta-lactam ring fused with a dihydrothiazolidine ring. Together with cephamycins they belong to a sub-group called cephems. Cephalosporin are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "36017": {"category_aro_accession": "3000008", "category_aro_cvterm_id": "36017", "category_aro_name": "penam", "category_aro_description": "Penams are a group of antibiotics derived from Penicillium fungi that share a skeleton beta-lactam moiety fused with a thiazolidine ring. This is the most defining feature of penicillins. Penicillin antibiotics are historically significant because they are the first drugs that were effective against many previously serious diseases such as syphilis and Staphylococcus infections. Penicillins are still widely used today, though many types of bacteria are now resistant. All penicillins are beta-lactam antibiotics in the penam sub-group, and are used in the treatment of bacterial infections caused by susceptible, usually Gram-positive, organisms.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 9.04307, "max_identities": 7, "bit_score": 21.9422, "cvterm_id": "36772", "query": "AQHPFQPSESFKTLGA", "match": "A+ PF P+ +FK   A", "sequence_from_db": "AKEPFSPASTFKIFNA", "sequence_from_broadstreet": "MKKILLLFSLFYSFALANDKLKDFFKDYNTSGVFITFDGKHYASNDFKRAKEPFSPASTFKIFNALIALDNGIVKDTKEIFYHYKGEKVFLPSWKQDASLSSAIKRSQVPAFKELARKIGLKTMQESLNKLSYGNTKISKIDTFWLDNSLQISAKNQADLLFKLSQNSLPFSKKSQEEVKKIILFKEDKIQKIYAKTGFNDGINLAWIVGFIESKNKILSFALNVDIKDIKNIKIREELLEKYIYSLN", "dna_sequence_from_broadstreet": "TTGAAAAAAATACTTTTACTTTTTAGTCTTTTTTACTCTTTTGCTTTGGCAAATGATAAATTAAAAGATTTTTTTAAAGACTACAATACAAGCGGAGTTTTTATAACTTTTGATGGAAAACATTATGCAAGTAATGATTTTAAAAGAGCTAAAGAACCTTTTTCTCCTGCTTCGACTTTTAAAATTTTTAATGCTTTAATTGCGCTTGATAACGGTATAGTTAAAGATACAAAGGAAATTTTTTATCATTATAAGGGTGAAAAAGTATTTTTGCCTTCTTGGAAACAAGATGCTAGTTTAAGCTCAGCCATAAAACGCTCTCAAGTGCCTGCTTTTAAAGAATTGGCAAGAAAAATAGGACTTAAAACCATGCAAGAAAGCTTAAATAAACTTTCCTATGGAAATACAAAAATTTCAAAAATCGATACCTTTTGGTTGGATAATTCTTTACAAATTTCTGCAAAAAATCAAGCTGATTTGCTTTTTAAACTTTCACAAAATTCTTTACCTTTTTCCAAGAAAAGTCAAGAAGAAGTTAAAAAAATTATTCTTTTTAAAGAAGATAAAATCCAAAAAATTTATGCTAAAACAGGTTTTAATGATGGTATAAATTTGGCTTGGATTGTTGGATTTATAGAGAGTAAAAACAAAATTTTATCTTTTGCTTTAAATGTTGATATAAAGGACATTAAAAATATTAAAATAAGAGAAGAATTGCTAGAAAAATATATTTATTCTTTAAACTAA", "partial": "0", "query_start": 49306, "query_end": 49353, "hit_start": 147, "hit_end": 195, "orf_dna_sequence": "ATGAACCAAGAAGCCGTCTTTCAACTGCTCGTCTCCCACGCGCGCGAGGTCGTGCCGCATCTCGCGCAGCATCCGTTCCAGCCTTCCGAGAGCTTCAAGACGCTCGGCGCGAATTCGATGGACCGCGCGGACATCCTGATGATGACGATGGAGGCGCTGTCGATCCGCTGCTCGCTCACCGAGCTCGCCGGGCCGGCCAACATCGGCGAGCTCGCCGCGCTGCTCGCGCAAAAGGCGCGCCATGGCTAG", "orf_prot_sequence": "MNQEAVFQLLVSHAREVVPHLAQHPFQPSESFKTLGANSMDRADILMMTMEALSIRCSLTELAGPANIGELAALLAQKARHG", "perc_identity": 43.75}, "gnl|BL_ORD_ID|2614|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 49243, "orf_end": 49491, "orf_from": "BGC0000186.1|Thailandamide_10 ", "model_name": "OXA-185", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "550", "model_id": "3423", "ARO_accession": "3001477", "ARO_name": "OXA-185", "ARO_category": {"36026": {"category_aro_accession": "3000017", "category_aro_cvterm_id": "36026", "category_aro_name": "OXA beta-lactamase", "category_aro_description": "OXA beta-lactamases were long recognized as a less common but also plasmid-mediated beta-lactamase variety that could hydrolyze oxacillin and related anti-staphylococcal penicillins. These beta-lactamases differ from the TEM and SHV enzymes in that they belong to molecular class D and functional group 2d. The OXA-type beta-lactamases confer resistance to ampicillin and cephalothin and are characterized by their high hydrolytic activity against oxacillin and cloxacillin and the fact that they are poorly inhibited by clavulanic acid. Amino acid substitutions in OXA enzymes can also give the ESBL phenotype. The OXA beta-lactamase family was originally created as a phenotypic rather than a genotypic group for a few beta-lactamases that had a specific hydrolysis profile. Therefore, there is as little as 20% sequence homology among some of the members of this family. However, recent additions to this family show some degree of homology to one or more of the existing members of the OXA beta-lactamase family. Some confer resistance predominantly to ceftazidime, but OXA-17 confers greater resistance to cefotaxime and cefepime than it does resistance to ceftazidime.", "category_aro_class_name": "AMR Gene Family"}, "35930": {"category_aro_accession": "0000011", "category_aro_cvterm_id": "35930", "category_aro_name": "cloxacillin", "category_aro_description": "Cloxacillin is a semisynthetic, isoxazolyl penicillin derivative in the beta-lactam class of antibiotics. It interferes with peptidogylcan synthesis and is commonly used for treating penicillin-resistant Staphylococcus aureus infections.", "category_aro_class_name": "Antibiotic"}, "35973": {"category_aro_accession": "0000056", "category_aro_cvterm_id": "35973", "category_aro_name": "oxacillin", "category_aro_description": "Oxacillin is a penicillinase-resistant beta-lactam. It is similar to methicillin, and has replaced methicillin in clinical use. Oxacillin, especially in combination with other antibiotics, is effective against many penicillinase-producing strains of Staphylococcus aureus and Staphylococcus epidermidis.", "category_aro_class_name": "Antibiotic"}, "37084": {"category_aro_accession": "3000704", "category_aro_cvterm_id": "37084", "category_aro_name": "cefalotin", "category_aro_description": "Cefalotin is a semisynthetic cephalosporin antibiotic activate against staphylococci. It is resistant to staphylococci beta-lactamases but hydrolyzed by enterobacterial beta-lactamases.", "category_aro_class_name": "Antibiotic"}, "35939": {"category_aro_accession": "0000020", "category_aro_cvterm_id": "35939", "category_aro_name": "carbapenem", "category_aro_description": "Carbapenems are a class of beta-lactam antibiotics with a broad spectrum of antibacterial activity, and have a structure which renders them highly resistant to beta-lactamases. Carbapenem antibiotics are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "35951": {"category_aro_accession": "0000032", "category_aro_cvterm_id": "35951", "category_aro_name": "cephalosporin", "category_aro_description": "Cephalosporins are a class of beta-lactam antibiotics, containing the beta-lactam ring fused with a dihydrothiazolidine ring. Together with cephamycins they belong to a sub-group called cephems. Cephalosporin are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "36017": {"category_aro_accession": "3000008", "category_aro_cvterm_id": "36017", "category_aro_name": "penam", "category_aro_description": "Penams are a group of antibiotics derived from Penicillium fungi that share a skeleton beta-lactam moiety fused with a thiazolidine ring. This is the most defining feature of penicillins. Penicillin antibiotics are historically significant because they are the first drugs that were effective against many previously serious diseases such as syphilis and Staphylococcus infections. Penicillins are still widely used today, though many types of bacteria are now resistant. All penicillins are beta-lactam antibiotics in the penam sub-group, and are used in the treatment of bacterial infections caused by susceptible, usually Gram-positive, organisms.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 9.04307, "max_identities": 7, "bit_score": 21.9422, "cvterm_id": "36772", "query": "AQHPFQPSESFKTLGA", "match": "A+ PF P+ +FK   A", "sequence_from_db": "AKEPFSPASTFKIFNA", "sequence_from_broadstreet": "MKKILLLFSLFYSFALANDKLKDFFKDYNTSGVFITFDGKHYASNNFKRAKEPFSPASTFKIFNALIALDNGVVKDTKEIFYHYKGEKVFLPSWKQDASLSSAIKRSQVPAFKELARKIGLKTMQESLNKLSYGNTKISKIDTFWLDNSLQISAKNQADLLFKLSQNSLPFSKKSQEEVKKIILFKEDKIQKIYAKTGFNDGINLAWIVGFIESKNKILSFALNVDIKNIKNIKIREELLEKYIYSLN", "dna_sequence_from_broadstreet": "TTGAAAAAAATACTTTTACTTTTTAGTCTTTTTTACTCTTTTGCTTTGGCAAATGATAAATTAAAAGATTTTTTTAAAGACTACAATACAAGCGGAGTTTTTATAACTTTTGATGGAAAACATTATGCAAGTAATAATTTTAAAAGAGCTAAAGAACCTTTTTCTCCTGCTTCGACTTTTAAAATTTTTAATGCTTTAATTGCGCTTGATAATGGTGTAGTTAAAGATACAAAGGAAATTTTTTATCATTATAAGGGTGAAAAAGTATTTTTGCCCTCTTGGAAACAAGATGCTAGTTTAAGCTCAGCCATAAAACGCTCTCAAGTGCCTGCTTTTAAAGAATTGGCAAGAAAAATAGGACTTAAAACCATGCAAGAAAGCTTAAATAAACTTTCCTATGGAAATACAAAAATTTCAAAAATCGATACCTTTTGGTTGGATAATTCTTTACAAATTTCTGCAAAAAATCAAGCTGATTTGCTTTTTAAACTTTCACAAAATTCTTTACCTTTTTCCAAGAAAAGTCAAGAAGAAGTTAAAAAAATTATTCTTTTTAAAGAAGATAAAATCCAAAAAATTTATGCTAAAACAGGTTTTAATGATGGTATAAATTTGGCTTGGATTGTTGGATTTATAGAGAGTAAAAACAAAATTTTATCTTTTGCCTTAAATGTTGATATAAAGAACATTAAAAATATTAAAATAAGAGAAGAATTGCTAGAAAAATATATTTATTCTTTAAACTAA", "partial": "0", "query_start": 49306, "query_end": 49353, "hit_start": 147, "hit_end": 195, "orf_dna_sequence": "ATGAACCAAGAAGCCGTCTTTCAACTGCTCGTCTCCCACGCGCGCGAGGTCGTGCCGCATCTCGCGCAGCATCCGTTCCAGCCTTCCGAGAGCTTCAAGACGCTCGGCGCGAATTCGATGGACCGCGCGGACATCCTGATGATGACGATGGAGGCGCTGTCGATCCGCTGCTCGCTCACCGAGCTCGCCGGGCCGGCCAACATCGGCGAGCTCGCCGCGCTGCTCGCGCAAAAGGCGCGCCATGGCTAG", "orf_prot_sequence": "MNQEAVFQLLVSHAREVVPHLAQHPFQPSESFKTLGANSMDRADILMMTMEALSIRCSLTELAGPANIGELAALLAQKARHG", "perc_identity": 43.75}, "gnl|BL_ORD_ID|3886|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 49243, "orf_end": 49491, "orf_from": "BGC0000186.1|Thailandamide_10 ", "model_name": "OXA-630", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "500", "model_id": "4956", "ARO_accession": "3005851", "ARO_name": "OXA-630", "ARO_category": {"36026": {"category_aro_accession": "3000017", "category_aro_cvterm_id": "36026", "category_aro_name": "OXA beta-lactamase", "category_aro_description": "OXA beta-lactamases were long recognized as a less common but also plasmid-mediated beta-lactamase variety that could hydrolyze oxacillin and related anti-staphylococcal penicillins. These beta-lactamases differ from the TEM and SHV enzymes in that they belong to molecular class D and functional group 2d. The OXA-type beta-lactamases confer resistance to ampicillin and cephalothin and are characterized by their high hydrolytic activity against oxacillin and cloxacillin and the fact that they are poorly inhibited by clavulanic acid. Amino acid substitutions in OXA enzymes can also give the ESBL phenotype. The OXA beta-lactamase family was originally created as a phenotypic rather than a genotypic group for a few beta-lactamases that had a specific hydrolysis profile. Therefore, there is as little as 20% sequence homology among some of the members of this family. However, recent additions to this family show some degree of homology to one or more of the existing members of the OXA beta-lactamase family. Some confer resistance predominantly to ceftazidime, but OXA-17 confers greater resistance to cefotaxime and cefepime than it does resistance to ceftazidime.", "category_aro_class_name": "AMR Gene Family"}, "35930": {"category_aro_accession": "0000011", "category_aro_cvterm_id": "35930", "category_aro_name": "cloxacillin", "category_aro_description": "Cloxacillin is a semisynthetic, isoxazolyl penicillin derivative in the beta-lactam class of antibiotics. It interferes with peptidogylcan synthesis and is commonly used for treating penicillin-resistant Staphylococcus aureus infections.", "category_aro_class_name": "Antibiotic"}, "35973": {"category_aro_accession": "0000056", "category_aro_cvterm_id": "35973", "category_aro_name": "oxacillin", "category_aro_description": "Oxacillin is a penicillinase-resistant beta-lactam. It is similar to methicillin, and has replaced methicillin in clinical use. Oxacillin, especially in combination with other antibiotics, is effective against many penicillinase-producing strains of Staphylococcus aureus and Staphylococcus epidermidis.", "category_aro_class_name": "Antibiotic"}, "37084": {"category_aro_accession": "3000704", "category_aro_cvterm_id": "37084", "category_aro_name": "cefalotin", "category_aro_description": "Cefalotin is a semisynthetic cephalosporin antibiotic activate against staphylococci. It is resistant to staphylococci beta-lactamases but hydrolyzed by enterobacterial beta-lactamases.", "category_aro_class_name": "Antibiotic"}, "35939": {"category_aro_accession": "0000020", "category_aro_cvterm_id": "35939", "category_aro_name": "carbapenem", "category_aro_description": "Carbapenems are a class of beta-lactam antibiotics with a broad spectrum of antibacterial activity, and have a structure which renders them highly resistant to beta-lactamases. Carbapenem antibiotics are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "35951": {"category_aro_accession": "0000032", "category_aro_cvterm_id": "35951", "category_aro_name": "cephalosporin", "category_aro_description": "Cephalosporins are a class of beta-lactam antibiotics, containing the beta-lactam ring fused with a dihydrothiazolidine ring. Together with cephamycins they belong to a sub-group called cephems. Cephalosporin are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "36017": {"category_aro_accession": "3000008", "category_aro_cvterm_id": "36017", "category_aro_name": "penam", "category_aro_description": "Penams are a group of antibiotics derived from Penicillium fungi that share a skeleton beta-lactam moiety fused with a thiazolidine ring. This is the most defining feature of penicillins. Penicillin antibiotics are historically significant because they are the first drugs that were effective against many previously serious diseases such as syphilis and Staphylococcus infections. Penicillins are still widely used today, though many types of bacteria are now resistant. All penicillins are beta-lactam antibiotics in the penam sub-group, and are used in the treatment of bacterial infections caused by susceptible, usually Gram-positive, organisms.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 9.13204, "max_identities": 7, "bit_score": 21.9422, "cvterm_id": "36772", "query": "AQHPFQPSESFKTLGA", "match": "A+ PF P+ +FK   A", "sequence_from_db": "AKEPFSPASTFKIFNA", "sequence_from_broadstreet": "MKKILLLFSLFYSFALANDKLKDFFKDYNTSGVFITFDGKHYASNNFKRAKEPFSPASTFKIFNALIALDNGVVKDTKEIFYHYKGEKVFLPSWKQDASLRSAIKRSQVPAFKELARKIGLKTMQESLNKLSYGNTKISKIDTFWLDNSLQISAKNQADLLFKLSQNSLPFSKKSQEEVKKIILFKEDKIQKIYAKTGFNDGINLAWIVGFMESKNKILSFALNVDIKNIKNLKIREELLEKYIYSLN", "dna_sequence_from_broadstreet": "TTGAAAAAAATACTTTTACTTTTTAGTCTTTTTTACTCTTTTGCTTTGGCAAATGATAAATTAAAAGATTTTTTTAAAGACTACAATACAAGCGGAGTTTTTATAACTTTTGATGGAAAACATTATGCAAGTAATAATTTTAAAAGAGCTAAAGAACCTTTTTCTCCTGCTTCGACTTTTAAAATTTTTAATGCTTTAATTGCGCTTGATAATGGTGTAGTTAAAGATACAAAGGAAATTTTTTATCATTATAAGGGTGAAAAAGTATTTTTGCCCTCTTGGAAACAAGATGCTAGTTTAAGATCAGCCATAAAACGCTCTCAAGTGCCTGCTTTTAAAGAATTGGCAAGAAAAATAGGACTTAAAACCATGCAAGAAAGCTTAAATAAACTTTCCTATGGAAATACAAAAATTTCAAAAATCGATACCTTTTGGTTGGATAATTCTTTACAAATTTCTGCAAAAAATCAAGCTGATTTGCTTTTTAAACTTTCACAAAATTCTTTACCTTTTTCCAAGAAAAGTCAAGAAGAAGTTAAAAAAATTATTCTTTTTAAAGAAGATAAAATCCAAAAAATTTATGCTAAAACAGGTTTTAATGATGGTATAAATTTGGCTTGGATTGTTGGATTTATGGAGAGTAAAAACAAAATTTTATCTTTTGCCTTAAATGTTGATATAAAGAACATTAAAAATCTTAAAATAAGAGAAGAATTGCTAGAAAAATATATTTATTCTTTAAACTAA", "partial": "0", "query_start": 49306, "query_end": 49353, "hit_start": 147, "hit_end": 195, "orf_dna_sequence": "ATGAACCAAGAAGCCGTCTTTCAACTGCTCGTCTCCCACGCGCGCGAGGTCGTGCCGCATCTCGCGCAGCATCCGTTCCAGCCTTCCGAGAGCTTCAAGACGCTCGGCGCGAATTCGATGGACCGCGCGGACATCCTGATGATGACGATGGAGGCGCTGTCGATCCGCTGCTCGCTCACCGAGCTCGCCGGGCCGGCCAACATCGGCGAGCTCGCCGCGCTGCTCGCGCAAAAGGCGCGCCATGGCTAG", "orf_prot_sequence": "MNQEAVFQLLVSHAREVVPHLAQHPFQPSESFKTLGANSMDRADILMMTMEALSIRCSLTELAGPANIGELAALLAQKARHG", "perc_identity": 43.75}, "gnl|BL_ORD_ID|2597|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 49243, "orf_end": 49491, "orf_from": "BGC0000186.1|Thailandamide_10 ", "model_name": "OXA-466", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "450", "model_id": "3531", "ARO_accession": "3003622", "ARO_name": "OXA-466", "ARO_category": {"36026": {"category_aro_accession": "3000017", "category_aro_cvterm_id": "36026", "category_aro_name": "OXA beta-lactamase", "category_aro_description": "OXA beta-lactamases were long recognized as a less common but also plasmid-mediated beta-lactamase variety that could hydrolyze oxacillin and related anti-staphylococcal penicillins. These beta-lactamases differ from the TEM and SHV enzymes in that they belong to molecular class D and functional group 2d. The OXA-type beta-lactamases confer resistance to ampicillin and cephalothin and are characterized by their high hydrolytic activity against oxacillin and cloxacillin and the fact that they are poorly inhibited by clavulanic acid. Amino acid substitutions in OXA enzymes can also give the ESBL phenotype. The OXA beta-lactamase family was originally created as a phenotypic rather than a genotypic group for a few beta-lactamases that had a specific hydrolysis profile. Therefore, there is as little as 20% sequence homology among some of the members of this family. However, recent additions to this family show some degree of homology to one or more of the existing members of the OXA beta-lactamase family. Some confer resistance predominantly to ceftazidime, but OXA-17 confers greater resistance to cefotaxime and cefepime than it does resistance to ceftazidime.", "category_aro_class_name": "AMR Gene Family"}, "35930": {"category_aro_accession": "0000011", "category_aro_cvterm_id": "35930", "category_aro_name": "cloxacillin", "category_aro_description": "Cloxacillin is a semisynthetic, isoxazolyl penicillin derivative in the beta-lactam class of antibiotics. It interferes with peptidogylcan synthesis and is commonly used for treating penicillin-resistant Staphylococcus aureus infections.", "category_aro_class_name": "Antibiotic"}, "35973": {"category_aro_accession": "0000056", "category_aro_cvterm_id": "35973", "category_aro_name": "oxacillin", "category_aro_description": "Oxacillin is a penicillinase-resistant beta-lactam. It is similar to methicillin, and has replaced methicillin in clinical use. Oxacillin, especially in combination with other antibiotics, is effective against many penicillinase-producing strains of Staphylococcus aureus and Staphylococcus epidermidis.", "category_aro_class_name": "Antibiotic"}, "37084": {"category_aro_accession": "3000704", "category_aro_cvterm_id": "37084", "category_aro_name": "cefalotin", "category_aro_description": "Cefalotin is a semisynthetic cephalosporin antibiotic activate against staphylococci. It is resistant to staphylococci beta-lactamases but hydrolyzed by enterobacterial beta-lactamases.", "category_aro_class_name": "Antibiotic"}, "35939": {"category_aro_accession": "0000020", "category_aro_cvterm_id": "35939", "category_aro_name": "carbapenem", "category_aro_description": "Carbapenems are a class of beta-lactam antibiotics with a broad spectrum of antibacterial activity, and have a structure which renders them highly resistant to beta-lactamases. Carbapenem antibiotics are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "35951": {"category_aro_accession": "0000032", "category_aro_cvterm_id": "35951", "category_aro_name": "cephalosporin", "category_aro_description": "Cephalosporins are a class of beta-lactam antibiotics, containing the beta-lactam ring fused with a dihydrothiazolidine ring. Together with cephamycins they belong to a sub-group called cephems. Cephalosporin are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "36017": {"category_aro_accession": "3000008", "category_aro_cvterm_id": "36017", "category_aro_name": "penam", "category_aro_description": "Penams are a group of antibiotics derived from Penicillium fungi that share a skeleton beta-lactam moiety fused with a thiazolidine ring. This is the most defining feature of penicillins. Penicillin antibiotics are historically significant because they are the first drugs that were effective against many previously serious diseases such as syphilis and Staphylococcus infections. Penicillins are still widely used today, though many types of bacteria are now resistant. All penicillins are beta-lactam antibiotics in the penam sub-group, and are used in the treatment of bacterial infections caused by susceptible, usually Gram-positive, organisms.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 9.13204, "max_identities": 7, "bit_score": 21.9422, "cvterm_id": "36772", "query": "AQHPFQPSESFKTLGA", "match": "A+ PF P+ +FK   A", "sequence_from_db": "AKEPFSPASTFKIFNA", "sequence_from_broadstreet": "MKKILLLFSLFYSFALANDKLKDFFKDYNTSGVFITFDGKHYASNNFKRAKEPFSPASTFKIFNALIALDNGVVKDTKEIFYHYKGEKVFLPSWKQDASLRSAIKRSQVPAFKELARKIGLKTMQESLNKLSYGNTKISKIDTFWLDNSLQISAKNQADLLFKLSQNSLPFSKKSQEEVKKIILFKEDKIQKIYAKTGFNDGINLAWIVGFIESKNKILSFALNVDIKNIKNLKIREELLEKYIYSLN", "dna_sequence_from_broadstreet": "TTGAAAAAAATACTTTTACTTTTTAGTCTTTTTTACTCTTTTGCTTTGGCAAATGATAAATTAAAAGATTTTTTTAAAGACTACAATACAAGCGGAGTTTTTATAACTTTTGATGGAAAACATTATGCAAGTAATAATTTTAAAAGAGCTAAAGAACCTTTTTCTCCTGCTTCGACTTTTAAAATTTTTAATGCTTTAATTGCGCTTGATAATGGTGTAGTTAAAGATACAAAGGAAATTTTTTATCATTATAAGGGTGAAAAAGTATTTTTGCCCTCTTGGAAACAAGATGCTAGTTTAAGATCAGCCATAAAACGCTCTCAAGTGCCTGCTTTTAAAGAATTGGCAAGAAAAATAGGACTTAAAACCATGCAAGAAAGCTTAAATAAACTTTCCTATGGAAATACAAAAATTTCAAAAATCGATACCTTTTGGTTGGATAATTCTTTACAAATTTCTGCAAAAAATCAAGCTGATTTGCTTTTTAAACTTTCACAAAATTCTTTACCTTTTTCCAAGAAAAGTCAAGAAGAAGTTAAAAAAATTATTCTTTTTAAAGAAGATAAAATCCAAAAAATTTATGCTAAAACAGGTTTTAATGATGGTATAAATTTGGCTTGGATTGTTGGATTTATAGAGAGTAAAAACAAAATTTTATCTTTTGCCTTAAATGTTGATATAAAGAACATTAAAAATCTTAAAATAAGAGAAGAATTGCTAGAAAAATATATTTATTCTTTAAACTAA", "partial": "0", "query_start": 49306, "query_end": 49353, "hit_start": 147, "hit_end": 195, "orf_dna_sequence": "ATGAACCAAGAAGCCGTCTTTCAACTGCTCGTCTCCCACGCGCGCGAGGTCGTGCCGCATCTCGCGCAGCATCCGTTCCAGCCTTCCGAGAGCTTCAAGACGCTCGGCGCGAATTCGATGGACCGCGCGGACATCCTGATGATGACGATGGAGGCGCTGTCGATCCGCTGCTCGCTCACCGAGCTCGCCGGGCCGGCCAACATCGGCGAGCTCGCCGCGCTGCTCGCGCAAAAGGCGCGCCATGGCTAG", "orf_prot_sequence": "MNQEAVFQLLVSHAREVVPHLAQHPFQPSESFKTLGANSMDRADILMMTMEALSIRCSLTELAGPANIGELAALLAQKARHG", "perc_identity": 43.75}, "gnl|BL_ORD_ID|1030|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 49243, "orf_end": 49491, "orf_from": "BGC0000186.1|Thailandamide_10 ", "model_name": "OXA-184", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "450", "model_id": "1126", "ARO_accession": "3001476", "ARO_name": "OXA-184", "ARO_category": {"36026": {"category_aro_accession": "3000017", "category_aro_cvterm_id": "36026", "category_aro_name": "OXA beta-lactamase", "category_aro_description": "OXA beta-lactamases were long recognized as a less common but also plasmid-mediated beta-lactamase variety that could hydrolyze oxacillin and related anti-staphylococcal penicillins. These beta-lactamases differ from the TEM and SHV enzymes in that they belong to molecular class D and functional group 2d. The OXA-type beta-lactamases confer resistance to ampicillin and cephalothin and are characterized by their high hydrolytic activity against oxacillin and cloxacillin and the fact that they are poorly inhibited by clavulanic acid. Amino acid substitutions in OXA enzymes can also give the ESBL phenotype. The OXA beta-lactamase family was originally created as a phenotypic rather than a genotypic group for a few beta-lactamases that had a specific hydrolysis profile. Therefore, there is as little as 20% sequence homology among some of the members of this family. However, recent additions to this family show some degree of homology to one or more of the existing members of the OXA beta-lactamase family. Some confer resistance predominantly to ceftazidime, but OXA-17 confers greater resistance to cefotaxime and cefepime than it does resistance to ceftazidime.", "category_aro_class_name": "AMR Gene Family"}, "35930": {"category_aro_accession": "0000011", "category_aro_cvterm_id": "35930", "category_aro_name": "cloxacillin", "category_aro_description": "Cloxacillin is a semisynthetic, isoxazolyl penicillin derivative in the beta-lactam class of antibiotics. It interferes with peptidogylcan synthesis and is commonly used for treating penicillin-resistant Staphylococcus aureus infections.", "category_aro_class_name": "Antibiotic"}, "35973": {"category_aro_accession": "0000056", "category_aro_cvterm_id": "35973", "category_aro_name": "oxacillin", "category_aro_description": "Oxacillin is a penicillinase-resistant beta-lactam. It is similar to methicillin, and has replaced methicillin in clinical use. Oxacillin, especially in combination with other antibiotics, is effective against many penicillinase-producing strains of Staphylococcus aureus and Staphylococcus epidermidis.", "category_aro_class_name": "Antibiotic"}, "37084": {"category_aro_accession": "3000704", "category_aro_cvterm_id": "37084", "category_aro_name": "cefalotin", "category_aro_description": "Cefalotin is a semisynthetic cephalosporin antibiotic activate against staphylococci. It is resistant to staphylococci beta-lactamases but hydrolyzed by enterobacterial beta-lactamases.", "category_aro_class_name": "Antibiotic"}, "35939": {"category_aro_accession": "0000020", "category_aro_cvterm_id": "35939", "category_aro_name": "carbapenem", "category_aro_description": "Carbapenems are a class of beta-lactam antibiotics with a broad spectrum of antibacterial activity, and have a structure which renders them highly resistant to beta-lactamases. Carbapenem antibiotics are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "35951": {"category_aro_accession": "0000032", "category_aro_cvterm_id": "35951", "category_aro_name": "cephalosporin", "category_aro_description": "Cephalosporins are a class of beta-lactam antibiotics, containing the beta-lactam ring fused with a dihydrothiazolidine ring. Together with cephamycins they belong to a sub-group called cephems. Cephalosporin are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "36017": {"category_aro_accession": "3000008", "category_aro_cvterm_id": "36017", "category_aro_name": "penam", "category_aro_description": "Penams are a group of antibiotics derived from Penicillium fungi that share a skeleton beta-lactam moiety fused with a thiazolidine ring. This is the most defining feature of penicillins. Penicillin antibiotics are historically significant because they are the first drugs that were effective against many previously serious diseases such as syphilis and Staphylococcus infections. Penicillins are still widely used today, though many types of bacteria are now resistant. All penicillins are beta-lactam antibiotics in the penam sub-group, and are used in the treatment of bacterial infections caused by susceptible, usually Gram-positive, organisms.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 9.13204, "max_identities": 7, "bit_score": 21.9422, "cvterm_id": "36772", "query": "AQHPFQPSESFKTLGA", "match": "A+ PF P+ +FK   A", "sequence_from_db": "AKEPFSPASTFKIFNA", "sequence_from_broadstreet": "MKKILLLFSLFYSFALANDKLKDFFKDYNTSGVFITFDGKHYASNNFKRAKEPFSPASTFKIFNALIALDNGVVKDTKEIFYHYKGEKVFLPSWKQDASLSSAIKRSQVPAFKELARKIGLKTMQESLNKLSYGNTKISKIDTFWLDNSLQISAKNQADLLFKLSQNSLPFSKKSQEEVKKIILFKEDKIQKIYAKTGFNDGINLAWIVGFIESKNKILSFALNVDIKNIKNLKIREELLEKYIYSLN", "dna_sequence_from_broadstreet": "TTGAAAAAAATACTTTTACTTTTTAGTCTTTTTTACTCTTTTGCTTTGGCAAATGATAAATTAAAAGATTTTTTTAAAGACTACAATACAAGCGGAGTTTTTATAACTTTTGATGGAAAACATTATGCAAGTAATAATTTTAAAAGAGCTAAAGAACCTTTTTCTCCTGCTTCGACTTTTAAAATTTTTAATGCTTTAATTGCGCTTGATAATGGTGTAGTTAAAGATACAAAGGAAATTTTTTATCATTATAAGGGTGAAAAAGTATTTTTGCCCTCTTGGAAACAAGATGCTAGTTTAAGCTCAGCCATAAAACGCTCTCAAGTGCCTGCTTTTAAAGAATTGGCAAGAAAAATAGGACTTAAAACCATGCAAGAAAGCTTAAATAAACTTTCCTATGGAAATACAAAAATTTCAAAAATCGATACCTTTTGGTTGGATAATTCTTTACAAATTTCTGCAAAAAATCAAGCTGATTTGCTTTTTAAACTTTCACAAAATTCTTTACCTTTTTCCAAGAAAAGTCAAGAAGAAGTTAAAAAAATTATTCTTTTTAAAGAAGATAAAATCCAAAAAATTTATGCTAAAACAGGTTTTAATGATGGTATAAATTTGGCTTGGATTGTTGGATTTATAGAGAGTAAAAACAAAATTTTATCTTTTGCCTTAAATGTTGATATAAAGAACATTAAAAATCTTAAAATAAGAGAAGAATTGCTAGAAAAATATATTTATTCTTTAAACTAA", "partial": "0", "query_start": 49306, "query_end": 49353, "hit_start": 147, "hit_end": 195, "orf_dna_sequence": "ATGAACCAAGAAGCCGTCTTTCAACTGCTCGTCTCCCACGCGCGCGAGGTCGTGCCGCATCTCGCGCAGCATCCGTTCCAGCCTTCCGAGAGCTTCAAGACGCTCGGCGCGAATTCGATGGACCGCGCGGACATCCTGATGATGACGATGGAGGCGCTGTCGATCCGCTGCTCGCTCACCGAGCTCGCCGGGCCGGCCAACATCGGCGAGCTCGCCGCGCTGCTCGCGCAAAAGGCGCGCCATGGCTAG", "orf_prot_sequence": "MNQEAVFQLLVSHAREVVPHLAQHPFQPSESFKTLGANSMDRADILMMTMEALSIRCSLTELAGPANIGELAALLAQKARHG", "perc_identity": 43.75}, "gnl|BL_ORD_ID|3884|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 49243, "orf_end": 49491, "orf_from": "BGC0000186.1|Thailandamide_10 ", "model_name": "OXA-628", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "500", "model_id": "4954", "ARO_accession": "3005849", "ARO_name": "OXA-628", "ARO_category": {"36026": {"category_aro_accession": "3000017", "category_aro_cvterm_id": "36026", "category_aro_name": "OXA beta-lactamase", "category_aro_description": "OXA beta-lactamases were long recognized as a less common but also plasmid-mediated beta-lactamase variety that could hydrolyze oxacillin and related anti-staphylococcal penicillins. These beta-lactamases differ from the TEM and SHV enzymes in that they belong to molecular class D and functional group 2d. The OXA-type beta-lactamases confer resistance to ampicillin and cephalothin and are characterized by their high hydrolytic activity against oxacillin and cloxacillin and the fact that they are poorly inhibited by clavulanic acid. Amino acid substitutions in OXA enzymes can also give the ESBL phenotype. The OXA beta-lactamase family was originally created as a phenotypic rather than a genotypic group for a few beta-lactamases that had a specific hydrolysis profile. Therefore, there is as little as 20% sequence homology among some of the members of this family. However, recent additions to this family show some degree of homology to one or more of the existing members of the OXA beta-lactamase family. Some confer resistance predominantly to ceftazidime, but OXA-17 confers greater resistance to cefotaxime and cefepime than it does resistance to ceftazidime.", "category_aro_class_name": "AMR Gene Family"}, "35930": {"category_aro_accession": "0000011", "category_aro_cvterm_id": "35930", "category_aro_name": "cloxacillin", "category_aro_description": "Cloxacillin is a semisynthetic, isoxazolyl penicillin derivative in the beta-lactam class of antibiotics. It interferes with peptidogylcan synthesis and is commonly used for treating penicillin-resistant Staphylococcus aureus infections.", "category_aro_class_name": "Antibiotic"}, "35973": {"category_aro_accession": "0000056", "category_aro_cvterm_id": "35973", "category_aro_name": "oxacillin", "category_aro_description": "Oxacillin is a penicillinase-resistant beta-lactam. It is similar to methicillin, and has replaced methicillin in clinical use. Oxacillin, especially in combination with other antibiotics, is effective against many penicillinase-producing strains of Staphylococcus aureus and Staphylococcus epidermidis.", "category_aro_class_name": "Antibiotic"}, "37084": {"category_aro_accession": "3000704", "category_aro_cvterm_id": "37084", "category_aro_name": "cefalotin", "category_aro_description": "Cefalotin is a semisynthetic cephalosporin antibiotic activate against staphylococci. It is resistant to staphylococci beta-lactamases but hydrolyzed by enterobacterial beta-lactamases.", "category_aro_class_name": "Antibiotic"}, "35939": {"category_aro_accession": "0000020", "category_aro_cvterm_id": "35939", "category_aro_name": "carbapenem", "category_aro_description": "Carbapenems are a class of beta-lactam antibiotics with a broad spectrum of antibacterial activity, and have a structure which renders them highly resistant to beta-lactamases. Carbapenem antibiotics are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "35951": {"category_aro_accession": "0000032", "category_aro_cvterm_id": "35951", "category_aro_name": "cephalosporin", "category_aro_description": "Cephalosporins are a class of beta-lactam antibiotics, containing the beta-lactam ring fused with a dihydrothiazolidine ring. Together with cephamycins they belong to a sub-group called cephems. Cephalosporin are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "36017": {"category_aro_accession": "3000008", "category_aro_cvterm_id": "36017", "category_aro_name": "penam", "category_aro_description": "Penams are a group of antibiotics derived from Penicillium fungi that share a skeleton beta-lactam moiety fused with a thiazolidine ring. This is the most defining feature of penicillins. Penicillin antibiotics are historically significant because they are the first drugs that were effective against many previously serious diseases such as syphilis and Staphylococcus infections. Penicillins are still widely used today, though many types of bacteria are now resistant. All penicillins are beta-lactam antibiotics in the penam sub-group, and are used in the treatment of bacterial infections caused by susceptible, usually Gram-positive, organisms.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 9.22188, "max_identities": 7, "bit_score": 21.9422, "cvterm_id": "36772", "query": "AQHPFQPSESFKTLGA", "match": "A+ PF P+ +FK   A", "sequence_from_db": "AKEPFSPASTFKIFNA", "sequence_from_broadstreet": "MKKILLLFSLFYSFALANDKLKDFFKDYNTSGVFITFDGKHYASNNFKRAKEPFSPASTFKIFNALIALDNGVVKDTKEIFYHYKGEKVFLPSWKQDASLSSAIKRSQVPAFKELARKIGLKTMQESLNKLSCGNTKISKIDTFWLDNSLQISAKNQADLLFKLSQNSLPFSKKSQEEVKKIILFKEDKIQKIYAKTGFNDGINLAWIVGFIESKNKILSFALNVDIKNIKNLKIREELLEKYIYSLN", "dna_sequence_from_broadstreet": "TTGAAAAAAATACTTTTACTTTTTAGTCTTTTTTACTCTTTTGCTTTGGCAAATGATAAATTAAAAGATTTTTTTAAAGACTACAATACAAGCGGAGTTTTTATAACTTTTGATGGAAAACATTATGCAAGTAATAATTTTAAAAGAGCTAAAGAACCTTTTTCTCCTGCTTCGACTTTTAAAATTTTTAATGCTTTAATTGCGCTTGATAATGGTGTAGTTAAAGATACAAAGGAAATTTTTTATCATTATAAGGGTGAAAAAGTATTTTTGCCCTCTTGGAAACAAGATGCTAGTTTAAGCTCAGCCATAAAACGCTCTCAAGTGCCTGCTTTTAAAGAATTGGCAAGAAAAATAGGACTTAAAACCATGCAAGAAAGCTTAAATAAACTTTCCTGTGGAAATACAAAAATTTCAAAAATCGATACCTTTTGGTTGGATAATTCTTTACAAATTTCTGCAAAAAATCAAGCTGATTTGCTTTTTAAACTTTCACAAAATTCTTTACCTTTTTCCAAGAAAAGTCAAGAAGAAGTTAAAAAAATTATTCTTTTTAAAGAAGATAAAATCCAAAAAATTTATGCTAAAACAGGTTTTAATGATGGTATAAATTTGGCTTGGATTGTTGGATTTATAGAGAGTAAAAACAAAATTTTATCTTTTGCCTTAAATGTTGATATAAAGAACATTAAAAATCTTAAAATAAGAGAAGAATTGCTAGAAAAATATATTTATTCTTTAAACTAA", "partial": "0", "query_start": 49306, "query_end": 49353, "hit_start": 147, "hit_end": 195, "orf_dna_sequence": "ATGAACCAAGAAGCCGTCTTTCAACTGCTCGTCTCCCACGCGCGCGAGGTCGTGCCGCATCTCGCGCAGCATCCGTTCCAGCCTTCCGAGAGCTTCAAGACGCTCGGCGCGAATTCGATGGACCGCGCGGACATCCTGATGATGACGATGGAGGCGCTGTCGATCCGCTGCTCGCTCACCGAGCTCGCCGGGCCGGCCAACATCGGCGAGCTCGCCGCGCTGCTCGCGCAAAAGGCGCGCCATGGCTAG", "orf_prot_sequence": "MNQEAVFQLLVSHAREVVPHLAQHPFQPSESFKTLGANSMDRADILMMTMEALSIRCSLTELAGPANIGELAALLAQKARHG", "perc_identity": 43.75}, "gnl|BL_ORD_ID|2574|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 49243, "orf_end": 49491, "orf_from": "BGC0000186.1|Thailandamide_10 ", "model_name": "OXA-465", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "440", "model_id": "3530", "ARO_accession": "3003621", "ARO_name": "OXA-465", "ARO_category": {"36026": {"category_aro_accession": "3000017", "category_aro_cvterm_id": "36026", "category_aro_name": "OXA beta-lactamase", "category_aro_description": "OXA beta-lactamases were long recognized as a less common but also plasmid-mediated beta-lactamase variety that could hydrolyze oxacillin and related anti-staphylococcal penicillins. These beta-lactamases differ from the TEM and SHV enzymes in that they belong to molecular class D and functional group 2d. The OXA-type beta-lactamases confer resistance to ampicillin and cephalothin and are characterized by their high hydrolytic activity against oxacillin and cloxacillin and the fact that they are poorly inhibited by clavulanic acid. Amino acid substitutions in OXA enzymes can also give the ESBL phenotype. The OXA beta-lactamase family was originally created as a phenotypic rather than a genotypic group for a few beta-lactamases that had a specific hydrolysis profile. Therefore, there is as little as 20% sequence homology among some of the members of this family. However, recent additions to this family show some degree of homology to one or more of the existing members of the OXA beta-lactamase family. Some confer resistance predominantly to ceftazidime, but OXA-17 confers greater resistance to cefotaxime and cefepime than it does resistance to ceftazidime.", "category_aro_class_name": "AMR Gene Family"}, "35930": {"category_aro_accession": "0000011", "category_aro_cvterm_id": "35930", "category_aro_name": "cloxacillin", "category_aro_description": "Cloxacillin is a semisynthetic, isoxazolyl penicillin derivative in the beta-lactam class of antibiotics. It interferes with peptidogylcan synthesis and is commonly used for treating penicillin-resistant Staphylococcus aureus infections.", "category_aro_class_name": "Antibiotic"}, "35973": {"category_aro_accession": "0000056", "category_aro_cvterm_id": "35973", "category_aro_name": "oxacillin", "category_aro_description": "Oxacillin is a penicillinase-resistant beta-lactam. It is similar to methicillin, and has replaced methicillin in clinical use. Oxacillin, especially in combination with other antibiotics, is effective against many penicillinase-producing strains of Staphylococcus aureus and Staphylococcus epidermidis.", "category_aro_class_name": "Antibiotic"}, "37084": {"category_aro_accession": "3000704", "category_aro_cvterm_id": "37084", "category_aro_name": "cefalotin", "category_aro_description": "Cefalotin is a semisynthetic cephalosporin antibiotic activate against staphylococci. It is resistant to staphylococci beta-lactamases but hydrolyzed by enterobacterial beta-lactamases.", "category_aro_class_name": "Antibiotic"}, "35939": {"category_aro_accession": "0000020", "category_aro_cvterm_id": "35939", "category_aro_name": "carbapenem", "category_aro_description": "Carbapenems are a class of beta-lactam antibiotics with a broad spectrum of antibacterial activity, and have a structure which renders them highly resistant to beta-lactamases. Carbapenem antibiotics are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "35951": {"category_aro_accession": "0000032", "category_aro_cvterm_id": "35951", "category_aro_name": "cephalosporin", "category_aro_description": "Cephalosporins are a class of beta-lactam antibiotics, containing the beta-lactam ring fused with a dihydrothiazolidine ring. Together with cephamycins they belong to a sub-group called cephems. Cephalosporin are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "36017": {"category_aro_accession": "3000008", "category_aro_cvterm_id": "36017", "category_aro_name": "penam", "category_aro_description": "Penams are a group of antibiotics derived from Penicillium fungi that share a skeleton beta-lactam moiety fused with a thiazolidine ring. This is the most defining feature of penicillins. Penicillin antibiotics are historically significant because they are the first drugs that were effective against many previously serious diseases such as syphilis and Staphylococcus infections. Penicillins are still widely used today, though many types of bacteria are now resistant. All penicillins are beta-lactam antibiotics in the penam sub-group, and are used in the treatment of bacterial infections caused by susceptible, usually Gram-positive, organisms.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 9.22188, "max_identities": 7, "bit_score": 21.9422, "cvterm_id": "36772", "query": "AQHPFQPSESFKTLGA", "match": "A+ PF P+ +FK   A", "sequence_from_db": "AKEPFSPASTFKIFNA", "sequence_from_broadstreet": "MKKILLLFSLFYSFALANDKLKDFFKDYNTSGVFITFDGKHYASNDFKRAKEPFSPASTFKIFNALIALDNGVVKDTKEIFYHYKGEKVFLPSWKQDASLSSAIKRSQVPAFKELARKIGLKTMQESLNKLSYGNAKISKIDTFWLDNSLQISAKNQADLLFKLSQNSLPFSKKSQEEVKKIILFKEDKIQKIYAKTGFNDGINLAWIVGFIESKNKILSFALNVDIKDIKNIKIREELLEKYIYSLN", "dna_sequence_from_broadstreet": "TTGAAAAAAATACTTTTACTTTTTAGTCTTTTTTACTCTTTTGCTTTGGCAAATGATAAATTAAAAGATTTTTTTAAAGACTACAATACAAGCGGAGTTTTTATAACTTTTGATGGAAAACATTATGCAAGTAATGATTTTAAAAGAGCTAAAGAACCTTTTTCTCCTGCTTCGACTTTTAAAATTTTTAATGCTTTAATTGCGCTTGATAACGGTGTAGTTAAAGATACAAAGGAAATTTTTTATCATTATAAGGGTGAAAAAGTATTTTTGCCTTCTTGGAAACAAGATGCTAGTTTAAGCTCAGCCATAAAACGCTCTCAAGTGCCTGCTTTTAAAGAATTGGCAAGAAAAATAGGACTTAAAACCATGCAAGAAAGCTTAAATAAACTTTCCTATGGAAATGCAAAAATTTCAAAAATCGATACCTTTTGGTTGGATAATTCTTTACAAATTTCTGCAAAAAATCAAGCTGATTTGCTTTTTAAACTTTCACAAAATTCTTTACCTTTTTCCAAGAAAAGTCAAGAAGAAGTTAAAAAAATTATTCTTTTTAAAGAAGATAAAATCCAAAAAATTTATGCTAAAACAGGTTTTAATGATGGTATAAATTTGGCTTGGATTGTCGGATTTATAGAGAGTAAAAACAAAATTTTATCTTTTGCCTTAAATGTTGATATAAAGGACATTAAAAATATTAAAATAAGAGAAGAATTGCTAGAAAAATATATTTATTCTTTAAACTAA", "partial": "0", "query_start": 49306, "query_end": 49353, "hit_start": 147, "hit_end": 195, "orf_dna_sequence": "ATGAACCAAGAAGCCGTCTTTCAACTGCTCGTCTCCCACGCGCGCGAGGTCGTGCCGCATCTCGCGCAGCATCCGTTCCAGCCTTCCGAGAGCTTCAAGACGCTCGGCGCGAATTCGATGGACCGCGCGGACATCCTGATGATGACGATGGAGGCGCTGTCGATCCGCTGCTCGCTCACCGAGCTCGCCGGGCCGGCCAACATCGGCGAGCTCGCCGCGCTGCTCGCGCAAAAGGCGCGCCATGGCTAG", "orf_prot_sequence": "MNQEAVFQLLVSHAREVVPHLAQHPFQPSESFKTLGANSMDRADILMMTMEALSIRCSLTELAGPANIGELAALLAQKARHG", "perc_identity": 43.75}, "gnl|BL_ORD_ID|4023|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 49243, "orf_end": 49491, "orf_from": "BGC0000186.1|Thailandamide_10 ", "model_name": "OXA-785", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "500", "model_id": "5093", "ARO_accession": "3005988", "ARO_name": "OXA-785", "ARO_category": {"36026": {"category_aro_accession": "3000017", "category_aro_cvterm_id": "36026", "category_aro_name": "OXA beta-lactamase", "category_aro_description": "OXA beta-lactamases were long recognized as a less common but also plasmid-mediated beta-lactamase variety that could hydrolyze oxacillin and related anti-staphylococcal penicillins. These beta-lactamases differ from the TEM and SHV enzymes in that they belong to molecular class D and functional group 2d. The OXA-type beta-lactamases confer resistance to ampicillin and cephalothin and are characterized by their high hydrolytic activity against oxacillin and cloxacillin and the fact that they are poorly inhibited by clavulanic acid. Amino acid substitutions in OXA enzymes can also give the ESBL phenotype. The OXA beta-lactamase family was originally created as a phenotypic rather than a genotypic group for a few beta-lactamases that had a specific hydrolysis profile. Therefore, there is as little as 20% sequence homology among some of the members of this family. However, recent additions to this family show some degree of homology to one or more of the existing members of the OXA beta-lactamase family. Some confer resistance predominantly to ceftazidime, but OXA-17 confers greater resistance to cefotaxime and cefepime than it does resistance to ceftazidime.", "category_aro_class_name": "AMR Gene Family"}, "35930": {"category_aro_accession": "0000011", "category_aro_cvterm_id": "35930", "category_aro_name": "cloxacillin", "category_aro_description": "Cloxacillin is a semisynthetic, isoxazolyl penicillin derivative in the beta-lactam class of antibiotics. It interferes with peptidogylcan synthesis and is commonly used for treating penicillin-resistant Staphylococcus aureus infections.", "category_aro_class_name": "Antibiotic"}, "35973": {"category_aro_accession": "0000056", "category_aro_cvterm_id": "35973", "category_aro_name": "oxacillin", "category_aro_description": "Oxacillin is a penicillinase-resistant beta-lactam. It is similar to methicillin, and has replaced methicillin in clinical use. Oxacillin, especially in combination with other antibiotics, is effective against many penicillinase-producing strains of Staphylococcus aureus and Staphylococcus epidermidis.", "category_aro_class_name": "Antibiotic"}, "37084": {"category_aro_accession": "3000704", "category_aro_cvterm_id": "37084", "category_aro_name": "cefalotin", "category_aro_description": "Cefalotin is a semisynthetic cephalosporin antibiotic activate against staphylococci. It is resistant to staphylococci beta-lactamases but hydrolyzed by enterobacterial beta-lactamases.", "category_aro_class_name": "Antibiotic"}, "35939": {"category_aro_accession": "0000020", "category_aro_cvterm_id": "35939", "category_aro_name": "carbapenem", "category_aro_description": "Carbapenems are a class of beta-lactam antibiotics with a broad spectrum of antibacterial activity, and have a structure which renders them highly resistant to beta-lactamases. Carbapenem antibiotics are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "35951": {"category_aro_accession": "0000032", "category_aro_cvterm_id": "35951", "category_aro_name": "cephalosporin", "category_aro_description": "Cephalosporins are a class of beta-lactam antibiotics, containing the beta-lactam ring fused with a dihydrothiazolidine ring. Together with cephamycins they belong to a sub-group called cephems. Cephalosporin are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "36017": {"category_aro_accession": "3000008", "category_aro_cvterm_id": "36017", "category_aro_name": "penam", "category_aro_description": "Penams are a group of antibiotics derived from Penicillium fungi that share a skeleton beta-lactam moiety fused with a thiazolidine ring. This is the most defining feature of penicillins. Penicillin antibiotics are historically significant because they are the first drugs that were effective against many previously serious diseases such as syphilis and Staphylococcus infections. Penicillins are still widely used today, though many types of bacteria are now resistant. All penicillins are beta-lactam antibiotics in the penam sub-group, and are used in the treatment of bacterial infections caused by susceptible, usually Gram-positive, organisms.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 9.31261, "max_identities": 7, "bit_score": 21.9422, "cvterm_id": "36772", "query": "AQHPFQPSESFKTLGA", "match": "A+ PF P+ +FK   A", "sequence_from_db": "AKEPFSPASTFKIFNA", "sequence_from_broadstreet": "MKKILLLFSLFYSFALANDKLKDFFKDYNTSGVFITFDGKHYASNDFKRAKEPFSPASTFKIFNALIALDNGVVKDTKEIFYHYKGEKVFLPSWKQDASLSSAIKRSQVPAFKELARKIGLKTMQESLNKLSYGNAKISKIDTFWLDNSLQISAKNQADLLFKLSQNSLPFSKKSQEEVKKIILFKEDKIQKIYAKTGFNDGVNLAWIVGFIESKNKILSFALNVDIKNIKNLKIREELLEKYIYSLN", "dna_sequence_from_broadstreet": "TTGAAAAAAATACTTTTACTTTTTAGTCTTTTTTACTCTTTTGCTTTGGCAAATGATAAATTAAAAGATTTTTTTAAAGACTACAATACAAGCGGAGTTTTTATAACTTTTGATGGAAAACATTATGCAAGTAATGATTTTAAAAGAGCTAAAGAACCTTTTTCTCCTGCTTCGACTTTTAAAATTTTTAATGCTTTAATTGCGCTTGATAACGGTGTAGTTAAAGATACAAAGGAAATTTTTTATCATTATAAGGGTGAAAAAGTATTTTTGCCTTCTTGGAAACAAGATGCTAGTTTAAGCTCAGCCATAAAACGCTCTCAAGTGCCTGCTTTTAAAGAATTGGCAAGAAAAATAGGACTTAAAACCATGCAAGAAAGCTTAAATAAACTTTCCTATGGAAATGCAAAAATTTCAAAAATCGATACCTTTTGGTTGGATAATTCTTTACAAATTTCTGCAAAAAATCAAGCTGATTTGCTTTTTAAACTTTCACAAAATTCTTTACCTTTTTCCAAGAAAAGTCAAGAAGAAGTTAAAAAAATTATTCTTTTTAAAGAAGATAAAATCCAAAAAATTTATGCTAAAACAGGTTTTAATGATGGTGTAAATTTGGCTTGGATTGTCGGATTTATAGAGAGTAAAAACAAAATTTTATCTTTTGCCTTAAATGTTGATATAAAGAATATTAAAAATCTTAAAATAAGAGAAGAATTACTAGAAAAATATATTTATTCTTTAAACTAA", "partial": "0", "query_start": 49306, "query_end": 49353, "hit_start": 147, "hit_end": 195, "orf_dna_sequence": "ATGAACCAAGAAGCCGTCTTTCAACTGCTCGTCTCCCACGCGCGCGAGGTCGTGCCGCATCTCGCGCAGCATCCGTTCCAGCCTTCCGAGAGCTTCAAGACGCTCGGCGCGAATTCGATGGACCGCGCGGACATCCTGATGATGACGATGGAGGCGCTGTCGATCCGCTGCTCGCTCACCGAGCTCGCCGGGCCGGCCAACATCGGCGAGCTCGCCGCGCTGCTCGCGCAAAAGGCGCGCCATGGCTAG", "orf_prot_sequence": "MNQEAVFQLLVSHAREVVPHLAQHPFQPSESFKTLGANSMDRADILMMTMEALSIRCSLTELAGPANIGELAALLAQKARHG", "perc_identity": 43.75}, "gnl|BL_ORD_ID|3881|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 49243, "orf_end": 49491, "orf_from": "BGC0000186.1|Thailandamide_10 ", "model_name": "OXA-625", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "500", "model_id": "4951", "ARO_accession": "3005846", "ARO_name": "OXA-625", "ARO_category": {"36026": {"category_aro_accession": "3000017", "category_aro_cvterm_id": "36026", "category_aro_name": "OXA beta-lactamase", "category_aro_description": "OXA beta-lactamases were long recognized as a less common but also plasmid-mediated beta-lactamase variety that could hydrolyze oxacillin and related anti-staphylococcal penicillins. These beta-lactamases differ from the TEM and SHV enzymes in that they belong to molecular class D and functional group 2d. The OXA-type beta-lactamases confer resistance to ampicillin and cephalothin and are characterized by their high hydrolytic activity against oxacillin and cloxacillin and the fact that they are poorly inhibited by clavulanic acid. Amino acid substitutions in OXA enzymes can also give the ESBL phenotype. The OXA beta-lactamase family was originally created as a phenotypic rather than a genotypic group for a few beta-lactamases that had a specific hydrolysis profile. Therefore, there is as little as 20% sequence homology among some of the members of this family. However, recent additions to this family show some degree of homology to one or more of the existing members of the OXA beta-lactamase family. Some confer resistance predominantly to ceftazidime, but OXA-17 confers greater resistance to cefotaxime and cefepime than it does resistance to ceftazidime.", "category_aro_class_name": "AMR Gene Family"}, "35930": {"category_aro_accession": "0000011", "category_aro_cvterm_id": "35930", "category_aro_name": "cloxacillin", "category_aro_description": "Cloxacillin is a semisynthetic, isoxazolyl penicillin derivative in the beta-lactam class of antibiotics. It interferes with peptidogylcan synthesis and is commonly used for treating penicillin-resistant Staphylococcus aureus infections.", "category_aro_class_name": "Antibiotic"}, "35973": {"category_aro_accession": "0000056", "category_aro_cvterm_id": "35973", "category_aro_name": "oxacillin", "category_aro_description": "Oxacillin is a penicillinase-resistant beta-lactam. It is similar to methicillin, and has replaced methicillin in clinical use. Oxacillin, especially in combination with other antibiotics, is effective against many penicillinase-producing strains of Staphylococcus aureus and Staphylococcus epidermidis.", "category_aro_class_name": "Antibiotic"}, "37084": {"category_aro_accession": "3000704", "category_aro_cvterm_id": "37084", "category_aro_name": "cefalotin", "category_aro_description": "Cefalotin is a semisynthetic cephalosporin antibiotic activate against staphylococci. It is resistant to staphylococci beta-lactamases but hydrolyzed by enterobacterial beta-lactamases.", "category_aro_class_name": "Antibiotic"}, "35939": {"category_aro_accession": "0000020", "category_aro_cvterm_id": "35939", "category_aro_name": "carbapenem", "category_aro_description": "Carbapenems are a class of beta-lactam antibiotics with a broad spectrum of antibacterial activity, and have a structure which renders them highly resistant to beta-lactamases. Carbapenem antibiotics are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "35951": {"category_aro_accession": "0000032", "category_aro_cvterm_id": "35951", "category_aro_name": "cephalosporin", "category_aro_description": "Cephalosporins are a class of beta-lactam antibiotics, containing the beta-lactam ring fused with a dihydrothiazolidine ring. Together with cephamycins they belong to a sub-group called cephems. Cephalosporin are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "36017": {"category_aro_accession": "3000008", "category_aro_cvterm_id": "36017", "category_aro_name": "penam", "category_aro_description": "Penams are a group of antibiotics derived from Penicillium fungi that share a skeleton beta-lactam moiety fused with a thiazolidine ring. This is the most defining feature of penicillins. Penicillin antibiotics are historically significant because they are the first drugs that were effective against many previously serious diseases such as syphilis and Staphylococcus infections. Penicillins are still widely used today, though many types of bacteria are now resistant. All penicillins are beta-lactam antibiotics in the penam sub-group, and are used in the treatment of bacterial infections caused by susceptible, usually Gram-positive, organisms.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 9.31261, "max_identities": 7, "bit_score": 21.9422, "cvterm_id": "36772", "query": "AQHPFQPSESFKTLGA", "match": "A+ PF P+ +FK   A", "sequence_from_db": "AKEPFSPASTFKIFNA", "sequence_from_broadstreet": "MKKILLLFSLFYSFALANDKLKDFFKDYNTSGVFITFDGKHYASNDFKRAKEPFSPASTFKIFNALIALDNGVVKDTKEIFYHYKGEKVFLPSWKQDASLSSAIKRSQVPAFKELARKIGLKTMQESLNKLSYGNAKISKIDTFWLDNSLQISAKNQADLLFKLSQNSLPFSKKSQEEVKKIILFKEDKIQKIYAKTGFNDGINLAWIVGFIESKNKILSFALNVDIKNIKNLKIREELLEKYIYSLN", "dna_sequence_from_broadstreet": "TTGAAAAAAATACTTTTACTTTTTAGTCTTTTTTACTCTTTTGCTTTGGCAAATGATAAATTAAAAGATTTTTTTAAAGACTACAATACAAGCGGAGTTTTTATAACTTTTGATGGAAAACATTATGCAAGTAATGATTTTAAAAGAGCTAAAGAACCTTTTTCTCCTGCTTCGACTTTTAAAATTTTTAATGCTTTAATTGCGCTTGATAACGGTGTAGTTAAAGATACAAAGGAAATTTTTTATCATTATAAGGGTGAAAAAGTATTTTTGCCTTCTTGGAAACAAGATGCTAGTTTAAGCTCAGCCATAAAACGCTCTCAAGTGCCTGCTTTTAAAGAATTGGCAAGAAAAATAGGACTTAAAACCATGCAAGAAAGCTTAAATAAACTTTCCTATGGAAATGCGAAAATTTCAAAAATCGATACCTTTTGGTTGGATAATTCTTTACAAATTTCTGCAAAAAATCAAGCTGATTTGCTTTTTAAACTTTCACAAAATTCTTTACCTTTTTCCAAGAAAAGTCAAGAAGAAGTTAAAAAAATTATTCTTTTTAAAGAAGATAAAATCCAAAAAATTTATGCTAAAACAGGTTTTAATGATGGTATAAATTTGGCTTGGATTGTCGGATTTATAGAGAGTAAAAACAAAATTTTATCTTTTGCCTTAAATGTTGATATAAAGAATATTAAAAATCTTAAAATAAGAGAAGAATTGCTAGAAAAATATATTTATTCTTTAAACTAA", "partial": "0", "query_start": 49306, "query_end": 49353, "hit_start": 147, "hit_end": 195, "orf_dna_sequence": "ATGAACCAAGAAGCCGTCTTTCAACTGCTCGTCTCCCACGCGCGCGAGGTCGTGCCGCATCTCGCGCAGCATCCGTTCCAGCCTTCCGAGAGCTTCAAGACGCTCGGCGCGAATTCGATGGACCGCGCGGACATCCTGATGATGACGATGGAGGCGCTGTCGATCCGCTGCTCGCTCACCGAGCTCGCCGGGCCGGCCAACATCGGCGAGCTCGCCGCGCTGCTCGCGCAAAAGGCGCGCCATGGCTAG", "orf_prot_sequence": "MNQEAVFQLLVSHAREVVPHLAQHPFQPSESFKTLGANSMDRADILMMTMEALSIRCSLTELAGPANIGELAALLAQKARHG", "perc_identity": 43.75}, "gnl|BL_ORD_ID|3885|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 49243, "orf_end": 49491, "orf_from": "BGC0000186.1|Thailandamide_10 ", "model_name": "OXA-629", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "500", "model_id": "4955", "ARO_accession": "3005850", "ARO_name": "OXA-629", "ARO_category": {"36026": {"category_aro_accession": "3000017", "category_aro_cvterm_id": "36026", "category_aro_name": "OXA beta-lactamase", "category_aro_description": "OXA beta-lactamases were long recognized as a less common but also plasmid-mediated beta-lactamase variety that could hydrolyze oxacillin and related anti-staphylococcal penicillins. These beta-lactamases differ from the TEM and SHV enzymes in that they belong to molecular class D and functional group 2d. The OXA-type beta-lactamases confer resistance to ampicillin and cephalothin and are characterized by their high hydrolytic activity against oxacillin and cloxacillin and the fact that they are poorly inhibited by clavulanic acid. Amino acid substitutions in OXA enzymes can also give the ESBL phenotype. The OXA beta-lactamase family was originally created as a phenotypic rather than a genotypic group for a few beta-lactamases that had a specific hydrolysis profile. Therefore, there is as little as 20% sequence homology among some of the members of this family. However, recent additions to this family show some degree of homology to one or more of the existing members of the OXA beta-lactamase family. Some confer resistance predominantly to ceftazidime, but OXA-17 confers greater resistance to cefotaxime and cefepime than it does resistance to ceftazidime.", "category_aro_class_name": "AMR Gene Family"}, "35930": {"category_aro_accession": "0000011", "category_aro_cvterm_id": "35930", "category_aro_name": "cloxacillin", "category_aro_description": "Cloxacillin is a semisynthetic, isoxazolyl penicillin derivative in the beta-lactam class of antibiotics. It interferes with peptidogylcan synthesis and is commonly used for treating penicillin-resistant Staphylococcus aureus infections.", "category_aro_class_name": "Antibiotic"}, "35973": {"category_aro_accession": "0000056", "category_aro_cvterm_id": "35973", "category_aro_name": "oxacillin", "category_aro_description": "Oxacillin is a penicillinase-resistant beta-lactam. It is similar to methicillin, and has replaced methicillin in clinical use. Oxacillin, especially in combination with other antibiotics, is effective against many penicillinase-producing strains of Staphylococcus aureus and Staphylococcus epidermidis.", "category_aro_class_name": "Antibiotic"}, "37084": {"category_aro_accession": "3000704", "category_aro_cvterm_id": "37084", "category_aro_name": "cefalotin", "category_aro_description": "Cefalotin is a semisynthetic cephalosporin antibiotic activate against staphylococci. It is resistant to staphylococci beta-lactamases but hydrolyzed by enterobacterial beta-lactamases.", "category_aro_class_name": "Antibiotic"}, "35939": {"category_aro_accession": "0000020", "category_aro_cvterm_id": "35939", "category_aro_name": "carbapenem", "category_aro_description": "Carbapenems are a class of beta-lactam antibiotics with a broad spectrum of antibacterial activity, and have a structure which renders them highly resistant to beta-lactamases. Carbapenem antibiotics are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "35951": {"category_aro_accession": "0000032", "category_aro_cvterm_id": "35951", "category_aro_name": "cephalosporin", "category_aro_description": "Cephalosporins are a class of beta-lactam antibiotics, containing the beta-lactam ring fused with a dihydrothiazolidine ring. Together with cephamycins they belong to a sub-group called cephems. Cephalosporin are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "36017": {"category_aro_accession": "3000008", "category_aro_cvterm_id": "36017", "category_aro_name": "penam", "category_aro_description": "Penams are a group of antibiotics derived from Penicillium fungi that share a skeleton beta-lactam moiety fused with a thiazolidine ring. This is the most defining feature of penicillins. Penicillin antibiotics are historically significant because they are the first drugs that were effective against many previously serious diseases such as syphilis and Staphylococcus infections. Penicillins are still widely used today, though many types of bacteria are now resistant. All penicillins are beta-lactam antibiotics in the penam sub-group, and are used in the treatment of bacterial infections caused by susceptible, usually Gram-positive, organisms.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 9.40423, "max_identities": 7, "bit_score": 21.9422, "cvterm_id": "36772", "query": "AQHPFQPSESFKTLGA", "match": "A+ PF P+ +FK   A", "sequence_from_db": "AKEPFSPASTFKIFNA", "sequence_from_broadstreet": "MKKILLLFSLFYSFALANDKLKDFFKDYNTSGVFITFDGKHYASNNFKRAKEPFSPASTFKIFNALIALDNGVVKDTKEIFYHYKGEKVFLPSWKQDASLSSAIKRSQVPAFKELARKIGLKTMQESLNKLSYGNTKISKIDTFWLDNSLQISAKNQADLLFKLSQNSLPFSKKSQEEVKKIILFKEDKIQKIYAKTGFNDGINLAWIVGFIESKTKFLSFALNVDIKNIKNLKIREELLEKYIYSLN", "dna_sequence_from_broadstreet": "TTGAAAAAAATACTTTTACTTTTTAGTCTTTTTTACTCTTTTGCTTTGGCAAATGATAAATTAAAAGATTTTTTTAAAGACTACAATACAAGCGGAGTTTTTATAACTTTTGATGGAAAACATTATGCAAGTAATAATTTTAAAAGAGCTAAAGAACCTTTTTCTCCTGCTTCGACTTTTAAAATTTTTAATGCTTTAATTGCGCTTGATAATGGTGTAGTTAAAGATACAAAGGAAATTTTTTATCATTATAAGGGTGAAAAAGTATTTTTGCCCTCTTGGAAACAAGATGCTAGTTTAAGCTCAGCCATAAAACGCTCTCAAGTGCCTGCTTTTAAAGAATTGGCAAGAAAAATAGGACTTAAAACCATGCAAGAAAGCTTAAATAAACTTTCCTATGGAAATACAAAAATTTCAAAAATCGATACCTTTTGGTTGGATAATTCTTTACAAATTTCTGCAAAAAATCAAGCTGATTTGCTTTTTAAACTTTCACAAAATTCTTTACCTTTTTCCAAGAAAAGTCAAGAAGAAGTTAAAAAAATTATTCTTTTTAAAGAAGATAAAATCCAAAAAATTTATGCTAAAACAGGTTTTAATGATGGTATAAATTTGGCTTGGATTGTTGGATTTATAGAGAGTAAAACAAAATTTTTATCTTTTGCCTTAAATGTTGATATAAAGAACATTAAAAATCTTAAAATAAGAGAAGAATTGCTAGAAAAATATATTTATTCTTTAAACTAA", "partial": "0", "query_start": 49306, "query_end": 49353, "hit_start": 147, "hit_end": 195, "orf_dna_sequence": "ATGAACCAAGAAGCCGTCTTTCAACTGCTCGTCTCCCACGCGCGCGAGGTCGTGCCGCATCTCGCGCAGCATCCGTTCCAGCCTTCCGAGAGCTTCAAGACGCTCGGCGCGAATTCGATGGACCGCGCGGACATCCTGATGATGACGATGGAGGCGCTGTCGATCCGCTGCTCGCTCACCGAGCTCGCCGGGCCGGCCAACATCGGCGAGCTCGCCGCGCTGCTCGCGCAAAAGGCGCGCCATGGCTAG", "orf_prot_sequence": "MNQEAVFQLLVSHAREVVPHLAQHPFQPSESFKTLGANSMDRADILMMTMEALSIRCSLTELAGPANIGELAALLAQKARHG", "perc_identity": 43.75}, "gnl|BL_ORD_ID|3883|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 49243, "orf_end": 49491, "orf_from": "BGC0000186.1|Thailandamide_10 ", "model_name": "OXA-627", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "500", "model_id": "4953", "ARO_accession": "3005848", "ARO_name": "OXA-627", "ARO_category": {"36026": {"category_aro_accession": "3000017", "category_aro_cvterm_id": "36026", "category_aro_name": "OXA beta-lactamase", "category_aro_description": "OXA beta-lactamases were long recognized as a less common but also plasmid-mediated beta-lactamase variety that could hydrolyze oxacillin and related anti-staphylococcal penicillins. These beta-lactamases differ from the TEM and SHV enzymes in that they belong to molecular class D and functional group 2d. The OXA-type beta-lactamases confer resistance to ampicillin and cephalothin and are characterized by their high hydrolytic activity against oxacillin and cloxacillin and the fact that they are poorly inhibited by clavulanic acid. Amino acid substitutions in OXA enzymes can also give the ESBL phenotype. The OXA beta-lactamase family was originally created as a phenotypic rather than a genotypic group for a few beta-lactamases that had a specific hydrolysis profile. Therefore, there is as little as 20% sequence homology among some of the members of this family. However, recent additions to this family show some degree of homology to one or more of the existing members of the OXA beta-lactamase family. Some confer resistance predominantly to ceftazidime, but OXA-17 confers greater resistance to cefotaxime and cefepime than it does resistance to ceftazidime.", "category_aro_class_name": "AMR Gene Family"}, "35930": {"category_aro_accession": "0000011", "category_aro_cvterm_id": "35930", "category_aro_name": "cloxacillin", "category_aro_description": "Cloxacillin is a semisynthetic, isoxazolyl penicillin derivative in the beta-lactam class of antibiotics. It interferes with peptidogylcan synthesis and is commonly used for treating penicillin-resistant Staphylococcus aureus infections.", "category_aro_class_name": "Antibiotic"}, "35973": {"category_aro_accession": "0000056", "category_aro_cvterm_id": "35973", "category_aro_name": "oxacillin", "category_aro_description": "Oxacillin is a penicillinase-resistant beta-lactam. It is similar to methicillin, and has replaced methicillin in clinical use. Oxacillin, especially in combination with other antibiotics, is effective against many penicillinase-producing strains of Staphylococcus aureus and Staphylococcus epidermidis.", "category_aro_class_name": "Antibiotic"}, "37084": {"category_aro_accession": "3000704", "category_aro_cvterm_id": "37084", "category_aro_name": "cefalotin", "category_aro_description": "Cefalotin is a semisynthetic cephalosporin antibiotic activate against staphylococci. It is resistant to staphylococci beta-lactamases but hydrolyzed by enterobacterial beta-lactamases.", "category_aro_class_name": "Antibiotic"}, "35939": {"category_aro_accession": "0000020", "category_aro_cvterm_id": "35939", "category_aro_name": "carbapenem", "category_aro_description": "Carbapenems are a class of beta-lactam antibiotics with a broad spectrum of antibacterial activity, and have a structure which renders them highly resistant to beta-lactamases. Carbapenem antibiotics are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "35951": {"category_aro_accession": "0000032", "category_aro_cvterm_id": "35951", "category_aro_name": "cephalosporin", "category_aro_description": "Cephalosporins are a class of beta-lactam antibiotics, containing the beta-lactam ring fused with a dihydrothiazolidine ring. Together with cephamycins they belong to a sub-group called cephems. Cephalosporin are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "36017": {"category_aro_accession": "3000008", "category_aro_cvterm_id": "36017", "category_aro_name": "penam", "category_aro_description": "Penams are a group of antibiotics derived from Penicillium fungi that share a skeleton beta-lactam moiety fused with a thiazolidine ring. This is the most defining feature of penicillins. Penicillin antibiotics are historically significant because they are the first drugs that were effective against many previously serious diseases such as syphilis and Staphylococcus infections. Penicillins are still widely used today, though many types of bacteria are now resistant. All penicillins are beta-lactam antibiotics in the penam sub-group, and are used in the treatment of bacterial infections caused by susceptible, usually Gram-positive, organisms.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 9.59017, "max_identities": 7, "bit_score": 21.9422, "cvterm_id": "37052", "query": "AQHPFQPSESFKTLGA", "match": "A+ PF P+ +FK   A", "sequence_from_db": "AKEPFSPASTFKIFNA", "sequence_from_broadstreet": "MKKILLLFSLFYSFALANDKLKDFFKDYNTSGVFITFDGKHYASNNFKRAKEPFSPASTFKIFNALIALDNGVVKDTKEIFYHYKGEKVFLPSWKQDAGLSSAIKRSQVPAFKELARKIGLKTMQESLNKLSYGNTKISKIDTFWLDNSLQISAKNQADLLFKLSQNSLPFSKKSQEEVKKIILFKEDKIQKIYAKTGFNDGINLAWIVGFIESKNKILSFALNVDIKNIKNLKIREELLEKYIYSLN", "dna_sequence_from_broadstreet": "TTGAAAAAAATACTTTTACTTTTTAGTCTTTTTTACTCTTTTGCTTTGGCAAATGATAAATTAAAAGATTTTTTTAAAGACTACAATACAAGCGGAGTTTTTATAACTTTTGATGGAAAACATTATGCAAGTAATAATTTTAAAAGAGCTAAAGAACCTTTTTCTCCTGCTTCGACTTTTAAAATTTTTAATGCTTTAATTGCGCTTGATAATGGTGTAGTTAAAGATACAAAGGAAATTTTTTATCATTATAAGGGTGAAAAAGTATTTTTGCCCTCTTGGAAACAAGATGCTGGTTTAAGCTCAGCCATAAAACGCTCTCAAGTGCCTGCTTTTAAAGAATTGGCAAGAAAAATAGGACTTAAAACCATGCAAGAAAGCTTAAATAAACTTTCCTATGGAAATACAAAAATTTCAAAAATCGATACCTTTTGGTTGGATAATTCTTTACAAATTTCTGCAAAAAATCAAGCTGATTTGCTTTTTAAACTTTCACAAAATTCTTTACCTTTTTCCAAGAAAAGTCAAGAAGAAGTTAAAAAAATTATTCTTTTTAAAGAAGATAAAATCCAAAAAATTTATGCTAAAACAGGTTTTAATGATGGTATAAATTTGGCTTGGATTGTTGGATTTATAGAGAGTAAAAACAAAATTTTATCTTTTGCCTTAAATGTTGATATAAAGAACATTAAAAATCTTAAAATAAGAGAAGAATTGCTAGAAAAATATATTTATTCTTTAAACTAA", "partial": "0", "query_start": 49306, "query_end": 49353, "hit_start": 147, "hit_end": 195, "orf_dna_sequence": "ATGAACCAAGAAGCCGTCTTTCAACTGCTCGTCTCCCACGCGCGCGAGGTCGTGCCGCATCTCGCGCAGCATCCGTTCCAGCCTTCCGAGAGCTTCAAGACGCTCGGCGCGAATTCGATGGACCGCGCGGACATCCTGATGATGACGATGGAGGCGCTGTCGATCCGCTGCTCGCTCACCGAGCTCGCCGGGCCGGCCAACATCGGCGAGCTCGCCGCGCTGCTCGCGCAAAAGGCGCGCCATGGCTAG", "orf_prot_sequence": "MNQEAVFQLLVSHAREVVPHLAQHPFQPSESFKTLGANSMDRADILMMTMEALSIRCSLTELAGPANIGELAALLAQKARHG", "perc_identity": 43.75}, "gnl|BL_ORD_ID|3890|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 49243, "orf_end": 49491, "orf_from": "BGC0000186.1|Thailandamide_10 ", "model_name": "OXA-634", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "500", "model_id": "4960", "ARO_accession": "3005855", "ARO_name": "OXA-634", "ARO_category": {"36026": {"category_aro_accession": "3000017", "category_aro_cvterm_id": "36026", "category_aro_name": "OXA beta-lactamase", "category_aro_description": "OXA beta-lactamases were long recognized as a less common but also plasmid-mediated beta-lactamase variety that could hydrolyze oxacillin and related anti-staphylococcal penicillins. These beta-lactamases differ from the TEM and SHV enzymes in that they belong to molecular class D and functional group 2d. The OXA-type beta-lactamases confer resistance to ampicillin and cephalothin and are characterized by their high hydrolytic activity against oxacillin and cloxacillin and the fact that they are poorly inhibited by clavulanic acid. Amino acid substitutions in OXA enzymes can also give the ESBL phenotype. The OXA beta-lactamase family was originally created as a phenotypic rather than a genotypic group for a few beta-lactamases that had a specific hydrolysis profile. Therefore, there is as little as 20% sequence homology among some of the members of this family. However, recent additions to this family show some degree of homology to one or more of the existing members of the OXA beta-lactamase family. Some confer resistance predominantly to ceftazidime, but OXA-17 confers greater resistance to cefotaxime and cefepime than it does resistance to ceftazidime.", "category_aro_class_name": "AMR Gene Family"}, "35930": {"category_aro_accession": "0000011", "category_aro_cvterm_id": "35930", "category_aro_name": "cloxacillin", "category_aro_description": "Cloxacillin is a semisynthetic, isoxazolyl penicillin derivative in the beta-lactam class of antibiotics. It interferes with peptidogylcan synthesis and is commonly used for treating penicillin-resistant Staphylococcus aureus infections.", "category_aro_class_name": "Antibiotic"}, "35973": {"category_aro_accession": "0000056", "category_aro_cvterm_id": "35973", "category_aro_name": "oxacillin", "category_aro_description": "Oxacillin is a penicillinase-resistant beta-lactam. It is similar to methicillin, and has replaced methicillin in clinical use. Oxacillin, especially in combination with other antibiotics, is effective against many penicillinase-producing strains of Staphylococcus aureus and Staphylococcus epidermidis.", "category_aro_class_name": "Antibiotic"}, "37084": {"category_aro_accession": "3000704", "category_aro_cvterm_id": "37084", "category_aro_name": "cefalotin", "category_aro_description": "Cefalotin is a semisynthetic cephalosporin antibiotic activate against staphylococci. It is resistant to staphylococci beta-lactamases but hydrolyzed by enterobacterial beta-lactamases.", "category_aro_class_name": "Antibiotic"}, "35939": {"category_aro_accession": "0000020", "category_aro_cvterm_id": "35939", "category_aro_name": "carbapenem", "category_aro_description": "Carbapenems are a class of beta-lactam antibiotics with a broad spectrum of antibacterial activity, and have a structure which renders them highly resistant to beta-lactamases. Carbapenem antibiotics are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "35951": {"category_aro_accession": "0000032", "category_aro_cvterm_id": "35951", "category_aro_name": "cephalosporin", "category_aro_description": "Cephalosporins are a class of beta-lactam antibiotics, containing the beta-lactam ring fused with a dihydrothiazolidine ring. Together with cephamycins they belong to a sub-group called cephems. Cephalosporin are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "36017": {"category_aro_accession": "3000008", "category_aro_cvterm_id": "36017", "category_aro_name": "penam", "category_aro_description": "Penams are a group of antibiotics derived from Penicillium fungi that share a skeleton beta-lactam moiety fused with a thiazolidine ring. This is the most defining feature of penicillins. Penicillin antibiotics are historically significant because they are the first drugs that were effective against many previously serious diseases such as syphilis and Staphylococcus infections. Penicillins are still widely used today, though many types of bacteria are now resistant. All penicillins are beta-lactam antibiotics in the penam sub-group, and are used in the treatment of bacterial infections caused by susceptible, usually Gram-positive, organisms.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 9.97314, "max_identities": 7, "bit_score": 21.9422, "cvterm_id": "36772", "query": "AQHPFQPSESFKTLGA", "match": "A+ PF P+ +FK   A", "sequence_from_db": "AKEPFSPASTFKIFNA", "sequence_from_broadstreet": "MKKYFYFLVFFYSFALANDKLKDFFKDYNTSGVFITFDGKHYASNNFKRAKEPFSPASTFKIFNALIALDNGVVKDTKEIFYHYKGEKVFLPSWKQDASLSSAIKRSQVPAFKELARKIGLKTMQESLNKLSYGNTKISKIDTFWLDNSLQISAKNQADLLFKLSQNSLPFSKKSQEEVKKIILFKEDKIQKIYAKTGFNDGINLAWIVGFIESKNKILSFALNVDIKNIKNLKIREELLEKYIYSLN", "dna_sequence_from_broadstreet": "TTGAAAAAATACTTTTACTTTTTAGTCTTTTTTTACTCTTTTGCTTTGGCAAATGATAAATTAAAAGATTTTTTTAAAGACTACAATACAAGCGGAGTTTTTATAACTTTTGATGGAAAACATTATGCAAGTAATAATTTTAAAAGAGCTAAAGAACCTTTTTCTCCTGCTTCGACTTTTAAAATTTTTAATGCTTTAATTGCGCTTGATAATGGTGTAGTTAAAGATACAAAGGAAATTTTTTATCATTATAAGGGTGAAAAAGTATTTTTGCCCTCTTGGAAACAAGATGCTAGTTTAAGCTCAGCCATAAAACGCTCTCAAGTGCCTGCTTTTAAAGAATTGGCAAGAAAAATAGGACTTAAAACCATGCAAGAAAGCTTAAATAAACTTTCCTATGGAAATACAAAAATTTCAAAAATCGATACCTTTTGGCTGGATAATTCTTTACAAATTTCTGCAAAAAATCAAGCTGATTTGCTTTTTAAACTTTCACAAAATTCTTTACCTTTTTCCAAGAAAAGTCAAGAAGAAGTTAAAAAAATTATTCTTTTTAAAGAAGATAAAATCCAAAAAATTTATGCTAAAACAGGTTTTAATGATGGTATAAATTTGGCTTGGATTGTTGGATTTATAGAGAGTAAAAACAAAATTTTATCTTTTGCCTTAAATGTTGATATAAAGAACATTAAAAATCTTAAAATAAGAGAAGAATTGCTAGAAAAATATATTTATTCTTTAAATTAA", "partial": "0", "query_start": 49306, "query_end": 49353, "hit_start": 147, "hit_end": 195, "orf_dna_sequence": "ATGAACCAAGAAGCCGTCTTTCAACTGCTCGTCTCCCACGCGCGCGAGGTCGTGCCGCATCTCGCGCAGCATCCGTTCCAGCCTTCCGAGAGCTTCAAGACGCTCGGCGCGAATTCGATGGACCGCGCGGACATCCTGATGATGACGATGGAGGCGCTGTCGATCCGCTGCTCGCTCACCGAGCTCGCCGGGCCGGCCAACATCGGCGAGCTCGCCGCGCTGCTCGCGCAAAAGGCGCGCCATGGCTAG", "orf_prot_sequence": "MNQEAVFQLLVSHAREVVPHLAQHPFQPSESFKTLGANSMDRADILMMTMEALSIRCSLTELAGPANIGELAALLAQKARHG", "perc_identity": 43.75}}, "BGC0000186.1|Thailandamide_11 # 49526 # 61084 # -1 # ID=1_11;partial=00;start_type=GTG;rbs_motif=GGAG;rbs_spacer=5bp;gc_cont=0.751": {"gnl|BL_ORD_ID|4935|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 49526, "orf_end": 61084, "orf_from": "BGC0000186.1|Thailandamide_11 ", "model_name": "almE", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "1000", "model_id": "5928", "ARO_accession": "3007433", "ARO_name": "almE", "ARO_category": {"46184": {"category_aro_accession": "3007428", "category_aro_cvterm_id": "46184", "category_aro_name": "polymyxin resistance operon", "category_aro_description": "Operon or gene clusters confering resistance to polymyxin antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "46188": {"category_aro_accession": "3007432", "category_aro_cvterm_id": "46188", "category_aro_name": "alm glycyltransferase", "category_aro_description": "Glycyl transferase associated with polymyxin resistance operons not interacting with lipid A.", "category_aro_class_name": "AMR Gene Family"}, "36966": {"category_aro_accession": "3000622", "category_aro_cvterm_id": "36966", "category_aro_name": "colistin A", "category_aro_description": "Colistin A, or polymyxin E1, has a 6-octanoic acid lipid tail. Polymyxins disrupt the cell membrane of Gram-negative bacteria.", "category_aro_class_name": "Antibiotic"}, "36968": {"category_aro_accession": "3000624", "category_aro_cvterm_id": "36968", "category_aro_name": "colistin B", "category_aro_description": "Colistin B, or polymyxin E2, has a 6-heptanoic acid lipid tail. Polymyxins disrupt the cell membrane of Gram-negative bacteria.", "category_aro_class_name": "Antibiotic"}, "36192": {"category_aro_accession": "3000053", "category_aro_cvterm_id": "36192", "category_aro_name": "peptide antibiotic", "category_aro_description": "Peptide antibiotics have a wide range of antibacterial mechanisms, depending on the amino acids that make up the antibiotic, although most act to disrupt the cell membrane in some manner. Subclasses of peptide antibiotics can include additional sidechains of other types, such as lipids in the case of the lipopeptide antibiotics.", "category_aro_class_name": "Drug Class"}, "35997": {"category_aro_accession": "0001001", "category_aro_cvterm_id": "35997", "category_aro_name": "antibiotic target alteration", "category_aro_description": "Mutational alteration or enzymatic modification of antibiotic target which results in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 1.00567e-21, "max_identities": 115, "bit_score": 99.7525, "cvterm_id": "36789", "query": "VGVCMTRSVDLLAALIGVMKAGAAYVPLDPRYPDARLRAIVDDAQLEHVLTDAESAPVAAPL---CADGARVM------LDAARCAAGGSRAPLPRATPDDL---------------AYVIYTSGSTGKPKGVMVPHRAVVNLLCSMARAPGMAAGERMLALATYAFDMSVPELFLPLAVGGECMLAQADAAR-DPRVLMEAIAERRPTIMQITPTACAMLFEAGWRNAE-----RVALLCGAEPLTETVRRRLAETGTRAWNMYGPTETTVWSTMAPIAADR---PITLGAPLANTRVYIVDGQDRLL-----PPGLYGEMVIAGDGVARGYLGRPELSAERFVRDPFVNAGRGANAYRTGDIARWRDDGSLEFAGRSDAQVKLRGFRIELGDIEAHLKRHPAIEDAVAVVNEAHGLKRLVGYVVVRGGAAAPSWSALRS--------WLLAA---LPAHMVPACYEALPAVPLTPNGKIDRRGL", "match": "V +   R +   +A+      G  Y+PL+ R    +++  +   Q + ++ DA+     + L   C D   +       ++  R           + T  D+               AY++ TSGSTGKPK + V +  +   +  + +   + A +R+   +   FD+SV ++F  L + G C+    + A+  P    E I   + T+    PT   +  +            R++  CG   L +   +    T     N+YGPTE T+  T     A      + +G       + I++ Q  L+     P G  GE++++G  +  GYL  P  +   F    F + GR    YR+GDI   + +G L   GR D QVK+ G R+EL +IE  ++R          V +AH +  +V + +   G A+ + + + +        WL      L    VP  + A+  +P   NGK D + L", "sequence_from_db": "VAILSVRDLAAYSAIWASYLGGMTYIPLNARATTEQIQETLIATQCDSIMVDAQQLSRLSSLLDTCIDRLHIYALPDVDMEPLRQQYPQHTFHTVQITEQDVELLVAKYHLDNEHEYAYIMQTSGSTGKPKRIAVSYSNLHCYISQIDKLFPLNAQDRVGQYSDLTFDLSVHDIFYSL-ISGACLYVVPELAKLSP---AEFIRHHQLTVWLSVPTVIELALQRQTLTPHSLPSLRLSFFCGQALLHDLAEQWQQATQQPVINLYGPTECTIAITYHRFVAHSGMASVPIGRAFEEECLAIINEQGELMRFESAPEGYRGELLLSGKQLVNGYLNDPLNTQSAF----FQHEGR--IWYRSGDIVT-KSNGVLIHLGRRDHQVKIAGQRVELEEIETVVRR----------VTQAHSVA-IVPWPLSESGYASGTVAFVDTHTQWQPDLWLSQCKQQLNPTFVPKRWYAIEQLPRNANGKTDIKAL", "sequence_from_broadstreet": "MPYNSATDLLQREGYGVVHNQFINKMAMCCETRHSILAAIQANRHAPALWVKQKTYTYQEMTDMALSLSDYWHLQGVQRVAILSVRDLAAYSAIWASYLGGMTYIPLNARATTEQIQETLIATQCDSIMVDAQQLSRLSSLLDTCIDRLHIYALPDVDMEPLRQQYPQHTFHTVQITEQDVELLVAKYHLDNEHEYAYIMQTSGSTGKPKRIAVSYSNLHCYISQIDKLFPLNAQDRVGQYSDLTFDLSVHDIFYSLISGACLYVVPELAKLSPAEFIRHHQLTVWLSVPTVIELALQRQTLTPHSLPSLRLSFFCGQALLHDLAEQWQQATQQPVINLYGPTECTIAITYHRFVAHSGMASVPIGRAFEEECLAIINEQGELMRFESAPEGYRGELLLSGKQLVNGYLNDPLNTQSAFFQHEGRIWYRSGDIVTKSNGVLIHLGRRDHQVKIAGQRVELEEIETVVRRVTQAHSVAIVPWPLSESGYASGTVAFVDTHTQWQPDLWLSQCKQQLNPTFVPKRWYAIEQLPRNANGKTDIKALQQQLASQTYETSH", "dna_sequence_from_broadstreet": "ATGCCATACAATTCTGCGACAGATTTGTTACAGAGAGAGGGTTATGGTGTCGTGCATAACCAATTTATCAATAAAATGGCGATGTGCTGCGAGACAAGACACTCTATTTTGGCGGCCATTCAGGCTAACCGACATGCCCCTGCATTATGGGTTAAACAGAAAACCTACACCTATCAAGAGATGACCGATATGGCACTCTCATTGAGTGACTATTGGCATTTACAGGGCGTGCAGCGAGTTGCGATCCTTTCGGTACGCGATCTCGCGGCTTATTCTGCGATTTGGGCGAGCTATTTGGGCGGTATGACTTATATTCCGCTCAATGCGCGAGCAACAACAGAACAGATCCAAGAGACGCTGATCGCGACACAATGTGATTCCATCATGGTAGACGCGCAGCAATTGAGTCGTTTGTCCTCCTTACTAGATACTTGCATTGACCGATTACACATTTATGCGCTGCCTGATGTGGATATGGAACCGTTACGTCAGCAATATCCTCAGCACACTTTTCACACAGTGCAAATAACCGAACAAGATGTGGAATTACTGGTAGCGAAATACCATTTAGACAATGAACATGAGTACGCTTATATCATGCAAACCTCAGGTTCGACTGGTAAACCCAAACGTATTGCGGTCAGCTACAGTAATTTGCATTGCTATATCAGTCAAATTGACAAACTATTTCCACTCAATGCGCAAGATCGAGTGGGGCAATATTCTGATTTGACTTTTGATCTTTCGGTACATGATATTTTTTACAGTTTGATCTCTGGTGCTTGTTTATATGTTGTGCCTGAATTAGCGAAATTAAGTCCAGCGGAATTTATTCGTCACCATCAATTAACGGTATGGCTTTCTGTGCCTACTGTTATTGAGTTGGCCCTACAAAGACAAACCTTAACCCCACACAGTTTACCTTCTCTGCGACTGAGTTTTTTCTGCGGACAAGCCTTGCTGCATGATTTAGCCGAACAATGGCAACAGGCCACCCAGCAGCCGGTGATCAATCTGTATGGTCCAACAGAGTGCACGATTGCTATTACCTATCATCGATTTGTCGCCCATTCAGGTATGGCATCGGTGCCGATTGGCCGTGCTTTTGAAGAGGAGTGTTTAGCCATCATCAACGAACAAGGTGAATTGATGCGCTTTGAATCTGCACCCGAGGGGTATCGCGGAGAATTACTTCTGTCGGGCAAACAATTAGTCAATGGTTATCTGAATGATCCGCTGAATACGCAAAGTGCCTTTTTCCAGCACGAAGGGCGTATTTGGTATCGTTCAGGTGACATTGTCACTAAATCAAATGGCGTGCTGATTCATCTTGGGCGTCGCGATCACCAAGTGAAAATTGCCGGACAACGGGTGGAATTAGAAGAGATTGAAACCGTTGTTCGCCGCGTGACTCAAGCGCACAGCGTGGCGATAGTGCCTTGGCCTTTAAGTGAGTCGGGCTATGCCAGCGGCACGGTGGCGTTTGTGGATACCCATACCCAATGGCAACCAGATCTGTGGTTGAGCCAATGCAAACAACAATTAAATCCAACTTTTGTGCCTAAGCGTTGGTATGCCATTGAACAATTACCAAGAAATGCCAATGGCAAAACCGATATTAAAGCTTTACAACAACAATTAGCGAGTCAGACATATGAAACAAGCCATTGA", "partial": "0", "query_start": 51152, "query_end": 52462, "hit_start": 237, "hit_end": 1629, "orf_dna_sequence": "GTGAACAAGAAAGACATACTGCTCGCCTATCGCGAGGGCCTGCTCGACACCGGCTCGGCGCAGCGCGTGCTCGACGCGCTGCGCGAGCGCTCGGCGAGCGCGCCGCTTTCGTCGGTCGAGCAGGGCATCTGGGCGACGCAGCGCGCGGCGCCCGGCAGCACCGCGTATCACGTGCCCGTCGTGCTGCACGTCGCGCGGGCGCTTGACATCGATGCGCTGCGCCGCGCGTGTCTCGATCTCGCGCTCGCGTTTCCGATCCTCACGTCGACGATCGTCGAGCGCGACGGCGAGCCGCGGCGCGCGGCGTTTTCGTCGGCGCCCGCGCAGTTGCGCCACGAGCGCGTCGGCGCGTTGTCCGACGATGCGCTCGCCGCGCGTCTCGCCGACGCGAAGCGCGAGCCGTTCGATCTGCGCGCGGGGCCGCTGTGGCGGCTCTTCGCGTTCGAGCGGGGCCGCGCCGATTTCGTGCTGATGCTCGTCGTCCATCATCTGTCGTACGACGGCGCGTCGACGCTGCCGCTCGTCGACACGCTGCTCGCGATGCACGACGCGCGCGCGGCGGGCGCGACGCCCGCCATCGAGCCGTTCGCGCCGGCACACGACGCGTACGTCGCCGACGAGGCGCGCTGGCTCGCGAGCGCGGACGCCGCCGCGACGCTCGACTACTGGCGGCGCGCGCTCGACGGCGCGCCGCCCGCGCTCGAGCTGCCGCTCGACCGCCCGCGCCCCGCGCAGCAGACGTTCAACGGCAAGGTCGTGCAGCGCGCGCTGCCCGAGGTGCTCGGCGAGCGCGCCGCCGCGTTCGCCGCGCAAGGCGGGCTCACGCGCGCGGCGCTGTTTCTCGCCGTGTTCAAGCTGCTGCTGTCGCGCTACGCCGCGCAGGACGACATCGTCGTCGGCGTGCCGGTGTCGCGCCGGCCGCTCGCCGCGCGCGGCGCGGTCGGCAACTTCGTCAATCTGCTGCCGCTGCGCAGCCGCGTCGACGCACGGCTGACGTTCGCCGCGTTCGCCGCGCAGGTGCAGGGCACGCTCAACGCCGGCCGCGATCACGCCGCGTATCCGTTCCCGGAGCTCGTCAAGCGGCTCAACGTGCCGCGCGACGCGGCGCTCGCGCCCGTGTTCCAGGCGCTCTTCGCGTATCAGAACTTCGCGGGCGCCGACGCCGAGGCCGCGTTCTGCGCGCGGCACCGCGCGCGCTTCCTGCAGATCGAGCATCAGGCGGGCGAGAGCGAGATCGGCGTCGAGGTGTTCGAGCGCGCGTCCGCGAGCGTCGTGCACCTGAAATTCAATCCCGATCTGTTCGACGACGCGAGCGCCGCGCGCATGCTCGATCACTTCGTCCACCTGCTCGACGCGACGCTTGCCGATCCGCGGCGCCCGCTGGCGGATTACCCGCTCGTCACGCCGGCCGAGCGCGAGCGGATCGTATCGCGATGGAACGCGACGGCGGCACCGTATCCGGACGATCGTTGCCTGCACGAGCTGGTCGACGAGCACGCGCGCACGCGCGCCGACGCGCGCGCGGTGTCCGATGCGCGCGACGCGCTCGGCTTCGGCGAGCTGAAGCGCCGCAGCGACGCGATCGCGGCGGCGCTCGTCGATGCGGGCGCCGCGCCGCGCGCGCTCGTCGGCGTGTGCATGACGCGCTCGGTCGATCTGCTCGCCGCGCTCATCGGCGTCATGAAGGCGGGCGCCGCATACGTGCCGCTCGATCCGCGCTATCCCGACGCGCGCCTGCGGGCGATCGTCGACGATGCGCAGCTCGAGCACGTGCTCACCGACGCCGAATCCGCGCCCGTCGCGGCGCCGCTCTGCGCCGACGGCGCGCGCGTGATGCTCGACGCGGCGCGCTGCGCGGCGGGCGGCTCGCGCGCGCCGCTGCCGCGCGCGACGCCCGACGATCTCGCGTACGTGATCTACACGTCGGGCAGCACGGGCAAGCCCAAGGGCGTGATGGTGCCGCACCGCGCGGTCGTGAACCTGCTGTGCTCGATGGCGCGCGCGCCGGGCATGGCGGCCGGCGAGCGGATGCTCGCGCTCGCGACGTACGCGTTCGACATGTCGGTGCCCGAGCTCTTTCTGCCGCTCGCCGTCGGCGGTGAGTGCATGCTCGCGCAAGCGGACGCCGCGCGCGATCCGCGCGTGCTGATGGAGGCGATCGCCGAGCGTCGTCCGACGATCATGCAAATCACGCCGACCGCGTGCGCGATGCTGTTCGAAGCGGGCTGGCGCAACGCCGAGCGCGTCGCGCTCCTCTGCGGCGCCGAGCCGCTCACCGAGACGGTGCGGCGGCGCCTCGCCGAAACCGGCACGCGCGCGTGGAACATGTACGGGCCGACCGAGACGACGGTCTGGTCGACGATGGCGCCGATTGCGGCGGACCGCCCGATCACGCTCGGCGCGCCGCTGGCGAACACGCGCGTGTACATCGTCGACGGGCAGGACCGGCTGCTGCCGCCCGGCCTCTACGGCGAGATGGTGATCGCGGGCGACGGCGTCGCGCGCGGCTATCTGGGCCGGCCCGAGTTGAGCGCCGAGCGCTTCGTTCGCGATCCGTTCGTCAATGCCGGGCGCGGCGCGAACGCGTACCGCACGGGCGACATCGCGCGCTGGCGCGACGACGGCTCGCTCGAGTTCGCCGGACGCTCGGACGCGCAGGTGAAGCTGCGCGGCTTTCGCATCGAGCTCGGCGACATCGAGGCGCACCTGAAGCGCCATCCGGCGATCGAGGACGCGGTCGCCGTCGTCAACGAGGCGCATGGGCTCAAGCGGCTCGTCGGCTACGTGGTCGTGCGCGGCGGCGCGGCCGCGCCGTCGTGGTCCGCGCTGCGCTCATGGCTGCTCGCGGCGCTGCCGGCGCACATGGTGCCGGCATGCTACGAGGCGCTGCCCGCCGTGCCGCTCACGCCGAACGGCAAGATCGACCGCCGCGGGCTTGCCGCGCGGCCGCTCGCCGCGGCGGCCGGCGCGCAGGCGGCGGATGGGCTGGAGGCAGGCGGGCTGGTGGGGGGCCTGGAGGGCGAGGTGCTCGCGCTGTGGCGCGAGACGCTGAAGGTCGGCGACATCGGCCCGACCGACGGCTTCTTCGACGCGGGCGGCGACTCGATTCTCGCGGTCGCGCTCGCCGCGCGCATCGAGCAGCGGTTCGGCGTGACGTTCTCCGCGACGACGCTGTTCAAGTACGCGTGCGTGCGGGACATCGCCGGCTACATCGCGTCGGCCGAGGCGCGCCCGCGCGCCGGCGGCGCGAACGCGCGCGCGGGCGTCGAAGCCGGCGCGGCGGTGGCGACGCCGCCGGGCCGGCCGGCAGGCGAGGCGGCGGGCGCGCAGCGCGACCGAGCGCCCCGGGCGGCGGACGAGCGGGCAGACGCGCCGCCGGCCGCGCCGTCCGATGCGCATGCATCGAAGGCCGCCGCAATCGATTCGCGCGGCGGCGCGGCCGGCGGCGACGGCGAGCCCGCGCGAGCCGCCTCGCACGGCGACGCGCCGGCCGACGGCCTCGCGATCATCGGCATCGCGCTGCGCGTGCCGGGCGCCGCAGACGCGCGCGCGTTCTGGCGCAATCTGCGCGAAGGCCGCTCGGCGCTCGAGCGGCTCGACGCGCGGCGGCTGATGGCGCACGGCGTCGCGTCGGCGCTCGCGGGCGCGCGGCAGACGGTCGGCGTGCGCGCGACGATCGCCGACAAGCACCGCTTCGACGCGGAGTTCTTCGGCGTCTCGATGCGCGACGCCGCGCTGATGGACCCGCAGGCGCGGCAGTTGCTGCAGCACGCGTGGCTTGCGTTCGAGGACGCGGGCTACGTGCCCGCCGACGCGCCCGACACGGCGGTGTTCGTATCGGCGAGCCACAGCCGGTACGCGGCGAAGCAGGCCGACGGCGCGCGCGCGGCGGCCGAGGCGGTGCTCGACGATCCGGCCGACTACGTCGGATGGATACTCGAGCAGGGCGGCACGATTCCGGCGCTCATCTCGTACAAGCTCGGGCTGACCGGGCCGAGCCTGTACGTCCACACGAACTGCTCGTCGTCGCTCGCCGCGCTGTACGCGGCGTGGCAGACGATCCGCGCGGGCGACGCGAAGCAGGCGCTCGTCGCGGCCGCGACGCTCTTCGCCGATGAGCGGCTCGGCTACGTCCACCAGCCGGGGCTGAATTTCTCGAGCGACGGCCGCATCAAGACGTTCGACCGGAACGCGGACGGCATGGTGCCGGGCGAGGGCGTCGTCGCGGTGCTCGTCAAGCGCGTCGCGGAAGCGCTCGCCGACGGCGACCGAATCTACGCGATCGTGCGCGACGTCGCGCTCAACAACGACGGCGCGGCGAAGGCCGGCTTCTACGCGCCGAGCGTGCGCGGCCAGGCGCAGGTGATCGACGCGTTGCTGCGCAGGACGGGCGTGCGCGCGGCCGACATCGTCTACGTGGAGGCGCACGGCACGGGCACGCAGATCGGCGATCCGATCGAAGTGGCCGCGCTGACCGACGCGTATCGCGCGCACGGCGCGGGCACGGGCCATTGCGGGCTCGGCTCGGTCAAGACCAACGTCGGGCACCTGGACACGGCGGCCGGGCTCGTCGGCCTCGTCAAGGTCGCGCTGAGTCTCGAGCAGCGCATGCTGCCGCCCAGCCTGAACTTCGATGCGCCGAATCCGGCGCTCGATCTCGCGTCGTCGCCGTTCTACGTGGTCGAGCGCGCGACGCCGATCGCGCCGCGCGCCGGCCGCACGTTCGCCGCGGTGAGCGCGTTCGGCGTCGGCGGCACGAACGCGCACGCGCTCGTCGAAGCGCATCGCGACGCGCGCGACGCCGCGATTGCGACCGGCGCGACCGGAGCGCCCGATGTGCCCGATGCGCCCGATGCGCCCGATGCGCCCGACGCGCAGACGGTCGTGCCGCTGTCGGCGAAGACGCCTGCGCAACTGACGCAGCGCGCCGCGCAACTGCTCGACGCGCTGCGCGGCGACGACGCGCGGCGGCCGGCGCTCGCCGACGTCGCGTTCACGCTGCAGCGCGGGCGGCAGCCGATGGGCTCGCGCGCCGCGTTCGTCGTGGACTCGATCGACATGCTGTGCGAGCAGCTCGCCGCCTACGTCGCGGCGGGCGGCGCGCATGCGCCGCGCGGCGCCGCGCGCGCGGACGCGACGCATGCGCACGCGGGCGACGCGCACCGGCTCGCCGAGCGGTGGGTCGCGGGCGACGACGTCGACTGGCGCGCGCTCTCGCGCGGCGGCCGGCGAATCGGGCTGCCGGGCTATCCGTTCGGCGGCGACGTGTACGGCGGCGCGCGGGACGCGCACGATCCGTCGCGCCGGCTTCATCCGCTGCTGCACCGGAATGTGTCGACGCTGTCGCAGGTCGCGTTCACGTCGACGTTCGACGGCGGCGAGCCGTTCCTGCGCGATCACCTGCTGCACGGCCGCCGCGTGCTGCCGGGCGCCGCGTACCTGGAGATGATCCACGCGGCGGCCGAGCGCGCGCTCGCGCCCGCGGCGGGCGCCGGCGCGGGGGTCGCGCTGGCGAACGTCGTGTGGGTCCGGCCCGTCGAGGTCGTCGACGCGAGCGTCACCGTGCGGCTCGCGTTCGCGCCGGCGGACGACGACGGCCTCGTCGCGTTCGAGATCCGCAGCGAGACCGCCGGCGGCGGCGGCGCGCTGCACTGCCGGGGGCACGTGCAGCGGATCGCCGAGCCGGCGCCCGGGCAGATCGATCTGCATGCGCTGCGCGAGCGGTGCGCGGCGCCGCGGCTGAGCGCGGCGCGCTGCTACGAAACCTATGCGCGGCTCGGGCTCGACTACGGGCCGTCGCATCGCGGCGTCGTCGACGTGCGCGGCGAGCGCGAGCACCTGCTCGCGCGCATCGTGCTGGCCGGCCTGCCCGACGCCGACGCGCGCCCGATGCATGCGGGCCTCGTCGATTCGGCGTTCCAGGCGACGCTCGCCGCGGTCGCCGAGACGCCCGACGAGCTCGAACGGCTCGACGCCGCGCCCGTGCCGTTCGCGCTCGGCCGCCTCGACGTGCTCGCGCCGTGCGCGCCGCAGATGTGGGCGTCGATTCGCGTGCGGCGCATCGGCGGCGCTCACGCGGACGGCGGCCGCACCGCGTCGGACGACGCGCTGCTCGCGAAAATCGACATCGATCTGGTCGACGACGCGGGCAACGTCTGCGTGCGCGTGCGGGATCTGGCCGCGCGCCGCTTCGTGCGGGAGCCGGCGCGCGCGCCGTCGCGCACGCTCGCCGTGCGCGCGCGATGGCGTGGCGCGCGGGCCTCGGGCGTGCCGGGCGCGTCGGGCGGCGTGCCGCGCGAGGTCGTGCTCGTCGGCGTCGACGCGCGTGCGGCCGAGCCGATCCGGGCGGCGCTCGGCGCGAGCGGCGTCGCATGCGAAGTCTGGCCGATTCCCGCCGATGCCGACCCGGCCGGACAGTTCGCCGCGCTTGCGGCGCGCGTGCTCGAACGGCTGCAGGCGGCGGTGCGGGCGCGGCCGACGTCGCCGCGGCTGCTGCAGCTCGTGTCGCTCGACGACGCGCCGTGGTTCGCCGCCGCGCTCGCGGCGATGCTGAAGACGGCCGCGCTGGAGCAGCCGTGCGTTCTCGGGCAGCAGATCGCGCTGCCGTCGCGTCTTTCGCCCGCGCGCATCGCGGCGGCGCTCGCCGACTGCGCGGCGATGCCCGACGCGCGCCGGCTGCGATTCGGCGCGAACGACGCCGACGCCGACGCCGACGGCGCGCTCGAGGTCGAGACGTTCGCCGAGCTCGACGCGTGGCCCGAGCAGGCCGCGCCGCCGTGGAAGGCGGGCGGCGTCTATCTCGTGACGGGCGGCGGCGGGCGCATCGCGCGCCGGTTGATCGACGCGATCGCCGCGCACGCGGCGAATGCGACCGTCGTCGTCGCGAGCCGCACGCAGCCAGGCGCGGCGCGCGCCGATGCGCGGCACGCAACGGACGCCTCCGACACGCCGCACGCCCCGGGCGTCACCGTCGATCGCATCGCGCTGGACGTGACGGACGGCGCGCGCGTGCGCGACGCCGTGCGAAGCATCGTGAGCCGGCACGGCCGGCTCGACGGCGTGCTGCATGGCGCGGGCGTGCTCGACGACGACTTCATCCTGAACAAGGACGCCCGTGCGCTGCATGCGGTCATCGCGCCGAAGGCGCAGGGCGCGTGGCATCTCGATGCCGCCACCGCGTCGCTCGATCTCGATTGCTTCGTGCTGTTCTCGTCGGTGGCGGGCGCGCTCGGCAATGCCGGGCAGGTCGACTACAGCGGCGCGAACGCGTTCATGGATGCGTTCGCGCACTGGCGCCGCGCGCGCGTTGCGGCCGGCGAGCGGCGCGGGCGCACGGTGTCGATCGGCTGGCCGCTCTGGGCGGAAGGCGGCATGCGGATCGACGATGCTTCGCTCGCCGCGCTCGAGCGCAGCCTCGGGATGCGGCCGATGCCGACGCCCGCGGCGATCGGCGCGCTCTACGCGGCGCTCGCGTGCGGCGAGAGCCACGTCGTGCTGTTTCACGGCGATCCGGCGCCGCTGCGCCGCGCCGCATGGCTCGCCGCGAGCGCGCCGACGCAAGACGACCCCGCCGCCGCCTCGATCGAGCCGGCGGCTTCCTCCACGGAGCTTCCCGAGATGAACGTCCAAGCGACCGCGCCGGCCGACGCCGGCGCCCGCCCGCGCGACGACGCGCCCGCCGCCGCAGTCGCACATGCCGCGCCCGATGCGTCCGATGCGCCCGATGCGCGCCCGGCCGATGCCGCGCCGGCCGACGACGCGCGGCTGACCGAGCACGCGCTCGCGCTCCTGAAGCGGCTGCTGTCGACGGCGCTGCACACGCCCGCGTCGCGGCTCGACGCGCACGCGCCGCTCGAGCGCTACGGGATCGATTCGATCGTCGTCGTCAGCATGAACGGCGAGCTCGAGAAGGCGTTCGGCTCGCTGTCGAAGACGCTGTTCTTCGAATACCGGACGCTGCACGAGCTCGCCTGCTATTTCGTCGCGCATCATCGCGAGCGGCTTGCGCGGCTGCTGCCCGCCGGGCACGGCGCGCGCCTCGCGCCAGCGCCGGCGCAGCCGCTTGCGCCGCGCGCGCCGTCCGCCGAGCCGGCGCGCGACGCCGCGCGTTCGCTGGAGCCGGAGCAGGGGCAGGGGCAGGGGCAGGGGCAGGAGCCGGAGCCAGCATCCCAAACCGCAGCCGCATCGGAATCCGCGCGCGCGCCGGCGCAAGCGAGCGCGCATGCGCGGCGCGAGCGCGCGGCACCGGAAACGCGAACGCAGGCACCGGCACAGGCGCACGCGCCGGCGCAAGCGAGCGCGCCCGACGCCGCCCGCGACGCGTTCGACATCGCGATCGTCGGCCTGGCCGGACGCTATCCGGGCGCGGATTCGGTCGACGCGTTCTGGGCGAACCTGCGCGACGGCCGCGACTGCGTGACGGAGGTGCCCGCCGAGCGCTGGGATCACGCGCGCTACTTCCATCCGGACAAGGCGCACCCGGGCACGACCTACGCGAAGTGGGGCGGCTTCGTCGACGGCGTCGACCGCTTCGACGCGGCCTTCTTCAACATGTCGCCGCGCGAGGCGGCGATCGTCGATCCGCAGGAGCGGCTGTTCCTCGAAACGGTCTACGAGGCGATCGAGGACGCCGGCTACACGCCCCGCACGCTCGCGGGCGGCGCGGGCCGTGACGCGGCGGTCGGCGTGTACGTCGGCGTGATGTATCAGGAGTATCAGCTCTACGGCGCGCAGGCGAGCGCGCTCGGCGAGCCGTGCGCGCTGCCGAGCAGCCCGTCGTCGATCGCGAACCGCGTGTCGTTCTTCTGCGATTTCGACGGGCCGAGCATCGCCGTCGACACGATGTGCTCGTCGTCGCTGACGGCGATCCATCTCGCGTGCCAGAGCCTGCGCTCCGGCGAATGCGCGGCGGCCGTCGCGGGCGGCGTGAACCTCACGCTGCATCCGAACAAGTATCTGCTGCTGTCGTTCGGGCGCTTCGCGTCGAGCAAGGGGCGCTGCGAGAGCTTCGGCGCGGGCGGCGACGGCTACGTGCCCGCCGAGGGCGTCGGCGCGGTCGTCCTCAAGCCGCTCGCGCGAGCGCGCGCGGACGGCGATCACGTCTACGGCGTCATCAAGGGTTCCGCGCTCAATCACGGCGGGCGCACCAACGGCTTCACGGTGCCGAATCCGGCGTCGCAGCGGCGCGTGATCCTGCGCGCGCTGCGCGAGGCGGGCGTCGATCCGCGGCGGCTCGGCTACGTCGAGGCGCACGGCACCGGCACGTCGCTCGGAGACCCGATCGAGATCGACGCGCTCAGCCGCGCGTTCGCCGAGTTCACGCAGGACAAGCAGTTCTGCCCGATCGGCTCGGTCAAGTCGAACATCGGGCACGCGGAAAGCGCGGCCGGCGTCGCCGCGCTCACGAAGGTGCTGATGCAGCTCAAGCACGACACGCTCGCGCCGTCGCTGCACGCGGACGTGCTCAACCCGAACATCGATTTCGCGGCGACGCCGTTCTACGTGCAGCGCGAGCGCGCCGACTGGCCGCCCGCCGTCGACGCGGGCGAAGCCGGCGGCGTCGCGCGCCGCCGGCCGCGCGTGTGCGCCGTTTCGTCGTTCGGCGCGGGCGGCTCGAACGCGCACCTGATCGTCGAGGAATACGTCGCGAGCGACGGCGAGCGGGCCGTGCGCTCCGCGTCCGACCAGCTCGTCGTGCTGTCCGCGCGCTCGCCCGAGCAGCTTCGGGAACGGGCGCGCCGGTTGCGCGCGCGGCTGCTCGCCGACGCGGGCGGCACGCCGCTCGATGCGCTCGCCTACACGCTGCAGGTTGGGCGCGAGGCGATGGCCTATCGTTTCGCGACGATCGTCGCGACGCGCGATGCGCTCGCCGCGCGGCTCGATGCGCTCGCGAACGACGCGCTGTTCGACGGACAGGCGCTGCCGGGCGATGCCGACGGCTTCGCCCGGCGGGCGGAGCGCGACGAAACGCTCGTGTCGCTCGCGCGCGACGACGCGTTTCGCGACGCGGTCGGCCGATGGGTTGCCGAAGGTCAGCTCGCGCGGCTCGCGCAACTGTGGGTGCGCGGCGTGGATCTCGACTGGACGCTGCTGCATCGCAGCCCGCCCGCGCGGATCAGCCTGCCGACCTATCCGTTCAAGCGCGACCGGCATTGGGGCGTGCCGAACCTGGCGGGGCTGCCGGGCGCGGCGGGCGTCGCGAACGTCGCGGGCGTCGCCGGGGCGGCGGGTCCGGCGGGCGTCGAGCATGCCGCGAGCGGCGCGGGCGCGGCGAGTGTCGCCAGTGCGGCGGGCGCTGCAAGTGCCGCGAGCACGGCGAGCACGGCGAGTAGGGCCGGCACGCCGAGCCCTGCCGTCGCGGCCTCGACGGGTGAGACTGTCGCCGCGCCGGCCAGTCATGACGCGTTCGCGACAGCCGGCGCGAAGCCGGGAGTCGTGCTCGCGCCGGCGACGGCGGCCGGCTACGTCGCGACGCCGCGACCGAAGCCGACCGTCATGCTCGACACCGACGCCGCCGCGGCGGCGCGCGCGCGGCCTGGGGCCGCGTCGTCACCGTCACCGTCGTCGCCGTCTCCATTGCCTTCGTCGCCGCCGCGGATGTCGTCGCGGCAGCACGCGTCGCCGGCCGCCGCGCCGGACCCGCGCGCGGCGCTGCTCGACATTGAGGCGTTCCTGGCCGGCTCGCTCGCCGCCGCGCTGATGGCGACGACGGACGAGATCGACCGGGAGCAGACGTTCAACGCGCTCGGCGTCGATTCGATCGTCGGCGTCGAGTGGGTCCGCGCGATCAACGATCGCTACGGCACCGCGCTGCCCGCCACCGTCATCTACGACCATCCGAGCGTGCGCGCGATGGCGCGCCACGTGTCGTCGAACGCGACGCCCGGTGTGGCCGGCGTCGCGCGCGGCGACGCATCCGCGCCGCAGGCTGCGCCGTCGGCGTTCGCAGCGGCGGCTTCGTCTGCGTCGGGGGCGGTTTCGCCGGCGCCCTTCGCGTCCGCCGCGCCGCCTGAGCCGCCTGCGTCGCCCGCGCGCGCGGACGGCGCGCTTGACGCAGCCGGCGCGACGAGCCTCGACGCGATCCGCGCGCATCTCGTCGACAGCCTCGCGCAGGCCCTTTACGTCGAGCCCGCCGAGATCGGCGTCGACCAGCCGTTCGCCGAGCTCGGGCTCGATTCGATCGTGGGCGTCGAGTGGATCACCGCGGTGAACCGGCGTTTCGGCACCGCGCTGCCGGCCGTCGCGATCTATGACCACCCGAGCGTCGTGGCGCTCGCGCGATTCGTCGGCACGCAGCTCGGCGCGCGCCTGCCGGCCGCGCAGGCGGCGCGCGCGGGCGCGTTCGCCGGCGTCGAGCCCGGCGAGCCCGACGCGCGCGCGCTGCCCGCTGCCGCCCGCGCCGCCGCGCCGCCCGCGCACACCGACGCCGCTGCCCACACCGATACCGACGCATTGCTGCGCGCGATCGAGCGCGGCGAGCTCGACGCCGGCGACGCCGACGCGATCTGGCGGCGCATGCAGTCGCGCGCGGCGCGGCCCGAGCCGCTCGCGCAGCCGTGA", "orf_prot_sequence": "MNKKDILLAYREGLLDTGSAQRVLDALRERSASAPLSSVEQGIWATQRAAPGSTAYHVPVVLHVARALDIDALRRACLDLALAFPILTSTIVERDGEPRRAAFSSAPAQLRHERVGALSDDALAARLADAKREPFDLRAGPLWRLFAFERGRADFVLMLVVHHLSYDGASTLPLVDTLLAMHDARAAGATPAIEPFAPAHDAYVADEARWLASADAAATLDYWRRALDGAPPALELPLDRPRPAQQTFNGKVVQRALPEVLGERAAAFAAQGGLTRAALFLAVFKLLLSRYAAQDDIVVGVPVSRRPLAARGAVGNFVNLLPLRSRVDARLTFAAFAAQVQGTLNAGRDHAAYPFPELVKRLNVPRDAALAPVFQALFAYQNFAGADAEAAFCARHRARFLQIEHQAGESEIGVEVFERASASVVHLKFNPDLFDDASAARMLDHFVHLLDATLADPRRPLADYPLVTPAERERIVSRWNATAAPYPDDRCLHELVDEHARTRADARAVSDARDALGFGELKRRSDAIAAALVDAGAAPRALVGVCMTRSVDLLAALIGVMKAGAAYVPLDPRYPDARLRAIVDDAQLEHVLTDAESAPVAAPLCADGARVMLDAARCAAGGSRAPLPRATPDDLAYVIYTSGSTGKPKGVMVPHRAVVNLLCSMARAPGMAAGERMLALATYAFDMSVPELFLPLAVGGECMLAQADAARDPRVLMEAIAERRPTIMQITPTACAMLFEAGWRNAERVALLCGAEPLTETVRRRLAETGTRAWNMYGPTETTVWSTMAPIAADRPITLGAPLANTRVYIVDGQDRLLPPGLYGEMVIAGDGVARGYLGRPELSAERFVRDPFVNAGRGANAYRTGDIARWRDDGSLEFAGRSDAQVKLRGFRIELGDIEAHLKRHPAIEDAVAVVNEAHGLKRLVGYVVVRGGAAAPSWSALRSWLLAALPAHMVPACYEALPAVPLTPNGKIDRRGLAARPLAAAAGAQAADGLEAGGLVGGLEGEVLALWRETLKVGDIGPTDGFFDAGGDSILAVALAARIEQRFGVTFSATTLFKYACVRDIAGYIASAEARPRAGGANARAGVEAGAAVATPPGRPAGEAAGAQRDRAPRAADERADAPPAAPSDAHASKAAAIDSRGGAAGGDGEPARAASHGDAPADGLAIIGIALRVPGAADARAFWRNLREGRSALERLDARRLMAHGVASALAGARQTVGVRATIADKHRFDAEFFGVSMRDAALMDPQARQLLQHAWLAFEDAGYVPADAPDTAVFVSASHSRYAAKQADGARAAAEAVLDDPADYVGWILEQGGTIPALISYKLGLTGPSLYVHTNCSSSLAALYAAWQTIRAGDAKQALVAAATLFADERLGYVHQPGLNFSSDGRIKTFDRNADGMVPGEGVVAVLVKRVAEALADGDRIYAIVRDVALNNDGAAKAGFYAPSVRGQAQVIDALLRRTGVRAADIVYVEAHGTGTQIGDPIEVAALTDAYRAHGAGTGHCGLGSVKTNVGHLDTAAGLVGLVKVALSLEQRMLPPSLNFDAPNPALDLASSPFYVVERATPIAPRAGRTFAAVSAFGVGGTNAHALVEAHRDARDAAIATGATGAPDVPDAPDAPDAPDAQTVVPLSAKTPAQLTQRAAQLLDALRGDDARRPALADVAFTLQRGRQPMGSRAAFVVDSIDMLCEQLAAYVAAGGAHAPRGAARADATHAHAGDAHRLAERWVAGDDVDWRALSRGGRRIGLPGYPFGGDVYGGARDAHDPSRRLHPLLHRNVSTLSQVAFTSTFDGGEPFLRDHLLHGRRVLPGAAYLEMIHAAAERALAPAAGAGAGVALANVVWVRPVEVVDASVTVRLAFAPADDDGLVAFEIRSETAGGGGALHCRGHVQRIAEPAPGQIDLHALRERCAAPRLSAARCYETYARLGLDYGPSHRGVVDVRGEREHLLARIVLAGLPDADARPMHAGLVDSAFQATLAAVAETPDELERLDAAPVPFALGRLDVLAPCAPQMWASIRVRRIGGAHADGGRTASDDALLAKIDIDLVDDAGNVCVRVRDLAARRFVREPARAPSRTLAVRARWRGARASGVPGASGGVPREVVLVGVDARAAEPIRAALGASGVACEVWPIPADADPAGQFAALAARVLERLQAAVRARPTSPRLLQLVSLDDAPWFAAALAAMLKTAALEQPCVLGQQIALPSRLSPARIAAALADCAAMPDARRLRFGANDADADADGALEVETFAELDAWPEQAAPPWKAGGVYLVTGGGGRIARRLIDAIAAHAANATVVVASRTQPGAARADARHATDASDTPHAPGVTVDRIALDVTDGARVRDAVRSIVSRHGRLDGVLHGAGVLDDDFILNKDARALHAVIAPKAQGAWHLDAATASLDLDCFVLFSSVAGALGNAGQVDYSGANAFMDAFAHWRRARVAAGERRGRTVSIGWPLWAEGGMRIDDASLAALERSLGMRPMPTPAAIGALYAALACGESHVVLFHGDPAPLRRAAWLAASAPTQDDPAAASIEPAASSTELPEMNVQATAPADAGARPRDDAPAAAVAHAAPDASDAPDARPADAAPADDARLTEHALALLKRLLSTALHTPASRLDAHAPLERYGIDSIVVVSMNGELEKAFGSLSKTLFFEYRTLHELACYFVAHHRERLARLLPAGHGARLAPAPAQPLAPRAPSAEPARDAARSLEPEQGQGQGQGQEPEPASQTAAASESARAPAQASAHARRERAAPETRTQAPAQAHAPAQASAPDAARDAFDIAIVGLAGRYPGADSVDAFWANLRDGRDCVTEVPAERWDHARYFHPDKAHPGTTYAKWGGFVDGVDRFDAAFFNMSPREAAIVDPQERLFLETVYEAIEDAGYTPRTLAGGAGRDAAVGVYVGVMYQEYQLYGAQASALGEPCALPSSPSSIANRVSFFCDFDGPSIAVDTMCSSSLTAIHLACQSLRSGECAAAVAGGVNLTLHPNKYLLLSFGRFASSKGRCESFGAGGDGYVPAEGVGAVVLKPLARARADGDHVYGVIKGSALNHGGRTNGFTVPNPASQRRVILRALREAGVDPRRLGYVEAHGTGTSLGDPIEIDALSRAFAEFTQDKQFCPIGSVKSNIGHAESAAGVAALTKVLMQLKHDTLAPSLHADVLNPNIDFAATPFYVQRERADWPPAVDAGEAGGVARRRPRVCAVSSFGAGGSNAHLIVEEYVASDGERAVRSASDQLVVLSARSPEQLRERARRLRARLLADAGGTPLDALAYTLQVGREAMAYRFATIVATRDALAARLDALANDALFDGQALPGDADGFARRAERDETLVSLARDDAFRDAVGRWVAEGQLARLAQLWVRGVDLDWTLLHRSPPARISLPTYPFKRDRHWGVPNLAGLPGAAGVANVAGVAGAAGPAGVEHAASGAGAASVASAAGAASAASTASTASRAGTPSPAVAASTGETVAAPASHDAFATAGAKPGVVLAPATAAGYVATPRPKPTVMLDTDAAAAARARPGAASSPSPSSPSPLPSSPPRMSSRQHASPAAAPDPRAALLDIEAFLAGSLAAALMATTDEIDREQTFNALGVDSIVGVEWVRAINDRYGTALPATVIYDHPSVRAMARHVSSNATPGVAGVARGDASAPQAAPSAFAAAASSASGAVSPAPFASAAPPEPPASPARADGALDAAGATSLDAIRAHLVDSLAQALYVEPAEIGVDQPFAELGLDSIVGVEWITAVNRRFGTALPAVAIYDHPSVVALARFVGTQLGARLPAAQAARAGAFAGVEPGEPDARALPAAARAAAPPAHTDAAAHTDTDALLRAIERGELDAGDADAIWRRMQSRAARPEPLAQP", "perc_identity": 23.66}}, "BGC0000186.1|Thailandamide_12 # 61095 # 77981 # -1 # ID=1_12;partial=00;start_type=ATG;rbs_motif=GAG;rbs_spacer=11bp;gc_cont=0.748": {"gnl|BL_ORD_ID|2714|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 61095, "orf_end": 77981, "orf_from": "BGC0000186.1|Thailandamide_12 ", "model_name": "ICR-Mo", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "600", "model_id": "3271", "ARO_accession": "3004569", "ARO_name": "ICR-Mo", "ARO_category": {"41681": {"category_aro_accession": "3004465", "category_aro_cvterm_id": "41681", "category_aro_name": "intrinsic colistin resistant phosphoethanolamine transferase", "category_aro_description": "Chromosomally-encoded phosphoethanolamine (PEtN) transferases shown to confer resistance to polymyxin antibiotics, including colistin.", "category_aro_class_name": "AMR Gene Family"}, "36966": {"category_aro_accession": "3000622", "category_aro_cvterm_id": "36966", "category_aro_name": "colistin A", "category_aro_description": "Colistin A, or polymyxin E1, has a 6-octanoic acid lipid tail. Polymyxins disrupt the cell membrane of Gram-negative bacteria.", "category_aro_class_name": "Antibiotic"}, "36968": {"category_aro_accession": "3000624", "category_aro_cvterm_id": "36968", "category_aro_name": "colistin B", "category_aro_description": "Colistin B, or polymyxin E2, has a 6-heptanoic acid lipid tail. Polymyxins disrupt the cell membrane of Gram-negative bacteria.", "category_aro_class_name": "Antibiotic"}, "36192": {"category_aro_accession": "3000053", "category_aro_cvterm_id": "36192", "category_aro_name": "peptide antibiotic", "category_aro_description": "Peptide antibiotics have a wide range of antibacterial mechanisms, depending on the amino acids that make up the antibiotic, although most act to disrupt the cell membrane in some manner. Subclasses of peptide antibiotics can include additional sidechains of other types, such as lipids in the case of the lipopeptide antibiotics.", "category_aro_class_name": "Drug Class"}, "35997": {"category_aro_accession": "0001001", "category_aro_cvterm_id": "35997", "category_aro_name": "antibiotic target alteration", "category_aro_description": "Mutational alteration or enzymatic modification of antibiotic target which results in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 5.69224, "max_identities": 23, "bit_score": 30.4166, "cvterm_id": "42478", "query": "DTSVRLAEAFADEPLDFMLFFSSFAAFSFPQGQANYAAGCAFQ---DAFAQHLAARAPFAVKTVNW", "match": "DT + L +     P  F  +   F  F+ P  Q+N  A C  Q   +AF   L A   F  KTVNW", "sequence_from_db": "DTLIVLHQMGNHGPAYFKRYDKQFEKFT-PVCQSNELAKCDPQSVINAFDNALLATDDFLAKTVNW", "sequence_from_broadstreet": "MVHLDKVSNRMSVNNSRWLAWRQQGINAYVMMGIVALFLTLTANITFFDKATEVYPFAQHIGFIGSLPLVLFGVMLLVIVLLSYRYTLKAVLIFLLLTAAVTAYFTDTYGTVYDVNMLQNALQTDKAESADLFNVNFILRILLLGVLPSVWVAWQKVTFPPIKRSILQRGLTYLVSLGLVVLPILAMSKNYASFFREHKQLRSYTNPATPVYALGKLASIQLKQAQAPKTQIMHATDAVQVSNPTTRKPKLVVFVVGETARGDHVQLNGYNRTTFPQMAATAGVTNFNQVIACGTSTAYSVPCMFSYVGMKDYDVDTANYQENVLDTLHRLKVNILWRDNNSSSKGVTNRLPAADFVDYKTARNNTMCNTNPYGECRDVGMLVGLDDYVKQQANQNTLNQDTLIVLHQMGNHGPAYFKRYDKQFEKFTPVCQSNELAKCDPQSVINAFDNALLATDDFLAKTVNWLDKYDSTHQVAMLYVSDHGESLGENGIYLHGMPYKIAPKAQKHVASMFWAGKHSGIQAVPSNTELTHDAITPTLLKLFDVRAQTVQGKPLFIK", "dna_sequence_from_broadstreet": "TTGGTGCATTTAGATAAGGTGAGTAATCGTATGTCAGTGAATAACTCTCGATGGTTAGCATGGCGTCAGCAAGGTATTAATGCTTATGTGATGATGGGTATTGTCGCGCTATTTTTGACCCTAACCGCCAATATTACTTTCTTTGATAAAGCCACGGAAGTCTATCCGTTTGCCCAGCATATTGGGTTTATAGGCTCATTGCCGTTGGTGCTATTCGGTGTCATGCTACTGGTTATTGTGCTGCTCAGCTATCGTTACACCCTTAAAGCGGTATTGATTTTTTTGCTATTGACCGCGGCAGTCACGGCGTATTTTACTGATACTTATGGCACTGTCTATGATGTCAATATGCTACAAAACGCGCTACAAACCGATAAAGCAGAAAGCGCCGATTTGTTTAACGTCAATTTTATCTTACGCATTTTATTGCTTGGGGTATTGCCTAGTGTGTGGGTGGCGTGGCAAAAGGTCACATTTCCCCCCATCAAGCGCAGCATATTGCAGCGCGGCTTGACGTATTTGGTCAGCCTCGGTTTGGTAGTGTTACCGATTTTGGCAATGAGTAAAAATTACGCCAGTTTTTTCCGTGAACATAAACAGCTTCGTAGCTATACCAATCCTGCAACCCCTGTATATGCACTGGGTAAACTTGCCAGTATACAGCTCAAACAAGCACAAGCTCCCAAAACCCAAATCATGCATGCCACCGATGCGGTGCAGGTGAGTAATCCTACCACCCGTAAGCCAAAACTGGTGGTATTTGTAGTTGGAGAAACCGCGCGCGGCGACCATGTGCAGCTAAATGGGTATAACCGAACTACCTTCCCGCAGATGGCAGCGACGGCTGGGGTAACTAATTTTAACCAAGTCATCGCCTGCGGTACCTCAACCGCTTATTCGGTGCCTTGTATGTTTAGTTATGTCGGCATGAAAGACTACGATGTGGATACCGCCAACTACCAAGAAAACGTACTTGATACCTTACATCGCCTAAAGGTTAATATCTTGTGGCGTGATAACAACTCAAGCTCAAAAGGCGTCACTAATCGTTTGCCCGCGGCGGATTTTGTCGATTATAAAACTGCGCGCAACAATACGATGTGTAATACCAACCCCTATGGCGAGTGCCGCGATGTGGGTATGCTAGTAGGCTTAGATGACTACGTCAAACAACAAGCTAACCAAAATACGCTTAACCAGGATACCCTAATTGTGCTGCACCAAATGGGTAATCACGGACCTGCGTATTTTAAACGATATGATAAGCAATTTGAAAAATTCACCCCAGTCTGCCAAAGCAATGAACTTGCCAAATGCGACCCACAAAGCGTGATTAATGCCTTTGACAATGCGCTACTTGCCACCGATGACTTTTTGGCAAAAACGGTGAACTGGTTAGACAAATATGACAGCACCCACCAAGTAGCGATGCTGTATGTCAGTGACCACGGTGAAAGTCTGGGCGAAAACGGCATCTATTTACATGGTATGCCTTATAAAATCGCGCCTAAAGCGCAAAAACACGTCGCATCGATGTTTTGGGCAGGTAAACACTCAGGCATTCAAGCAGTGCCATCTAATACTGAGCTCACCCATGATGCCATTACCCCAACCTTGTTAAAACTGTTTGATGTGCGTGCGCAAACCGTACAAGGCAAACCTTTATTTATCAAGTAA", "partial": "0", "query_start": 73932, "query_end": 74120, "hit_start": 1200, "hit_end": 1395, "orf_dna_sequence": "ATGGGGATCGAGCAATTGAACACCACGCGTGCGCAGCATGACGACATCGCCGTGATCGGCATCGCGTGCCGGTTTCCCGGCGCGTCGGACTATCGGCAATTCTGGGACAACCTGTGCGAGCGGCGCGTGAGCATCGGCGAGATTCCCGGCGAGCGCTGGGACTGGCGCGCGTACTGGGGCGATCCGCAGCAGGACGCGAACGCGTGCAACAGCCGCTGGGGCGGCTTCGTCGACGAGGTCGGCGCGTTCGATCTCGGGTTCTTCGGGATGTCCGCGCGCGAGGTCGACAAGATGGACCCGCAGCAGCGGCTCGCGCTCGAGCTCGCGTGGCACTGCTTCGAGGATGCGGGGCTGCGTCCGTCGGCGGTCGCGAAGCGCGATGTCGGGGTGTTCGTCGGGATCGCGAATCTCGACTACAAGGAAATCGTCGAGGCGCACGCGAGCGAGATCGATGCGTATTACGCGTCGGGCGTCGCGGCGTCGGTCGCGTCGAACCGTCTGTCGTACTGGTTCGATCTGCGCGGGCCGAGCGTGACGGTCGACACCGCGTGCTCCGGCTCGCTTTACGCGCTGCATCTCGCGCGCGAGGCGCTGCGGCGGGGCGAATGCGAAATGGCGCTCGCGGGCGGCGTGAGCCTGCTGCTGACGCCCCGGCGCTACCTGGGATTCGCGCGCGCGCGGATGCTGTCGCCGACGGGCGCGATCCGCGCGTTCGACGACGCGGCCGACGGCATGGTGCGCGGCGAGGGCGGCGGGCTCGTGCTCCTCAAGCCGCTGTCGCGCGCGCTCGACGACGGCGACCGGATCTTCGGCGTGCTCGCGGGCAGCGCCGTCAATCACAGCGGCCGGACGTACTCGCTCACGTATCCCGACGCCGACGCGCAGGCGCGCGTGATCCGCGCCGCGTTCGACGCGGCCGGCGTGTCGCCCGCGCAGGTGTCGTACGTCGAGGCGCACGGCACCGGCACGCCGAAGGGCGATCCGATCGAGCTGGAAGGGCTGTTGCGCGTGTTCGGCGCGCAGCCGCGCGATGCGCTCGCGCCGCGCTGCGCGATCGGCAGCGTCAAGGCGAACATCGGGCATCTCGAATCGGCCGCGGGCATCGCGGGCGTCATCAAGACGCTGCTCGCGCTGCATCACGGGATGCTGCCGCCGATGCCGCATTTCGCTGCGCTCAATCACCGCGTCGACGCGGCACGCTTCGCGGCCGCGGGCCTCGCGGTCGCCGACGCGCTTGCGCCATGGGAGGCCGGCGCTTCGGCCGACGGCGCGAGCGCGGCGCGAATCGCGGGCGTGAGCGCGTTCGGCTTCGCCGGCACCAACGCGCACGTCGTGCTGCGCGAAGCGCCGGCCGCCGCGCGCGCCGCCGTCGCCGCCGGGCGGGCGGACGGCGCGGGCGTGCTGTGCCTGTCGGCGAAGACCGATGCCGCGCTCGAGCGCGTGCGCGCGGGCTTCGTCGAATGGCTCGCGCGAGACGGCGCGCGCCATGCGTTCGCCGACATCTGCGCGGCGCTCGTGAGCCGAAGGGAGCATTTCGCGTCGCGCATCGCGGTGGCCGCATGCGACGTCGACGGCGCGCTCGCGGCGCTGCGCGCGCGGGCCGACACGGCGTCGTCGGTTTATCGTGCGGGGCGGGTCGCGCTCGACGACGACGGCAATCTCGTCGACGCGTCCGGGCCGCACGACGAGCAGGCCGATCACGATGGCAGTGGCGAACACGGCGAACACGGCGAACGCGCGCGCGCGGGCGCGGACGATCTGAGCCGCGCGCGCCGCCGTGCATCGCGGTACGTCCGCGGCGCATCGCCCGACGCTTGGGGCCCCTCCGACGGCCCGACGCCGCACGTCCCGTTGCCAGACTATCCGTTCGAGCGCACCGTGTGCTGGACCGGTCCCCGCCCGTCGCGCGCGGTCGCCGGGCCGGCGCGCGGGCCGGCTGTCGATGAAGCGGTCGATGAGGCCGTCGATGAAGCCGGAGCGGCGGACGGCGACGTGTTCGTCCTCGAGCCCCGATGGCACCTTGCGCCGGCGGCGGACGCGCGGCCTGCGCCGGCGCGGCCGGAGGATGCCGCCGTCGTCGTCTGCGTCGTTGCGGACGCCGCGCAACGCGCGGCAGTCGAGCGCGCGCTTGCGCGGATCGCGACGGCGCCCGCCTGCATGTTCGTCGAGCCGGATGCGACGATGGGCGAGCCGGCGCGCGCGGTCGACGCGCTTGTGCGCACGCTCGACGGCATCGCGGATCGGGCCCGCGCGGATGTGTCGGGCGTGGATACTTCCGGCGCGGCCGCGCCCATCTCGGTCTGGTATTGCGCGGATCTCGCGCGCGATGCGCGCGCGCCGATCGACGTTCGCGCTTACGACCGCCTGCTGACGCTGCTCCAGGCGCTTGCGAAGACGCGCGCCCCGCTGCGGCGCGTGCTTCTGGCGGGCGTGTCGGAAAGCCTTGCCGCCGACGCATGGCCGGCGCTCGTCACCGTGCTCGCGCCGCGGCGCCCGGCGCTCGCGGTGACGCCGGTACTGTTCGATCACGGCACGCCCGAGGCGCTCTGGGTGAGCGCGCTCCTGCAGGAAGCGCGCGCGGCGGGCGGCGCGGCCGTGCGCTACGCGGCGGGCGAACGCAGCGTGGCGGTGCTCGCGCGGGCCGCGAACGCGGCGTCGGAGAACGCGGCGCGCTTGGCCGGCGGCGCGCCGCTGCGCACGGGCGGCTGCTATCTGCTGACGGGCGGCCTGGGCGGCCTCGGCCGGTTGTTCGCCGTCCGCCTGATGCGCCGGTACGGCGCGCGGGTCGTCGCGCTCGGGCGATCGGCGCACGATGCGGGCGTGCAGGCGAGCGTCGCGGCGCTGTGCGCGGAGGCCGGCGCGGGCACGCTGCGCTATCTGCAAGCCGACGTCTGCGACGCGGCGGCGATGGCCGCGGTGCTCGACGATATCGGCCGTCACGAAGGGCGGCTGAACGGCGTGATCCATGCGGCCGGTTGCGAGGATCGCGCGAGCCTCGCCGACAAATCGCTCGACGACGTGCACGCGGTGCTCGCGCCGAAGCTCGCGGCCGCGACGGTGCTCGACCGCCTGACGGCCGGGCTGCCGCTCGATTTCGTTTGCCTGTTCTCGTCGCTGGCCGGCATCGTCGGCGATTTCGGCTGCGGCGCGTACGCGCTCGGCAACCGGCTGCTGATGTCCTACGCGCAGCGCGCCGACGGCCGCGTGGACGCGCACGGACGCCGCCGCCGGGTCGTCGCGATCGCGTGGCCGCTGTGGCGCGACGGCGCGATGGGATTCGACGATCCGGTCAAGCGCGACCGCTATCTCGCGGCGAGCGGCCAGCGGATGCTGGATGCGGACGAAGGCTTCGCGTGGTTCGAGCGCCTGCTCGCGAGCCCGAGCGCCGCGCCCGTCGTGCTCGCGGGCGAGCGGGCGCGCATCGTGTCGTGGCTCGGCTCGATCGACGGCGCGCCGGTGGCCGACGCATCGCCGGGCGCGGCATCGAGCGGGGCGGCTGCACCGAATGCGGCGAGCGACGCGAGCCGGGATACCGAACGGGCGGAGGCAACCGACGCGGCCGCGCCGATCGTGGCGGCCGGCGCGCCGGCGCATGCGCATGCGAGCGCGCCGCGCGAGCGCGACGCGCACGGATCGGCGCGACTGCCCGCGTTGCGCGGGATCGCCGCGCGCGTGCTCGGCGCCGACGCGGCTTTGCTCGACGAGCAGGCGAGCTTCGCCGATCTCGGTTTCGACTCGATCGGGTTGATGGATTTCGCGCGCGCCGTCGGCGAAGCGTTCGGCATCGACATGTCGCCCGCGATGCTGTTCAGCCATGTGACGCTCAAGCGGCTTGCCGGCCACCTCGCGACGCGTCTGGACGATGCGCCGCGGGCCGTCGCGGGCGCGCGCTCCGGCGCGGCGCACGCGAGCGCCGGCCGCGCATGCGCGGCGGCCGGCCGCGCCGACGGCGCGCGCGCGAGCCGGATCGACGTGCGGCCGCCCGAGGCGGGCGCGGGCGAGCGCGCAGCCGACGCGCGCCCGCCGCTCACGGCGCCCGAAATCGCGCCCGAAATCGCGCCGGAGTCCGCGTCCGGGTTCGCATCCGCGCCGCACCCGGCGCCGATTCCCCCCGCCTACGAACCGATCGCGATCGTCGGCATGAGCGGCCGCTTTCCCGACGCGCGCGATATCGACGCGTTCTGGTCGCTGCTGATGAGCGGGCGCGGCGCCGCGCGGCGCGTCGATCCGCACGACCGCTTCGCCGCGCCGCGCGACGAAGCGGCGGCGTGGCTCGCGCCGGTGCCCGGCATCGACGAATTCGATCCGCTCTTTTTCGACATCGCGCCCGCCGAAGCGCAGCGGATGGACCCGCGCGAGCGCCTGCTGCTGCAGCACGCGTGGCTTGCGCTCGAGGACGCGGGCATCGGCGCGCGCGCGCTCGCCGACCATGCGCTCGGCATGTTCGTCGGCGCGGAAGCGGGCGAATACGGCGGGCTGTCGCGAGAGCCGCGCAGCATCGTGAGCGACCACAACGGCGTGCTCGCCGCGCGGCTGTCGTATTTTCTCGATCTCACGGGCCCGAACCTCTCGGTGAACACCGCGTGCTCGTCGGGCCTCGTCGCGCTGCATCTCGCGATCCGCAGCCTGCACGCGCGCGAATGCGGGATCGCGCTCGCCGCGGGCGTCAACCTGATGCTGTCGGCCGAACTGCACGACAAGATGGCGCGCGCCGGCATGCTGTCGCAACACGGCGTGTGCCGCGCGCTCGATCGCGACGCCGACGGCTTCGTGCCCGGCGAGGCCGTCGTCGTCGTCGCGCTCAAGCGCCTCGCCGACGCGCTCGCCGACGGCGACGCGATTCACGGCGTCATTCGCGCGAGCGGCGTCAACTACGACGGCCGCACGAACGGCATGACCGCGCCGAGCGGCCTCGCGCAGGCCCGGCTGCTGACGGACGCGTGGCGCACCGCGGGCATCGACCCGGCCGAACTGGGCTATGTGGTCGCGCACGGCACCGGCACGCGCCTCGGCGATCCGGTCGAGCTCAATGCGCTCGGCGACGCGCTGCGCGCGTCCACCGGCCGCCGGCATTTCTGCGCGGTCACGTCGAACAAGCCGAACGTCGGTCACACGCTTGCCGCATCGGGGCTCGTGAGCCTCGTCAATCTCGTCGAGGCGCTGCGCCGCGCGGTGATTCCGCCGAGCGCGCACTGGCGCGAGGGCAACGAATTCGTCGCGTGGGGCGACAGCCCGCTGCGCGTGAACACAGTCGCGAGCGCGTGGCCGGACGGCGCGCGGCGGCTCGGCGGGGCCAGCGCGTTCGGGATGAGCGGCACGAACGCGCACGTCATCGTGGAGGCGGCCGAGCCGGCGCGCGCGCGGGCGCCGCACGCGCCGCGCGGCGGCGTGCTCTTCGTCGTATCGGCGAAGACGGGCGACGCGCTCGCGCAGCGTCTTCGCGACCTGGCCGATTGCCTCGCGTCCGACGCATGGTCGGACGGCGATCTGGCCGACGTCGCGCATACGTTGCTGCACGGCCGCCAGCATTTCGAGCATCGCAGCGCCGTGTTCGCGCGCGGCAAGGCCGACGCGATCGACGCGCTGCGCGCGGCGGCCGACGCGGTGCGCAACGCGCCCGCGCGGCGCACGGGCGCGTTGCGCCTGCTCGACGATTACGCGGCGCACCTGAGCGCGCGCTATGCCGCATGGCGTGACGCGCCCGCGCGCGACGTCGACGAAGCGCGGCGTCTGCTCGAGGCGATCGGCGACGCGTACCGCGAAGGCGCGACGCCGTCGGCGCTCGTCGTCGCACCCGCGCCGGGGCGCACCGTGCGGCTGCCGGGCTATCCGTTCGCGTGCGAACGCCACTGGCATCCGGCGCCGGCGCGCGCGGGCGGCGCATCGGCCGGGGCGAACGCGCGCGAGCCGGGCGCGCGCGAGCGCGCGGAGGCGGCGGCCGCGCCGCACGTCGTCGTGTTGACGCTCACGGGCAGCGAGCCGTATCTGCGCGATCATCTGATCGATGGGCAGCGCGTGCTGCCCGGCGCCGCGCATCTCGACATGGCGCGGGCGGCGTTCGAGCGCGTGCGGGCGGCGGGCGGGCGCGCGGCGCGCTTCGTCGCGTTGCGCGACGTCGTCTGGCGCGCGCCGCTCGTCGCGGGCGACGCGGGCGCCGAGGTGCACGTCGAGCTGACGCCGTCGGGGACGGCGTTCGCGTATCGCATCTTGAGCCGGCCGGCCGATCGGGCGGCGGCGGTCGGCGCGGCGTTGACGCTGCACAGCGAGGGCGTCGTCGACGAACTGAACGAGCCGGCCCCCGAGCCGCTCGACCTCGACGGATGGCGTGCGGCCTGCGCGGGCGAGCGCGTCGACGGGGCGGCGCTCCACGCGCGCTTCGCCTCGCTCGGCATCGGCTACGGGCCGTCCCATCGCGGCGTCGCGCACGTGCGGCTCGGCGAGCATGCGGCGCTCGCGCGCCTCGATCTCGGCGCGCTCGCCGATGCCGATTTCGACGGCTTCGGCCTGCACCCGGGCATCGTCGATTCGGCGTTCCAGGCGTCGGCGGCGCTGAGCGCGCCGCGCGAGGACGCGGCGGTGCCGTTCATGCTGCGCGCGCTGCACGTGTACTCGCGCGCCGCGCGGACGATGTGGGCGGCGATACGCGTCGCGGCGCCCGCGGGCGGCGGCGCGGGCGGCGTCGATACGCGCCCGATCGACATCGATCTCGTGCACGACGACGGCGCGATCTGCGCGAGCCTGCGCGGCTGGGTTTCCGCGCGTTGGCGCAAGTTGGCGGGGGCGCCGCCCGCCGCGCGCGCGACGGCCGCGCTGCGCGGGTGGCGCTGGCGCGCGGCCGAGCCCGATCCGCGCGCGGCCGAAGCCGCGACGCGGGTCGTGCTGCTCGCGCCGGACTTCGGCGCGCTGGCGGCCGAGCTGGCCGCGCATGACGCCGTGCGCTGCGAAATGCTGGACGACGTGTCGTCGCACGCGCTGCCCGATGCGTTCGCCGCGCGCGCGACGCAGGCGTTCGCCGCCGTTCGCCGCGAGCTGGCCGCGAAGCCGGGCCGGCCCGTGCTGTTTCAGGCCGTCTGCCGCGAAGCGGATTCGGCGACGGCCTGGGGCCTTGCAGGCTTGTTCAAGACGGCGGCCGACGAGAATCCGCTCGCGAGCGGGCACGTGGTGCTCGTGTCGGAGTCGTTCGACCGCGCGCGGCTCGCCGCGGCGCTGCTCGCCGAGCGCGCGTGGACGGGGCATCTGCGCTACGGCGGCGCGGGCCGCGAAGCGTTCGCGATCGATGCCGACGAAGACGATCGCGACGGCCGCGAGCCCGCAGGCGGCCCGCCGCTGCGCGACGACGGCGTCTATGCGATCTCCGGCGGCGCGGGCGGCATCGGCCGCGCGATCGCGCGCGACATCGTTGCCCGCACGCGCGCGGCGCGCGTGTATCTGCTCGGGCGCTCGGCGCATGCGCCGTCCGATCTGTTCGCGACGGCGGACGAGCGCGCGCGGATTCGCTACTGCCGCGTCGACGTCGCCGATCGCGAGCAGGTGCACGCATGGATCGCCGGCCTGAAGCGGGACGGCGAAGCGTTGCGCGGCGTCGTGCACGCGGCGGGCGTCGTCGACGACGCATTCGTCGTCGCGAAGGAGCCGTCGCGCGTGCATGCGGTGCTGCGCCCGAAAGTGGCGGGCGCCGTGTGGCTCGACGAAGCGACGCGCGACGCGCCGCTCGATTTCTTCGTCGCGTTCTCGTCGCTCGCGAGCGCGTTCGGCAACGCCGGGCAGGCCGACTACGCGATGGCGAACGCGTTTGTCGACGGCTACATGACCGAGCGCCGCGCGCGAGTGGCGGGCGGCGTGTCGCGCGGCGCGTCGTTGTCGATCCAGTGGCCGCTGTGGGCGGATGCGGGGATGCGCATGCCCGCGGCGATCGCGTCGCGGCTCGCGGCGGCGACGGGGCTCGCGCCGCTGCCGAGCGCCGAGGGCATCGCGGCGTGGCGCGCGGCGCTCGCGCGCGACGACGCGAACGTCGCGGTGCTGTACGGCGAGCGCGCGGCGATCGCCGCGTGGCTCGCGACGTCGGACGCCATGCCGCCGCGCGCGCGCGCGGCGCGGCCGATGCCCGCCGCGCGCGTCGATCTGCACGCGCTGCGCGCGCTCGCGGCGTCGCTGATCGGCGTCGATGCGCATGACATCAACGTCGACGCCGACATCGACGAATACGGGCTGGACGCCGTCGCGCTCGCGCATCTCGCGCGGGAAATCGGCGAGCGCGCGGGCCGGGCCGACGTCGGCCTCGGGTTCGTGCGCGGCGAGCGCACGCTGCGCGCGATCGCCCGCGCGCTCGACGCGAGCGCGCCGGGCGGCGACGCCGAAGTCGACATCGGCGCCGACGCCGACGCTGACGCCGACAACGCCCCCGACGCTGAGGCCTGCGTCGAGTGCGCCGGCATCGACGCCCGTGCGACGCCGCCCGACGCCGGAGCGCCGCAACGCGGCGCGCACGCGGCCGCCGCCGAAGGTTCGGCGCGCGACGAGGCGGCGCGATCGATCGCGCCGCTTGCCGGCGCGGGCTCGCCGGATGGCGCGTCGGCGCTGCGCGCGCGCGTCGGCGCGCGCCTGAGTGCGCTGCTCGCGGACGTGCTGAAGGTGCCCGTCGCACGGCTGGAGCCGGACGCGCCGTTCGAGCGATACGGAATCGATTCGCTGACCGTCGTTGCGCTCAATGAGTCGCTCGGGCGGCATGTCGACGCGCTGCCGAAGACGCTGTTCTTCGAATACCGGACGCTCGCCGAGCTGACCGACTATTTCGTGCGACGGCATGCGGGCGCGGCGTGGTTCGCGCCCGACGCGCGCGCCGAGCACGGCGCGGCCGGCGCATTGGCCACGCTGGGCGCGGCCACGCGGGCGACGCAGACGGAACAGGCGGAACAGTCGCGTGTTGCGCCGCTCGCGCCGCCGCGCCGCGTGTTTGCCGCAGCCACGGCCGCCACGCGCTCGCGCGCCGCGAGCGCGCCGCCGGCCGCGACGGCGGACGCGATCGCCGTGATCGGCCTCGCCGGCCGCTATCCGCAGGCGCGCGACCTCGACGCGTTCTGGCGCAATCTGCGCGACGGCCGCGACTGCATCACGGAGATTCCCGCCGAGCGCTGGAACCACGGCGATTTCTTCGATCCGCAGAAGGGCGTGGCGGGCAAGACCTACAGCAAGTGGGGCGGCTTCATCGAAGGCGTCGACGAATTCGACGCGGCGTTCTTCAACATCGCGCCGCGCGACGCCGAGCGCATGGACCCGCAGGAGCGGCTCTTCCTGCAGGCGTCGTATCAGGCGATCGAGGATGCGGGCTACGCGCGCGCGTCGCTCGGCGCGGGCCGCGTCGGCGTGTTCGCGGGCGTCATGTACTCCGAATACCAGCTTTACGGCATCGAGGAATCGGCGGCCGGCCGGCCGGCCGCGCTGTCGGGCAGCGCCGCGTCGATCGCCAATCGCGTGTCGTATCACCTGGACCTGCACGGGCCGAGCATGGCCGTCGACACGATGTGCTCGTCGTCGCTGACAGCGCTCCATCTCGCGTGCCGCAGCCTGCAGCGCGGCGAATGCGAGCTGGCGCTGGCGGGCGGCGTGAACGTGTCGGTCCATCCGAACAAGTATCTGATGCTCGCCGACAACCGCTTCGTGTCGAGCGCCGGCCGCTGCGAAAGCTTCGGCGCGGGCGGCGACGGCTACGTGCCGGCCGAGGGCGTTGGCGTCGCGGTGCTCAAGCCGCTGCGCGCGGCGATCGCGGACGGCGACGCGATCCACGGTGTCATTTGTGCGACGGCGCTCAATCACGGCGGGAAGAACAACGGCTACACGGTGCCGAATCCGGCGTGGCAGGCGGCCGTGATCGAAGCCGCGCTCGGCGAGGCGGGCGTCGCGCCCGGCGACGTGAGCTATGTCGAAGCGCACGGCACCGGCACGACGCTCGGCGATCCGATCGAGATCGCCGGGCTCGCGCGCGCGTTCGGCGAGCCCGGCGCGCGCCGCGGCGCGCCGTGCGCGATCGGCTCGGTCAAGTCGAACATCGGGCACGCGGAAAGCGCGGCGGGCATCGCGGGCCTGACGAAGGTGCTGCTGCAGATGCGGCATCGGATGCTCGTGCCGTCGCTGCACGCGGACACGCTCAATCCGAACATCGCGTTCGAGACCACGCCGTTTTGCGTGCAGCGCGCGCTGGAGCGATGGGAGCGGCCGGGCGATGGCGAGCGTGTCGCGGGCGTGTCGTCGTTCGGCGCGGGCGGGGCGAACGCGCACGTGATCGTGCGCGAATACCGCAGCGACGACGAGCGCGACGGCCGCGACGAGCCCGCATCGACCGCGCCGGCCCGCGCGCGGCCGGCGTGGATCGTGCTGTCGGCGAGAAACGAGGACGGCCTGCGCGCGCGCGCCGCGCAGTTGCGCGAATTAGCGGCCGGCTGCGAGGGCGACGCCGATCTGCACGCAATCGCCTATACGCTGCAGACGGGGCGCGATGCGATGGATGAGCGGCTCGCGTTCGAGGCGACGTCGATCGCCGATCTGATCGCCTCGCTCGATGCGTTCGCGCGCGGCGAACCGGGCAAGAAGCAACTGCGCGGGAACGGCCGCGCCCGGCGCGGCGACGCGCCGCCCGCCGGCGTCGCCGACGCGCGGCTCGCGCGCGGCGAGCACCGCGCGGCGCTCGACGACTGGGTGCGCGGCGCGTCGATCGACTGGCGGCGCGCATACGGCCCGGGCGCGCCGTTCGGACCCGCGCCGCGCCGCATGCATCTGCCGGTCTATCCGTTCGCGCGCACGCGCCACTGGCTGCCGGCGCCGCTCGACGCGCGCCGGCGCGCGGCGCGCGCGGGCGGCGGCCTGCATCCGATGCTGGATGCGAACCGCTCGGAATTCGGCCGCCAGCGTTTCGTCGTCGAATTCGATGGCCGCGAGCCTTGGCTTGCCGATCATCGCGTCGACGGCCGCCGCGTGCTGCCGGGCGTCGCGTATCTCGAAATGGCGCGCGCCGCGCTCGCAGCGTCCGCGCCGGACATGCATGCGGACGGCGGCGCGACGCTGGAGGACGTGCGATGGCTGCGGCCGTGCATCGTGCCGGACGGCGGCGCGACGCTCGAGATCGCGCTCGAGCGCGACGGCGACGGCATCGCGTTCTCGATCTCGCAAACGTCCGCGCACGCGCAGCCGGCGCTTTGCTGCACGGGACGCTCGCCGTCGCGCGCCGCACGCGGCGGCGGCGAGCGGATCGACGTCGATGCGATGCGCGACGCGTTTCGCGCGGCGCCCGCCTTCGACGCCGACGCGTGCTATCGCGCGTTCGCCCGGCGTGGCGTGCAGTACGGGCCGAGCCATCGGACGATCGAGCGCGTGTGGGCGGATGGCGATCGCGCGCTTGCGCGGCTGCGCAGCGCGCGCCCGGCGGACCCGCGCCTCGTGATGTGGCCTGGCCTGCTCGACGGCGCGCTTCAGTCGCTCATCGGCCTGCACGGCCTCGACGGCGACCTGCTCGCAGCGCCTTACCGGCTCGCGCGGCTCGACGTGCACGGCGCGTGCGGCCCGGCGATGTGGGCGCTCGCGCGCCGCGCCGGCGACGGCGCGCTCGATCTCGTGCTGTGCGACGACGCAGGCGAAGCCTGCGTGACGATGCGCGGCTTCGCGTCGCGCGCGGCCGCTTCGTGGCGGACGGCGGCGCAGGCGGCGGGTGCGCCGCACGAAGCGGTTGCCGGCGGCGACGCGCGGGCCGCATTCGGCCCGGCCGCGGAATCGCCATCGGCGGCGACATCGACATCGGCGGCGACATCGCCGGCGATATCGACATCGGCGGCGACGCCGGCGGCCGCCGACGGCGACGACTGGCTGCTGCTGCCGCGCTGGCTCGCGTGCGACCTCGATCCCGAGCGCGACGCCGGCGCGCGGGCCGTCGCGCCGCGCAGCGTGCTCGCGATCGCCGACGACGCCTGCGTGCACGATCTGTCCGCGGCGGCGTTCGGCGGCGCGAGCGTGCGCCGCATGCCGGCATCCGACGCGGCCGACGCCGCGCGGCTCGCGGCGATCCTCGGCGACGCGCCGCGGCTCGACGCGCTCGTGTTCGTCGCGCCGGGCGCGCACGCGCGCTCGGCTCAGGCATTGATCGACGCGCAGGAGTCGGGCGCGATCGCGCTCTTTCGCATCGTCAAGGCGCTGCTCGCGCACGGCTACCGCGACGACGCGCTCACGCTCGCGATCGTCACCGAGCAGGCGGTCGCGCTGTATCCCGGCGAGCCGATCGATCCCGCGCACGCGGCGCTGCACGGCATGGCCGGCGTGCTGGGCCGGGATCTGCCGCGCTGGCGCGTTCTGTGCGCGGACGTCGAGCGCGCTCGCGCATACGCGGGCGCGGCGCTCGTCGCGCAAGCCGGGCCGGCGGGCGAGGGCCCGCGGATCAACCGCCTCGGCCGCTGGCACCGGCGCGCGCTCGCGCGCGTCGACGCGCCGGCCGCGCGCGAATCCGCGTTCCGTCGCGGCGGCGTCTACGTGATCGTCGGCGGCGCGGGCGGCCTCGGCCGCGTGCTGACCGAGCATCTGATCCGCCGCGCGGACGCACGCGTCGTATGGGTCGGGCGGCGCGCGGCCGACGGGCGGATCGCCGCCGATTGCGCGTCGTTCGAATCGATCGGCGCGCCGCCGCTGTACCTGCAGGCCGACGCGAGCGACGCCGGTGCGATGGGCGCGGTGCGCGACGCGGTGAAGGCGCGCTACGGCGCGATCCACGGCGTCGTGCATTCGGCGCTCGCGCTGCGCGACGCGACGCTTGCGACGATGACCGAGGCCGACTTCCGGCGCGTGCTCGCGGCCAAGCTGGACACGAGCGTGCGGCTTGCCGAAGCGTTCGCGGACGAGCCGCTCGACTTCATGCTGTTCTTCTCGTCGTTCGCCGCGTTCTCGTTCCCGCAGGGGCAGGCGAACTACGCGGCGGGCTGCGCGTTCCAGGATGCGTTCGCGCAGCATCTCGCCGCGCGTGCGCCGTTCGCCGTGAAGACGGTGAACTGGGGCTTCTGGGGGCATGCGGGCGTCGTCGCGACGCCCGCGCACCGCGACCGGATGGCGCGGCTCGGCATCGGCTCGATCGAGCCGGACGCGGCGATGCGCTCGCTCGAATGCCTGCTTGCGTGCGACGTCGGCCAGCTCGCGCTCATCAACGTGCGGCGCGACGACGCGATCGCGCCGCTCATGACGCCGCGCCGCGTCGCGCTGCATGCGCCGGGCGCGGGCCCGCGCGCGCTCGACAGCGTCGCGCGCGTGCGGCCGGACGCCGAGCGGACCGCGGCGGCGCGGCTGCATGGCGGGCTGCAGCGCGATGAATGGCGCGACGTGCTGCTGTCGCTGCTCGACGCGACGTTCGACGCGCTCGGCGCGCGGCGCGCCGCCGAAGCGGGCGGCGACGCGCTGCGCGCCGCGCTCGGCATCGCGCCGCGGCACGCGCGCTGGTTCGCCGCGTCGCTCGACTGGCTGCGCGCGTTGCGCGAGGGCGCGCACGCGGCTGCCGCGATGTCGGCCGACGACGCGTGGCGGGCGTGGGCGCGGCTCGGCGCGGCGTGCGACGGCGACGCCGGCCGAAGCGCGCAATACGCGCTCGTCGACGCGACGCTGCGCCATCTGGCCGACATCGTGACAGGACGGCGCAAGGCGACCGAAATCATGTTCCCGAAGGGCTCGATGGCGCTCGTCGAGAATGTCTATCGCCATCATCCCGTCGCCGATTACTTCAACCTGGCCGTCGCGGAGATCGTCGCCGCGCGCGCGGCGGACGTGGTCCGCGAGCGCGGCGTGCGCATCCTCGAGGTCGGCGCGGGCACGGGCGGCACGACGGCGCGCGTGCTCGCGGTGCTGCGCGAGCGCGGCGTGCGCGTGGACGACTACCGCTTCACCGACGTCTCGCCGGGCTTTCTCGATCACGCGGCGGCCCGTTTCGGCGCGGGCGCGCCGTTCATGAGCTACGGCCTGTTCGACGTGATGCGCGCGCCGGCCGCGCAGGGCATCGCGCCGCACGGCTTCGACATCGTCGTCGCGACGAACGTGCTGCATGCGACGGCCGACGTGCGCGCGAGCCTGCGGCATTGCCGCGACGCGCTGCGGGCGGGCGGGCTGCTCGTCGTCAACGAGATCAGCGACAAGTCGCTCTTCACGCATCTGACGTTCGGCCTGCTCGACGGCTGGTGGGCATACGAGGACGCCGCGCTGCGCATCGACGGCTCGCCCGCGCTCGACGCGCACCACTGGGCGTTCGCGCTGCGCAGCGAAGGGTATGCCGACGTCGCGTTCCCGTGGGCGGATGCGCACGATCTCGGCCAGCAGATCGTGCTCGCCGACGCGGGCGACGTCGTCGACGCGGCGGATGCGCAAGCGATGCGTGCGCGCGAGGCCGAGCCGTGGGCGTGGGCGACGGGAGCGGAGTCGGAATCGGTGTTGGAGGCGGTATCGGAGACGGAGACGGCGCTGACGCCGGCGCCCACGCAATCGCCCGCCGCGCCATCCGACGCGACGCGCACCGCCGCGCTGCTGCGCAGCCTGCTCGGCGAGGCGCTCAAGGTCGAGCCGGTCAGCATCGAGGGCGACGGCGCGTTCGGCGACTACGGGCTCGACTCGATCATCGGGATGGGCTTCGTCGACGCGATCAACCGCGCGCTCGATCTCTCGCTCGACGTGACAGCCGTGTTCGAGCACAACACGGTCGACGCGCTCGCCGCGTACGTCGGCTCGCAGCTCGCGGCGCGCGCGCCGGCAGCGGCGGGCGCGCGCGATGTCGAGCCCGCATCGTCGCTCGCATCGTCGTCCGCATCCGATTTCGTCTCCGCGCGCTTGCCGGCCGTCGACGCCGCCGCATCGTCCGCGTTCGACGCCGCGCCGCGCGCTCGCACGGGCGCGGATGCGCCGGACACTTCGCTTGCATCGTCCGCATCGTCCATCTCGTCCGCGCGGGCATCGTCACCCGCATCGCCCGCGCGCGACGCGGCGTCGTTCGACGTCGCGATCGTCGGCGCGAGTTGCCGCTTCCCGGGCGCGGACGGCCTCGACGCGCTGTGGCGCTGCATCGTCGACGAGCGCTCGTGCGTGCGCGACGTGGGCGCGAAGTGGCTGCGCACGCGCGATCCCGCCGACGCGGGCGCGGATTACCGCGCCGCCGTGCTCGACGGCATCGATCGCTTCGATGCGGCGCGCTTCGGCATCTCGCCGCGCGAGGCGCGCCGGATGGACCCGCAGCAGCGGCTGCTGCTGACCGAGGCGTGGCGCGCGCTGCAGGACGCGGGCGACGCGGCGCGCGCGGCCGCGCACCGGACCGGCGTGTTCGTCGCGGCGGGCGCGAACGAATACGGCGCCGGCCTCGACGCCGCCGACAACCCGTTCTCGATGACGTCGATGGCGCCCGCGCTGATGCCCAACCGCATCTCGTACGCGCTCGACCTGCGCGGGCCGAGCGAAATGACGGACACCGCGTGCTCGTCGTCGCTCGTCGCGCTGCATCGCGCGGTGCGCAGCCTGCGCGACGGCGAGTGCGACCAGGCGGTCGTGGCCGCCGTCAATCTGCTGCTGTCGGCCGAGAAGTTCGAGGGTTTCGCCGAGCTCGGCTTCCTGAGCCCGAGCGGGCGCACGCGCTCGTTCGACGCGGCGGGCGACGGCTTCGTGCGCGGCGAGGGCGCGGCCGCGCTCGTGCTCAAGCCGCTCGCGGCCGCGCGGCGCGACGGCGACTTCGTCTACGCATGCATCAAGGGCACGGCCGTTCATCACGGCGGCCGAGGCGCGGCGCTGACCGCGCCGAACGCGGCCGGCATTCGCGAGGCGATGTCCGCCGCCTATCGAAACGCGGGCATCGACGCGCGCACCGTGTCGTACCTGGAAGCGCACGGCGTGGGCTCGCCCGTCGGCGACGCGATCGAGCTGAACGCGATTCGCGACGCGTATGCGGCGTTGTCGGGCGAGCCCGCGCCGGCCGCGCCCGCCGCGTCGTGCCGGATCGGCAGCGTCAAGCCGGTCTTCGGTCATGTCGAGCTGGCTTCGGGGCTGCTCGCGGTCTGCAAGGTGCTGATGGCGTTGCGTCACGGCGTGCTGCCGGGCGTGCCCGGCTTCGAGCGGCCGAATCCGCACGCGAACCTCGCGGGCTCGCCGCTCGTCGTCGCGCGCGCGGCGGCGCCGTGGCCCGCGCCGCGAGACGACGCGAACGGCGCGGCGGTGCCGCGCCGCGCGAGCGTCAACAGCTTCGGTTTCGGCGGCGTCAACGCGCACGTCGTGCTGGAGGAGGACGTGTCGAGCCGGCATGCGCCGCGCGTTTTCGCGCAGCCGCCGCTCGACGGGGCGCGCCACTGGGAGTGTCCGCGCGAGATCGCCGGCGCGCCGGCCGCACGGCCCGGGCGGCCGGCCCCCGACGCGCCGCACGCGCGGATCGAGGCGGTGATCCGCGACGCGCTCGCGCAGGCGCTCGGCGTCGCGCCCGATGCGTTCGAGCTTGCGGTGCCGCTCGGCGAGTACGGCGCGGATTCGATGCTCGACCTGCATCTCGCGACGCGCATCGAGGAGACGCTCGGCGTGCAGCTGAGCGTGCGCGAGCTGTTCGCGCATCGCACGCTCGGCGCGTTGCGCGATCACGTCGCCGAGCGGATCGCGCGCGACGGCGGGCGGCGCGCCGCCGAGGCTGCGCGAGCGCCGGATGCCGCGATGGCGTCCGACGTGGCTGAAGCGTCTGTCGTGTCCGAAGCAACCGAGGCATCCGACGCATCCGAAGCATCCGACGCATCCGAAGCATCCGAAGCATCCGAAGCATCCGAGGCATCCAAAGCACCCGCGGATCTCGCGGCGCTGCTCGAGCGCTTCCGCGCGGGGCAAATGGATCTCGACGACATCGTCGACCTGGTTTGA", "orf_prot_sequence": "MGIEQLNTTRAQHDDIAVIGIACRFPGASDYRQFWDNLCERRVSIGEIPGERWDWRAYWGDPQQDANACNSRWGGFVDEVGAFDLGFFGMSAREVDKMDPQQRLALELAWHCFEDAGLRPSAVAKRDVGVFVGIANLDYKEIVEAHASEIDAYYASGVAASVASNRLSYWFDLRGPSVTVDTACSGSLYALHLAREALRRGECEMALAGGVSLLLTPRRYLGFARARMLSPTGAIRAFDDAADGMVRGEGGGLVLLKPLSRALDDGDRIFGVLAGSAVNHSGRTYSLTYPDADAQARVIRAAFDAAGVSPAQVSYVEAHGTGTPKGDPIELEGLLRVFGAQPRDALAPRCAIGSVKANIGHLESAAGIAGVIKTLLALHHGMLPPMPHFAALNHRVDAARFAAAGLAVADALAPWEAGASADGASAARIAGVSAFGFAGTNAHVVLREAPAAARAAVAAGRADGAGVLCLSAKTDAALERVRAGFVEWLARDGARHAFADICAALVSRREHFASRIAVAACDVDGALAALRARADTASSVYRAGRVALDDDGNLVDASGPHDEQADHDGSGEHGEHGERARAGADDLSRARRRASRYVRGASPDAWGPSDGPTPHVPLPDYPFERTVCWTGPRPSRAVAGPARGPAVDEAVDEAVDEAGAADGDVFVLEPRWHLAPAADARPAPARPEDAAVVVCVVADAAQRAAVERALARIATAPACMFVEPDATMGEPARAVDALVRTLDGIADRARADVSGVDTSGAAAPISVWYCADLARDARAPIDVRAYDRLLTLLQALAKTRAPLRRVLLAGVSESLAADAWPALVTVLAPRRPALAVTPVLFDHGTPEALWVSALLQEARAAGGAAVRYAAGERSVAVLARAANAASENAARLAGGAPLRTGGCYLLTGGLGGLGRLFAVRLMRRYGARVVALGRSAHDAGVQASVAALCAEAGAGTLRYLQADVCDAAAMAAVLDDIGRHEGRLNGVIHAAGCEDRASLADKSLDDVHAVLAPKLAAATVLDRLTAGLPLDFVCLFSSLAGIVGDFGCGAYALGNRLLMSYAQRADGRVDAHGRRRRVVAIAWPLWRDGAMGFDDPVKRDRYLAASGQRMLDADEGFAWFERLLASPSAAPVVLAGERARIVSWLGSIDGAPVADASPGAASSGAAAPNAASDASRDTERAEATDAAAPIVAAGAPAHAHASAPRERDAHGSARLPALRGIAARVLGADAALLDEQASFADLGFDSIGLMDFARAVGEAFGIDMSPAMLFSHVTLKRLAGHLATRLDDAPRAVAGARSGAAHASAGRACAAAGRADGARASRIDVRPPEAGAGERAADARPPLTAPEIAPEIAPESASGFASAPHPAPIPPAYEPIAIVGMSGRFPDARDIDAFWSLLMSGRGAARRVDPHDRFAAPRDEAAAWLAPVPGIDEFDPLFFDIAPAEAQRMDPRERLLLQHAWLALEDAGIGARALADHALGMFVGAEAGEYGGLSREPRSIVSDHNGVLAARLSYFLDLTGPNLSVNTACSSGLVALHLAIRSLHARECGIALAAGVNLMLSAELHDKMARAGMLSQHGVCRALDRDADGFVPGEAVVVVALKRLADALADGDAIHGVIRASGVNYDGRTNGMTAPSGLAQARLLTDAWRTAGIDPAELGYVVAHGTGTRLGDPVELNALGDALRASTGRRHFCAVTSNKPNVGHTLAASGLVSLVNLVEALRRAVIPPSAHWREGNEFVAWGDSPLRVNTVASAWPDGARRLGGASAFGMSGTNAHVIVEAAEPARARAPHAPRGGVLFVVSAKTGDALAQRLRDLADCLASDAWSDGDLADVAHTLLHGRQHFEHRSAVFARGKADAIDALRAAADAVRNAPARRTGALRLLDDYAAHLSARYAAWRDAPARDVDEARRLLEAIGDAYREGATPSALVVAPAPGRTVRLPGYPFACERHWHPAPARAGGASAGANAREPGARERAEAAAAPHVVVLTLTGSEPYLRDHLIDGQRVLPGAAHLDMARAAFERVRAAGGRAARFVALRDVVWRAPLVAGDAGAEVHVELTPSGTAFAYRILSRPADRAAAVGAALTLHSEGVVDELNEPAPEPLDLDGWRAACAGERVDGAALHARFASLGIGYGPSHRGVAHVRLGEHAALARLDLGALADADFDGFGLHPGIVDSAFQASAALSAPREDAAVPFMLRALHVYSRAARTMWAAIRVAAPAGGGAGGVDTRPIDIDLVHDDGAICASLRGWVSARWRKLAGAPPAARATAALRGWRWRAAEPDPRAAEAATRVVLLAPDFGALAAELAAHDAVRCEMLDDVSSHALPDAFAARATQAFAAVRRELAAKPGRPVLFQAVCREADSATAWGLAGLFKTAADENPLASGHVVLVSESFDRARLAAALLAERAWTGHLRYGGAGREAFAIDADEDDRDGREPAGGPPLRDDGVYAISGGAGGIGRAIARDIVARTRAARVYLLGRSAHAPSDLFATADERARIRYCRVDVADREQVHAWIAGLKRDGEALRGVVHAAGVVDDAFVVAKEPSRVHAVLRPKVAGAVWLDEATRDAPLDFFVAFSSLASAFGNAGQADYAMANAFVDGYMTERRARVAGGVSRGASLSIQWPLWADAGMRMPAAIASRLAAATGLAPLPSAEGIAAWRAALARDDANVAVLYGERAAIAAWLATSDAMPPRARAARPMPAARVDLHALRALAASLIGVDAHDINVDADIDEYGLDAVALAHLAREIGERAGRADVGLGFVRGERTLRAIARALDASAPGGDAEVDIGADADADADNAPDAEACVECAGIDARATPPDAGAPQRGAHAAAAEGSARDEAARSIAPLAGAGSPDGASALRARVGARLSALLADVLKVPVARLEPDAPFERYGIDSLTVVALNESLGRHVDALPKTLFFEYRTLAELTDYFVRRHAGAAWFAPDARAEHGAAGALATLGAATRATQTEQAEQSRVAPLAPPRRVFAAATAATRSRAASAPPAATADAIAVIGLAGRYPQARDLDAFWRNLRDGRDCITEIPAERWNHGDFFDPQKGVAGKTYSKWGGFIEGVDEFDAAFFNIAPRDAERMDPQERLFLQASYQAIEDAGYARASLGAGRVGVFAGVMYSEYQLYGIEESAAGRPAALSGSAASIANRVSYHLDLHGPSMAVDTMCSSSLTALHLACRSLQRGECELALAGGVNVSVHPNKYLMLADNRFVSSAGRCESFGAGGDGYVPAEGVGVAVLKPLRAAIADGDAIHGVICATALNHGGKNNGYTVPNPAWQAAVIEAALGEAGVAPGDVSYVEAHGTGTTLGDPIEIAGLARAFGEPGARRGAPCAIGSVKSNIGHAESAAGIAGLTKVLLQMRHRMLVPSLHADTLNPNIAFETTPFCVQRALERWERPGDGERVAGVSSFGAGGANAHVIVREYRSDDERDGRDEPASTAPARARPAWIVLSARNEDGLRARAAQLRELAAGCEGDADLHAIAYTLQTGRDAMDERLAFEATSIADLIASLDAFARGEPGKKQLRGNGRARRGDAPPAGVADARLARGEHRAALDDWVRGASIDWRRAYGPGAPFGPAPRRMHLPVYPFARTRHWLPAPLDARRRAARAGGGLHPMLDANRSEFGRQRFVVEFDGREPWLADHRVDGRRVLPGVAYLEMARAALAASAPDMHADGGATLEDVRWLRPCIVPDGGATLEIALERDGDGIAFSISQTSAHAQPALCCTGRSPSRAARGGGERIDVDAMRDAFRAAPAFDADACYRAFARRGVQYGPSHRTIERVWADGDRALARLRSARPADPRLVMWPGLLDGALQSLIGLHGLDGDLLAAPYRLARLDVHGACGPAMWALARRAGDGALDLVLCDDAGEACVTMRGFASRAAASWRTAAQAAGAPHEAVAGGDARAAFGPAAESPSAATSTSAATSPAISTSAATPAAADGDDWLLLPRWLACDLDPERDAGARAVAPRSVLAIADDACVHDLSAAAFGGASVRRMPASDAADAARLAAILGDAPRLDALVFVAPGAHARSAQALIDAQESGAIALFRIVKALLAHGYRDDALTLAIVTEQAVALYPGEPIDPAHAALHGMAGVLGRDLPRWRVLCADVERARAYAGAALVAQAGPAGEGPRINRLGRWHRRALARVDAPAARESAFRRGGVYVIVGGAGGLGRVLTEHLIRRADARVVWVGRRAADGRIAADCASFESIGAPPLYLQADASDAGAMGAVRDAVKARYGAIHGVVHSALALRDATLATMTEADFRRVLAAKLDTSVRLAEAFADEPLDFMLFFSSFAAFSFPQGQANYAAGCAFQDAFAQHLAARAPFAVKTVNWGFWGHAGVVATPAHRDRMARLGIGSIEPDAAMRSLECLLACDVGQLALINVRRDDAIAPLMTPRRVALHAPGAGPRALDSVARVRPDAERTAAARLHGGLQRDEWRDVLLSLLDATFDALGARRAAEAGGDALRAALGIAPRHARWFAASLDWLRALREGAHAAAAMSADDAWRAWARLGAACDGDAGRSAQYALVDATLRHLADIVTGRRKATEIMFPKGSMALVENVYRHHPVADYFNLAVAEIVAARAADVVRERGVRILEVGAGTGGTTARVLAVLRERGVRVDDYRFTDVSPGFLDHAAARFGAGAPFMSYGLFDVMRAPAAQGIAPHGFDIVVATNVLHATADVRASLRHCRDALRAGGLLVVNEISDKSLFTHLTFGLLDGWWAYEDAALRIDGSPALDAHHWAFALRSEGYADVAFPWADAHDLGQQIVLADAGDVVDAADAQAMRAREAEPWAWATGAESESVLEAVSETETALTPAPTQSPAAPSDATRTAALLRSLLGEALKVEPVSIEGDGAFGDYGLDSIIGMGFVDAINRALDLSLDVTAVFEHNTVDALAAYVGSQLAARAPAAAGARDVEPASSLASSSASDFVSARLPAVDAAASSAFDAAPRARTGADAPDTSLASSASSISSARASSPASPARDAASFDVAIVGASCRFPGADGLDALWRCIVDERSCVRDVGAKWLRTRDPADAGADYRAAVLDGIDRFDAARFGISPREARRMDPQQRLLLTEAWRALQDAGDAARAAAHRTGVFVAAGANEYGAGLDAADNPFSMTSMAPALMPNRISYALDLRGPSEMTDTACSSSLVALHRAVRSLRDGECDQAVVAAVNLLLSAEKFEGFAELGFLSPSGRTRSFDAAGDGFVRGEGAAALVLKPLAAARRDGDFVYACIKGTAVHHGGRGAALTAPNAAGIREAMSAAYRNAGIDARTVSYLEAHGVGSPVGDAIELNAIRDAYAALSGEPAPAAPAASCRIGSVKPVFGHVELASGLLAVCKVLMALRHGVLPGVPGFERPNPHANLAGSPLVVARAAAPWPAPRDDANGAAVPRRASVNSFGFGGVNAHVVLEEDVSSRHAPRVFAQPPLDGARHWECPREIAGAPAARPGRPAPDAPHARIEAVIRDALAQALGVAPDAFELAVPLGEYGADSMLDLHLATRIEETLGVQLSVRELFAHRTLGALRDHVAERIARDGGRRAAEAARAPDAAMASDVAEASVVSEATEASDASEASDASEASEASEASEASKAPADLAALLERFRAGQMDLDDIVDLV", "perc_identity": 34.85}}, "BGC0000186.1|Thailandamide_13 # 78034 # 81537 # -1 # ID=1_13;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.704": {"gnl|BL_ORD_ID|4134|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 78034, "orf_end": 81537, "orf_from": "BGC0000186.1|Thailandamide_13 ", "model_name": "OXA-912", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "500", "model_id": "5204", "ARO_accession": "3006099", "ARO_name": "OXA-912", "ARO_category": {"36026": {"category_aro_accession": "3000017", "category_aro_cvterm_id": "36026", "category_aro_name": "OXA beta-lactamase", "category_aro_description": "OXA beta-lactamases were long recognized as a less common but also plasmid-mediated beta-lactamase variety that could hydrolyze oxacillin and related anti-staphylococcal penicillins. These beta-lactamases differ from the TEM and SHV enzymes in that they belong to molecular class D and functional group 2d. The OXA-type beta-lactamases confer resistance to ampicillin and cephalothin and are characterized by their high hydrolytic activity against oxacillin and cloxacillin and the fact that they are poorly inhibited by clavulanic acid. Amino acid substitutions in OXA enzymes can also give the ESBL phenotype. The OXA beta-lactamase family was originally created as a phenotypic rather than a genotypic group for a few beta-lactamases that had a specific hydrolysis profile. Therefore, there is as little as 20% sequence homology among some of the members of this family. However, recent additions to this family show some degree of homology to one or more of the existing members of the OXA beta-lactamase family. Some confer resistance predominantly to ceftazidime, but OXA-17 confers greater resistance to cefotaxime and cefepime than it does resistance to ceftazidime.", "category_aro_class_name": "AMR Gene Family"}, "35930": {"category_aro_accession": "0000011", "category_aro_cvterm_id": "35930", "category_aro_name": "cloxacillin", "category_aro_description": "Cloxacillin is a semisynthetic, isoxazolyl penicillin derivative in the beta-lactam class of antibiotics. It interferes with peptidogylcan synthesis and is commonly used for treating penicillin-resistant Staphylococcus aureus infections.", "category_aro_class_name": "Antibiotic"}, "35973": {"category_aro_accession": "0000056", "category_aro_cvterm_id": "35973", "category_aro_name": "oxacillin", "category_aro_description": "Oxacillin is a penicillinase-resistant beta-lactam. It is similar to methicillin, and has replaced methicillin in clinical use. Oxacillin, especially in combination with other antibiotics, is effective against many penicillinase-producing strains of Staphylococcus aureus and Staphylococcus epidermidis.", "category_aro_class_name": "Antibiotic"}, "37084": {"category_aro_accession": "3000704", "category_aro_cvterm_id": "37084", "category_aro_name": "cefalotin", "category_aro_description": "Cefalotin is a semisynthetic cephalosporin antibiotic activate against staphylococci. It is resistant to staphylococci beta-lactamases but hydrolyzed by enterobacterial beta-lactamases.", "category_aro_class_name": "Antibiotic"}, "35939": {"category_aro_accession": "0000020", "category_aro_cvterm_id": "35939", "category_aro_name": "carbapenem", "category_aro_description": "Carbapenems are a class of beta-lactam antibiotics with a broad spectrum of antibacterial activity, and have a structure which renders them highly resistant to beta-lactamases. Carbapenem antibiotics are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "35951": {"category_aro_accession": "0000032", "category_aro_cvterm_id": "35951", "category_aro_name": "cephalosporin", "category_aro_description": "Cephalosporins are a class of beta-lactam antibiotics, containing the beta-lactam ring fused with a dihydrothiazolidine ring. Together with cephamycins they belong to a sub-group called cephems. Cephalosporin are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "36017": {"category_aro_accession": "3000008", "category_aro_cvterm_id": "36017", "category_aro_name": "penam", "category_aro_description": "Penams are a group of antibiotics derived from Penicillium fungi that share a skeleton beta-lactam moiety fused with a thiazolidine ring. This is the most defining feature of penicillins. Penicillin antibiotics are historically significant because they are the first drugs that were effective against many previously serious diseases such as syphilis and Staphylococcus infections. Penicillins are still widely used today, though many types of bacteria are now resistant. All penicillins are beta-lactam antibiotics in the penam sub-group, and are used in the treatment of bacterial infections caused by susceptible, usually Gram-positive, organisms.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.528704, "max_identities": 20, "bit_score": 30.8018, "cvterm_id": "37047", "query": "RDAFGPSR-----IVWMFSGQGSQYVGMGRALYESEPTFRHHVDRFDEVTRDKTG", "match": "R+   P R     +VW FS Q ++++GM R        F+ +VDRFD   RD +G", "sequence_from_db": "RETTTPRRWETYSVVW-FSQQITEWLGMER--------FQQYVDRFDYGNRDLSG", "sequence_from_broadstreet": "MSRLLLSSLLAAGLLAALPASAASGCFLYADGNGQTLSSEGDCSSQLPPASTFKIPLALMGYDSGYLVDEEHPALPYKPSYDGWLPAWRETTTPRRWETYSVVWFSQQITEWLGMERFQQYVDRFDYGNRDLSGNPGKHDGLTQAWLSSSLAISPEEQARFLGKMLSGKLPVSAQTLQYTANILKVSEIDGWQIHGKTGMGYPKKLDGSLNRDQQIGWFVGWASKPGKQLIFVHTVVQKPGKQFASLKAKEEVLAALPAQLKKQ", "dna_sequence_from_broadstreet": "ATGTCCCGCCTGCTTCTCTCCAGCCTGCTGGCTGCCGGTCTGCTCGCAGCCCTGCCTGCCTCCGCCGCCAGCGGCTGCTTTCTCTATGCTGACGGCAACGGCCAGACCCTCTCCAGCGAAGGGGACTGCTCCAGCCAGCTGCCACCCGCGTCCACCTTCAAGATCCCGCTGGCGCTGATGGGTTACGACAGTGGCTATCTGGTGGATGAAGAGCATCCGGCACTGCCTTACAAACCGAGCTATGACGGCTGGCTGCCCGCCTGGCGTGAAACCACCACCCCGCGCCGCTGGGAAACCTACTCGGTGGTCTGGTTCTCCCAGCAGATCACCGAATGGCTGGGGATGGAGCGCTTCCAGCAATATGTCGACCGCTTCGACTACGGCAATCGGGATCTCTCCGGTAATCCGGGCAAACATGATGGCCTGACCCAGGCCTGGCTCAGCTCCAGCCTCGCCATCAGTCCGGAGGAGCAGGCCCGCTTCCTCGGCAAGATGCTGAGCGGCAAGCTTCCGGTCTCTGCGCAGACCCTGCAGTACACCGCCAATATCCTCAAGGTGAGCGAGATCGACGGCTGGCAGATCCACGGCAAAACCGGCATGGGCTACCCGAAGAAGCTGGATGGCAGCCTCAACCGCGATCAGCAGATCGGCTGGTTCGTCGGCTGGGCCAGCAAACCGGGCAAACAGCTGATCTTCGTCCATACCGTGGTGCAAAAGCCCGGCAAGCAGTTCGCCTCCCTCAAGGCAAAAGAGGAGGTGCTGGCCGCCCTGCCTGCACAACTTAAAAAGCAGTGA", "partial": "0", "query_start": 78040, "query_end": 78189, "hit_start": 264, "hit_end": 402, "orf_dna_sequence": "ATGCGGCGCGATGCATTCGGCCCGTCCAGAATCGTCTGGATGTTTTCGGGGCAAGGCAGCCAGTACGTCGGAATGGGGCGCGCGCTGTACGAGTCCGAGCCGACGTTCCGTCATCACGTCGACCGGTTCGACGAAGTGACGCGCGACAAGACGGGGACGTCGCTCGTCGCGCGTCTGTATGGCCGCGACGCGCGCGCGGGCGAGCCGTTCGACGACACGCACGTCACGCATCCGGCGCTGTTCGCGGTGCAGTACGCGCTCGCGAGAACGCTGCAGGCGCGCGGCGCGCAACCGGACATCGTGCTCGGCTCGAGCCTCGGCGATTTCGTCGCGGCCGCGCTCGCGCAAGTCGCACCGGCGCAGGAGATCGTCGCGTGGCTCATCGATCAGGCCGCTTCGATGGCGCGCGCGTGCGAGCCCGGCTTCATGCTCGCGGTGCTCGGCCCGGCCTCGATTTATCGAGGCAGCGACACGCTGCGCGAGTTCAGCGATCTCGTCGGCGTCAACTACGCGGAGCATTTCGTCATCGGCGGCAATCGCGCCGATCTTGTGCGGGTTGAAGCGGCGCTCGCGCGCGAGGGCGTCGTCTTCCATCGTCTGCCGGTGCGCTTCGGCTTTCATTCGCGCAACGTCGCGCCCGTCGTGCCGTGGCTGCACGCGCGCGAAGCGAACCTGTCGTGCCGCGCGCCGACGATCCCGTGGGCGTCATGCACGGCGGGCGGCATCGTCGAGGCGCCGACCGCGCGCTTTCTCACGCGCATCGCGATCGATCCGCTGCGTTTTCAGGAGGCGGCGCGTGCGATCGAGCAAACCGGCTCGCCCGACACGCTGCACTGGGTGGATCTCGGCCCGTCCGGCACGCTCGCGAACTTCGCGCGCAGGCTGGGCGTGCCGAACGACCGGTTGCACGTCGTGATGGGCCCGTTCGGCGACGACGCGCGCGCGCTCGGGCGAGTCTCGAATCTTCATGCAAGCAATGCGCGGCCGGCGGGTGCGCCGGCCGCGCCAGTCAGCGAGGGCGTATCCATGCACGCGTTTCTGTTTCCAGGGCAAGGCTCGCAGGTCAAGGGGATGGGGGCCGCGTTGTTCGCGCGGTTTCCCGATCGCATGCGGCTCGCAAACGAGATCTTGGGCTACGACCTCGCGGCGCTCTGCATCGAGAATCCCGACAACCGGCTCGGGCAGACGCAGTTCACGCAGCCGGCGATGTACGTGGTCAACGCGCTTGCGTATCTGGCGCGGCGCGAGGACGACGCCGGCGCGCCGGCGTTCGTCGCGGGGCACAGCCTCGGCGAGTACAGCGCGCTGTTCGCCGCGGGCGCGTTCTCGTTCGAGGACGGCCTGCGGCTCGTCAAGAAGCGCGGCGAACTGATGAGCGCCGCGCGCGACGGCGGCATGGCGGCGGTGCTCGGCCTCGATGAAGCGCGGGTGGCCGAGATCCTCGCGTTGTCGGACCTGCGCGGGATCGACATCGCGAATCTGAACGCGCCGACGCAGATCGTGATCGCCGGGCCGGCCGACGAGATTCGCCGCGCCCAGCAGTGGTTCGAGCAGGGCGGTTGCTATGCGTATGTGGTGCTGCCGGTGTCGGGCGCGTTCCATTCGCGGATGATGCGCGATGCGCAGCGCGAGTTCGAGCGCTTCATCGCGCCGTTCGATATCGGCGCGCCGGGCATTCCGGTGATCGCGAACGTCACGGGGCGCCCGTATCGCGGCGACGAGGTCCGCCGCGGCCTCGTCGAGCAAATCGCGAGTCCCGTCAGGTGGGTCGATACGATTCGCTATCTGTCGGAGCAGGGTGTCGAGCGTTTCGCCGAAATCGGCACGGGCACCGTGCTCACGGATCTGCTGCGCAAGATCCTGCCGCAGAAGGCCGGCGCGAGCGGCGCGGCGGCGCGGCCGCAGGCCGGTGCGGCGTCGGCCGTCGCTGCGTCGGCGCCGCCTCGGCCGACGGGGATGGCCGACGCGCAACCGCCGGCCGCGTCGCCGGCGCGTGCGGCGACGGCCGCGTCGACAATGCCGCCCGCATCCGCATCCGCATCCGCATCCGCACCGGCACCGGCACCGGCACCGGCACCGGCACCGGCACCGGCACCGGCACCGGCACCGGCACTTGCGCCCGCATTCGCGCGGGCACCGGCGTCAACGTCGACCAACGGCATCGCGCCGGCCGCGCGCGTCGAGCAACTCGGCTGTCCCGAGTTCAAGCGCCGCTTCGGCCTGAAGTACGCGTACGTCGCGGGCGGCATGGTGCACGGCATCGCATCGGTGCGCATGGTCGTCGCGATGGCGAAGGCCGGCATGAAGGGCTACTTCGGCACGGGCGGCCTGTCGCTCGACGCGATCCGCGACGCGGTCCGCGCGATCCGCGGCGCGCTGCCGGCGGGCGAGCCGTACGGGATGAACCTGCTGAGCGGGCGGCTGGAGGAAGCGACGGTCGATCTCTATCTGCGCGAAGGCGTGACGAGCGTCGAGGCCGCGGCGTACATGCACGTCACGCCGGCGCTCGCGCGCTTCAAGCTCGCGGGCCTCAGCGTGGACCGCGACGGCGCGACCGTGAGCGCGCACAAGATTCTCGCGAAGGTGTCGCGGCCGGAGGTCGCGACGGCGTTCATGTCGCCGATCCCGGAGAAATTCCTCGAGCGGTTCGTGCGCGACGGCGTGATCTCGGACGCGCAGGCGCGCGCGGCGCGCGCGATGCCGGTGGCGGACGCCGTGTGCGTCGAGGCCGATTCGGGCGGCCACACGGACATGGGCGCGATGCCCGCGCTGCTGCCCGCGATCCGGCGGCTGTGCGCGGACATCGCGGGCGAGCGCGGCTATCGCGACAAGGTGCCGGTGGGTGTCGCGGGCGGCATCGGCACCCCGGAGGCGGCGGCCGCGGCGTTCGTGCTCGGCGCGGACTTCATCCTGACGGGCTCGATCAACCAGTGCACGGTCGAATCGGGCATCAGCGACGTCGTGAAGGACATGCTGCAGCAGATCAACGTGCACGACACCGACTACGCGCCGGCGGGCGACATGTTCGAGCTGGGCGCGAAGGTTCAGGTGCTGCGGCGCGGCGTGTTCTTCCCGGCGCGCGCGAATCGCCTGTACGAGCTCTACAAGCAGTACGACAGCGTCGACGACCTGCCGGACGCGGTGCGGCGTCAGCTCGAAGACAAGTACTTCGGCAAGTCGCTCGCCGAGGTCTACGCCGATTGCGAGCGCTATTACCCGGCCGACGAGATCGAGCGCGCGCGCGGCAATCCGAAGCAGAAGCTCGCGCTGATCTTCCGCTGGTATTTCGGGTTCGCGACGCGCGCGGCGCTCGCCGGCAACGAGGCGGACAAGGTCAATTTCCAGGTGCAGTGCGGCCCCGCGCTCGGCGCGTTCAACCAGTGGGTCAGGAACACCGCGCTCGAGAACTGGCGCAACCGCCATGTCGCCGAGATGGCCGCGCGCATCCTGCAGGACGCGGCCGATCTGCTGAGCCGGCGTTATCTGTCGATGGTGGGCCGCTGA", "orf_prot_sequence": "MRRDAFGPSRIVWMFSGQGSQYVGMGRALYESEPTFRHHVDRFDEVTRDKTGTSLVARLYGRDARAGEPFDDTHVTHPALFAVQYALARTLQARGAQPDIVLGSSLGDFVAAALAQVAPAQEIVAWLIDQAASMARACEPGFMLAVLGPASIYRGSDTLREFSDLVGVNYAEHFVIGGNRADLVRVEAALAREGVVFHRLPVRFGFHSRNVAPVVPWLHAREANLSCRAPTIPWASCTAGGIVEAPTARFLTRIAIDPLRFQEAARAIEQTGSPDTLHWVDLGPSGTLANFARRLGVPNDRLHVVMGPFGDDARALGRVSNLHASNARPAGAPAAPVSEGVSMHAFLFPGQGSQVKGMGAALFARFPDRMRLANEILGYDLAALCIENPDNRLGQTQFTQPAMYVVNALAYLARREDDAGAPAFVAGHSLGEYSALFAAGAFSFEDGLRLVKKRGELMSAARDGGMAAVLGLDEARVAEILALSDLRGIDIANLNAPTQIVIAGPADEIRRAQQWFEQGGCYAYVVLPVSGAFHSRMMRDAQREFERFIAPFDIGAPGIPVIANVTGRPYRGDEVRRGLVEQIASPVRWVDTIRYLSEQGVERFAEIGTGTVLTDLLRKILPQKAGASGAAARPQAGAASAVAASAPPRPTGMADAQPPAASPARAATAASTMPPASASASASAPAPAPAPAPAPAPAPAPAPALAPAFARAPASTSTNGIAPAARVEQLGCPEFKRRFGLKYAYVAGGMVHGIASVRMVVAMAKAGMKGYFGTGGLSLDAIRDAVRAIRGALPAGEPYGMNLLSGRLEEATVDLYLREGVTSVEAAAYMHVTPALARFKLAGLSVDRDGATVSAHKILAKVSRPEVATAFMSPIPEKFLERFVRDGVISDAQARAARAMPVADAVCVEADSGGHTDMGAMPALLPAIRRLCADIAGERGYRDKVPVGVAGGIGTPEAAAAAFVLGADFILTGSINQCTVESGISDVVKDMLQQINVHDTDYAPAGDMFELGAKVQVLRRGVFFPARANRLYELYKQYDSVDDLPDAVRRQLEDKYFGKSLAEVYADCERYYPADEIERARGNPKQKLALIFRWYFGFATRAALAGNEADKVNFQVQCGPALGAFNQWVRNTALENWRNRHVAEMAARILQDAADLLSRRYLSMVGR", "perc_identity": 36.36}, "gnl|BL_ORD_ID|169|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 78034, "orf_end": 81537, "orf_from": "BGC0000186.1|Thailandamide_13 ", "model_name": "OXA-12", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "500", "model_id": "186", "ARO_accession": "3001407", "ARO_name": "OXA-12", "ARO_category": {"36026": {"category_aro_accession": "3000017", "category_aro_cvterm_id": "36026", "category_aro_name": "OXA beta-lactamase", "category_aro_description": "OXA beta-lactamases were long recognized as a less common but also plasmid-mediated beta-lactamase variety that could hydrolyze oxacillin and related anti-staphylococcal penicillins. These beta-lactamases differ from the TEM and SHV enzymes in that they belong to molecular class D and functional group 2d. The OXA-type beta-lactamases confer resistance to ampicillin and cephalothin and are characterized by their high hydrolytic activity against oxacillin and cloxacillin and the fact that they are poorly inhibited by clavulanic acid. Amino acid substitutions in OXA enzymes can also give the ESBL phenotype. The OXA beta-lactamase family was originally created as a phenotypic rather than a genotypic group for a few beta-lactamases that had a specific hydrolysis profile. Therefore, there is as little as 20% sequence homology among some of the members of this family. However, recent additions to this family show some degree of homology to one or more of the existing members of the OXA beta-lactamase family. Some confer resistance predominantly to ceftazidime, but OXA-17 confers greater resistance to cefotaxime and cefepime than it does resistance to ceftazidime.", "category_aro_class_name": "AMR Gene Family"}, "35930": {"category_aro_accession": "0000011", "category_aro_cvterm_id": "35930", "category_aro_name": "cloxacillin", "category_aro_description": "Cloxacillin is a semisynthetic, isoxazolyl penicillin derivative in the beta-lactam class of antibiotics. It interferes with peptidogylcan synthesis and is commonly used for treating penicillin-resistant Staphylococcus aureus infections.", "category_aro_class_name": "Antibiotic"}, "35973": {"category_aro_accession": "0000056", "category_aro_cvterm_id": "35973", "category_aro_name": "oxacillin", "category_aro_description": "Oxacillin is a penicillinase-resistant beta-lactam. It is similar to methicillin, and has replaced methicillin in clinical use. Oxacillin, especially in combination with other antibiotics, is effective against many penicillinase-producing strains of Staphylococcus aureus and Staphylococcus epidermidis.", "category_aro_class_name": "Antibiotic"}, "37084": {"category_aro_accession": "3000704", "category_aro_cvterm_id": "37084", "category_aro_name": "cefalotin", "category_aro_description": "Cefalotin is a semisynthetic cephalosporin antibiotic activate against staphylococci. It is resistant to staphylococci beta-lactamases but hydrolyzed by enterobacterial beta-lactamases.", "category_aro_class_name": "Antibiotic"}, "35939": {"category_aro_accession": "0000020", "category_aro_cvterm_id": "35939", "category_aro_name": "carbapenem", "category_aro_description": "Carbapenems are a class of beta-lactam antibiotics with a broad spectrum of antibacterial activity, and have a structure which renders them highly resistant to beta-lactamases. Carbapenem antibiotics are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "35951": {"category_aro_accession": "0000032", "category_aro_cvterm_id": "35951", "category_aro_name": "cephalosporin", "category_aro_description": "Cephalosporins are a class of beta-lactam antibiotics, containing the beta-lactam ring fused with a dihydrothiazolidine ring. Together with cephamycins they belong to a sub-group called cephems. Cephalosporin are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "36017": {"category_aro_accession": "3000008", "category_aro_cvterm_id": "36017", "category_aro_name": "penam", "category_aro_description": "Penams are a group of antibiotics derived from Penicillium fungi that share a skeleton beta-lactam moiety fused with a thiazolidine ring. This is the most defining feature of penicillins. Penicillin antibiotics are historically significant because they are the first drugs that were effective against many previously serious diseases such as syphilis and Staphylococcus infections. Penicillins are still widely used today, though many types of bacteria are now resistant. All penicillins are beta-lactam antibiotics in the penam sub-group, and are used in the treatment of bacterial infections caused by susceptible, usually Gram-positive, organisms.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.693531, "max_identities": 20, "bit_score": 30.4166, "cvterm_id": "36957", "query": "RDAFGPSR-----IVWMFSGQGSQYVGMGRALYESEPTFRHHVDRFDEVTRDKTG", "match": "R+   P R     +VW FS Q ++++GM R        F+ +VDRFD   RD +G", "sequence_from_db": "RETTTPRRWETYSVVW-FSQQITEWLGMER--------FQQYVDRFDYGNRDLSG", "sequence_from_broadstreet": "MSRLLLSGLLATGLLCAVPASAASGCFLYADGNGQTLSSEGDCSSQLPPASTFKIPLALMGYDSGFLVNEEHPALPYKPSYDGWLPAWRETTTPRRWETYSVVWFSQQITEWLGMERFQQYVDRFDYGNRDLSGNPGKHDGLTQAWLSSSLAISPEEQARFLGKMVSGKLPVSAQTLQYTANILKVSEVEGWQIHGKTGMGYPKKLDGSLNRDQQIGWFVGWASKPGKQLIFVHTVVQKPGKQFASIKAKEEVLAALPAQLKKL", "dna_sequence_from_broadstreet": "ATGTCTCGCCTGCTTCTTTCCGGCCTGCTGGCTACCGGTCTGCTCTGTGCAGTACCGGCCTCCGCCGCCAGCGGCTGTTTTCTCTATGCCGATGGCAACGGTCAGACCCTCTCCAGCGAAGGGGACTGCTCCAGCCAGCTGCCGCCCGCATCCACCTTCAAGATCCCGCTGGCGCTGATGGGTTATGACAGTGGCTTTCTGGTGAATGAAGAGCATCCGGCGCTGCCCTACAAGCCGAGCTATGACGGCTGGCTGCCCGCCTGGCGCGAAACCACTACCCCGCGCCGCTGGGAAACCTATTCGGTGGTCTGGTTCTCCCAGCAGATCACCGAGTGGCTGGGGATGGAGCGCTTCCAGCAATACGTCGACCGCTTCGACTACGGCAACCGGGATCTCTCCGGCAATCCGGGCAAGCATGACGGTCTGACCCAAGCCTGGCTCAGCTCGAGCCTCGCCATCAGTCCGGAGGAGCAGGCTCGCTTCCTCGGCAAGATGGTGAGCGGCAAGCTGCCGGTCTCGGCGCAGACCCTGCAGTACACCGCCAATATCCTCAAGGTGAGCGAGGTCGAGGGCTGGCAGATCCACGGCAAGACCGGCATGGGCTACCCGAAGAAACTGGATGGCAGCCTCAACCGCGATCAGCAGATCGGCTGGTTCGTCGGCTGGGCCAGCAAACCGGGCAAGCAGCTCATTTTCGTTCATACCGTGGTGCAGAAACCGGGCAAGCAATTCGCCTCTATCAAGGCGAAAGAAGAGGTGCTGGCCGCCCTGCCCGCGCAACTCAAGAAACTCTGA", "partial": "0", "query_start": 78040, "query_end": 78189, "hit_start": 264, "hit_end": 402, "orf_dna_sequence": "ATGCGGCGCGATGCATTCGGCCCGTCCAGAATCGTCTGGATGTTTTCGGGGCAAGGCAGCCAGTACGTCGGAATGGGGCGCGCGCTGTACGAGTCCGAGCCGACGTTCCGTCATCACGTCGACCGGTTCGACGAAGTGACGCGCGACAAGACGGGGACGTCGCTCGTCGCGCGTCTGTATGGCCGCGACGCGCGCGCGGGCGAGCCGTTCGACGACACGCACGTCACGCATCCGGCGCTGTTCGCGGTGCAGTACGCGCTCGCGAGAACGCTGCAGGCGCGCGGCGCGCAACCGGACATCGTGCTCGGCTCGAGCCTCGGCGATTTCGTCGCGGCCGCGCTCGCGCAAGTCGCACCGGCGCAGGAGATCGTCGCGTGGCTCATCGATCAGGCCGCTTCGATGGCGCGCGCGTGCGAGCCCGGCTTCATGCTCGCGGTGCTCGGCCCGGCCTCGATTTATCGAGGCAGCGACACGCTGCGCGAGTTCAGCGATCTCGTCGGCGTCAACTACGCGGAGCATTTCGTCATCGGCGGCAATCGCGCCGATCTTGTGCGGGTTGAAGCGGCGCTCGCGCGCGAGGGCGTCGTCTTCCATCGTCTGCCGGTGCGCTTCGGCTTTCATTCGCGCAACGTCGCGCCCGTCGTGCCGTGGCTGCACGCGCGCGAAGCGAACCTGTCGTGCCGCGCGCCGACGATCCCGTGGGCGTCATGCACGGCGGGCGGCATCGTCGAGGCGCCGACCGCGCGCTTTCTCACGCGCATCGCGATCGATCCGCTGCGTTTTCAGGAGGCGGCGCGTGCGATCGAGCAAACCGGCTCGCCCGACACGCTGCACTGGGTGGATCTCGGCCCGTCCGGCACGCTCGCGAACTTCGCGCGCAGGCTGGGCGTGCCGAACGACCGGTTGCACGTCGTGATGGGCCCGTTCGGCGACGACGCGCGCGCGCTCGGGCGAGTCTCGAATCTTCATGCAAGCAATGCGCGGCCGGCGGGTGCGCCGGCCGCGCCAGTCAGCGAGGGCGTATCCATGCACGCGTTTCTGTTTCCAGGGCAAGGCTCGCAGGTCAAGGGGATGGGGGCCGCGTTGTTCGCGCGGTTTCCCGATCGCATGCGGCTCGCAAACGAGATCTTGGGCTACGACCTCGCGGCGCTCTGCATCGAGAATCCCGACAACCGGCTCGGGCAGACGCAGTTCACGCAGCCGGCGATGTACGTGGTCAACGCGCTTGCGTATCTGGCGCGGCGCGAGGACGACGCCGGCGCGCCGGCGTTCGTCGCGGGGCACAGCCTCGGCGAGTACAGCGCGCTGTTCGCCGCGGGCGCGTTCTCGTTCGAGGACGGCCTGCGGCTCGTCAAGAAGCGCGGCGAACTGATGAGCGCCGCGCGCGACGGCGGCATGGCGGCGGTGCTCGGCCTCGATGAAGCGCGGGTGGCCGAGATCCTCGCGTTGTCGGACCTGCGCGGGATCGACATCGCGAATCTGAACGCGCCGACGCAGATCGTGATCGCCGGGCCGGCCGACGAGATTCGCCGCGCCCAGCAGTGGTTCGAGCAGGGCGGTTGCTATGCGTATGTGGTGCTGCCGGTGTCGGGCGCGTTCCATTCGCGGATGATGCGCGATGCGCAGCGCGAGTTCGAGCGCTTCATCGCGCCGTTCGATATCGGCGCGCCGGGCATTCCGGTGATCGCGAACGTCACGGGGCGCCCGTATCGCGGCGACGAGGTCCGCCGCGGCCTCGTCGAGCAAATCGCGAGTCCCGTCAGGTGGGTCGATACGATTCGCTATCTGTCGGAGCAGGGTGTCGAGCGTTTCGCCGAAATCGGCACGGGCACCGTGCTCACGGATCTGCTGCGCAAGATCCTGCCGCAGAAGGCCGGCGCGAGCGGCGCGGCGGCGCGGCCGCAGGCCGGTGCGGCGTCGGCCGTCGCTGCGTCGGCGCCGCCTCGGCCGACGGGGATGGCCGACGCGCAACCGCCGGCCGCGTCGCCGGCGCGTGCGGCGACGGCCGCGTCGACAATGCCGCCCGCATCCGCATCCGCATCCGCATCCGCACCGGCACCGGCACCGGCACCGGCACCGGCACCGGCACCGGCACCGGCACCGGCACCGGCACTTGCGCCCGCATTCGCGCGGGCACCGGCGTCAACGTCGACCAACGGCATCGCGCCGGCCGCGCGCGTCGAGCAACTCGGCTGTCCCGAGTTCAAGCGCCGCTTCGGCCTGAAGTACGCGTACGTCGCGGGCGGCATGGTGCACGGCATCGCATCGGTGCGCATGGTCGTCGCGATGGCGAAGGCCGGCATGAAGGGCTACTTCGGCACGGGCGGCCTGTCGCTCGACGCGATCCGCGACGCGGTCCGCGCGATCCGCGGCGCGCTGCCGGCGGGCGAGCCGTACGGGATGAACCTGCTGAGCGGGCGGCTGGAGGAAGCGACGGTCGATCTCTATCTGCGCGAAGGCGTGACGAGCGTCGAGGCCGCGGCGTACATGCACGTCACGCCGGCGCTCGCGCGCTTCAAGCTCGCGGGCCTCAGCGTGGACCGCGACGGCGCGACCGTGAGCGCGCACAAGATTCTCGCGAAGGTGTCGCGGCCGGAGGTCGCGACGGCGTTCATGTCGCCGATCCCGGAGAAATTCCTCGAGCGGTTCGTGCGCGACGGCGTGATCTCGGACGCGCAGGCGCGCGCGGCGCGCGCGATGCCGGTGGCGGACGCCGTGTGCGTCGAGGCCGATTCGGGCGGCCACACGGACATGGGCGCGATGCCCGCGCTGCTGCCCGCGATCCGGCGGCTGTGCGCGGACATCGCGGGCGAGCGCGGCTATCGCGACAAGGTGCCGGTGGGTGTCGCGGGCGGCATCGGCACCCCGGAGGCGGCGGCCGCGGCGTTCGTGCTCGGCGCGGACTTCATCCTGACGGGCTCGATCAACCAGTGCACGGTCGAATCGGGCATCAGCGACGTCGTGAAGGACATGCTGCAGCAGATCAACGTGCACGACACCGACTACGCGCCGGCGGGCGACATGTTCGAGCTGGGCGCGAAGGTTCAGGTGCTGCGGCGCGGCGTGTTCTTCCCGGCGCGCGCGAATCGCCTGTACGAGCTCTACAAGCAGTACGACAGCGTCGACGACCTGCCGGACGCGGTGCGGCGTCAGCTCGAAGACAAGTACTTCGGCAAGTCGCTCGCCGAGGTCTACGCCGATTGCGAGCGCTATTACCCGGCCGACGAGATCGAGCGCGCGCGCGGCAATCCGAAGCAGAAGCTCGCGCTGATCTTCCGCTGGTATTTCGGGTTCGCGACGCGCGCGGCGCTCGCCGGCAACGAGGCGGACAAGGTCAATTTCCAGGTGCAGTGCGGCCCCGCGCTCGGCGCGTTCAACCAGTGGGTCAGGAACACCGCGCTCGAGAACTGGCGCAACCGCCATGTCGCCGAGATGGCCGCGCGCATCCTGCAGGACGCGGCCGATCTGCTGAGCCGGCGTTATCTGTCGATGGTGGGCCGCTGA", "orf_prot_sequence": "MRRDAFGPSRIVWMFSGQGSQYVGMGRALYESEPTFRHHVDRFDEVTRDKTGTSLVARLYGRDARAGEPFDDTHVTHPALFAVQYALARTLQARGAQPDIVLGSSLGDFVAAALAQVAPAQEIVAWLIDQAASMARACEPGFMLAVLGPASIYRGSDTLREFSDLVGVNYAEHFVIGGNRADLVRVEAALAREGVVFHRLPVRFGFHSRNVAPVVPWLHAREANLSCRAPTIPWASCTAGGIVEAPTARFLTRIAIDPLRFQEAARAIEQTGSPDTLHWVDLGPSGTLANFARRLGVPNDRLHVVMGPFGDDARALGRVSNLHASNARPAGAPAAPVSEGVSMHAFLFPGQGSQVKGMGAALFARFPDRMRLANEILGYDLAALCIENPDNRLGQTQFTQPAMYVVNALAYLARREDDAGAPAFVAGHSLGEYSALFAAGAFSFEDGLRLVKKRGELMSAARDGGMAAVLGLDEARVAEILALSDLRGIDIANLNAPTQIVIAGPADEIRRAQQWFEQGGCYAYVVLPVSGAFHSRMMRDAQREFERFIAPFDIGAPGIPVIANVTGRPYRGDEVRRGLVEQIASPVRWVDTIRYLSEQGVERFAEIGTGTVLTDLLRKILPQKAGASGAAARPQAGAASAVAASAPPRPTGMADAQPPAASPARAATAASTMPPASASASASAPAPAPAPAPAPAPAPAPAPALAPAFARAPASTSTNGIAPAARVEQLGCPEFKRRFGLKYAYVAGGMVHGIASVRMVVAMAKAGMKGYFGTGGLSLDAIRDAVRAIRGALPAGEPYGMNLLSGRLEEATVDLYLREGVTSVEAAAYMHVTPALARFKLAGLSVDRDGATVSAHKILAKVSRPEVATAFMSPIPEKFLERFVRDGVISDAQARAARAMPVADAVCVEADSGGHTDMGAMPALLPAIRRLCADIAGERGYRDKVPVGVAGGIGTPEAAAAAFVLGADFILTGSINQCTVESGISDVVKDMLQQINVHDTDYAPAGDMFELGAKVQVLRRGVFFPARANRLYELYKQYDSVDDLPDAVRRQLEDKYFGKSLAEVYADCERYYPADEIERARGNPKQKLALIFRWYFGFATRAALAGNEADKVNFQVQCGPALGAFNQWVRNTALENWRNRHVAEMAARILQDAADLLSRRYLSMVGR", "perc_identity": 36.36}, "gnl|BL_ORD_ID|3966|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 78034, "orf_end": 81537, "orf_from": "BGC0000186.1|Thailandamide_13 ", "model_name": "OXA-726", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "500", "model_id": "5036", "ARO_accession": "3005931", "ARO_name": "OXA-726", "ARO_category": {"36026": {"category_aro_accession": "3000017", "category_aro_cvterm_id": "36026", "category_aro_name": "OXA beta-lactamase", "category_aro_description": "OXA beta-lactamases were long recognized as a less common but also plasmid-mediated beta-lactamase variety that could hydrolyze oxacillin and related anti-staphylococcal penicillins. These beta-lactamases differ from the TEM and SHV enzymes in that they belong to molecular class D and functional group 2d. The OXA-type beta-lactamases confer resistance to ampicillin and cephalothin and are characterized by their high hydrolytic activity against oxacillin and cloxacillin and the fact that they are poorly inhibited by clavulanic acid. Amino acid substitutions in OXA enzymes can also give the ESBL phenotype. The OXA beta-lactamase family was originally created as a phenotypic rather than a genotypic group for a few beta-lactamases that had a specific hydrolysis profile. Therefore, there is as little as 20% sequence homology among some of the members of this family. However, recent additions to this family show some degree of homology to one or more of the existing members of the OXA beta-lactamase family. Some confer resistance predominantly to ceftazidime, but OXA-17 confers greater resistance to cefotaxime and cefepime than it does resistance to ceftazidime.", "category_aro_class_name": "AMR Gene Family"}, "35930": {"category_aro_accession": "0000011", "category_aro_cvterm_id": "35930", "category_aro_name": "cloxacillin", "category_aro_description": "Cloxacillin is a semisynthetic, isoxazolyl penicillin derivative in the beta-lactam class of antibiotics. It interferes with peptidogylcan synthesis and is commonly used for treating penicillin-resistant Staphylococcus aureus infections.", "category_aro_class_name": "Antibiotic"}, "35973": {"category_aro_accession": "0000056", "category_aro_cvterm_id": "35973", "category_aro_name": "oxacillin", "category_aro_description": "Oxacillin is a penicillinase-resistant beta-lactam. It is similar to methicillin, and has replaced methicillin in clinical use. Oxacillin, especially in combination with other antibiotics, is effective against many penicillinase-producing strains of Staphylococcus aureus and Staphylococcus epidermidis.", "category_aro_class_name": "Antibiotic"}, "37084": {"category_aro_accession": "3000704", "category_aro_cvterm_id": "37084", "category_aro_name": "cefalotin", "category_aro_description": "Cefalotin is a semisynthetic cephalosporin antibiotic activate against staphylococci. It is resistant to staphylococci beta-lactamases but hydrolyzed by enterobacterial beta-lactamases.", "category_aro_class_name": "Antibiotic"}, "35939": {"category_aro_accession": "0000020", "category_aro_cvterm_id": "35939", "category_aro_name": "carbapenem", "category_aro_description": "Carbapenems are a class of beta-lactam antibiotics with a broad spectrum of antibacterial activity, and have a structure which renders them highly resistant to beta-lactamases. Carbapenem antibiotics are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "35951": {"category_aro_accession": "0000032", "category_aro_cvterm_id": "35951", "category_aro_name": "cephalosporin", "category_aro_description": "Cephalosporins are a class of beta-lactam antibiotics, containing the beta-lactam ring fused with a dihydrothiazolidine ring. Together with cephamycins they belong to a sub-group called cephems. Cephalosporin are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "36017": {"category_aro_accession": "3000008", "category_aro_cvterm_id": "36017", "category_aro_name": "penam", "category_aro_description": "Penams are a group of antibiotics derived from Penicillium fungi that share a skeleton beta-lactam moiety fused with a thiazolidine ring. This is the most defining feature of penicillins. Penicillin antibiotics are historically significant because they are the first drugs that were effective against many previously serious diseases such as syphilis and Staphylococcus infections. Penicillins are still widely used today, though many types of bacteria are now resistant. All penicillins are beta-lactam antibiotics in the penam sub-group, and are used in the treatment of bacterial infections caused by susceptible, usually Gram-positive, organisms.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.737345, "max_identities": 20, "bit_score": 30.4166, "cvterm_id": "36810", "query": "RDAFGPSR-----IVWMFSGQGSQYVGMGRALYESEPTFRHHVDRFDEVTRDKTG", "match": "R+   P R     +VW FS Q ++++GM R        F+ +VDRFD   RD +G", "sequence_from_db": "RETTTPRRWETYSVVW-FSQQITEWLGMER--------FQQYVDRFDYGNRDLSG", "sequence_from_broadstreet": "MSRLLLSGLLGAGLLFSLPASAATGCFLYADGNGQTLSSEGDCSSQLPPASTFKIPLALMGYDSGFLVDEEHPALPFKPGYDDWLPAWRETTTPRRWETYSVVWFSQQITEWLGMERFQQYVDRFDYGNRDLSGNPGKHDGLTQAWLSASLAISPQEQARFLGKMVSGKLPVSAQTLQYTANILKVSEIDGWQIHGKTGMGYPKKLDGSLNRDQQIGWFVGWASKPGKQLIFVHTVVQKPGKQFASLKAKEEVLAALPAKLKTL", "dna_sequence_from_broadstreet": "ATGTCCCGCCTTCTGTTATCCGGCCTGCTCGGCGCAGGCCTGCTGTTCTCGCTGCCGGCCAGCGCCGCCACCGGCTGTTTTCTCTATGCCGACGGCAACGGCCAGACCCTCTCCAGCGAAGGGGATTGTTCAAGCCAGCTGCCACCCGCGTCCACCTTCAAGATCCCGCTGGCGCTGATGGGCTACGACAGTGGCTTTCTGGTGGACGAAGAGCACCCGGCACTGCCTTTCAAGCCGGGTTACGACGACTGGCTGCCCGCCTGGCGGGAAACCACCACCCCGCGCCGCTGGGAAACCTACTCGGTGGTCTGGTTCTCCCAGCAGATCACCGAATGGCTGGGGATGGAGCGCTTCCAGCAGTACGTCGACCGTTTTGACTACGGCAACCGGGATCTCTCCGGCAATCCTGGCAAGCACGACGGTCTGACCCAGGCCTGGCTCAGTGCCAGCCTTGCCATCAGTCCACAGGAGCAGGCCCGCTTCCTCGGCAAGATGGTGAGCGGCAAGCTGCCGGTGTCGGCGCAAACCCTGCAGTACACCGCCAACATCCTCAAGGTGAGCGAGATCGACGGCTGGCAGATCCACGGCAAGACCGGCATGGGCTACCCGAAGAAGCTGGATGGCAGCCTCAACCGCGATCAGCAGATCGGCTGGTTCGTCGGCTGGGCCAGCAAGCCGGGCAAGCAGCTCATCTTCGTCCATACCGTGGTGCAGAAACCCGGCAAGCAGTTCGCCTCGCTCAAGGCCAAGGAAGAGGTGCTGGCCGCCCTGCCGGCCAAACTGAAAACCCTGTGA", "partial": "0", "query_start": 78040, "query_end": 78189, "hit_start": 264, "hit_end": 402, "orf_dna_sequence": "ATGCGGCGCGATGCATTCGGCCCGTCCAGAATCGTCTGGATGTTTTCGGGGCAAGGCAGCCAGTACGTCGGAATGGGGCGCGCGCTGTACGAGTCCGAGCCGACGTTCCGTCATCACGTCGACCGGTTCGACGAAGTGACGCGCGACAAGACGGGGACGTCGCTCGTCGCGCGTCTGTATGGCCGCGACGCGCGCGCGGGCGAGCCGTTCGACGACACGCACGTCACGCATCCGGCGCTGTTCGCGGTGCAGTACGCGCTCGCGAGAACGCTGCAGGCGCGCGGCGCGCAACCGGACATCGTGCTCGGCTCGAGCCTCGGCGATTTCGTCGCGGCCGCGCTCGCGCAAGTCGCACCGGCGCAGGAGATCGTCGCGTGGCTCATCGATCAGGCCGCTTCGATGGCGCGCGCGTGCGAGCCCGGCTTCATGCTCGCGGTGCTCGGCCCGGCCTCGATTTATCGAGGCAGCGACACGCTGCGCGAGTTCAGCGATCTCGTCGGCGTCAACTACGCGGAGCATTTCGTCATCGGCGGCAATCGCGCCGATCTTGTGCGGGTTGAAGCGGCGCTCGCGCGCGAGGGCGTCGTCTTCCATCGTCTGCCGGTGCGCTTCGGCTTTCATTCGCGCAACGTCGCGCCCGTCGTGCCGTGGCTGCACGCGCGCGAAGCGAACCTGTCGTGCCGCGCGCCGACGATCCCGTGGGCGTCATGCACGGCGGGCGGCATCGTCGAGGCGCCGACCGCGCGCTTTCTCACGCGCATCGCGATCGATCCGCTGCGTTTTCAGGAGGCGGCGCGTGCGATCGAGCAAACCGGCTCGCCCGACACGCTGCACTGGGTGGATCTCGGCCCGTCCGGCACGCTCGCGAACTTCGCGCGCAGGCTGGGCGTGCCGAACGACCGGTTGCACGTCGTGATGGGCCCGTTCGGCGACGACGCGCGCGCGCTCGGGCGAGTCTCGAATCTTCATGCAAGCAATGCGCGGCCGGCGGGTGCGCCGGCCGCGCCAGTCAGCGAGGGCGTATCCATGCACGCGTTTCTGTTTCCAGGGCAAGGCTCGCAGGTCAAGGGGATGGGGGCCGCGTTGTTCGCGCGGTTTCCCGATCGCATGCGGCTCGCAAACGAGATCTTGGGCTACGACCTCGCGGCGCTCTGCATCGAGAATCCCGACAACCGGCTCGGGCAGACGCAGTTCACGCAGCCGGCGATGTACGTGGTCAACGCGCTTGCGTATCTGGCGCGGCGCGAGGACGACGCCGGCGCGCCGGCGTTCGTCGCGGGGCACAGCCTCGGCGAGTACAGCGCGCTGTTCGCCGCGGGCGCGTTCTCGTTCGAGGACGGCCTGCGGCTCGTCAAGAAGCGCGGCGAACTGATGAGCGCCGCGCGCGACGGCGGCATGGCGGCGGTGCTCGGCCTCGATGAAGCGCGGGTGGCCGAGATCCTCGCGTTGTCGGACCTGCGCGGGATCGACATCGCGAATCTGAACGCGCCGACGCAGATCGTGATCGCCGGGCCGGCCGACGAGATTCGCCGCGCCCAGCAGTGGTTCGAGCAGGGCGGTTGCTATGCGTATGTGGTGCTGCCGGTGTCGGGCGCGTTCCATTCGCGGATGATGCGCGATGCGCAGCGCGAGTTCGAGCGCTTCATCGCGCCGTTCGATATCGGCGCGCCGGGCATTCCGGTGATCGCGAACGTCACGGGGCGCCCGTATCGCGGCGACGAGGTCCGCCGCGGCCTCGTCGAGCAAATCGCGAGTCCCGTCAGGTGGGTCGATACGATTCGCTATCTGTCGGAGCAGGGTGTCGAGCGTTTCGCCGAAATCGGCACGGGCACCGTGCTCACGGATCTGCTGCGCAAGATCCTGCCGCAGAAGGCCGGCGCGAGCGGCGCGGCGGCGCGGCCGCAGGCCGGTGCGGCGTCGGCCGTCGCTGCGTCGGCGCCGCCTCGGCCGACGGGGATGGCCGACGCGCAACCGCCGGCCGCGTCGCCGGCGCGTGCGGCGACGGCCGCGTCGACAATGCCGCCCGCATCCGCATCCGCATCCGCATCCGCACCGGCACCGGCACCGGCACCGGCACCGGCACCGGCACCGGCACCGGCACCGGCACCGGCACTTGCGCCCGCATTCGCGCGGGCACCGGCGTCAACGTCGACCAACGGCATCGCGCCGGCCGCGCGCGTCGAGCAACTCGGCTGTCCCGAGTTCAAGCGCCGCTTCGGCCTGAAGTACGCGTACGTCGCGGGCGGCATGGTGCACGGCATCGCATCGGTGCGCATGGTCGTCGCGATGGCGAAGGCCGGCATGAAGGGCTACTTCGGCACGGGCGGCCTGTCGCTCGACGCGATCCGCGACGCGGTCCGCGCGATCCGCGGCGCGCTGCCGGCGGGCGAGCCGTACGGGATGAACCTGCTGAGCGGGCGGCTGGAGGAAGCGACGGTCGATCTCTATCTGCGCGAAGGCGTGACGAGCGTCGAGGCCGCGGCGTACATGCACGTCACGCCGGCGCTCGCGCGCTTCAAGCTCGCGGGCCTCAGCGTGGACCGCGACGGCGCGACCGTGAGCGCGCACAAGATTCTCGCGAAGGTGTCGCGGCCGGAGGTCGCGACGGCGTTCATGTCGCCGATCCCGGAGAAATTCCTCGAGCGGTTCGTGCGCGACGGCGTGATCTCGGACGCGCAGGCGCGCGCGGCGCGCGCGATGCCGGTGGCGGACGCCGTGTGCGTCGAGGCCGATTCGGGCGGCCACACGGACATGGGCGCGATGCCCGCGCTGCTGCCCGCGATCCGGCGGCTGTGCGCGGACATCGCGGGCGAGCGCGGCTATCGCGACAAGGTGCCGGTGGGTGTCGCGGGCGGCATCGGCACCCCGGAGGCGGCGGCCGCGGCGTTCGTGCTCGGCGCGGACTTCATCCTGACGGGCTCGATCAACCAGTGCACGGTCGAATCGGGCATCAGCGACGTCGTGAAGGACATGCTGCAGCAGATCAACGTGCACGACACCGACTACGCGCCGGCGGGCGACATGTTCGAGCTGGGCGCGAAGGTTCAGGTGCTGCGGCGCGGCGTGTTCTTCCCGGCGCGCGCGAATCGCCTGTACGAGCTCTACAAGCAGTACGACAGCGTCGACGACCTGCCGGACGCGGTGCGGCGTCAGCTCGAAGACAAGTACTTCGGCAAGTCGCTCGCCGAGGTCTACGCCGATTGCGAGCGCTATTACCCGGCCGACGAGATCGAGCGCGCGCGCGGCAATCCGAAGCAGAAGCTCGCGCTGATCTTCCGCTGGTATTTCGGGTTCGCGACGCGCGCGGCGCTCGCCGGCAACGAGGCGGACAAGGTCAATTTCCAGGTGCAGTGCGGCCCCGCGCTCGGCGCGTTCAACCAGTGGGTCAGGAACACCGCGCTCGAGAACTGGCGCAACCGCCATGTCGCCGAGATGGCCGCGCGCATCCTGCAGGACGCGGCCGATCTGCTGAGCCGGCGTTATCTGTCGATGGTGGGCCGCTGA", "orf_prot_sequence": "MRRDAFGPSRIVWMFSGQGSQYVGMGRALYESEPTFRHHVDRFDEVTRDKTGTSLVARLYGRDARAGEPFDDTHVTHPALFAVQYALARTLQARGAQPDIVLGSSLGDFVAAALAQVAPAQEIVAWLIDQAASMARACEPGFMLAVLGPASIYRGSDTLREFSDLVGVNYAEHFVIGGNRADLVRVEAALAREGVVFHRLPVRFGFHSRNVAPVVPWLHAREANLSCRAPTIPWASCTAGGIVEAPTARFLTRIAIDPLRFQEAARAIEQTGSPDTLHWVDLGPSGTLANFARRLGVPNDRLHVVMGPFGDDARALGRVSNLHASNARPAGAPAAPVSEGVSMHAFLFPGQGSQVKGMGAALFARFPDRMRLANEILGYDLAALCIENPDNRLGQTQFTQPAMYVVNALAYLARREDDAGAPAFVAGHSLGEYSALFAAGAFSFEDGLRLVKKRGELMSAARDGGMAAVLGLDEARVAEILALSDLRGIDIANLNAPTQIVIAGPADEIRRAQQWFEQGGCYAYVVLPVSGAFHSRMMRDAQREFERFIAPFDIGAPGIPVIANVTGRPYRGDEVRRGLVEQIASPVRWVDTIRYLSEQGVERFAEIGTGTVLTDLLRKILPQKAGASGAAARPQAGAASAVAASAPPRPTGMADAQPPAASPARAATAASTMPPASASASASAPAPAPAPAPAPAPAPAPAPALAPAFARAPASTSTNGIAPAARVEQLGCPEFKRRFGLKYAYVAGGMVHGIASVRMVVAMAKAGMKGYFGTGGLSLDAIRDAVRAIRGALPAGEPYGMNLLSGRLEEATVDLYLREGVTSVEAAAYMHVTPALARFKLAGLSVDRDGATVSAHKILAKVSRPEVATAFMSPIPEKFLERFVRDGVISDAQARAARAMPVADAVCVEADSGGHTDMGAMPALLPAIRRLCADIAGERGYRDKVPVGVAGGIGTPEAAAAAFVLGADFILTGSINQCTVESGISDVVKDMLQQINVHDTDYAPAGDMFELGAKVQVLRRGVFFPARANRLYELYKQYDSVDDLPDAVRRQLEDKYFGKSLAEVYADCERYYPADEIERARGNPKQKLALIFRWYFGFATRAALAGNEADKVNFQVQCGPALGAFNQWVRNTALENWRNRHVAEMAARILQDAADLLSRRYLSMVGR", "perc_identity": 36.36}, "gnl|BL_ORD_ID|2611|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 78034, "orf_end": 81537, "orf_from": "BGC0000186.1|Thailandamide_13 ", "model_name": "OXA-724", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "525", "model_id": "3633", "ARO_accession": "3004837", "ARO_name": "OXA-724", "ARO_category": {"36026": {"category_aro_accession": "3000017", "category_aro_cvterm_id": "36026", "category_aro_name": "OXA beta-lactamase", "category_aro_description": "OXA beta-lactamases were long recognized as a less common but also plasmid-mediated beta-lactamase variety that could hydrolyze oxacillin and related anti-staphylococcal penicillins. These beta-lactamases differ from the TEM and SHV enzymes in that they belong to molecular class D and functional group 2d. The OXA-type beta-lactamases confer resistance to ampicillin and cephalothin and are characterized by their high hydrolytic activity against oxacillin and cloxacillin and the fact that they are poorly inhibited by clavulanic acid. Amino acid substitutions in OXA enzymes can also give the ESBL phenotype. The OXA beta-lactamase family was originally created as a phenotypic rather than a genotypic group for a few beta-lactamases that had a specific hydrolysis profile. Therefore, there is as little as 20% sequence homology among some of the members of this family. However, recent additions to this family show some degree of homology to one or more of the existing members of the OXA beta-lactamase family. Some confer resistance predominantly to ceftazidime, but OXA-17 confers greater resistance to cefotaxime and cefepime than it does resistance to ceftazidime.", "category_aro_class_name": "AMR Gene Family"}, "35930": {"category_aro_accession": "0000011", "category_aro_cvterm_id": "35930", "category_aro_name": "cloxacillin", "category_aro_description": "Cloxacillin is a semisynthetic, isoxazolyl penicillin derivative in the beta-lactam class of antibiotics. It interferes with peptidogylcan synthesis and is commonly used for treating penicillin-resistant Staphylococcus aureus infections.", "category_aro_class_name": "Antibiotic"}, "35973": {"category_aro_accession": "0000056", "category_aro_cvterm_id": "35973", "category_aro_name": "oxacillin", "category_aro_description": "Oxacillin is a penicillinase-resistant beta-lactam. It is similar to methicillin, and has replaced methicillin in clinical use. Oxacillin, especially in combination with other antibiotics, is effective against many penicillinase-producing strains of Staphylococcus aureus and Staphylococcus epidermidis.", "category_aro_class_name": "Antibiotic"}, "37084": {"category_aro_accession": "3000704", "category_aro_cvterm_id": "37084", "category_aro_name": "cefalotin", "category_aro_description": "Cefalotin is a semisynthetic cephalosporin antibiotic activate against staphylococci. It is resistant to staphylococci beta-lactamases but hydrolyzed by enterobacterial beta-lactamases.", "category_aro_class_name": "Antibiotic"}, "35939": {"category_aro_accession": "0000020", "category_aro_cvterm_id": "35939", "category_aro_name": "carbapenem", "category_aro_description": "Carbapenems are a class of beta-lactam antibiotics with a broad spectrum of antibacterial activity, and have a structure which renders them highly resistant to beta-lactamases. Carbapenem antibiotics are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "35951": {"category_aro_accession": "0000032", "category_aro_cvterm_id": "35951", "category_aro_name": "cephalosporin", "category_aro_description": "Cephalosporins are a class of beta-lactam antibiotics, containing the beta-lactam ring fused with a dihydrothiazolidine ring. Together with cephamycins they belong to a sub-group called cephems. Cephalosporin are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "36017": {"category_aro_accession": "3000008", "category_aro_cvterm_id": "36017", "category_aro_name": "penam", "category_aro_description": "Penams are a group of antibiotics derived from Penicillium fungi that share a skeleton beta-lactam moiety fused with a thiazolidine ring. This is the most defining feature of penicillins. Penicillin antibiotics are historically significant because they are the first drugs that were effective against many previously serious diseases such as syphilis and Staphylococcus infections. Penicillins are still widely used today, though many types of bacteria are now resistant. All penicillins are beta-lactam antibiotics in the penam sub-group, and are used in the treatment of bacterial infections caused by susceptible, usually Gram-positive, organisms.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.840759, "max_identities": 17, "bit_score": 30.4166, "cvterm_id": "36810", "query": "IVWMFSGQGSQYVGMGRALYESEPTFRHHVDRFDEVTRDKTG", "match": "+VW FS Q ++++GM R        F+ +VDRFD   RD +G", "sequence_from_db": "VVW-FSQQITEWLGMER--------FQQYVDRFDYGNRDLSG", "sequence_from_broadstreet": "MSRLLLSGLLGAGLLFSLPASAATGCFLYADGNGQALSSEGDCSSQLPPASTFKIPLALMGYDSGFLVDEEHPALPFKPGYDDWLPAWRETTTPRRWETYSVVWFSQQITEWLGMERFQQYVDRFDYGNRDLSGNPGKHDGLTQAWLSSSLAISPQEQARFLGKMVSGKLPVSAQTLQYTANILKVSESDGWQIHGKTGMGYPKKLDGSLNREQQIGWFVGWASKPGKQLIFVHTVVQKPGKQFASLKAKEEVLAALPAKLKTL", "dna_sequence_from_broadstreet": "ATGTCCCGCCTTCTCTTATCCGGCCTGCTCGGCGCAGGCCTGCTGTTCTCGCTGCCGGCCAGCGCCGCCACCGGCTGCTTTCTCTATGCCGACGGCAACGGCCAGGCCCTCTCCAGCGAAGGGGATTGTTCAAGCCAGCTGCCACCCGCGTCCACCTTCAAGATCCCGCTGGCGCTGATGGGCTACGACAGCGGCTTTCTGGTGGACGAAGAGCACCCGGCACTGCCTTTCAAGCCGGGTTACGACGACTGGCTGCCCGCCTGGCGGGAAACAACCACCCCGCGCCGCTGGGAAACCTACTCGGTGGTCTGGTTCTCCCAGCAGATCACCGAATGGCTGGGGATGGAGCGCTTCCAGCAGTACGTCGACCGTTTTGACTACGGCAACCGGGATCTCTCCGGCAATCCTGGCAAGCACGACGGTCTGACCCAGGCCTGGCTCAGTTCCAGCCTTGCCATCAGTCCACAGGAGCAGGCCCGCTTCCTCGGCAAGATGGTGAGCGGCAAGCTGCCGGTGTCGGCGCAAACCCTGCAGTACACCGCCAACATCCTCAAGGTGAGCGAGAGCGACGGCTGGCAGATCCACGGCAAGACCGGCATGGGCTACCCGAAGAAGCTGGATGGCAGCCTCAACCGGGAGCAGCAGATCGGCTGGTTCGTCGGCTGGGCCAGCAAGCCGGGCAAACAGCTGATCTTCGTCCATACCGTGGTGCAGAAACCCGGCAAACAGTTCGCCTCGCTCAAGGCCAAGGAAGAGGTGCTGGCCGCCCTGCCGGCCAAACTGAAAACCCTGTGA", "partial": "0", "query_start": 78064, "query_end": 78189, "hit_start": 303, "hit_end": 402, "orf_dna_sequence": "ATGCGGCGCGATGCATTCGGCCCGTCCAGAATCGTCTGGATGTTTTCGGGGCAAGGCAGCCAGTACGTCGGAATGGGGCGCGCGCTGTACGAGTCCGAGCCGACGTTCCGTCATCACGTCGACCGGTTCGACGAAGTGACGCGCGACAAGACGGGGACGTCGCTCGTCGCGCGTCTGTATGGCCGCGACGCGCGCGCGGGCGAGCCGTTCGACGACACGCACGTCACGCATCCGGCGCTGTTCGCGGTGCAGTACGCGCTCGCGAGAACGCTGCAGGCGCGCGGCGCGCAACCGGACATCGTGCTCGGCTCGAGCCTCGGCGATTTCGTCGCGGCCGCGCTCGCGCAAGTCGCACCGGCGCAGGAGATCGTCGCGTGGCTCATCGATCAGGCCGCTTCGATGGCGCGCGCGTGCGAGCCCGGCTTCATGCTCGCGGTGCTCGGCCCGGCCTCGATTTATCGAGGCAGCGACACGCTGCGCGAGTTCAGCGATCTCGTCGGCGTCAACTACGCGGAGCATTTCGTCATCGGCGGCAATCGCGCCGATCTTGTGCGGGTTGAAGCGGCGCTCGCGCGCGAGGGCGTCGTCTTCCATCGTCTGCCGGTGCGCTTCGGCTTTCATTCGCGCAACGTCGCGCCCGTCGTGCCGTGGCTGCACGCGCGCGAAGCGAACCTGTCGTGCCGCGCGCCGACGATCCCGTGGGCGTCATGCACGGCGGGCGGCATCGTCGAGGCGCCGACCGCGCGCTTTCTCACGCGCATCGCGATCGATCCGCTGCGTTTTCAGGAGGCGGCGCGTGCGATCGAGCAAACCGGCTCGCCCGACACGCTGCACTGGGTGGATCTCGGCCCGTCCGGCACGCTCGCGAACTTCGCGCGCAGGCTGGGCGTGCCGAACGACCGGTTGCACGTCGTGATGGGCCCGTTCGGCGACGACGCGCGCGCGCTCGGGCGAGTCTCGAATCTTCATGCAAGCAATGCGCGGCCGGCGGGTGCGCCGGCCGCGCCAGTCAGCGAGGGCGTATCCATGCACGCGTTTCTGTTTCCAGGGCAAGGCTCGCAGGTCAAGGGGATGGGGGCCGCGTTGTTCGCGCGGTTTCCCGATCGCATGCGGCTCGCAAACGAGATCTTGGGCTACGACCTCGCGGCGCTCTGCATCGAGAATCCCGACAACCGGCTCGGGCAGACGCAGTTCACGCAGCCGGCGATGTACGTGGTCAACGCGCTTGCGTATCTGGCGCGGCGCGAGGACGACGCCGGCGCGCCGGCGTTCGTCGCGGGGCACAGCCTCGGCGAGTACAGCGCGCTGTTCGCCGCGGGCGCGTTCTCGTTCGAGGACGGCCTGCGGCTCGTCAAGAAGCGCGGCGAACTGATGAGCGCCGCGCGCGACGGCGGCATGGCGGCGGTGCTCGGCCTCGATGAAGCGCGGGTGGCCGAGATCCTCGCGTTGTCGGACCTGCGCGGGATCGACATCGCGAATCTGAACGCGCCGACGCAGATCGTGATCGCCGGGCCGGCCGACGAGATTCGCCGCGCCCAGCAGTGGTTCGAGCAGGGCGGTTGCTATGCGTATGTGGTGCTGCCGGTGTCGGGCGCGTTCCATTCGCGGATGATGCGCGATGCGCAGCGCGAGTTCGAGCGCTTCATCGCGCCGTTCGATATCGGCGCGCCGGGCATTCCGGTGATCGCGAACGTCACGGGGCGCCCGTATCGCGGCGACGAGGTCCGCCGCGGCCTCGTCGAGCAAATCGCGAGTCCCGTCAGGTGGGTCGATACGATTCGCTATCTGTCGGAGCAGGGTGTCGAGCGTTTCGCCGAAATCGGCACGGGCACCGTGCTCACGGATCTGCTGCGCAAGATCCTGCCGCAGAAGGCCGGCGCGAGCGGCGCGGCGGCGCGGCCGCAGGCCGGTGCGGCGTCGGCCGTCGCTGCGTCGGCGCCGCCTCGGCCGACGGGGATGGCCGACGCGCAACCGCCGGCCGCGTCGCCGGCGCGTGCGGCGACGGCCGCGTCGACAATGCCGCCCGCATCCGCATCCGCATCCGCATCCGCACCGGCACCGGCACCGGCACCGGCACCGGCACCGGCACCGGCACCGGCACCGGCACCGGCACTTGCGCCCGCATTCGCGCGGGCACCGGCGTCAACGTCGACCAACGGCATCGCGCCGGCCGCGCGCGTCGAGCAACTCGGCTGTCCCGAGTTCAAGCGCCGCTTCGGCCTGAAGTACGCGTACGTCGCGGGCGGCATGGTGCACGGCATCGCATCGGTGCGCATGGTCGTCGCGATGGCGAAGGCCGGCATGAAGGGCTACTTCGGCACGGGCGGCCTGTCGCTCGACGCGATCCGCGACGCGGTCCGCGCGATCCGCGGCGCGCTGCCGGCGGGCGAGCCGTACGGGATGAACCTGCTGAGCGGGCGGCTGGAGGAAGCGACGGTCGATCTCTATCTGCGCGAAGGCGTGACGAGCGTCGAGGCCGCGGCGTACATGCACGTCACGCCGGCGCTCGCGCGCTTCAAGCTCGCGGGCCTCAGCGTGGACCGCGACGGCGCGACCGTGAGCGCGCACAAGATTCTCGCGAAGGTGTCGCGGCCGGAGGTCGCGACGGCGTTCATGTCGCCGATCCCGGAGAAATTCCTCGAGCGGTTCGTGCGCGACGGCGTGATCTCGGACGCGCAGGCGCGCGCGGCGCGCGCGATGCCGGTGGCGGACGCCGTGTGCGTCGAGGCCGATTCGGGCGGCCACACGGACATGGGCGCGATGCCCGCGCTGCTGCCCGCGATCCGGCGGCTGTGCGCGGACATCGCGGGCGAGCGCGGCTATCGCGACAAGGTGCCGGTGGGTGTCGCGGGCGGCATCGGCACCCCGGAGGCGGCGGCCGCGGCGTTCGTGCTCGGCGCGGACTTCATCCTGACGGGCTCGATCAACCAGTGCACGGTCGAATCGGGCATCAGCGACGTCGTGAAGGACATGCTGCAGCAGATCAACGTGCACGACACCGACTACGCGCCGGCGGGCGACATGTTCGAGCTGGGCGCGAAGGTTCAGGTGCTGCGGCGCGGCGTGTTCTTCCCGGCGCGCGCGAATCGCCTGTACGAGCTCTACAAGCAGTACGACAGCGTCGACGACCTGCCGGACGCGGTGCGGCGTCAGCTCGAAGACAAGTACTTCGGCAAGTCGCTCGCCGAGGTCTACGCCGATTGCGAGCGCTATTACCCGGCCGACGAGATCGAGCGCGCGCGCGGCAATCCGAAGCAGAAGCTCGCGCTGATCTTCCGCTGGTATTTCGGGTTCGCGACGCGCGCGGCGCTCGCCGGCAACGAGGCGGACAAGGTCAATTTCCAGGTGCAGTGCGGCCCCGCGCTCGGCGCGTTCAACCAGTGGGTCAGGAACACCGCGCTCGAGAACTGGCGCAACCGCCATGTCGCCGAGATGGCCGCGCGCATCCTGCAGGACGCGGCCGATCTGCTGAGCCGGCGTTATCTGTCGATGGTGGGCCGCTGA", "orf_prot_sequence": "MRRDAFGPSRIVWMFSGQGSQYVGMGRALYESEPTFRHHVDRFDEVTRDKTGTSLVARLYGRDARAGEPFDDTHVTHPALFAVQYALARTLQARGAQPDIVLGSSLGDFVAAALAQVAPAQEIVAWLIDQAASMARACEPGFMLAVLGPASIYRGSDTLREFSDLVGVNYAEHFVIGGNRADLVRVEAALAREGVVFHRLPVRFGFHSRNVAPVVPWLHAREANLSCRAPTIPWASCTAGGIVEAPTARFLTRIAIDPLRFQEAARAIEQTGSPDTLHWVDLGPSGTLANFARRLGVPNDRLHVVMGPFGDDARALGRVSNLHASNARPAGAPAAPVSEGVSMHAFLFPGQGSQVKGMGAALFARFPDRMRLANEILGYDLAALCIENPDNRLGQTQFTQPAMYVVNALAYLARREDDAGAPAFVAGHSLGEYSALFAAGAFSFEDGLRLVKKRGELMSAARDGGMAAVLGLDEARVAEILALSDLRGIDIANLNAPTQIVIAGPADEIRRAQQWFEQGGCYAYVVLPVSGAFHSRMMRDAQREFERFIAPFDIGAPGIPVIANVTGRPYRGDEVRRGLVEQIASPVRWVDTIRYLSEQGVERFAEIGTGTVLTDLLRKILPQKAGASGAAARPQAGAASAVAASAPPRPTGMADAQPPAASPARAATAASTMPPASASASASAPAPAPAPAPAPAPAPAPAPALAPAFARAPASTSTNGIAPAARVEQLGCPEFKRRFGLKYAYVAGGMVHGIASVRMVVAMAKAGMKGYFGTGGLSLDAIRDAVRAIRGALPAGEPYGMNLLSGRLEEATVDLYLREGVTSVEAAAYMHVTPALARFKLAGLSVDRDGATVSAHKILAKVSRPEVATAFMSPIPEKFLERFVRDGVISDAQARAARAMPVADAVCVEADSGGHTDMGAMPALLPAIRRLCADIAGERGYRDKVPVGVAGGIGTPEAAAAAFVLGADFILTGSINQCTVESGISDVVKDMLQQINVHDTDYAPAGDMFELGAKVQVLRRGVFFPARANRLYELYKQYDSVDDLPDAVRRQLEDKYFGKSLAEVYADCERYYPADEIERARGNPKQKLALIFRWYFGFATRAALAGNEADKVNFQVQCGPALGAFNQWVRNTALENWRNRHVAEMAARILQDAADLLSRRYLSMVGR", "perc_identity": 40.48}, "gnl|BL_ORD_ID|2516|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 78034, "orf_end": 81537, "orf_from": "BGC0000186.1|Thailandamide_13 ", "model_name": "BIC-1", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "600", "model_id": "3561", "ARO_accession": "3004753", "ARO_name": "BIC-1", "ARO_category": {"42864": {"category_aro_accession": "3004752", "category_aro_cvterm_id": "42864", "category_aro_name": "BIC Beta-lactamase", "category_aro_description": "BIC is a class A beta-lactamase conferring resistance to carbapenem.", "category_aro_class_name": "AMR Gene Family"}, "35939": {"category_aro_accession": "0000020", "category_aro_cvterm_id": "35939", "category_aro_name": "carbapenem", "category_aro_description": "Carbapenems are a class of beta-lactam antibiotics with a broad spectrum of antibacterial activity, and have a structure which renders them highly resistant to beta-lactamases. Carbapenem antibiotics are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 1.75628, "max_identities": 23, "bit_score": 29.261, "cvterm_id": "36937", "query": "PFDDTHVTHPALFAVQYALARTLQARGAQPDIVLGSSLGDFVAAALAQVAPAQEIVAWLIDQAASMAR", "match": "P DD   + P      +A+AR+LQ       I LG +L         Q AP Q++V WLI      AR", "sequence_from_db": "PGDDRDTSTP------HAIARSLQK------IALGEAL---------QTAPRQQLVDWLIGNTTGGAR", "sequence_from_broadstreet": "MARPSKLALSFSLLLPFLPFTSFAETWPQGDIARQKIVKLEKDFGGRIGVSAIDTGANRTFDFRADERFPLCSSFKGFLAGAVLSHSQQQEGLLEKRIDYKNRVMEPHSPISAQHSSTGMTVAQLAAAALQYSDNGATNLLLENVLGGPAGMTTFMRTLGDTTFRLDRWELELNSAIPGDDRDTSTPHAIARSLQKIALGEALQTAPRQQLVDWLIGNTTGGARIRAGVPVEWVVGDKTGTCGVYGTANDYAVIWPKTSAPIVLAIYTAKPNKEDKHSDAVIAEVTRAVLESFE", "dna_sequence_from_broadstreet": "ATGGCACGTCCTTCTAAACTAGCTTTATCATTTTCTCTTCTGTTGCCTTTTTTACCCTTCACCAGCTTCGCTGAAACCTGGCCACAGGGCGATATCGCCCGACAAAAAATCGTAAAGCTGGAAAAGGATTTTGGTGGGCGGATTGGAGTATCTGCCATCGATACGGGCGCCAATCGAACTTTTGACTTTCGAGCGGACGAACGTTTCCCTTTATGCAGCTCCTTTAAGGGCTTTCTGGCTGGCGCCGTGCTCTCCCACAGCCAACAGCAGGAAGGCTTACTGGAGAAACGTATCGACTATAAGAATCGGGTGATGGAACCTCACTCTCCCATCAGCGCACAACATAGTTCGACGGGTATGACCGTGGCGCAATTAGCGGCAGCGGCGCTGCAGTACAGCGACAACGGTGCGACAAATTTGCTTCTGGAAAACGTTCTGGGCGGGCCCGCCGGGATGACGACCTTCATGAGGACCTTAGGCGATACAACGTTTCGCTTAGATCGATGGGAACTCGAACTCAATAGCGCCATTCCGGGCGACGATCGAGATACCTCGACCCCCCACGCCATAGCCCGCAGCTTGCAAAAAATAGCGTTGGGTGAGGCGTTGCAAACCGCACCGCGTCAGCAGCTGGTTGATTGGCTCATCGGAAATACGACAGGTGGAGCGCGGATCCGGGCAGGCGTTCCTGTCGAGTGGGTTGTAGGGGATAAAACGGGCACGTGCGGTGTGTACGGCACCGCCAATGATTATGCCGTCATATGGCCAAAAACATCCGCCCCGATTGTCTTGGCGATTTACACCGCGAAACCGAACAAGGAGGACAAACATAGCGATGCCGTTATTGCCGAAGTGACCCGTGCCGTTCTGGAAAGCTTTGAATAA", "partial": "0", "query_start": 78238, "query_end": 78441, "hit_start": 531, "hit_end": 672, "orf_dna_sequence": "ATGCGGCGCGATGCATTCGGCCCGTCCAGAATCGTCTGGATGTTTTCGGGGCAAGGCAGCCAGTACGTCGGAATGGGGCGCGCGCTGTACGAGTCCGAGCCGACGTTCCGTCATCACGTCGACCGGTTCGACGAAGTGACGCGCGACAAGACGGGGACGTCGCTCGTCGCGCGTCTGTATGGCCGCGACGCGCGCGCGGGCGAGCCGTTCGACGACACGCACGTCACGCATCCGGCGCTGTTCGCGGTGCAGTACGCGCTCGCGAGAACGCTGCAGGCGCGCGGCGCGCAACCGGACATCGTGCTCGGCTCGAGCCTCGGCGATTTCGTCGCGGCCGCGCTCGCGCAAGTCGCACCGGCGCAGGAGATCGTCGCGTGGCTCATCGATCAGGCCGCTTCGATGGCGCGCGCGTGCGAGCCCGGCTTCATGCTCGCGGTGCTCGGCCCGGCCTCGATTTATCGAGGCAGCGACACGCTGCGCGAGTTCAGCGATCTCGTCGGCGTCAACTACGCGGAGCATTTCGTCATCGGCGGCAATCGCGCCGATCTTGTGCGGGTTGAAGCGGCGCTCGCGCGCGAGGGCGTCGTCTTCCATCGTCTGCCGGTGCGCTTCGGCTTTCATTCGCGCAACGTCGCGCCCGTCGTGCCGTGGCTGCACGCGCGCGAAGCGAACCTGTCGTGCCGCGCGCCGACGATCCCGTGGGCGTCATGCACGGCGGGCGGCATCGTCGAGGCGCCGACCGCGCGCTTTCTCACGCGCATCGCGATCGATCCGCTGCGTTTTCAGGAGGCGGCGCGTGCGATCGAGCAAACCGGCTCGCCCGACACGCTGCACTGGGTGGATCTCGGCCCGTCCGGCACGCTCGCGAACTTCGCGCGCAGGCTGGGCGTGCCGAACGACCGGTTGCACGTCGTGATGGGCCCGTTCGGCGACGACGCGCGCGCGCTCGGGCGAGTCTCGAATCTTCATGCAAGCAATGCGCGGCCGGCGGGTGCGCCGGCCGCGCCAGTCAGCGAGGGCGTATCCATGCACGCGTTTCTGTTTCCAGGGCAAGGCTCGCAGGTCAAGGGGATGGGGGCCGCGTTGTTCGCGCGGTTTCCCGATCGCATGCGGCTCGCAAACGAGATCTTGGGCTACGACCTCGCGGCGCTCTGCATCGAGAATCCCGACAACCGGCTCGGGCAGACGCAGTTCACGCAGCCGGCGATGTACGTGGTCAACGCGCTTGCGTATCTGGCGCGGCGCGAGGACGACGCCGGCGCGCCGGCGTTCGTCGCGGGGCACAGCCTCGGCGAGTACAGCGCGCTGTTCGCCGCGGGCGCGTTCTCGTTCGAGGACGGCCTGCGGCTCGTCAAGAAGCGCGGCGAACTGATGAGCGCCGCGCGCGACGGCGGCATGGCGGCGGTGCTCGGCCTCGATGAAGCGCGGGTGGCCGAGATCCTCGCGTTGTCGGACCTGCGCGGGATCGACATCGCGAATCTGAACGCGCCGACGCAGATCGTGATCGCCGGGCCGGCCGACGAGATTCGCCGCGCCCAGCAGTGGTTCGAGCAGGGCGGTTGCTATGCGTATGTGGTGCTGCCGGTGTCGGGCGCGTTCCATTCGCGGATGATGCGCGATGCGCAGCGCGAGTTCGAGCGCTTCATCGCGCCGTTCGATATCGGCGCGCCGGGCATTCCGGTGATCGCGAACGTCACGGGGCGCCCGTATCGCGGCGACGAGGTCCGCCGCGGCCTCGTCGAGCAAATCGCGAGTCCCGTCAGGTGGGTCGATACGATTCGCTATCTGTCGGAGCAGGGTGTCGAGCGTTTCGCCGAAATCGGCACGGGCACCGTGCTCACGGATCTGCTGCGCAAGATCCTGCCGCAGAAGGCCGGCGCGAGCGGCGCGGCGGCGCGGCCGCAGGCCGGTGCGGCGTCGGCCGTCGCTGCGTCGGCGCCGCCTCGGCCGACGGGGATGGCCGACGCGCAACCGCCGGCCGCGTCGCCGGCGCGTGCGGCGACGGCCGCGTCGACAATGCCGCCCGCATCCGCATCCGCATCCGCATCCGCACCGGCACCGGCACCGGCACCGGCACCGGCACCGGCACCGGCACCGGCACCGGCACCGGCACTTGCGCCCGCATTCGCGCGGGCACCGGCGTCAACGTCGACCAACGGCATCGCGCCGGCCGCGCGCGTCGAGCAACTCGGCTGTCCCGAGTTCAAGCGCCGCTTCGGCCTGAAGTACGCGTACGTCGCGGGCGGCATGGTGCACGGCATCGCATCGGTGCGCATGGTCGTCGCGATGGCGAAGGCCGGCATGAAGGGCTACTTCGGCACGGGCGGCCTGTCGCTCGACGCGATCCGCGACGCGGTCCGCGCGATCCGCGGCGCGCTGCCGGCGGGCGAGCCGTACGGGATGAACCTGCTGAGCGGGCGGCTGGAGGAAGCGACGGTCGATCTCTATCTGCGCGAAGGCGTGACGAGCGTCGAGGCCGCGGCGTACATGCACGTCACGCCGGCGCTCGCGCGCTTCAAGCTCGCGGGCCTCAGCGTGGACCGCGACGGCGCGACCGTGAGCGCGCACAAGATTCTCGCGAAGGTGTCGCGGCCGGAGGTCGCGACGGCGTTCATGTCGCCGATCCCGGAGAAATTCCTCGAGCGGTTCGTGCGCGACGGCGTGATCTCGGACGCGCAGGCGCGCGCGGCGCGCGCGATGCCGGTGGCGGACGCCGTGTGCGTCGAGGCCGATTCGGGCGGCCACACGGACATGGGCGCGATGCCCGCGCTGCTGCCCGCGATCCGGCGGCTGTGCGCGGACATCGCGGGCGAGCGCGGCTATCGCGACAAGGTGCCGGTGGGTGTCGCGGGCGGCATCGGCACCCCGGAGGCGGCGGCCGCGGCGTTCGTGCTCGGCGCGGACTTCATCCTGACGGGCTCGATCAACCAGTGCACGGTCGAATCGGGCATCAGCGACGTCGTGAAGGACATGCTGCAGCAGATCAACGTGCACGACACCGACTACGCGCCGGCGGGCGACATGTTCGAGCTGGGCGCGAAGGTTCAGGTGCTGCGGCGCGGCGTGTTCTTCCCGGCGCGCGCGAATCGCCTGTACGAGCTCTACAAGCAGTACGACAGCGTCGACGACCTGCCGGACGCGGTGCGGCGTCAGCTCGAAGACAAGTACTTCGGCAAGTCGCTCGCCGAGGTCTACGCCGATTGCGAGCGCTATTACCCGGCCGACGAGATCGAGCGCGCGCGCGGCAATCCGAAGCAGAAGCTCGCGCTGATCTTCCGCTGGTATTTCGGGTTCGCGACGCGCGCGGCGCTCGCCGGCAACGAGGCGGACAAGGTCAATTTCCAGGTGCAGTGCGGCCCCGCGCTCGGCGCGTTCAACCAGTGGGTCAGGAACACCGCGCTCGAGAACTGGCGCAACCGCCATGTCGCCGAGATGGCCGCGCGCATCCTGCAGGACGCGGCCGATCTGCTGAGCCGGCGTTATCTGTCGATGGTGGGCCGCTGA", "orf_prot_sequence": "MRRDAFGPSRIVWMFSGQGSQYVGMGRALYESEPTFRHHVDRFDEVTRDKTGTSLVARLYGRDARAGEPFDDTHVTHPALFAVQYALARTLQARGAQPDIVLGSSLGDFVAAALAQVAPAQEIVAWLIDQAASMARACEPGFMLAVLGPASIYRGSDTLREFSDLVGVNYAEHFVIGGNRADLVRVEAALAREGVVFHRLPVRFGFHSRNVAPVVPWLHAREANLSCRAPTIPWASCTAGGIVEAPTARFLTRIAIDPLRFQEAARAIEQTGSPDTLHWVDLGPSGTLANFARRLGVPNDRLHVVMGPFGDDARALGRVSNLHASNARPAGAPAAPVSEGVSMHAFLFPGQGSQVKGMGAALFARFPDRMRLANEILGYDLAALCIENPDNRLGQTQFTQPAMYVVNALAYLARREDDAGAPAFVAGHSLGEYSALFAAGAFSFEDGLRLVKKRGELMSAARDGGMAAVLGLDEARVAEILALSDLRGIDIANLNAPTQIVIAGPADEIRRAQQWFEQGGCYAYVVLPVSGAFHSRMMRDAQREFERFIAPFDIGAPGIPVIANVTGRPYRGDEVRRGLVEQIASPVRWVDTIRYLSEQGVERFAEIGTGTVLTDLLRKILPQKAGASGAAARPQAGAASAVAASAPPRPTGMADAQPPAASPARAATAASTMPPASASASASAPAPAPAPAPAPAPAPAPAPALAPAFARAPASTSTNGIAPAARVEQLGCPEFKRRFGLKYAYVAGGMVHGIASVRMVVAMAKAGMKGYFGTGGLSLDAIRDAVRAIRGALPAGEPYGMNLLSGRLEEATVDLYLREGVTSVEAAAYMHVTPALARFKLAGLSVDRDGATVSAHKILAKVSRPEVATAFMSPIPEKFLERFVRDGVISDAQARAARAMPVADAVCVEADSGGHTDMGAMPALLPAIRRLCADIAGERGYRDKVPVGVAGGIGTPEAAAAAFVLGADFILTGSINQCTVESGISDVVKDMLQQINVHDTDYAPAGDMFELGAKVQVLRRGVFFPARANRLYELYKQYDSVDDLPDAVRRQLEDKYFGKSLAEVYADCERYYPADEIERARGNPKQKLALIFRWYFGFATRAALAGNEADKVNFQVQCGPALGAFNQWVRNTALENWRNRHVAEMAARILQDAADLLSRRYLSMVGR", "perc_identity": 33.82}, "gnl|BL_ORD_ID|4062|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 78034, "orf_end": 81537, "orf_from": "BGC0000186.1|Thailandamide_13 ", "model_name": "OXA-830", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "500", "model_id": "5132", "ARO_accession": "3006027", "ARO_name": "OXA-830", "ARO_category": {"36026": {"category_aro_accession": "3000017", "category_aro_cvterm_id": "36026", "category_aro_name": "OXA beta-lactamase", "category_aro_description": "OXA beta-lactamases were long recognized as a less common but also plasmid-mediated beta-lactamase variety that could hydrolyze oxacillin and related anti-staphylococcal penicillins. These beta-lactamases differ from the TEM and SHV enzymes in that they belong to molecular class D and functional group 2d. The OXA-type beta-lactamases confer resistance to ampicillin and cephalothin and are characterized by their high hydrolytic activity against oxacillin and cloxacillin and the fact that they are poorly inhibited by clavulanic acid. Amino acid substitutions in OXA enzymes can also give the ESBL phenotype. The OXA beta-lactamase family was originally created as a phenotypic rather than a genotypic group for a few beta-lactamases that had a specific hydrolysis profile. Therefore, there is as little as 20% sequence homology among some of the members of this family. However, recent additions to this family show some degree of homology to one or more of the existing members of the OXA beta-lactamase family. Some confer resistance predominantly to ceftazidime, but OXA-17 confers greater resistance to cefotaxime and cefepime than it does resistance to ceftazidime.", "category_aro_class_name": "AMR Gene Family"}, "35930": {"category_aro_accession": "0000011", "category_aro_cvterm_id": "35930", "category_aro_name": "cloxacillin", "category_aro_description": "Cloxacillin is a semisynthetic, isoxazolyl penicillin derivative in the beta-lactam class of antibiotics. It interferes with peptidogylcan synthesis and is commonly used for treating penicillin-resistant Staphylococcus aureus infections.", "category_aro_class_name": "Antibiotic"}, "35973": {"category_aro_accession": "0000056", "category_aro_cvterm_id": "35973", "category_aro_name": "oxacillin", "category_aro_description": "Oxacillin is a penicillinase-resistant beta-lactam. It is similar to methicillin, and has replaced methicillin in clinical use. Oxacillin, especially in combination with other antibiotics, is effective against many penicillinase-producing strains of Staphylococcus aureus and Staphylococcus epidermidis.", "category_aro_class_name": "Antibiotic"}, "37084": {"category_aro_accession": "3000704", "category_aro_cvterm_id": "37084", "category_aro_name": "cefalotin", "category_aro_description": "Cefalotin is a semisynthetic cephalosporin antibiotic activate against staphylococci. It is resistant to staphylococci beta-lactamases but hydrolyzed by enterobacterial beta-lactamases.", "category_aro_class_name": "Antibiotic"}, "35939": {"category_aro_accession": "0000020", "category_aro_cvterm_id": "35939", "category_aro_name": "carbapenem", "category_aro_description": "Carbapenems are a class of beta-lactam antibiotics with a broad spectrum of antibacterial activity, and have a structure which renders them highly resistant to beta-lactamases. Carbapenem antibiotics are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "35951": {"category_aro_accession": "0000032", "category_aro_cvterm_id": "35951", "category_aro_name": "cephalosporin", "category_aro_description": "Cephalosporins are a class of beta-lactam antibiotics, containing the beta-lactam ring fused with a dihydrothiazolidine ring. Together with cephamycins they belong to a sub-group called cephems. Cephalosporin are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "36017": {"category_aro_accession": "3000008", "category_aro_cvterm_id": "36017", "category_aro_name": "penam", "category_aro_description": "Penams are a group of antibiotics derived from Penicillium fungi that share a skeleton beta-lactam moiety fused with a thiazolidine ring. This is the most defining feature of penicillins. Penicillin antibiotics are historically significant because they are the first drugs that were effective against many previously serious diseases such as syphilis and Staphylococcus infections. Penicillins are still widely used today, though many types of bacteria are now resistant. All penicillins are beta-lactam antibiotics in the penam sub-group, and are used in the treatment of bacterial infections caused by susceptible, usually Gram-positive, organisms.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 3.72824, "max_identities": 18, "bit_score": 28.1054, "cvterm_id": "35506", "query": "PSR-----IVWMFSGQGSQYVGMGRALYESEPTFRHHVDRFDEVTRDKTG", "match": "PSR     +VW FS   ++++GM        P  +H+VD+FD   RD +G", "sequence_from_db": "PSRWMTYSVVW-FSQLMTEWLGM--------PRLQHYVDQFDYGNRDLSG", "sequence_from_broadstreet": "MTPILLRGLLAAGLLFALPAAANDGCFLFADGSGKTLSREGACSMRLPPASTFKIPLALMGYDSGYLVDEQRPALPFKPGYNGWLPAWHETTTPSRWMTYSVVWFSQLMTEWLGMPRLQHYVDQFDYGNRDLSGHPGKQDGLTQAWLSSSLQISPEEQARFLGRMLEGKLPVAASTLQHTANLLKVSEIDGWQIHGKTGMGYPKKLDGSLNRQRQIGWFVGWASKGSERRIFVHTVIQPPGKQFASLKAKEEVLAALPAKLAEQAN", "dna_sequence_from_broadstreet": "ATGACCCCCATTCTGCTGCGTGGCCTATTGGCCGCCGGTCTGCTTTTCGCCCTGCCAGCGGCCGCCAACGATGGCTGCTTCCTGTTTGCCGATGGCAGTGGCAAGACGCTCTCCCGTGAGGGCGCGTGCAGCATGCGTCTCCCACCGGCATCGACCTTCAAGATCCCGCTGGCCCTGATGGGCTATGACAGCGGCTATCTGGTTGATGAACAGCGGCCCGCGCTCCCCTTCAAGCCCGGTTATAACGGCTGGCTGCCCGCCTGGCACGAGACCACCACCCCGAGCCGCTGGATGACCTACTCGGTGGTGTGGTTCTCCCAGTTGATGACCGAGTGGCTCGGCATGCCGCGCCTTCAGCATTACGTCGACCAATTCGACTACGGCAACCGGGATCTCAGCGGCCATCCGGGCAAACAGGATGGCCTGACCCAGGCCTGGCTCAGCAGCAGCCTGCAAATCAGCCCCGAAGAGCAGGCCCGCTTCCTCGGCCGCATGCTGGAAGGCAAGTTGCCGGTGGCGGCGAGCACCCTGCAACATACCGCCAATCTCCTCAAGGTGAGCGAGATCGACGGCTGGCAGATCCATGGCAAGACCGGCATGGGCTATCCCAAGAAACTCGATGGCAGCCTCAACCGGCAACGACAGATCGGCTGGTTTGTCGGCTGGGCCAGCAAGGGCAGCGAACGACGCATCTTCGTGCATACCGTGATCCAGCCGCCCGGCAAGCAGTTCGCCTCGCTCAAAGCCAAGGAGGAGGTGCTGGCCGCCCTACCGGCCAAGCTGGCTGAGCAAGCTAACTAA", "partial": "0", "query_start": 78055, "query_end": 78189, "hit_start": 279, "hit_end": 402, "orf_dna_sequence": "ATGCGGCGCGATGCATTCGGCCCGTCCAGAATCGTCTGGATGTTTTCGGGGCAAGGCAGCCAGTACGTCGGAATGGGGCGCGCGCTGTACGAGTCCGAGCCGACGTTCCGTCATCACGTCGACCGGTTCGACGAAGTGACGCGCGACAAGACGGGGACGTCGCTCGTCGCGCGTCTGTATGGCCGCGACGCGCGCGCGGGCGAGCCGTTCGACGACACGCACGTCACGCATCCGGCGCTGTTCGCGGTGCAGTACGCGCTCGCGAGAACGCTGCAGGCGCGCGGCGCGCAACCGGACATCGTGCTCGGCTCGAGCCTCGGCGATTTCGTCGCGGCCGCGCTCGCGCAAGTCGCACCGGCGCAGGAGATCGTCGCGTGGCTCATCGATCAGGCCGCTTCGATGGCGCGCGCGTGCGAGCCCGGCTTCATGCTCGCGGTGCTCGGCCCGGCCTCGATTTATCGAGGCAGCGACACGCTGCGCGAGTTCAGCGATCTCGTCGGCGTCAACTACGCGGAGCATTTCGTCATCGGCGGCAATCGCGCCGATCTTGTGCGGGTTGAAGCGGCGCTCGCGCGCGAGGGCGTCGTCTTCCATCGTCTGCCGGTGCGCTTCGGCTTTCATTCGCGCAACGTCGCGCCCGTCGTGCCGTGGCTGCACGCGCGCGAAGCGAACCTGTCGTGCCGCGCGCCGACGATCCCGTGGGCGTCATGCACGGCGGGCGGCATCGTCGAGGCGCCGACCGCGCGCTTTCTCACGCGCATCGCGATCGATCCGCTGCGTTTTCAGGAGGCGGCGCGTGCGATCGAGCAAACCGGCTCGCCCGACACGCTGCACTGGGTGGATCTCGGCCCGTCCGGCACGCTCGCGAACTTCGCGCGCAGGCTGGGCGTGCCGAACGACCGGTTGCACGTCGTGATGGGCCCGTTCGGCGACGACGCGCGCGCGCTCGGGCGAGTCTCGAATCTTCATGCAAGCAATGCGCGGCCGGCGGGTGCGCCGGCCGCGCCAGTCAGCGAGGGCGTATCCATGCACGCGTTTCTGTTTCCAGGGCAAGGCTCGCAGGTCAAGGGGATGGGGGCCGCGTTGTTCGCGCGGTTTCCCGATCGCATGCGGCTCGCAAACGAGATCTTGGGCTACGACCTCGCGGCGCTCTGCATCGAGAATCCCGACAACCGGCTCGGGCAGACGCAGTTCACGCAGCCGGCGATGTACGTGGTCAACGCGCTTGCGTATCTGGCGCGGCGCGAGGACGACGCCGGCGCGCCGGCGTTCGTCGCGGGGCACAGCCTCGGCGAGTACAGCGCGCTGTTCGCCGCGGGCGCGTTCTCGTTCGAGGACGGCCTGCGGCTCGTCAAGAAGCGCGGCGAACTGATGAGCGCCGCGCGCGACGGCGGCATGGCGGCGGTGCTCGGCCTCGATGAAGCGCGGGTGGCCGAGATCCTCGCGTTGTCGGACCTGCGCGGGATCGACATCGCGAATCTGAACGCGCCGACGCAGATCGTGATCGCCGGGCCGGCCGACGAGATTCGCCGCGCCCAGCAGTGGTTCGAGCAGGGCGGTTGCTATGCGTATGTGGTGCTGCCGGTGTCGGGCGCGTTCCATTCGCGGATGATGCGCGATGCGCAGCGCGAGTTCGAGCGCTTCATCGCGCCGTTCGATATCGGCGCGCCGGGCATTCCGGTGATCGCGAACGTCACGGGGCGCCCGTATCGCGGCGACGAGGTCCGCCGCGGCCTCGTCGAGCAAATCGCGAGTCCCGTCAGGTGGGTCGATACGATTCGCTATCTGTCGGAGCAGGGTGTCGAGCGTTTCGCCGAAATCGGCACGGGCACCGTGCTCACGGATCTGCTGCGCAAGATCCTGCCGCAGAAGGCCGGCGCGAGCGGCGCGGCGGCGCGGCCGCAGGCCGGTGCGGCGTCGGCCGTCGCTGCGTCGGCGCCGCCTCGGCCGACGGGGATGGCCGACGCGCAACCGCCGGCCGCGTCGCCGGCGCGTGCGGCGACGGCCGCGTCGACAATGCCGCCCGCATCCGCATCCGCATCCGCATCCGCACCGGCACCGGCACCGGCACCGGCACCGGCACCGGCACCGGCACCGGCACCGGCACCGGCACTTGCGCCCGCATTCGCGCGGGCACCGGCGTCAACGTCGACCAACGGCATCGCGCCGGCCGCGCGCGTCGAGCAACTCGGCTGTCCCGAGTTCAAGCGCCGCTTCGGCCTGAAGTACGCGTACGTCGCGGGCGGCATGGTGCACGGCATCGCATCGGTGCGCATGGTCGTCGCGATGGCGAAGGCCGGCATGAAGGGCTACTTCGGCACGGGCGGCCTGTCGCTCGACGCGATCCGCGACGCGGTCCGCGCGATCCGCGGCGCGCTGCCGGCGGGCGAGCCGTACGGGATGAACCTGCTGAGCGGGCGGCTGGAGGAAGCGACGGTCGATCTCTATCTGCGCGAAGGCGTGACGAGCGTCGAGGCCGCGGCGTACATGCACGTCACGCCGGCGCTCGCGCGCTTCAAGCTCGCGGGCCTCAGCGTGGACCGCGACGGCGCGACCGTGAGCGCGCACAAGATTCTCGCGAAGGTGTCGCGGCCGGAGGTCGCGACGGCGTTCATGTCGCCGATCCCGGAGAAATTCCTCGAGCGGTTCGTGCGCGACGGCGTGATCTCGGACGCGCAGGCGCGCGCGGCGCGCGCGATGCCGGTGGCGGACGCCGTGTGCGTCGAGGCCGATTCGGGCGGCCACACGGACATGGGCGCGATGCCCGCGCTGCTGCCCGCGATCCGGCGGCTGTGCGCGGACATCGCGGGCGAGCGCGGCTATCGCGACAAGGTGCCGGTGGGTGTCGCGGGCGGCATCGGCACCCCGGAGGCGGCGGCCGCGGCGTTCGTGCTCGGCGCGGACTTCATCCTGACGGGCTCGATCAACCAGTGCACGGTCGAATCGGGCATCAGCGACGTCGTGAAGGACATGCTGCAGCAGATCAACGTGCACGACACCGACTACGCGCCGGCGGGCGACATGTTCGAGCTGGGCGCGAAGGTTCAGGTGCTGCGGCGCGGCGTGTTCTTCCCGGCGCGCGCGAATCGCCTGTACGAGCTCTACAAGCAGTACGACAGCGTCGACGACCTGCCGGACGCGGTGCGGCGTCAGCTCGAAGACAAGTACTTCGGCAAGTCGCTCGCCGAGGTCTACGCCGATTGCGAGCGCTATTACCCGGCCGACGAGATCGAGCGCGCGCGCGGCAATCCGAAGCAGAAGCTCGCGCTGATCTTCCGCTGGTATTTCGGGTTCGCGACGCGCGCGGCGCTCGCCGGCAACGAGGCGGACAAGGTCAATTTCCAGGTGCAGTGCGGCCCCGCGCTCGGCGCGTTCAACCAGTGGGTCAGGAACACCGCGCTCGAGAACTGGCGCAACCGCCATGTCGCCGAGATGGCCGCGCGCATCCTGCAGGACGCGGCCGATCTGCTGAGCCGGCGTTATCTGTCGATGGTGGGCCGCTGA", "orf_prot_sequence": "MRRDAFGPSRIVWMFSGQGSQYVGMGRALYESEPTFRHHVDRFDEVTRDKTGTSLVARLYGRDARAGEPFDDTHVTHPALFAVQYALARTLQARGAQPDIVLGSSLGDFVAAALAQVAPAQEIVAWLIDQAASMARACEPGFMLAVLGPASIYRGSDTLREFSDLVGVNYAEHFVIGGNRADLVRVEAALAREGVVFHRLPVRFGFHSRNVAPVVPWLHAREANLSCRAPTIPWASCTAGGIVEAPTARFLTRIAIDPLRFQEAARAIEQTGSPDTLHWVDLGPSGTLANFARRLGVPNDRLHVVMGPFGDDARALGRVSNLHASNARPAGAPAAPVSEGVSMHAFLFPGQGSQVKGMGAALFARFPDRMRLANEILGYDLAALCIENPDNRLGQTQFTQPAMYVVNALAYLARREDDAGAPAFVAGHSLGEYSALFAAGAFSFEDGLRLVKKRGELMSAARDGGMAAVLGLDEARVAEILALSDLRGIDIANLNAPTQIVIAGPADEIRRAQQWFEQGGCYAYVVLPVSGAFHSRMMRDAQREFERFIAPFDIGAPGIPVIANVTGRPYRGDEVRRGLVEQIASPVRWVDTIRYLSEQGVERFAEIGTGTVLTDLLRKILPQKAGASGAAARPQAGAASAVAASAPPRPTGMADAQPPAASPARAATAASTMPPASASASASAPAPAPAPAPAPAPAPAPAPALAPAFARAPASTSTNGIAPAARVEQLGCPEFKRRFGLKYAYVAGGMVHGIASVRMVVAMAKAGMKGYFGTGGLSLDAIRDAVRAIRGALPAGEPYGMNLLSGRLEEATVDLYLREGVTSVEAAAYMHVTPALARFKLAGLSVDRDGATVSAHKILAKVSRPEVATAFMSPIPEKFLERFVRDGVISDAQARAARAMPVADAVCVEADSGGHTDMGAMPALLPAIRRLCADIAGERGYRDKVPVGVAGGIGTPEAAAAAFVLGADFILTGSINQCTVESGISDVVKDMLQQINVHDTDYAPAGDMFELGAKVQVLRRGVFFPARANRLYELYKQYDSVDDLPDAVRRQLEDKYFGKSLAEVYADCERYYPADEIERARGNPKQKLALIFRWYFGFATRAALAGNEADKVNFQVQCGPALGAFNQWVRNTALENWRNRHVAEMAARILQDAADLLSRRYLSMVGR", "perc_identity": 36.0}}, "BGC0000186.1|Thailandamide_14 # 81544 # 82341 # -1 # ID=1_14;partial=00;start_type=ATG;rbs_motif=GAG;rbs_spacer=10bp;gc_cont=0.674": {"gnl|BL_ORD_ID|2152|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 81544, "orf_end": 82341, "orf_from": "BGC0000186.1|Thailandamide_14 ", "model_name": "oqxB", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "2000", "model_id": "2400", "ARO_accession": "3003923", "ARO_name": "oqxB", "ARO_category": {"36005": {"category_aro_accession": "0010004", "category_aro_cvterm_id": "36005", "category_aro_name": "resistance-nodulation-cell division (RND) antibiotic efflux pump", "category_aro_description": "Directed pumping of antibiotic out of a cell to confer resistance. Resistance-nodulation-division (RND) proteins are found in both prokaryotic and eukaryotic cells and have diverse substrate specificities and physiological roles. However, there are relatively few RND transporters and they are secondary transporters, energized not by ATP binding/hydrolysis but by proton movement down the transmembrane electrochemical gradient.", "category_aro_class_name": "AMR Gene Family"}, "35949": {"category_aro_accession": "0000030", "category_aro_cvterm_id": "35949", "category_aro_name": "tigecycline", "category_aro_description": "Tigecycline is an glycylcycline antibiotic. It works by inhibiting action of the prokaryotic 30S ribosome.", "category_aro_class_name": "Antibiotic"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35992": {"category_aro_accession": "0000075", "category_aro_cvterm_id": "35992", "category_aro_name": "nitrofurantoin", "category_aro_description": "Nitrofurantoin is an antibiotic used to treat urinary tract infections. It inhibits enzyme synthesis by inhibiting essential enzymes involved in the citric acid cycle, as well as those involved in DNA, RNA, and protein synthesis. It is marketed under the following brand names: Furadantin, Macrobid, Macrodantin, Nitro Macro and Urantoin.", "category_aro_class_name": "Antibiotic"}, "36327": {"category_aro_accession": "3000188", "category_aro_cvterm_id": "36327", "category_aro_name": "trimethoprim", "category_aro_description": "Trimethoprim is a synthetic 5-(3,4,5- trimethoxybenzyl) pyrimidine inhibitor of dihydrofolate reductase, inhibiting synthesis of tetrahydrofolic acid. Tetrahydrofolic acid is an essential precursor in the de novo synthesis of the DNA nucleotide thymidine. Trimethoprim is a bacteriostatic antibiotic mainly used in the prophylaxis and treatment of urinary tract infections in combination with sulfamethoxazole, a sulfonamide antibiotic.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35960": {"category_aro_accession": "0000042", "category_aro_cvterm_id": "35960", "category_aro_name": "glycylcycline", "category_aro_description": "Glycylcyclines are a new class of antibiotics derived from tetracycline. These tetracycline analogues are specifically designed to overcome two common mechanisms of tetracycline resistance. Presently, there is only one glycylcycline antibiotic for clinical use: tigecycline. It works by inhibiting action of the prokaryotic 30S ribosome, preventing the binding of aminoacyl-tRNA.", "category_aro_class_name": "Drug Class"}, "36189": {"category_aro_accession": "3000050", "category_aro_cvterm_id": "36189", "category_aro_name": "tetracycline antibiotic", "category_aro_description": "These antibiotics are derived from tetracycline, a polyketide antibiotic that inhibits the 30S subunit of bacterial ribosomes.", "category_aro_class_name": "Drug Class"}, "36310": {"category_aro_accession": "3000171", "category_aro_cvterm_id": "36310", "category_aro_name": "diaminopyrimidine antibiotic", "category_aro_description": "Diaminopyrimidines are a class of organic compounds containing a pyrimidine ring substituted by two amine groups.  They are inhibitors of dihydrofolate reductase, an enzyme critical for DNA synthesis.", "category_aro_class_name": "Drug Class"}, "41240": {"category_aro_accession": "3004116", "category_aro_cvterm_id": "41240", "category_aro_name": "nitrofuran antibiotic", "category_aro_description": "Nitrofurans are chemotherapeutic agents with antibacterial and antiprotozoal activity.", "category_aro_class_name": "Drug Class"}, "36298": {"category_aro_accession": "3000159", "category_aro_cvterm_id": "36298", "category_aro_name": "efflux pump complex or subunit conferring antibiotic resistance", "category_aro_description": "Efflux proteins that pump antibiotic out of a cell to confer resistance.", "category_aro_class_name": "Efflux Component"}, "36001": {"category_aro_accession": "0010000", "category_aro_cvterm_id": "36001", "category_aro_name": "antibiotic efflux", "category_aro_description": "Antibiotic resistance via the transport of antibiotics out of the cell.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 1.25808, "max_identities": 20, "bit_score": 27.7202, "cvterm_id": "35914", "query": "RDDRIVRFRDVAQADAHAHAWAFGAFAVDARYRVAVAVDASGGACSIELVRAGATDGARPLQASVVCRSP-DLRFA", "match": "+D  +VR RDVA+ +  + ++A  +  ++ +  V + +  S GA +I+L     ++  R   A +  R P D+++A", "sequence_from_db": "QDGSLVRLRDVARIEMGSGSYALRS-QLNNKDAVGIGIFQSPGANAIDL-----SNAVRAKMAELATRFPEDMQWA", "sequence_from_broadstreet": "MDFSRFFIDRPIFAAVLSILIFITGLIAIPLLPVSEYPDVVPPSVQVRAEYPGANPKVIAETVATPLEEAINGVENMMYMKSVAGSDGVLVTTVTFRPGTDPDQAQVQVQNRVAQAEARLPEDVRRLGITTQKQSPTLTLVVHLFSPGGKYDSLYMRNYATLKVKDELARLPGVGQIQIFGSGEYAMRVWLDPNKVAARGLTASDVVTAMQEQNVQVSAGQLGAEPLPQESDFLISINAQGRLHTEEEFGNIILKTAQDGSLVRLRDVARIEMGSGSYALRSQLNNKDAVGIGIFQSPGANAIDLSNAVRAKMAELATRFPEDMQWAAPYDPTVFVRDSIRAVVQTLLEAVVLVVLVVILFLQTWRASIIPLIAVPVSVVGTFSILYLLGFSLNTLSLFGLVLAIGIVVDDAIVVVENVERNIEEGLAPLAAAHQAMREVSGPIIAIALVLCAVFVPMAFLSGVTGQFYKQFAVTIAISTVISAINSLTLSPALAALLLKPHGAKKDLPTRLIDRLFGWIFRPFNRFFLRSSNGYQGLVGKTLGRRGAVFAVYLLLLCAAGVMFKVVPGGFIPTQDKLYLIGGVKMPEGSSLARTDAVIRKMSEIGMNTEGVDYAVAFPGLNALQFTNTPNTGTVFFGLKPFDQRKHTAAEINAEINAKIAQIQQGFGFSILPPPILGLGQGSGYSLYIQDRGGLGYGALQSAVNAMSGAIMQTPGMHFPISTYQANVPQLDVQVDRDKAKAQGVSLTDLFGTLQTYLGSSYVNDFNQFGRTWRVMAQADGPYRESVEDIANLRTRNNQGEMVPIGSMVNISTTYGPDPVIRYNGYPAADLIGDADPRVLSSSQAMTHLEELSKQILPNGMNIEWTDLSFQQATQGNTALIVFPVAVLLAFLVLAALYESWTLPLAVILIVPMTMLSALFGVWLTGGDNNVFVQVGLVVLMGLACKNAILIVEFARELEIQGKGIMEAALEACRLRLRPIVMTSIAFIAGTIPLILGHGAGAEVRGVTGITVFSGMLGVTLFGLFLTPVFYVTLRKLVTRRKPVQEDLPA", "dna_sequence_from_broadstreet": "ATGGACTTTTCCCGCTTTTTTATCGACAGGCCGATTTTCGCCGCGGTGCTGTCGATTTTAATTTTTATCACCGGGTTAATCGCTATCCCACTGCTGCCGGTGAGCGAATATCCGGATGTCGTCCCGCCGAGCGTCCAGGTGCGCGCGGAGTATCCCGGCGCCAACCCGAAAGTGATTGCCGAGACCGTGGCGACGCCGCTGGAGGAAGCGATCAACGGCGTTGAAAACATGATGTACATGAAATCGGTCGCCGGCTCCGACGGCGTGCTGGTCACCACCGTCACCTTCCGCCCGGGTACCGACCCGGATCAGGCGCAGGTTCAGGTGCAGAACCGCGTCGCGCAGGCCGAAGCGCGTCTGCCGGAGGATGTACGCCGTCTGGGGATCACCACCCAGAAGCAGTCTCCGACGCTGACCCTGGTGGTGCATCTGTTCTCCCCCGGCGGGAAGTACGACTCGCTGTATATGCGCAACTACGCCACGCTGAAAGTGAAGGATGAGCTGGCGCGCCTGCCCGGCGTCGGCCAGATCCAGATTTTTGGCTCCGGTGAATATGCGATGCGCGTCTGGCTGGATCCCAATAAGGTCGCTGCCCGCGGTCTGACGGCCTCGGATGTGGTGACGGCGATGCAGGAGCAAAACGTCCAGGTGTCTGCCGGACAGCTTGGCGCCGAGCCGCTGCCGCAGGAGAGCGATTTCCTGATCTCCATTAACGCCCAGGGCCGTCTGCATACCGAAGAAGAGTTTGGCAATATCATTCTGAAAACGGCGCAGGATGGCTCGCTGGTCCGCCTGCGCGACGTGGCGCGCATCGAGATGGGTTCCGGTAGCTATGCGCTGCGCTCCCAGCTCAACAATAAGGATGCGGTCGGGATCGGTATCTTCCAGTCACCCGGCGCTAACGCCATCGATCTGTCGAACGCGGTACGCGCCAAAATGGCCGAGCTGGCCACCCGCTTCCCGGAAGATATGCAATGGGCGGCGCCGTACGACCCGACGGTTTTCGTCCGCGACTCCATCCGCGCGGTGGTGCAGACGCTGCTGGAGGCGGTAGTGCTGGTGGTGCTGGTAGTGATCCTGTTCCTGCAGACCTGGCGCGCGTCGATTATCCCGTTGATCGCTGTGCCGGTATCGGTGGTGGGTACCTTCAGCATTCTCTATCTGCTGGGCTTCTCGCTGAATACCCTGAGCCTGTTCGGGCTGGTACTGGCTATCGGTATCGTGGTGGACGACGCCATCGTGGTGGTGGAGAACGTCGAGCGTAATATCGAAGAGGGGCTTGCGCCGCTTGCCGCGGCGCATCAGGCGATGCGTGAGGTCTCCGGGCCGATTATCGCCATTGCGCTGGTGCTGTGTGCGGTGTTCGTGCCGATGGCGTTTCTCTCCGGGGTCACCGGCCAGTTCTACAAACAGTTCGCGGTGACCATCGCCATCTCGACGGTGATCTCGGCCATCAACTCGCTGACGCTCTCCCCGGCGCTGGCGGCCCTGCTGTTAAAGCCGCACGGCGCGAAGAAAGACCTCCCTACCCGGCTGATCGATCGCCTGTTTGGCTGGATTTTCCGTCCGTTTAACCGCTTTTTCCTGCGCAGCTCGAACGGCTATCAGGGACTGGTAGGCAAAACGCTTGGACGCCGTGGCGCAGTGTTTGCGGTGTACCTGCTGCTGCTCTGCGCCGCTGGGGTGATGTTTAAAGTCGTCCCCGGCGGGTTTATTCCCACCCAGGATAAGCTGTATCTCATTGGCGGCGTGAAGATGCCGGAAGGGTCGTCGCTGGCGCGCACCGACGCGGTGATCCGCAAAATGAGCGAGATCGGGATGAATACCGAAGGGGTCGACTATGCGGTCGCTTTCCCGGGGCTTAACGCGCTGCAGTTCACCAACACGCCGAATACCGGGACGGTCTTTTTTGGCCTGAAACCGTTCGACCAGCGCAAACACACGGCGGCGGAAATTAACGCGGAGATCAACGCCAAAATCGCGCAAATCCAGCAGGGCTTTGGCTTTTCCATCCTGCCGCCGCCGATTTTAGGTCTGGGTCAGGGTTCCGGCTACTCCCTGTACATCCAGGATCGCGGAGGGCTGGGCTATGGCGCGCTGCAAAGCGCGGTGAATGCGATGTCCGGGGCGATTATGCAGACGCCGGGGATGCACTTCCCGATCTCGACTTACCAGGCTAACGTGCCGCAGCTGGACGTGCAGGTCGATCGCGATAAGGCGAAAGCGCAGGGGGTATCGCTAACCGATCTGTTCGGTACGCTGCAGACCTATCTCGGCTCGTCTTATGTCAATGACTTTAACCAGTTCGGGCGTACCTGGCGCGTGATGGCCCAGGCTGACGGACCATACCGCGAGAGCGTGGAAGATATCGCCAATCTGCGCACCCGCAATAATCAGGGCGAAATGGTACCGATCGGCAGTATGGTGAATATCAGTACCACCTACGGGCCGGATCCGGTGATCCGCTACAACGGTTATCCGGCGGCGGACCTGATTGGCGATGCCGATCCGCGGGTCCTCTCTTCTTCGCAGGCGATGACGCATCTGGAAGAGCTGTCGAAGCAGATCCTGCCGAATGGGATGAATATTGAGTGGACGGATCTCAGCTTCCAGCAGGCCACCCAGGGCAACACGGCGCTGATCGTCTTCCCGGTGGCGGTGCTGCTGGCATTCCTCGTACTGGCCGCGCTGTATGAAAGCTGGACCCTGCCGCTGGCGGTGATCCTTATCGTACCGATGACGATGCTCTCCGCGCTGTTTGGCGTCTGGCTGACCGGGGGCGATAACAACGTCTTCGTGCAGGTGGGTCTGGTGGTCCTGATGGGCCTGGCCTGTAAAAACGCCATTCTGATCGTCGAGTTTGCCCGCGAGCTGGAGATCCAGGGGAAAGGCATCATGGAAGCGGCGCTGGAGGCATGCCGCCTGCGTCTGCGCCCGATCGTGATGACCTCCATCGCCTTTATCGCCGGGACCATTCCGCTGATCCTCGGCCACGGCGCGGGGGCGGAAGTCCGCGGCGTCACCGGGATCACGGTGTTCTCCGGGATGCTGGGCGTGACGCTCTTCGGTCTGTTCCTGACGCCGGTGTTTTACGTGACGCTACGGAAACTGGTGACCCGCAGGAAGCCGGTCCAGGAGGATCTGCCCGCCTAG", "partial": "0", "query_start": 82096, "query_end": 82320, "hit_start": 771, "hit_end": 981, "orf_dna_sequence": "ATGGATTTCCCGGAATTGTCGCGCGAAAGGCACGTGCTGATTTTCGTTGCGCGCACGCATGCGATCGACGCGCGCGAGCTCGCGCGATTCGCCGCCGCGCTGTCCGAGGAGGAAGCCGCGCGCGCGGAGAAATTCCTGTTCTTTCCGAACAAGCGGGACTACGTGATCGCGCATTCGCTGTTGCGCGAGATTCTCGCGCATTACGCCGGCGTGCCCGCGTCGGACGTTTCGTTCGTCCGCAATCGGTTCGGCAAGCCCGCGCTTGCGCGCGACGCCCGCCTGCAATTCAATCTTTCCCATTGCGATGGCGGCGTGGCGATCGCGGTCGGATTCGACATGCGGATCGGCGTCGATATCGAGGACGCGTCGATCGCGCGTGCGCGCTATGCGGATATCGCCGCGCAATACTTCAGCGACATCGAGCAGGCGGCGATCCACGCCGCCGCTGACGGATTCGCGCGCTTCATCGAGACGTGGACGCTGAAGGAGGCGTACTTGAAGGCCATCGGTTTGGGGCTCGCCAAGCCGCTCGCGGACTGTCGCTTCGTGTGGCGTGACGATCGGATCGTGCGGTTTCGCGACGTCGCGCAGGCCGACGCTCACGCGCACGCATGGGCGTTCGGCGCCTTCGCGGTCGACGCACGGTATCGCGTGGCCGTGGCCGTCGACGCCTCGGGCGGCGCGTGCTCGATCGAGCTCGTGCGCGCCGGGGCGACGGACGGCGCGCGGCCGCTGCAGGCGAGCGTCGTTTGCCGCTCGCCCGATCTGCGTTTCGCGCACGACGCGTGCTGCGTCTGA", "orf_prot_sequence": "MDFPELSRERHVLIFVARTHAIDARELARFAAALSEEEAARAEKFLFFPNKRDYVIAHSLLREILAHYAGVPASDVSFVRNRFGKPALARDARLQFNLSHCDGGVAIAVGFDMRIGVDIEDASIARARYADIAAQYFSDIEQAAIHAAADGFARFIETWTLKEAYLKAIGLGLAKPLADCRFVWRDDRIVRFRDVAQADAHAHAWAFGAFAVDARYRVAVAVDASGGACSIELVRAGATDGARPLQASVVCRSPDLRFAHDACCV", "perc_identity": 26.32}, "gnl|BL_ORD_ID|1266|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 81544, "orf_end": 82341, "orf_from": "BGC0000186.1|Thailandamide_14 ", "model_name": "rmtG", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "450", "model_id": "1382", "ARO_accession": "3002668", "ARO_name": "rmtG", "ARO_category": {"41435": {"category_aro_accession": "3004271", "category_aro_cvterm_id": "41435", "category_aro_name": "16S rRNA methyltransferase (G1405)", "category_aro_description": "Methyltransferases that methylate the G1405 position of 16S rRNA, which is part of an aminoglycoside binding site.", "category_aro_class_name": "AMR Gene Family"}, "35932": {"category_aro_accession": "0000013", "category_aro_cvterm_id": "35932", "category_aro_name": "amikacin", "category_aro_description": "Amikacin is an aminoglycoside antibiotic that works by binding to the bacterial 30S ribosomal subunit, causing misreading of mRNA and leaving the bacterium unable to synthesize proteins vital to its growth.", "category_aro_class_name": "Antibiotic"}, "35969": {"category_aro_accession": "0000052", "category_aro_cvterm_id": "35969", "category_aro_name": "tobramycin", "category_aro_description": "Tobramycin is an aminoglycoside antibiotic used to treat different types of bacterial infections. Tobramycin works by binding to the bacterial 30S ribosomal subunit, causing misreading of mRNA and leaving the bacterium unable to synthesize proteins vital to its growth.", "category_aro_class_name": "Antibiotic"}, "36998": {"category_aro_accession": "3000654", "category_aro_cvterm_id": "36998", "category_aro_name": "arbekacin", "category_aro_description": "A synthetic derivative (1-N-(4-amino-2-hydroxybutyryl) of dibekacin used in Japan. It is active against methicillin-resistant Staph. aureus and shows synergy with ampicillin when treating gentamicin and vancomycin resistant enterocci.", "category_aro_class_name": "Antibiotic"}, "40942": {"category_aro_accession": "3004015", "category_aro_cvterm_id": "40942", "category_aro_name": "gentamicin A", "category_aro_description": "Gentamicin A is part of a complex of broad spectrum aminoglycoside antibiotics. Gentamicin inhibits protein synthesis, resulting in bacterial cell death.", "category_aro_class_name": "Antibiotic"}, "46133": {"category_aro_accession": "3007382", "category_aro_cvterm_id": "46133", "category_aro_name": "gentamicin", "category_aro_description": "Gentamicin is a commonly used aminoglycoside antibiotic derived from members of the Micromonospora genus of bacteria. It acts by binding the 30S ribosomal subunit, thus inhibiting protein synthesis. Gentamicin is typically used to treat Gram-negative infections of the repiratory and urinary tract, as well as infections of the bone and soft tissue. It also exhibits considerable nephrotoxicity and ototoxicity. Gentamicin is administered as a mixture of gentamicin type C (which makes about around 80% of the complex) and types A, B, and X (distributed in the remaining 20% of the complex).", "category_aro_class_name": "Antibiotic"}, "35935": {"category_aro_accession": "0000016", "category_aro_cvterm_id": "35935", "category_aro_name": "aminoglycoside antibiotic", "category_aro_description": "Aminoglycosides are a group of antibiotics that are mostly effective against Gram-negative bacteria. These molecules consist of aminated sugars attached to a dibasic cyclitol. Aminoglycosides work by binding to the bacterial 30S ribosomal subunit (some work by binding to the 50S subunit), inhibiting the translocation of the peptidyl-tRNA from the A-site to the P-site and also causing misreading of mRNA, leaving the bacterium unable to synthesize proteins vital to its growth.", "category_aro_class_name": "Drug Class"}, "35997": {"category_aro_accession": "0001001", "category_aro_cvterm_id": "35997", "category_aro_name": "antibiotic target alteration", "category_aro_description": "Mutational alteration or enzymatic modification of antibiotic target which results in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 2.65222, "max_identities": 22, "bit_score": 26.1794, "cvterm_id": "35915", "query": "LAKPLADCRFVWRDDRIVRFRDVAQADAHAHAWAFGAFAVDARYRVAVAVDASGGACSIELVRAGATDGAR-PLQAS", "match": "+A+ L +CR  +R     R +++ +A          AF  DA YR A+ +   GG  + EL+   A+   R PL+ +", "sequence_from_db": "IARILTECRAKYR-----REKEIDKAAREKLHGITAAFMTDAEYRRAMEIAVRGGELA-ELMECHASTRERLPLEET", "sequence_from_broadstreet": "MRDPLFEKLAASKKYRDVCPDTIARILTECRAKYRREKEIDKAAREKLHGITAAFMTDAEYRRAMEIAVRGGELAELMECHASTRERLPLEETDAVYARLLGAPDESALDLACGLNPAYLQNRYPEMRVTGIDISGQCVRVLRALGVDARLGDLLAENAIPRARYSVALLFKILPLLDRQSAGAARRILEAVNADALICSFPTRSLSGRNVGMAVHYAAWMRDQLPEKWRIERTVETDNELYYVLKEKQDGEAVRGGDSHRESE", "dna_sequence_from_broadstreet": "ATGCGTGATCCGTTGTTTGAAAAGCTGGCGGCTTCGAAGAAATACCGCGATGTGTGTCCGGATACGATCGCGCGCATTTTAACGGAATGCCGCGCGAAGTACCGGCGGGAAAAGGAAATCGATAAAGCGGCGCGCGAAAAGCTGCACGGCATCACCGCTGCGTTCATGACGGATGCGGAATACAGGCGCGCGATGGAAATTGCAGTGCGGGGCGGCGAACTGGCTGAATTGATGGAATGCCACGCCTCCACGCGCGAACGGCTGCCGCTGGAAGAAACAGATGCCGTGTATGCGCGTCTGTTGGGTGCGCCCGACGAATCGGCGCTGGATCTGGCGTGCGGGCTGAATCCCGCGTATCTGCAAAATCGATACCCCGAAATGCGCGTTACCGGAATCGATATCAGCGGCCAATGCGTGCGCGTGCTGCGCGCGCTGGGCGTGGATGCGCGCCTCGGCGATCTGCTTGCGGAGAACGCGATTCCGCGGGCGCGGTATTCCGTCGCGCTGCTGTTTAAAATTCTGCCGCTGCTGGATCGCCAGTCGGCGGGCGCGGCGCGGCGCATCCTGGAAGCGGTGAACGCCGATGCGCTGATCTGTTCGTTCCCCACGCGCAGCCTGTCCGGCAGAAATGTGGGCATGGCGGTGCATTACGCCGCGTGGATGCGGGATCAGCTGCCCGAAAAATGGCGAATCGAACGCACCGTGGAAACGGATAACGAGCTATATTACGTTCTGAAGGAGAAACAGGATGGCGAAGCTGTACGTGGTGGCGACTCCCATCGGGAATCTGAATGA", "partial": "0", "query_start": 82060, "query_end": 82287, "hit_start": 66, "hit_end": 279, "orf_dna_sequence": "ATGGATTTCCCGGAATTGTCGCGCGAAAGGCACGTGCTGATTTTCGTTGCGCGCACGCATGCGATCGACGCGCGCGAGCTCGCGCGATTCGCCGCCGCGCTGTCCGAGGAGGAAGCCGCGCGCGCGGAGAAATTCCTGTTCTTTCCGAACAAGCGGGACTACGTGATCGCGCATTCGCTGTTGCGCGAGATTCTCGCGCATTACGCCGGCGTGCCCGCGTCGGACGTTTCGTTCGTCCGCAATCGGTTCGGCAAGCCCGCGCTTGCGCGCGACGCCCGCCTGCAATTCAATCTTTCCCATTGCGATGGCGGCGTGGCGATCGCGGTCGGATTCGACATGCGGATCGGCGTCGATATCGAGGACGCGTCGATCGCGCGTGCGCGCTATGCGGATATCGCCGCGCAATACTTCAGCGACATCGAGCAGGCGGCGATCCACGCCGCCGCTGACGGATTCGCGCGCTTCATCGAGACGTGGACGCTGAAGGAGGCGTACTTGAAGGCCATCGGTTTGGGGCTCGCCAAGCCGCTCGCGGACTGTCGCTTCGTGTGGCGTGACGATCGGATCGTGCGGTTTCGCGACGTCGCGCAGGCCGACGCTCACGCGCACGCATGGGCGTTCGGCGCCTTCGCGGTCGACGCACGGTATCGCGTGGCCGTGGCCGTCGACGCCTCGGGCGGCGCGTGCTCGATCGAGCTCGTGCGCGCCGGGGCGACGGACGGCGCGCGGCCGCTGCAGGCGAGCGTCGTTTGCCGCTCGCCCGATCTGCGTTTCGCGCACGACGCGTGCTGCGTCTGA", "orf_prot_sequence": "MDFPELSRERHVLIFVARTHAIDARELARFAAALSEEEAARAEKFLFFPNKRDYVIAHSLLREILAHYAGVPASDVSFVRNRFGKPALARDARLQFNLSHCDGGVAIAVGFDMRIGVDIEDASIARARYADIAAQYFSDIEQAAIHAAADGFARFIETWTLKEAYLKAIGLGLAKPLADCRFVWRDDRIVRFRDVAQADAHAHAWAFGAFAVDARYRVAVAVDASGGACSIELVRAGATDGARPLQASVVCRSPDLRFAHDACCV", "perc_identity": 28.57}, "gnl|BL_ORD_ID|1270|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 81544, "orf_end": 82341, "orf_from": "BGC0000186.1|Thailandamide_14 ", "model_name": "ANT(9)-Ia", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "450", "model_id": "1386", "ARO_accession": "3002630", "ARO_name": "ANT(9)-Ia", "ARO_category": {"36367": {"category_aro_accession": "3000228", "category_aro_cvterm_id": "36367", "category_aro_name": "ANT(9)", "category_aro_description": "A category of aminoglycoside O-nucleotidyltransferase enzymes with modification regiospecificity based at the 9-hydroxyl group of the respective antibiotic. These enzymes inactivate aminoglycoside antibiotics, specifically streptomycin, by transfer of an AMP group from an ATP substrate to the 9-hydroxyl group of the compound.", "category_aro_class_name": "AMR Gene Family"}, "35957": {"category_aro_accession": "0000039", "category_aro_cvterm_id": "35957", "category_aro_name": "spectinomycin", "category_aro_description": "Spectinomycin is an aminoglycoside antibiotic used to treat different types of bacterial infections. Spectinomycin works by binding to the bacterial 30S ribosomal subunit inhibiting translation.", "category_aro_class_name": "Antibiotic"}, "35935": {"category_aro_accession": "0000016", "category_aro_cvterm_id": "35935", "category_aro_name": "aminoglycoside antibiotic", "category_aro_description": "Aminoglycosides are a group of antibiotics that are mostly effective against Gram-negative bacteria. These molecules consist of aminated sugars attached to a dibasic cyclitol. Aminoglycosides work by binding to the bacterial 30S ribosomal subunit (some work by binding to the 50S subunit), inhibiting the translocation of the peptidyl-tRNA from the A-site to the P-site and also causing misreading of mRNA, leaving the bacterium unable to synthesize proteins vital to its growth.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 3.38544, "max_identities": 9, "bit_score": 25.7942, "cvterm_id": "35508", "query": "RAGATDGARPLQASVVCRS", "match": "+ G TD  RPL+ +V+ RS", "sequence_from_db": "KIGNTDSVRPLEVTVINRS", "sequence_from_broadstreet": "MSNLINGKIPNQAIQTLKIVKDLFGSSIVGVYLFGSAVNGGLRINSDVDVLVVVNHSLPQLTRKKLTERLMTISGKIGNTDSVRPLEVTVINRSEVVPWQYPPKREFIYGEWLRGEFENGQIQEPSYDPDLAIVLAQARKNSISLFGPDSSSILVSVPLTDIRRAIKDSLPELIEGIKGDERNVILTLARMWQTVTTGEITSKDVAAEWAIPLLPKEHVTLLDIARKGYRGECDDKWEGLYSKVKALVKYMKNSIETSLN", "dna_sequence_from_broadstreet": "ATGAGCAATTTGATTAACGGAAAAATACCAAATCAAGCGATTCAAACATTAAAAATCGTAAAAGATTTATTTGGAAGTTCAATAGTTGGAGTATATCTATTTGGTTCAGCAGTAAATGGTGGTTTACGCATTAACAGCGATGTAGATGTTCTAGTCGTCGTGAATCATAGTTTACCTCAATTAACTCGAAAAAAACTAACAGAAAGACTAATGACTATATCAGGAAAGATTGGAAATACGGATTCTGTTAGACCACTTGAAGTTACGGTTATAAATAGGAGTGAAGTTGTCCCTTGGCAATATCCTCCAAAAAGAGAATTTATATACGGTGAGTGGCTCAGGGGTGAATTTGAGAATGGACAAATTCAGGAACCAAGCTATGATCCTGATTTGGCTATTGTTTTAGCACAAGCAAGAAAGAATAGTATTTCTCTATTTGGTCCTGATTCTTCAAGTATACTTGTCTCCGTACCTTTGACAGATATTCGAAGAGCAATTAAGGATTCTTTGCCAGAACTAATTGAGGGGATAAAAGGTGATGAGCGTAATGTAATTTTAACCCTAGCTCGAATGTGGCAAACAGTGACTACTGGTGAAATTACCTCGAAAGATGTCGCTGCAGAATGGGCTATACCTCTTTTACCTAAAGAGCATGTAACTTTACTGGATATAGCTAGAAAAGGCTATCGGGGAGAGTGTGATGATAAGTGGGAAGGACTATATTCAAAGGTGAAAGCACTCGTTAAGTATATGAAAAATTCTATAGAAACTTCTCTCAATTAG", "partial": "0", "query_start": 82246, "query_end": 82302, "hit_start": 225, "hit_end": 282, "orf_dna_sequence": "ATGGATTTCCCGGAATTGTCGCGCGAAAGGCACGTGCTGATTTTCGTTGCGCGCACGCATGCGATCGACGCGCGCGAGCTCGCGCGATTCGCCGCCGCGCTGTCCGAGGAGGAAGCCGCGCGCGCGGAGAAATTCCTGTTCTTTCCGAACAAGCGGGACTACGTGATCGCGCATTCGCTGTTGCGCGAGATTCTCGCGCATTACGCCGGCGTGCCCGCGTCGGACGTTTCGTTCGTCCGCAATCGGTTCGGCAAGCCCGCGCTTGCGCGCGACGCCCGCCTGCAATTCAATCTTTCCCATTGCGATGGCGGCGTGGCGATCGCGGTCGGATTCGACATGCGGATCGGCGTCGATATCGAGGACGCGTCGATCGCGCGTGCGCGCTATGCGGATATCGCCGCGCAATACTTCAGCGACATCGAGCAGGCGGCGATCCACGCCGCCGCTGACGGATTCGCGCGCTTCATCGAGACGTGGACGCTGAAGGAGGCGTACTTGAAGGCCATCGGTTTGGGGCTCGCCAAGCCGCTCGCGGACTGTCGCTTCGTGTGGCGTGACGATCGGATCGTGCGGTTTCGCGACGTCGCGCAGGCCGACGCTCACGCGCACGCATGGGCGTTCGGCGCCTTCGCGGTCGACGCACGGTATCGCGTGGCCGTGGCCGTCGACGCCTCGGGCGGCGCGTGCTCGATCGAGCTCGTGCGCGCCGGGGCGACGGACGGCGCGCGGCCGCTGCAGGCGAGCGTCGTTTGCCGCTCGCCCGATCTGCGTTTCGCGCACGACGCGTGCTGCGTCTGA", "orf_prot_sequence": "MDFPELSRERHVLIFVARTHAIDARELARFAAALSEEEAARAEKFLFFPNKRDYVIAHSLLREILAHYAGVPASDVSFVRNRFGKPALARDARLQFNLSHCDGGVAIAVGFDMRIGVDIEDASIARARYADIAAQYFSDIEQAAIHAAADGFARFIETWTLKEAYLKAIGLGLAKPLADCRFVWRDDRIVRFRDVAQADAHAHAWAFGAFAVDARYRVAVAVDASGGACSIELVRAGATDGARPLQASVVCRSPDLRFAHDACCV", "perc_identity": 47.37}}, "BGC0000186.1|Thailandamide_16 # 83146 # 83907 # -1 # ID=1_16;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.646": {"gnl|BL_ORD_ID|574|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 83146, "orf_end": 83907, "orf_from": "BGC0000186.1|Thailandamide_16 ", "model_name": "adeJ", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "2000", "model_id": "630", "ARO_accession": "3000781", "ARO_name": "adeJ", "ARO_category": {"36005": {"category_aro_accession": "0010004", "category_aro_cvterm_id": "36005", "category_aro_name": "resistance-nodulation-cell division (RND) antibiotic efflux pump", "category_aro_description": "Directed pumping of antibiotic out of a cell to confer resistance. Resistance-nodulation-division (RND) proteins are found in both prokaryotic and eukaryotic cells and have diverse substrate specificities and physiological roles. However, there are relatively few RND transporters and they are secondary transporters, energized not by ATP binding/hydrolysis but by proton movement down the transmembrane electrochemical gradient.", "category_aro_class_name": "AMR Gene Family"}, "35968": {"category_aro_accession": "0000051", "category_aro_cvterm_id": "35968", "category_aro_name": "tetracycline", "category_aro_description": "Tetracycline is a broad-spectrum polyketide antibiotic produced by many Streptomyces. It works by inhibiting action of the prokaryotic 30S ribosome.", "category_aro_class_name": "Antibiotic"}, "36308": {"category_aro_accession": "3000169", "category_aro_cvterm_id": "36308", "category_aro_name": "rifampin", "category_aro_description": "Rifampin is a semi-synthetic rifamycin, and inhibits RNA synthesis by binding to RNA polymerase. Rifampin is the mainstay agent for the treatment of tuberculosis, leprosy and complicated Gram-positive infections.", "category_aro_class_name": "Antibiotic"}, "36309": {"category_aro_accession": "3000170", "category_aro_cvterm_id": "36309", "category_aro_name": "imipenem", "category_aro_description": "Imipenem is a broad-spectrum antibiotic and is usually taken with cilastatin, which prevents hydrolysis of imipenem by renal dehydropeptidase-I. It is resistant to hydrolysis by most other beta-lactamases. Notable exceptions are the KPC beta-lactamases and Ambler Class B enzymes.", "category_aro_class_name": "Antibiotic"}, "36327": {"category_aro_accession": "3000188", "category_aro_cvterm_id": "36327", "category_aro_name": "trimethoprim", "category_aro_description": "Trimethoprim is a synthetic 5-(3,4,5- trimethoxybenzyl) pyrimidine inhibitor of dihydrofolate reductase, inhibiting synthesis of tetrahydrofolic acid. Tetrahydrofolic acid is an essential precursor in the de novo synthesis of the DNA nucleotide thymidine. Trimethoprim is a bacteriostatic antibiotic mainly used in the prophylaxis and treatment of urinary tract infections in combination with sulfamethoxazole, a sulfonamide antibiotic.", "category_aro_class_name": "Antibiotic"}, "36524": {"category_aro_accession": "3000385", "category_aro_cvterm_id": "36524", "category_aro_name": "chloramphenicol", "category_aro_description": "Chloramphenicol is a bacteriostatic antimicrobial originally derived from the bacterium Streptomyces venezuelae. It was the first antibiotic to be manufactured synthetically on a large scale. It functions by inhibiting peptidyl transferase activity of the bacterial ribosome, binding to A2451 and A2452 residues in the 23S rRNA of the 50S ribosomal subunit and preventing peptide bond formation.", "category_aro_class_name": "Antibiotic"}, "40523": {"category_aro_accession": "3003832", "category_aro_cvterm_id": "40523", "category_aro_name": "ticarcillin", "category_aro_description": "Ticarcillin is a carboxypenicillin used for the treatment of Gram-negative bacteria, particularly P. aeruginosa. Ticarcillin's antibiotic properties arise from its ability to prevent cross-linking of peptidoglycan during cell wall synthesis, when the bacteria try to divide, causing cell death.", "category_aro_class_name": "Antibiotic"}, "35919": {"category_aro_accession": "0000000", "category_aro_cvterm_id": "35919", "category_aro_name": "macrolide antibiotic", "category_aro_description": "Macrolides are a group of drugs (typically antibiotics) that have a large macrocyclic lactone ring of 12-16 carbons to which one or more deoxy sugars, usually cladinose and desosamine, may be attached. Macrolides bind to the 50S-subunit of bacterial ribosomes, inhibiting the synthesis of vital proteins.", "category_aro_class_name": "Drug Class"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35936": {"category_aro_accession": "0000017", "category_aro_cvterm_id": "35936", "category_aro_name": "lincosamide antibiotic", "category_aro_description": "Lincosamides (e.g. lincomycin, clindamycin) are a class of drugs which bind to the 23s portion of the 50S subunit of bacterial ribosomes. This interaction inhibits early elongation of peptide chains by inhibiting the transpeptidase reaction, acting similarly to macrolides.", "category_aro_class_name": "Drug Class"}, "35939": {"category_aro_accession": "0000020", "category_aro_cvterm_id": "35939", "category_aro_name": "carbapenem", "category_aro_description": "Carbapenems are a class of beta-lactam antibiotics with a broad spectrum of antibacterial activity, and have a structure which renders them highly resistant to beta-lactamases. Carbapenem antibiotics are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "35951": {"category_aro_accession": "0000032", "category_aro_cvterm_id": "35951", "category_aro_name": "cephalosporin", "category_aro_description": "Cephalosporins are a class of beta-lactam antibiotics, containing the beta-lactam ring fused with a dihydrothiazolidine ring. Together with cephamycins they belong to a sub-group called cephems. Cephalosporin are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "36189": {"category_aro_accession": "3000050", "category_aro_cvterm_id": "36189", "category_aro_name": "tetracycline antibiotic", "category_aro_description": "These antibiotics are derived from tetracycline, a polyketide antibiotic that inhibits the 30S subunit of bacterial ribosomes.", "category_aro_class_name": "Drug Class"}, "36296": {"category_aro_accession": "3000157", "category_aro_cvterm_id": "36296", "category_aro_name": "rifamycin antibiotic", "category_aro_description": "Rifamycin antibiotics are a group of broad-spectrum ansamycin antibiotics that inhibit bacterial RNA polymerase by binding to a highly conserved region, blocking the oligonucleotide exit tunnel, and preventing the extension of nascent mRNAs.", "category_aro_class_name": "Drug Class"}, "36310": {"category_aro_accession": "3000171", "category_aro_cvterm_id": "36310", "category_aro_name": "diaminopyrimidine antibiotic", "category_aro_description": "Diaminopyrimidines are a class of organic compounds containing a pyrimidine ring substituted by two amine groups.  They are inhibitors of dihydrofolate reductase, an enzyme critical for DNA synthesis.", "category_aro_class_name": "Drug Class"}, "36526": {"category_aro_accession": "3000387", "category_aro_cvterm_id": "36526", "category_aro_name": "phenicol antibiotic", "category_aro_description": "Phenicols are broad spectrum bacteriostatic antibiotics acting on bacterial protein synthesis. More specifically, the phenicols block peptide elongation by binding to the peptidyltansferase centre of the 70S ribosome.", "category_aro_class_name": "Drug Class"}, "40360": {"category_aro_accession": "3003706", "category_aro_cvterm_id": "40360", "category_aro_name": "penem", "category_aro_description": "Penems are a class of unsaturated beta-lactam antibiotics with a broad spectrum of antibacterial activity and have a structure which renders them highly resistant to beta-lactamases. All penems are all synthetically made and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. They are structurally similar to carbapenems, however, where carbapenems have a carbon, penems have a sulfur.", "category_aro_class_name": "Drug Class"}, "36298": {"category_aro_accession": "3000159", "category_aro_cvterm_id": "36298", "category_aro_name": "efflux pump complex or subunit conferring antibiotic resistance", "category_aro_description": "Efflux proteins that pump antibiotic out of a cell to confer resistance.", "category_aro_class_name": "Efflux Component"}, "36001": {"category_aro_accession": "0010000", "category_aro_cvterm_id": "36001", "category_aro_name": "antibiotic efflux", "category_aro_description": "Antibiotic resistance via the transport of antibiotics out of the cell.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 4.55391, "max_identities": 29, "bit_score": 25.7942, "cvterm_id": "35507", "query": "LRELAQRMGVRVDPFHAHGVSVVPLLAWY------------DY---SFGEPSD-----GLLQVWG-DYRRCVW-------PQDMTPADVARHLEAHNRE", "match": "L E  QR GV V      G S + ++A+Y            DY   S  EP       G +QV+G  Y   +W          +TP+D+A  L+A N +", "sequence_from_db": "LPEDVQRQGVTVT---KSGASFLQVIAFYSPDNNLSDSDIKDYVNSSIKEPLSRVAGVGEVQVFGGSYAMRIWLDPAKLTSYQLTPSDIATALQAQNSQ", "sequence_from_broadstreet": "MAQFFIHRPIFAWVIALVIMLAGILTLTKMPIAQYPTIAPPTVTIAATYPGASAETVENTVTQIIEQQMNGLDGLRYISSNSAGNGQASIQLNFEQGVDPDIAQVQVQNKLQSATALLPEDVQRQGVTVTKSGASFLQVIAFYSPDNNLSDSDIKDYVNSSIKEPLSRVAGVGEVQVFGGSYAMRIWLDPAKLTSYQLTPSDIATALQAQNSQVAVGQLGGAPAVQGQVLNATVNAQSLLQTPEQFKNIFLKNTASGAEVRLKDVARVELGSDNYQFDSKFNGKPAAGLAIKIATGANALDTAEAVEQRLSELRKNYPTGLADKLAYDTTPFIRLSIESVVHTLIEAVILVFIVMFLFLQNWRATIIPTLAVPVVVLGTFAVINIFGFSINTLTMFAMVLAIGLLVDDAIVVVENVERVMSEDHTDPVTATSRSMQQISGALVGITSVLTAVFVPMAFFGGTTGVIYRQFSITLVTAMVLSLIVALTFTPALCATILKQHDPNKEPSNNIFARFFRSFNNGFDRMSHSYQNGVSRMLKGKIFSGVLYAVVVALLVFLFQKLPSSFLPEEDQGVVMTLVQLPPNATLDRTGKVIDTMTNFFMNEKDTVESIFTVSGFSFTGVGQNAGIGFVKLKDWSKRTTPETQIGSLIQRGMALNMIIKDASYVMPLQLPAMPELGVTAGFNLQLKDSSGQGHEKLIAARNTILGLASQDKRLVGVRPNGQEDTPQYQINVDQAQAGAMGVSIAEINNTMRIAWGGSYINDFVDRGRVKKVYVQGDAGSRMMPEDLNKWYVRNNKGEMVPFSAFATGEWTYGSPRLERYNGVSSVNIQGTPAPGVSSGDAMKAMEEIIGKLPSMGLQGFDYEWTGLSLEERESGAQAPFLYALSLLIVFLCLAALYESWSIPFSVLLVVPLGVIGAIVLTYLGMIIKGDPNLSNNIYFQVAIIAVIGLSAKNAILIVEFAKELQEKGEDLLDATLHAAKMRLRPIIMTTLAFGFGVLPLALSTGAGAGSQHSVGFGVLGGVLSATFLGIFFIPVFYVWIRSMFKYKPKTINTQEHKS", "dna_sequence_from_broadstreet": "ATGGCACAATTTTTTATTCATCGCCCCATATTTGCGTGGGTGATTGCATTAGTCATTATGTTGGCGGGTATTCTTACGCTAACAAAAATGCCTATTGCACAATATCCAACGATTGCACCACCAACCGTAACGATTGCTGCGACTTATCCTGGTGCATCGGCTGAAACAGTTGAAAATACTGTAACCCAGATCATTGAACAACAAATGAATGGTCTTGATGGCTTACGTTATATTTCATCTAACAGTGCTGGTAATGGTCAGGCATCTATTCAATTAAACTTTGAACAAGGTGTTGACCCTGATATTGCACAGGTTCAAGTTCAAAACAAATTGCAATCTGCAACTGCGCTTTTACCTGAAGATGTACAACGTCAAGGTGTAACAGTTACTAAATCTGGTGCGAGCTTCTTGCAAGTTATTGCATTCTATTCACCAGATAACAACCTGTCAGACTCTGACATTAAAGACTACGTAAACTCGTCAATTAAAGAACCGCTTAGCCGTGTTGCCGGTGTTGGTGAGGTACAGGTCTTCGGTGGCTCATACGCAATGCGTATCTGGCTTGATCCAGCTAAATTAACAAGCTATCAACTTACTCCTAGTGATATTGCAACTGCCTTACAAGCGCAGAACTCGCAAGTTGCCGTAGGTCAGTTAGGTGGTGCTCCGGCTGTACAAGGTCAAGTTCTTAACGCAACAGTAAATGCACAAAGCTTATTGCAGACTCCTGAACAGTTTAAAAATATCTTCTTAAAGAACACAGCATCAGGTGCTGAGGTTCGATTAAAAGATGTTGCTCGCGTAGAATTAGGTTCGGATAACTATCAATTCGACTCGAAGTTTAACGGTAAACCGGCAGCTGGTCTTGCAATTAAAATTGCAACAGGTGCTAACGCACTCGACACAGCCGAAGCAGTTGAACAACGTTTATCTGAACTACGTAAGAACTATCCAACAGGTCTTGCAGATAAACTGGCTTATGACACGACTCCATTTATCCGTCTTTCAATTGAAAGTGTAGTACACACATTAATTGAAGCCGTGATTTTGGTATTCATTGTCATGTTCCTATTCTTACAAAACTGGCGTGCAACGATTATTCCAACGCTTGCAGTTCCAGTAGTTGTATTAGGTACATTTGCGGTCATTAATATCTTTGGCTTCTCAATTAACACCTTAACCATGTTCGCTATGGTATTGGCAATCGGTCTTCTGGTCGACGACGCCATTGTTGTAGTCGAAAACGTTGAACGTGTGATGAGTGAAGACCATACCGATCCGGTTACGGCCACTTCTCGCTCAATGCAGCAGATTTCTGGTGCGTTAGTAGGTATTACCAGCGTATTGACAGCGGTATTCGTACCAATGGCTTTCTTTGGTGGTACAACAGGTGTAATTTACCGCCAGTTCTCGATTACCCTTGTAACTGCAATGGTTCTGTCGTTAATTGTAGCGTTGACGTTCACACCGGCACTTTGTGCAACTATCTTGAAACAGCATGATCCTAATAAAGAACCAAGCAATAATATCTTTGCGCGTTTCTTTAGAAGCTTTAACAATGGTTTTGACCGCATGTCGCATAGCTACCAAAATGGTGTTAGCCGCATGCTTAAAGGCAAAATCTTCTCTGGCGTGCTCTATGCTGTTGTAGTTGCCCTTTTAGTCTTCTTGTTCCAAAAACTCCCGTCTTCATTCTTACCAGAAGAAGATCAGGGTGTGGTCATGACACTTGTACAATTACCACCAAATGCAACGCTTGACCGTACCGGTAAAGTGATTGATACCATGACTAACTTCTTTATGAATGAAAAAGATACCGTGGAATCTATTTTCACTGTTTCTGGTTTCTCATTCACAGGTGTTGGTCAAAACGCGGGTATTGGCTTCGTTAAGTTGAAAGACTGGAGCAAACGTACGACACCAGAAACTCAAATTGGTTCATTGATTCAGCGTGGTATGGCATTAAATATGATCATTAAAGATGCATCATACGTTATGCCGTTACAGCTTCCAGCAATGCCTGAACTTGGTGTAACTGCCGGATTTAACTTGCAGCTTAAAGATTCAAGTGGTCAAGGCCATGAGAAACTGATTGCAGCTCGTAACACGATTTTAGGTTTGGCATCACAAGATAAACGTCTTGTAGGTGTGCGTCCAAATGGTCAGGAAGATACTCCTCAGTATCAAATTAATGTAGATCAGGCTCAAGCTGGTGCTATGGGCGTTAGTATTGCCGAAATCAACAATACAATGCGTATTGCATGGGGTGGCTCATACATTAACGATTTCGTTGACCGTGGTCGTGTGAAAAAAGTTTATGTTCAAGGTGATGCGGGCAGCCGTATGATGCCTGAAGACTTAAACAAATGGTATGTACGTAATAACAAAGGTGAGATGGTTCCATTCTCGGCATTTGCTACAGGCGAATGGACGTATGGTTCTCCACGTCTCGAACGTTATAACGGCGTGTCATCGGTTAACATTCAAGGTACACCTGCACCTGGCGTGAGCTCTGGTGATGCCATGAAAGCAATGGAAGAAATTATTGGTAAGTTACCATCTATGGGCTTACAAGGTTTCGACTATGAGTGGACAGGCTTATCACTTGAAGAACGTGAGTCTGGTGCTCAAGCGCCGTTCTTATACGCACTTTCATTGTTAATCGTATTCCTTTGCTTGGCTGCACTATATGAAAGCTGGTCAATTCCGTTCTCGGTTTTACTTGTGGTACCACTTGGTGTCATTGGTGCAATCGTATTGACCTACTTGGGCATGATTATTAAAGGAGATCCAAATCTCTCAAATAACATTTACTTCCAGGTAGCGATTATTGCGGTTATCGGTCTTTCTGCAAAAAATGCGATCTTGATTGTTGAATTCGCAAAAGAATTGCAGGAAAAAGGTGAAGATCTACTTGATGCAACCTTACATGCTGCAAAAATGCGTTTACGTCCAATTATCATGACCACCCTTGCCTTCGGTTTCGGTGTACTTCCACTTGCACTTTCAACAGGTGCCGGTGCAGGAAGTCAGCACTCTGTAGGCTTTGGTGTACTTGGTGGCGTACTCAGCGCGACGTTCTTAGGAATCTTCTTTATCCCTGTATTCTATGTGTGGATTCGTAGTATGTTTAAGTACAAACCAAAAACCATAAACACTCAGGAGCATAAATCGTGA", "partial": "0", "query_start": 83404, "query_end": 83616, "hit_start": 351, "hit_end": 639, "orf_dna_sequence": "ATGCGCGTGTTCTCCATATCGGATCTGCACGTCGAATATCCGGAAAACGCCAGATGGCTGGACGCGCTGCCGCGATACGAGCACACGCGCGACGTCCTTATTCTGGCGGGTGACGTCGCCACCGATCTCGCTCACATCGAACGCGCCTTCGGCGCGTTCTGCGCGCGCTTCGAGGCGGTCGTGTTCGTGCCGGGCAATCACGACTTGTGGCTCGGGCCGCGCGATACGGCCGCGACGTCGATCGACAAGTGGCATGCGTTGCGCGAGCTCGCGCAACGCATGGGCGTGCGCGTCGATCCATTCCATGCGCACGGCGTTTCCGTCGTGCCGCTTCTCGCGTGGTACGACTACAGCTTCGGCGAGCCTTCCGACGGCCTGCTGCAAGTGTGGGGCGACTATCGCCGCTGCGTGTGGCCGCAGGACATGACACCCGCGGATGTCGCGCGACATCTGGAAGCGCACAATCGCGAATACTTGGATATCCGAAACGATATCGTGATCTCATGCTCGCACTTTCTGCCGCGCGCCGACCTGATGCCGTCGATGGCGCCGGCTTGGGTCAAGGCGCTTGCGCCCGTCATGGGATCGTGGCGGCTCGACCGGCAGATCCGCGCGCTGGGATCGGCCATTCACGTGTTCGGCCACAGCCATCTGAATCAGGCGCGCACCATTGACGGCGTGCGATACGTGAACAGCGCGCTCGGCACGCCGTCCGAGGCGCACATTTCCCGCAGGCGGTTGTCGCTGATCTGGTCGGATTGA", "orf_prot_sequence": "MRVFSISDLHVEYPENARWLDALPRYEHTRDVLILAGDVATDLAHIERAFGAFCARFEAVVFVPGNHDLWLGPRDTAATSIDKWHALRELAQRMGVRVDPFHAHGVSVVPLLAWYDYSFGEPSDGLLQVWGDYRRCVWPQDMTPADVARHLEAHNREYLDIRNDIVISCSHFLPRADLMPSMAPAWVKALAPVMGSWRLDRQIRALGSAIHVFGHSHLNQARTIDGVRYVNSALGTPSEAHISRRRLSLIWSD", "perc_identity": 29.29}, "gnl|BL_ORD_ID|325|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 83146, "orf_end": 83907, "orf_from": "BGC0000186.1|Thailandamide_16 ", "model_name": "ErmU", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "356", "ARO_accession": "3001305", "ARO_name": "ErmU", "ARO_category": {"36699": {"category_aro_accession": "3000560", "category_aro_cvterm_id": "36699", "category_aro_name": "Erm 23S ribosomal RNA methyltransferase", "category_aro_description": "Erm proteins are part of the RNA methyltransferase family and methylate A2058 (E. coli nomenclature) of the 23S ribosomal RNA conferring degrees of resistance to Macrolides, Lincosamides and Streptogramin b. This is called the MLSb phenotype.", "category_aro_class_name": "AMR Gene Family"}, "35964": {"category_aro_accession": "0000046", "category_aro_cvterm_id": "35964", "category_aro_name": "lincomycin", "category_aro_description": "Lincomycin is a lincosamide antibiotic that comes from the actinomyces Streptomyces lincolnensis. It binds to the 23s portion of the 50S subunit of bacterial ribosomes and inhibit early elongation of peptide chain by inhibiting transpeptidase reaction.", "category_aro_class_name": "Antibiotic"}, "35919": {"category_aro_accession": "0000000", "category_aro_cvterm_id": "35919", "category_aro_name": "macrolide antibiotic", "category_aro_description": "Macrolides are a group of drugs (typically antibiotics) that have a large macrocyclic lactone ring of 12-16 carbons to which one or more deoxy sugars, usually cladinose and desosamine, may be attached. Macrolides bind to the 50S-subunit of bacterial ribosomes, inhibiting the synthesis of vital proteins.", "category_aro_class_name": "Drug Class"}, "35936": {"category_aro_accession": "0000017", "category_aro_cvterm_id": "35936", "category_aro_name": "lincosamide antibiotic", "category_aro_description": "Lincosamides (e.g. lincomycin, clindamycin) are a class of drugs which bind to the 23s portion of the 50S subunit of bacterial ribosomes. This interaction inhibits early elongation of peptide chains by inhibiting the transpeptidase reaction, acting similarly to macrolides.", "category_aro_class_name": "Drug Class"}, "35945": {"category_aro_accession": "0000026", "category_aro_cvterm_id": "35945", "category_aro_name": "streptogramin antibiotic", "category_aro_description": "Streptogramin antibiotics are natural products produced by various members of the Streptomyces genus. These antibiotics bind to the P site of the 50S subunit of bacterial ribosomes to inhibit protein synthesis. The family consists of two subgroups, type A and type B, which are simultaneously produced by the same bacterial species in a ratio of roughly 70:30.", "category_aro_class_name": "Drug Class"}, "35997": {"category_aro_accession": "0001001", "category_aro_cvterm_id": "35997", "category_aro_name": "antibiotic target alteration", "category_aro_description": "Mutational alteration or enzymatic modification of antibiotic target which results in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 8.82596, "max_identities": 14, "bit_score": 24.6386, "cvterm_id": "36862", "query": "HALRELAQRMGVRVDP-----FHAHGVS", "match": "H LRE+ QR+G   D      F AHGVS", "sequence_from_db": "HGLREILQRIGRVQDSDLSAWFRAHGVS", "sequence_from_broadstreet": "MPSRYGSRQDLGQNFLVDPDIIKLIRRAPNERKVPSLIWRRRGHVTLPLSRLGRPVTAVELDPRRVKRLSARAPENVKVVGEDILRFRLPTVPHTVVGNIPFHVTTATMRRILVAPAWVSAVLVVQWEVARRRAGIGGCSLVTAESWPWFDFSVLKRVPRFAFRPAPSVDGGILVIERRPEPLVRERREYQAFVRQVFTGRGHGLREILQRIGRVQDSDLSAWFRAHGVSPQALPKDLTAEQWASLWGMARGGRSVPRTRRPRGLPPRTSRGPRRNSG", "dna_sequence_from_broadstreet": "GTGCCCAGCCGGTACGGCAGCCGGCAGGACCTCGGTCAGAACTTCCTCGTCGACCCCGACATCATCAAGCTGATCCGCCGAGCGCCGAACGAGCGGAAGGTCCCATCGTTGATCTGGCGCCGGAGAGGGCACGTGACGCTGCCCTTGAGTCGCTTGGGCCGCCCGGTCACCGCGGTTGAGCTCGACCCCCGCCGGGTCAAACGGCTCTCGGCGCGTGCCCCGGAAAACGTCAAGGTCGTCGGCGAGGACATCCTGCGCTTCCGGCTCCCGACCGTTCCGCACACCGTCGTGGGGAACATCCCCTTCCATGTCACGACGGCCACGATGCGCCGGATCCTCGTGGCTCCCGCATGGGTGTCGGCCGTCCTCGTGGTGCAGTGGGAAGTGGCGCGCCGCCGGGCCGGCATCGGCGGCTGCTCGCTGGTCACGGCGGAGTCCTGGCCGTGGTTCGACTTCTCGGTGCTCAAGCGGGTGCCGAGGTTCGCCTTCCGGCCCGCGCCCTCCGTGGACGGCGGGATCCTCGTCATCGAGCGGCGGCCCGAGCCACTGGTGCGGGAGCGCAGGGAGTACCAGGCATTCGTCAGACAGGTCTTCACCGGGCGCGGTCACGGGCTGCGGGAGATCCTCCAACGCATCGGGCGGGTCCAGGACAGCGACCTGTCCGCGTGGTTCAGGGCACATGGAGTCTCGCCGCAGGCGCTGCCGAAGGACCTCACCGCCGAGCAGTGGGCGTCGCTCTGGGGCATGGCGCGTGGCGGCCGGTCCGTGCCGCGGACGCGGCGACCCCGGGGCCTGCCGCCCCGCACGTCCCGCGGGCCGCGGCGCAACAGCGGCTGA", "partial": "0", "query_start": 83398, "query_end": 83466, "hit_start": 606, "hit_end": 690, "orf_dna_sequence": "ATGCGCGTGTTCTCCATATCGGATCTGCACGTCGAATATCCGGAAAACGCCAGATGGCTGGACGCGCTGCCGCGATACGAGCACACGCGCGACGTCCTTATTCTGGCGGGTGACGTCGCCACCGATCTCGCTCACATCGAACGCGCCTTCGGCGCGTTCTGCGCGCGCTTCGAGGCGGTCGTGTTCGTGCCGGGCAATCACGACTTGTGGCTCGGGCCGCGCGATACGGCCGCGACGTCGATCGACAAGTGGCATGCGTTGCGCGAGCTCGCGCAACGCATGGGCGTGCGCGTCGATCCATTCCATGCGCACGGCGTTTCCGTCGTGCCGCTTCTCGCGTGGTACGACTACAGCTTCGGCGAGCCTTCCGACGGCCTGCTGCAAGTGTGGGGCGACTATCGCCGCTGCGTGTGGCCGCAGGACATGACACCCGCGGATGTCGCGCGACATCTGGAAGCGCACAATCGCGAATACTTGGATATCCGAAACGATATCGTGATCTCATGCTCGCACTTTCTGCCGCGCGCCGACCTGATGCCGTCGATGGCGCCGGCTTGGGTCAAGGCGCTTGCGCCCGTCATGGGATCGTGGCGGCTCGACCGGCAGATCCGCGCGCTGGGATCGGCCATTCACGTGTTCGGCCACAGCCATCTGAATCAGGCGCGCACCATTGACGGCGTGCGATACGTGAACAGCGCGCTCGGCACGCCGTCCGAGGCGCACATTTCCCGCAGGCGGTTGTCGCTGATCTGGTCGGATTGA", "orf_prot_sequence": "MRVFSISDLHVEYPENARWLDALPRYEHTRDVLILAGDVATDLAHIERAFGAFCARFEAVVFVPGNHDLWLGPRDTAATSIDKWHALRELAQRMGVRVDPFHAHGVSVVPLLAWYDYSFGEPSDGLLQVWGDYRRCVWPQDMTPADVARHLEAHNREYLDIRNDIVISCSHFLPRADLMPSMAPAWVKALAPVMGSWRLDRQIRALGSAIHVFGHSHLNQARTIDGVRYVNSALGTPSEAHISRRRLSLIWSD", "perc_identity": 50.0}}, "BGC0000186.1|Thailandamide_17 # 83961 # 84929 # -1 # ID=1_17;partial=00;start_type=ATG;rbs_motif=GGAG;rbs_spacer=6bp;gc_cont=0.621": {"gnl|BL_ORD_ID|2781|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 83961, "orf_end": 84929, "orf_from": "BGC0000186.1|Thailandamide_17 ", "model_name": "LpsB", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "700", "model_id": "3793", "ARO_accession": "3005051", "ARO_name": "LpsB", "ARO_category": {"43251": {"category_aro_accession": "3005050", "category_aro_cvterm_id": "43251", "category_aro_name": "Intrinsic peptide antibiotic resistant Lps", "category_aro_description": "LpsB is involved in lipopolysaccharide synthesis. It provides intrinsic resistance to colistin and other peptide antibiotics such as polymyxins.", "category_aro_class_name": "AMR Gene Family"}, "36966": {"category_aro_accession": "3000622", "category_aro_cvterm_id": "36966", "category_aro_name": "colistin A", "category_aro_description": "Colistin A, or polymyxin E1, has a 6-octanoic acid lipid tail. Polymyxins disrupt the cell membrane of Gram-negative bacteria.", "category_aro_class_name": "Antibiotic"}, "36968": {"category_aro_accession": "3000624", "category_aro_cvterm_id": "36968", "category_aro_name": "colistin B", "category_aro_description": "Colistin B, or polymyxin E2, has a 6-heptanoic acid lipid tail. Polymyxins disrupt the cell membrane of Gram-negative bacteria.", "category_aro_class_name": "Antibiotic"}, "37037": {"category_aro_accession": "3000693", "category_aro_cvterm_id": "37037", "category_aro_name": "defensin", "category_aro_description": "Defensins are natural cationic peptides that have antibiotic properties. It is part of the innate immune system of plants and animals.", "category_aro_class_name": "Antibiotic"}, "36192": {"category_aro_accession": "3000053", "category_aro_cvterm_id": "36192", "category_aro_name": "peptide antibiotic", "category_aro_description": "Peptide antibiotics have a wide range of antibacterial mechanisms, depending on the amino acids that make up the antibiotic, although most act to disrupt the cell membrane in some manner. Subclasses of peptide antibiotics can include additional sidechains of other types, such as lipids in the case of the lipopeptide antibiotics.", "category_aro_class_name": "Drug Class"}, "36383": {"category_aro_accession": "3000244", "category_aro_cvterm_id": "36383", "category_aro_name": "reduced permeability to antibiotic", "category_aro_description": "Reduction in permeability to antibiotic, generally through reduced production of porins, can provide resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 7.02838, "max_identities": 10, "bit_score": 25.409, "cvterm_id": "35507", "query": "NQSEAIGRNLMEMASLQTPII", "match": "NQ+E  GR  +E  S+ TP+I", "sequence_from_db": "NQAETFGRTALEALSVGTPVI", "sequence_from_broadstreet": "MKVMQLLPELNSGGVERGTLEIARALVAQGHQSLVVSNGGRLVSQLEAEGSTHLTLPIHKKSLSSLWQIRPLRQLIEEHQPDIVHVRSRVPAWLTHFALRKIPANKRPHLISTVHGFYSVNRYSAIMTQAEKVIAVSDSVVKYITGHYKNCPPQDIIRIYRGIDPAAFPHNYQPSAQWFNQVFNDFPELENKFLLCLPGRITRLKGHESLIELMQQLHSQYPQLHAVVVGGADVKKQAYLSELQNTIQSKGLADKITFVGHRSDIREWLAFSDIVLSLSNQAETFGRTALEALSVGTPVIGWNRGGVAEILSHVYPQGLVEAENEKALLEIVKHHIEQPQTVAPVTMFSLKDMCDQTLELYQSVLK", "dna_sequence_from_broadstreet": "ATGAAAGTGATGCAACTTCTCCCAGAACTCAATAGCGGTGGCGTAGAACGCGGCACACTGGAAATTGCACGTGCACTGGTTGCACAAGGTCATCAGTCTCTAGTTGTGTCTAATGGCGGGCGTTTGGTCTCACAACTTGAAGCTGAAGGTTCCACACACTTAACACTGCCGATTCATAAAAAATCATTGTCGAGCTTGTGGCAAATCCGTCCATTACGTCAGCTTATTGAAGAACACCAACCAGACATTGTACATGTGCGCTCTCGCGTACCTGCATGGCTAACCCACTTCGCTTTAAGAAAAATACCAGCGAATAAACGCCCTCACCTCATTAGCACGGTACATGGTTTCTATTCAGTTAATCGTTATAGTGCGATCATGACTCAGGCAGAAAAAGTGATCGCTGTTTCTGACAGCGTAGTTAAATACATCACAGGCCATTATAAAAACTGTCCACCACAAGATATTATCCGGATTTATCGAGGAATTGACCCTGCCGCTTTTCCGCATAACTATCAACCTTCAGCACAGTGGTTTAACCAAGTCTTTAACGACTTTCCCGAACTTGAAAATAAATTTTTACTTTGCCTACCTGGCCGTATTACTCGTTTAAAAGGACATGAAAGTTTAATTGAACTGATGCAGCAACTTCATTCGCAATATCCTCAACTGCATGCTGTTGTTGTAGGTGGGGCTGATGTAAAAAAACAAGCCTATTTAAGTGAGTTGCAAAACACCATTCAAAGCAAAGGACTTGCAGATAAAATTACATTTGTAGGACATCGCTCAGATATACGCGAATGGCTCGCTTTTAGCGATATAGTGCTCTCTCTATCCAATCAAGCAGAAACATTCGGTAGAACAGCATTAGAAGCGCTCTCTGTCGGTACGCCGGTCATTGGCTGGAACCGTGGAGGTGTTGCCGAGATTTTATCTCATGTGTACCCGCAGGGTCTTGTTGAAGCAGAAAATGAAAAAGCTTTATTAGAAATAGTAAAGCATCATATTGAACAACCTCAAACAGTCGCTCCTGTGACAATGTTTAGTTTAAAAGATATGTGTGACCAAACCCTTGAGCTATATCAAAGTGTATTGAAATAA", "partial": "0", "query_start": 84480, "query_end": 84542, "hit_start": 837, "hit_end": 900, "orf_dna_sequence": "ATGACGAACGTAACGTATCTTGACTTCGAAAAGGCGATCGGCGAGCTGGATGCGAAGATCGACGCGCTGCGTTGTTCCGAGGATGAATCGGCGATCGATCTTTCCGAGGAAATCAACCGGTTGTCCGCGCGCAGCGAGAAGCTGACGAAGGAACTGTACGAGCGGCTCACGCCGTGGCAAATCGTCCAGGTGGCGCGGCATCCGGCGCGGCCTTATACGCTTGATTACGTCAATTTCATCTTCACGGATTTTCACGAGCTGCATGGCGATCGCAGCTATGCGGACGATCAGTCGATCGTCGGCGGGCTCGCGCGTTTCAACGATCGGCCGTGCGTCGTGGTGGGCCACCAGAAGGGGCGCAACACGAAGGAGCGCGCGATGCGCAATTTCGGCTATCCGCGGCCCGAGGGATACCGAAAGGCGCTGCGGCTTTTCAAGCTCGCCGAGAAATTCAGGCTGCCGATCTTCACGTTCATCGACACGCCGGGCGCGTGGCCCGGGATCGACGCCGAAGAGCACAACCAGTCCGAGGCGATCGGCCGCAATCTGATGGAAATGGCGAGCCTTCAGACGCCGATCATCACGACGGTGATCGGCGAGGGCGGCTCGGGCGGCGCGCTCGCGATCGGCGTCGGCGACGTGTCGATCATGCTCCAGTTCTCAACCTATTCGGTCATTTCGCCCGAAAGCTGCTCGTCGATTCTCTGGAAGAACCCGAACTACGCGGAGCAGGCGGCCAACGCGCTCGGCCTGACCGCGCACCGCCTCAAGGCGCTCGGGTTGATCGACAAGATCGCGAACGAGCCGGTCGGCGGCGCACATCGCGATCCGCAGCAAATGGCGCTGATGCTCAAGCGCGTGCTGCAGGAAAGCCTGCGCAACGTCGAATCGCTCGACGCGAAGCAGCTTCTCGTTCGCCGTCACGAGCGGCTCATGCACTACGGCAAGTTCCGCGAAACGGCGGTATGA", "orf_prot_sequence": "MTNVTYLDFEKAIGELDAKIDALRCSEDESAIDLSEEINRLSARSEKLTKELYERLTPWQIVQVARHPARPYTLDYVNFIFTDFHELHGDRSYADDQSIVGGLARFNDRPCVVVGHQKGRNTKERAMRNFGYPRPEGYRKALRLFKLAEKFRLPIFTFIDTPGAWPGIDAEEHNQSEAIGRNLMEMASLQTPIITTVIGEGGSGGALAIGVGDVSIMLQFSTYSVISPESCSSILWKNPNYAEQAANALGLTAHRLKALGLIDKIANEPVGGAHRDPQQMALMLKRVLQESLRNVESLDAKQLLVRRHERLMHYGKFRETAV", "perc_identity": 47.62}}, "BGC0000186.1|Thailandamide_18 # 85258 # 85809 # -1 # ID=1_18;partial=00;start_type=ATG;rbs_motif=GGAG;rbs_spacer=5bp;gc_cont=0.663": {"gnl|BL_ORD_ID|900|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 85258, "orf_end": 85809, "orf_from": "BGC0000186.1|Thailandamide_18 ", "model_name": "lmrC", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "1050", "model_id": "974", "ARO_accession": "3002881", "ARO_name": "lmrC", "ARO_category": {"45630": {"category_aro_accession": "3007068", "category_aro_cvterm_id": "45630", "category_aro_name": "Miscellaneous ABC-F subfamily ATP-binding cassette ribosomal protection proteins", "category_aro_description": "ABC-F subfamily ATP-binding cassette ribosomal protection proteins of unknown, unclear or miscellaneous classification which nevertheless confer resistance to antibiotics through ribosomal protection and not through antibiotic efflux. These proteins should be further reviewed to elucidate associated genes, their function, origin and classification.", "category_aro_class_name": "AMR Gene Family"}, "35964": {"category_aro_accession": "0000046", "category_aro_cvterm_id": "35964", "category_aro_name": "lincomycin", "category_aro_description": "Lincomycin is a lincosamide antibiotic that comes from the actinomyces Streptomyces lincolnensis. It binds to the 23s portion of the 50S subunit of bacterial ribosomes and inhibit early elongation of peptide chain by inhibiting transpeptidase reaction.", "category_aro_class_name": "Antibiotic"}, "35983": {"category_aro_accession": "0000066", "category_aro_cvterm_id": "35983", "category_aro_name": "clindamycin", "category_aro_description": "Clindamycin is a lincosamide antibiotic that blocks A-site aminoacyl-tRNA binding. It is usually used to treat infections with anaerobic bacteria but can also be used to treat some protozoal diseases, such as malaria.", "category_aro_class_name": "Antibiotic"}, "37630": {"category_aro_accession": "3001231", "category_aro_cvterm_id": "37630", "category_aro_name": "celesticetin", "category_aro_description": "Produced by Streptomyces caelestis, which also produces the macrolide niddamycin.", "category_aro_class_name": "Antibiotic"}, "35936": {"category_aro_accession": "0000017", "category_aro_cvterm_id": "35936", "category_aro_name": "lincosamide antibiotic", "category_aro_description": "Lincosamides (e.g. lincomycin, clindamycin) are a class of drugs which bind to the 23s portion of the 50S subunit of bacterial ribosomes. This interaction inhibits early elongation of peptide chains by inhibiting the transpeptidase reaction, acting similarly to macrolides.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 5.41345, "max_identities": 11, "bit_score": 25.0238, "cvterm_id": "36862", "query": "EGPAFDGKLIAAQGATCKVMGINGSG", "match": "E P FDG   A     C ++G NG+G", "sequence_from_db": "ETPVFDGLSFALGAGRCGLVGPNGAG", "sequence_from_broadstreet": "MADASIVCTNLSFSWPDETPVFDGLSFALGAGRCGLVGPNGAGKSTLLRLAVGELTPTAGSITAQGHVGYLPQSLPLIDGTVDEALEIASIRAALHAIESGDVDEAHFTTVGDHWDIEERTTIVLDRLGLGDVSLDRPLRSLSGGQVLAIGLAAQLLKRPDVLILDEPTNNLDLAARQRLYQVVEEWKGALLVVSHDRELLDRVDTIAELQASELRLYGGNFTAYTEAVELEQENVQRAVRGAEQELRRHKREAQAAQERAQRRASNAKRNKASSGVPRIHAGALQRQAQESAGRAASVHQDRVSQAKAKLDEASQGMREEARLAITLPQTSVPAGRTVLTCHEANVRYGERTLFTGSGVDLGIRGPERIALLGPNGSGKSTLLKLIAGELEPSSGTVTAPTDRVSYLSQRLDLLDLDASVLDNLRRFAPHLQDGEVRYRLAQFLFRGDRVHRTAGWLSGGERLRATLACVLSTDPAPQLLLLDEPTNNLDLNSAAQLENALNAFQGAFVVVSHDQAFLRAIGVSRWLRLADGTLEEIAEADDAWPHRDK", "dna_sequence_from_broadstreet": "ATGGCTGACGCGAGTATTGTCTGCACCAATCTCTCCTTCTCCTGGCCCGACGAGACGCCGGTCTTCGACGGGTTGTCCTTTGCCCTCGGCGCCGGCCGTTGCGGCCTCGTGGGCCCCAATGGCGCGGGAAAGTCCACACTGTTGCGGCTCGCCGTAGGGGAACTCACCCCTACCGCAGGCTCGATCACCGCGCAGGGACATGTCGGGTACCTGCCGCAGTCCCTGCCGCTGATCGACGGCACCGTCGACGAGGCCCTGGAGATCGCCTCCATCCGGGCGGCTCTGCATGCCATCGAGTCAGGTGACGTGGACGAGGCGCACTTCACCACTGTGGGCGATCACTGGGACATCGAGGAACGCACCACGATCGTCCTGGACCGTCTGGGTCTCGGCGACGTGTCCCTTGACCGCCCGCTTCGCTCCCTCAGCGGCGGCCAGGTCCTCGCCATCGGCCTGGCCGCGCAGCTCCTGAAGCGACCCGACGTGCTGATCCTCGACGAACCCACCAACAACCTTGACCTGGCCGCCCGGCAGCGGCTCTACCAGGTCGTCGAAGAGTGGAAGGGGGCCCTCCTCGTCGTCAGCCACGACCGGGAGCTCCTGGACCGCGTAGACACCATCGCCGAGCTGCAGGCATCCGAACTCCGCCTCTACGGTGGCAACTTCACCGCCTACACGGAAGCCGTCGAGCTGGAACAGGAGAACGTGCAGCGCGCGGTGCGCGGGGCGGAGCAGGAGTTGCGCCGCCACAAGCGCGAGGCGCAGGCGGCCCAGGAGCGGGCCCAGCGCCGGGCCAGCAACGCCAAGCGCAACAAGGCTTCGTCGGGGGTGCCCCGTATCCACGCGGGCGCCCTTCAGCGACAGGCTCAGGAATCGGCGGGCCGCGCCGCCTCGGTGCACCAGGACCGGGTGTCCCAGGCCAAGGCCAAGCTGGACGAGGCCAGTCAGGGGATGCGTGAGGAAGCGCGCCTGGCGATCACCCTTCCGCAGACCTCGGTCCCGGCCGGACGCACCGTGTTGACGTGCCATGAGGCCAATGTCCGGTACGGGGAACGGACGTTGTTCACCGGCTCGGGCGTCGACCTCGGGATCCGCGGGCCGGAGCGGATCGCGCTGCTCGGGCCCAACGGCTCGGGCAAGTCAACGCTGTTGAAGCTGATCGCCGGCGAGCTCGAACCCTCCTCGGGGACGGTCACGGCGCCGACGGACCGGGTGTCCTATCTCTCGCAGCGCCTCGATCTGCTCGACTTGGACGCCAGCGTCCTGGACAACCTGCGCCGTTTCGCCCCGCATCTGCAGGACGGCGAAGTCCGCTACCGCCTGGCGCAGTTCCTCTTCCGCGGCGACCGAGTTCATCGCACCGCCGGATGGCTCTCCGGCGGTGAGCGGCTGCGCGCGACCCTGGCGTGTGTCCTGTCCACGGACCCTGCCCCTCAGCTGCTCCTGCTGGACGAGCCGACGAACAACCTCGACCTCAACAGTGCCGCCCAGCTGGAGAACGCGCTCAACGCCTTCCAGGGCGCCTTCGTAGTCGTCAGCCACGACCAGGCGTTCCTGCGCGCCATCGGTGTCTCGCGCTGGCTGCGCCTGGCGGACGGAACCCTGGAGGAGATCGCGGAGGCGGACGACGCGTGGCCTCATCGGGATAAGTGA", "partial": "0", "query_start": 85702, "query_end": 85779, "hit_start": 51, "hit_end": 129, "orf_dna_sequence": "ATGGCCGTGGAATCCGTCATCGGCCGGCAAGGGCGGTTCTCGCTGAAGATCGTCGGCGGATACCGGCCCAACGTGCGCAAGCTGTCGTCGTGGATGGAGGACTGTCTCGCCGATTATGCGTGCGGCCGCTACCGGATCGCGTCGAGCCTCGAAACGTCGGGGCGCGGCGGCGTCGCGCATATCGATGTCGCGCAGGCCGGTTTCGACGTCGACGTCTGCGGGCGCAAGGCCGATCTGCTCGTCGCGCTCGACGTGCCGGCCATACTCGACCACGACGCGCTGCTTGACGGCAACACGGTTTGTCTCGTGGCCGATACGCGCGACGACGAAGACGGGATCGAGCACGCGCTGTCGGACGAATTGCGCGAGCGGGTGCCGAAGCTGCTGCGCAAGCGGCGCGCGTCCGGTTACTGGCTGCCGTTTTGCGAGGAATTTCTCGAGCTCGAAGGCCCGGCGTTCGACGGCAAGCTGATCGCGGCGCAAGGCGCGACGTGCAAGGTGATGGGCATCAACGGCAGCGGCGGCGTGGCGGGTTTCGACGAGATCACCTGA", "orf_prot_sequence": "MAVESVIGRQGRFSLKIVGGYRPNVRKLSSWMEDCLADYACGRYRIASSLETSGRGGVAHIDVAQAGFDVDVCGRKADLLVALDVPAILDHDALLDGNTVCLVADTRDDEDGIEHALSDELRERVPKLLRKRRASGYWLPFCEEFLELEGPAFDGKLIAAQGATCKVMGINGSGGVAGFDEIT", "perc_identity": 42.31}}, "BGC0000186.1|Thailandamide_19 # 85844 # 86362 # -1 # ID=1_19;partial=00;start_type=GTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.651": {"gnl|BL_ORD_ID|207|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 85844, "orf_end": 86362, "orf_from": "BGC0000186.1|Thailandamide_19 ", "model_name": "sdiA", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "470", "model_id": "228", "ARO_accession": "3000826", "ARO_name": "sdiA", "ARO_category": {"36005": {"category_aro_accession": "0010004", "category_aro_cvterm_id": "36005", "category_aro_name": "resistance-nodulation-cell division (RND) antibiotic efflux pump", "category_aro_description": "Directed pumping of antibiotic out of a cell to confer resistance. Resistance-nodulation-division (RND) proteins are found in both prokaryotic and eukaryotic cells and have diverse substrate specificities and physiological roles. However, there are relatively few RND transporters and they are secondary transporters, energized not by ATP binding/hydrolysis but by proton movement down the transmembrane electrochemical gradient.", "category_aro_class_name": "AMR Gene Family"}, "35949": {"category_aro_accession": "0000030", "category_aro_cvterm_id": "35949", "category_aro_name": "tigecycline", "category_aro_description": "Tigecycline is an glycylcycline antibiotic. It works by inhibiting action of the prokaryotic 30S ribosome.", "category_aro_class_name": "Antibiotic"}, "35968": {"category_aro_accession": "0000051", "category_aro_cvterm_id": "35968", "category_aro_name": "tetracycline", "category_aro_description": "Tetracycline is a broad-spectrum polyketide antibiotic produced by many Streptomyces. It works by inhibiting action of the prokaryotic 30S ribosome.", "category_aro_class_name": "Antibiotic"}, "36308": {"category_aro_accession": "3000169", "category_aro_cvterm_id": "36308", "category_aro_name": "rifampin", "category_aro_description": "Rifampin is a semi-synthetic rifamycin, and inhibits RNA synthesis by binding to RNA polymerase. Rifampin is the mainstay agent for the treatment of tuberculosis, leprosy and complicated Gram-positive infections.", "category_aro_class_name": "Antibiotic"}, "36524": {"category_aro_accession": "3000385", "category_aro_cvterm_id": "36524", "category_aro_name": "chloramphenicol", "category_aro_description": "Chloramphenicol is a bacteriostatic antimicrobial originally derived from the bacterium Streptomyces venezuelae. It was the first antibiotic to be manufactured synthetically on a large scale. It functions by inhibiting peptidyl transferase activity of the bacterial ribosome, binding to A2451 and A2452 residues in the 23S rRNA of the 50S ribosomal subunit and preventing peptide bond formation.", "category_aro_class_name": "Antibiotic"}, "36981": {"category_aro_accession": "3000637", "category_aro_cvterm_id": "36981", "category_aro_name": "ampicillin", "category_aro_description": "Ampicillin is a penicillin derivative that is highly acid stable, with its activity similar to benzylpenicillin.", "category_aro_class_name": "Antibiotic"}, "37084": {"category_aro_accession": "3000704", "category_aro_cvterm_id": "37084", "category_aro_name": "cefalotin", "category_aro_description": "Cefalotin is a semisynthetic cephalosporin antibiotic activate against staphylococci. It is resistant to staphylococci beta-lactamases but hydrolyzed by enterobacterial beta-lactamases.", "category_aro_class_name": "Antibiotic"}, "37250": {"category_aro_accession": "3000870", "category_aro_cvterm_id": "37250", "category_aro_name": "triclosan", "category_aro_description": "Triclosan is a common antibacterial agent added to many consumer products as a biocide.  It is an inhibitor of fatty acid biosynthesis by blocking enoyl-carrier protein reductase (FabI).", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35951": {"category_aro_accession": "0000032", "category_aro_cvterm_id": "35951", "category_aro_name": "cephalosporin", "category_aro_description": "Cephalosporins are a class of beta-lactam antibiotics, containing the beta-lactam ring fused with a dihydrothiazolidine ring. Together with cephamycins they belong to a sub-group called cephems. Cephalosporin are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "35960": {"category_aro_accession": "0000042", "category_aro_cvterm_id": "35960", "category_aro_name": "glycylcycline", "category_aro_description": "Glycylcyclines are a new class of antibiotics derived from tetracycline. These tetracycline analogues are specifically designed to overcome two common mechanisms of tetracycline resistance. Presently, there is only one glycylcycline antibiotic for clinical use: tigecycline. It works by inhibiting action of the prokaryotic 30S ribosome, preventing the binding of aminoacyl-tRNA.", "category_aro_class_name": "Drug Class"}, "36017": {"category_aro_accession": "3000008", "category_aro_cvterm_id": "36017", "category_aro_name": "penam", "category_aro_description": "Penams are a group of antibiotics derived from Penicillium fungi that share a skeleton beta-lactam moiety fused with a thiazolidine ring. This is the most defining feature of penicillins. Penicillin antibiotics are historically significant because they are the first drugs that were effective against many previously serious diseases such as syphilis and Staphylococcus infections. Penicillins are still widely used today, though many types of bacteria are now resistant. All penicillins are beta-lactam antibiotics in the penam sub-group, and are used in the treatment of bacterial infections caused by susceptible, usually Gram-positive, organisms.", "category_aro_class_name": "Drug Class"}, "36189": {"category_aro_accession": "3000050", "category_aro_cvterm_id": "36189", "category_aro_name": "tetracycline antibiotic", "category_aro_description": "These antibiotics are derived from tetracycline, a polyketide antibiotic that inhibits the 30S subunit of bacterial ribosomes.", "category_aro_class_name": "Drug Class"}, "36296": {"category_aro_accession": "3000157", "category_aro_cvterm_id": "36296", "category_aro_name": "rifamycin antibiotic", "category_aro_description": "Rifamycin antibiotics are a group of broad-spectrum ansamycin antibiotics that inhibit bacterial RNA polymerase by binding to a highly conserved region, blocking the oligonucleotide exit tunnel, and preventing the extension of nascent mRNAs.", "category_aro_class_name": "Drug Class"}, "36526": {"category_aro_accession": "3000387", "category_aro_cvterm_id": "36526", "category_aro_name": "phenicol antibiotic", "category_aro_description": "Phenicols are broad spectrum bacteriostatic antibiotics acting on bacterial protein synthesis. More specifically, the phenicols block peptide elongation by binding to the peptidyltansferase centre of the 70S ribosome.", "category_aro_class_name": "Drug Class"}, "43746": {"category_aro_accession": "3005386", "category_aro_cvterm_id": "43746", "category_aro_name": "disinfecting agents and antiseptics", "category_aro_description": "Disinfectants that can also interact with antimicrobial resistance mechanisms, e.g. molecule efflux, and thus are the targets of disinfectant resistance.", "category_aro_class_name": "Drug Class"}, "36298": {"category_aro_accession": "3000159", "category_aro_cvterm_id": "36298", "category_aro_name": "efflux pump complex or subunit conferring antibiotic resistance", "category_aro_description": "Efflux proteins that pump antibiotic out of a cell to confer resistance.", "category_aro_class_name": "Efflux Component"}, "36590": {"category_aro_accession": "3000451", "category_aro_cvterm_id": "36590", "category_aro_name": "protein(s) and two-component regulatory system modulating antibiotic efflux", "category_aro_description": "Protein(s) and two component regulatory systems that directly or indirectly change rates of antibiotic efflux.", "category_aro_class_name": "Efflux Regulator"}, "36001": {"category_aro_accession": "0010000", "category_aro_cvterm_id": "36001", "category_aro_name": "antibiotic efflux", "category_aro_description": "Antibiotic resistance via the transport of antibiotics out of the cell.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 4.48232e-19, "max_identities": 51, "bit_score": 78.5666, "cvterm_id": "35734", "query": "ADGLWAETSDQGVRYGWALSVRDRWGAVGTLKFARGTREIVQEELDDIEPEMIWLAHLAHDTIGSLMR--DETIPGEIARVSLVERQILLWTAEGKTVSEISSILQMSVRNINFHIQNVVGKLGATNKTHAAVKATLVGLI", "match": "A  +W      G+R G    V     A+G L F+R +        D++E   + L  LA +++ +L R  D+ +     R S  E++IL WTAEGKT SEI+ IL +S   +NFH +N+  K  A NKT  A  A   GLI", "sequence_from_db": "AKAMWDAAQRFGLRRGVTQCVMLPNRALGFLSFSRSSLRCSSFTYDEVE---LRLQLLARESLSALTRFEDDMVMAPEMRFSKREKEILKWTAEGKTSSEIAIILSISENTVNFHQKNMQKKFNAPNKTQIACYAAATGLI", "sequence_from_broadstreet": "MQENDFFTWRRAMLLRFQEMAAAEDVYTELQYQTQRLEFDYYALCVRHPVPFTRPKISLRTTYPPAWVTHYQSENYFAIDPVLKPENFRQGHLHWDDVLFHEAKAMWDAAQRFGLRRGVTQCVMLPNRALGFLSFSRSSLRCSSFTYDEVELRLQLLARESLSALTRFEDDMVMAPEMRFSKREKEILKWTAEGKTSSEIAIILSISENTVNFHQKNMQKKFNAPNKTQIACYAAATGLI", "dna_sequence_from_broadstreet": "ATGCAGGAAAATGATTTCTTCACCTGGCGACGCGCAATGTTGTTACGCTTTCAGGAGATGGCGGCAGCAGAGGATGTTTATACTGAATTGCAATATCAGACACAGCGGCTGGAATTTGATTATTATGCCCTGTGTGTTCGTCATCCCGTCCCCTTTACCCGGCCTAAAATATCGCTTCGTACCACTTATCCTCCGGCGTGGGTAACGCATTACCAGTCCGAAAACTATTTCGCGATCGATCCGGTATTAAAGCCGGAAAATTTCAGGCAGGGTCATTTACATTGGGATGACGTGCTATTTCATGAAGCGAAGGCGATGTGGGATGCCGCCCAGCGTTTCGGATTACGCAGAGGCGTAACCCAGTGTGTGATGTTGCCGAACCGGGCGCTGGGCTTTTTATCTTTCTCCCGTAGCAGTTTACGCTGCTCCTCGTTTACCTACGACGAAGTGGAGCTGAGGTTGCAACTGCTGGCGCGGGAGAGTCTTTCGGCGCTGACAAGATTTGAAGACGACATGGTGATGGCGCCTGAAATGCGTTTCAGTAAACGTGAGAAAGAGATTCTGAAGTGGACGGCGGAAGGGAAGACCTCATCGGAGATCGCCATTATTCTGTCGATTTCTGAAAATACCGTTAACTTCCATCAGAAAAATATGCAGAAGAAATTCAATGCGCCAAATAAAACACAGATTGCCTGCTACGCTGCGGCGACAGGTCTGATATGA", "partial": "0", "query_start": 85937, "query_end": 86353, "hit_start": 306, "hit_end": 720, "orf_dna_sequence": "GTGCTCGACGCGGACCGCAGCGGGCGCGGCGCCGACACGGACGCGCAGGCGTGCGGCGTGACGGCCGATGCGACGCAGGTATTCGAATCGATGGCGGACGGCCTTTGGGCCGAGACGTCCGATCAGGGCGTCCGGTATGGGTGGGCGCTGTCGGTGCGGGACCGCTGGGGCGCCGTCGGCACGCTGAAATTCGCTCGCGGGACGCGGGAAATCGTGCAGGAAGAACTGGACGACATCGAGCCTGAAATGATCTGGCTCGCGCATCTCGCGCACGACACGATCGGCAGCCTGATGCGCGACGAGACGATTCCCGGGGAGATCGCCCGCGTGTCGCTCGTCGAGCGACAGATATTGTTATGGACCGCTGAAGGAAAGACGGTGTCGGAGATTTCGAGCATCCTCCAGATGTCGGTGCGCAACATCAACTTCCACATTCAGAACGTCGTCGGCAAGCTCGGGGCGACGAACAAGACGCACGCGGCGGTCAAGGCGACCCTGGTCGGCCTGATTCCGGTGTAA", "orf_prot_sequence": "MLDADRSGRGADTDAQACGVTADATQVFESMADGLWAETSDQGVRYGWALSVRDRWGAVGTLKFARGTREIVQEELDDIEPEMIWLAHLAHDTIGSLMRDETIPGEIARVSLVERQILLWTAEGKTVSEISSILQMSVRNINFHIQNVVGKLGATNKTHAAVKATLVGLIPV", "perc_identity": 36.17}}}